A Case Study on Pharmacy to Explore the Perceptions of Pharmacy Leaders and Policy Makers on the Benefits, Risks, and Alternatives of the Doctorate as the Entry Level Degree in Health Professions by Crocker, Heidi Marie
Western Kentucky University
TopSCHOLAR®
Dissertations Graduate School
5-1-2013
A Case Study on Pharmacy to Explore the
Perceptions of Pharmacy Leaders and Policy
Makers on the Benefits, Risks, and Alternatives of
the Doctorate as the Entry Level Degree in Health
Professions
Heidi Marie Crocker
Western Kentucky University, heidi.crocker682@topper.wku.edu
Follow this and additional works at: http://digitalcommons.wku.edu/diss
Part of the Education Commons, Medical Education Commons, Pharmacy and Pharmaceutical
Sciences Commons, and the Public Health Commons
This Dissertation is brought to you for free and open access by TopSCHOLAR®. It has been accepted for inclusion in Dissertations by an authorized
administrator of TopSCHOLAR®. For more information, please contact connie.foster@wku.edu.
Recommended Citation
Crocker, Heidi Marie, "A Case Study on Pharmacy to Explore the Perceptions of Pharmacy Leaders and Policy Makers on the Benefits,
Risks, and Alternatives of the Doctorate as the Entry Level Degree in Health Professions" (2013). Dissertations. Paper 43.
http://digitalcommons.wku.edu/diss/43
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A CASE STUDY ON PHARMACY TO EXPLORE THE PERCEPTIONS OF 
PHARMACY LEADERS AND POLICY MAKERS ON THE BENEFITS, RISKS, AND 
ALTERNATIVES OF THE DOCTORATE AS THE ENTRY-LEVEL DEGREE IN 
HEALTH PROFESSIONS 
 
 
 
 
 
 
A Dissertation  
Presented to  
The Faculty of the Educational Leadership Doctoral Program 
Western Kentucky University 
Bowling Green, Kentucky 
 
 
 
 
 
 
 
 
 
 
 
In Partial Fulfillment 
Of the Requirements for the Degree 
Doctor of Education 
 
 
 
 
 
 
 
By 
Heidi Marie Crocker 
 
May 2013 
 
 

  
I dedicate this dissertation to my husband, Steve Crocker, who encouraged me to endure. 
Also, I dedicate this work to my son, Peter, and my daughters Samm and Natalie.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  iv 
ACKNOWLEDGEMENTS 
  
 Completing a dissertation in partial fulfillment of the requirements for a doctoral 
degree is in part the result of a great many people who have contributed to its production. 
I owe my gratitude to all those people who have made this dissertation possible and 
because of whom my goal of a doctorate in education has been completed. 
 My deepest gratitude is to my chairperson, Dr. Stephen K. Miller. I have been 
fortunate to have a chairperson who taught me the dispositions and attitudes that mark a 
researcher, gave me the freedom to explore on my own, and at the same time provided 
the guidance when my thoughts became jammed. Steve taught me how to question 
thoughts, express ideas, and obtain a deep respect for the work of intellectuals in the field 
of sociology, education, and research design. More importantly, Steve’s unwavering 
commitment to excellence, accompanied by unconditional patience and support, were the 
foundation for the completion of this empirical and theoretical compilation.  
 I also would like to express my appreciation to each of my committee members. 
Dr. Beverly Siegrist gave infinite encouragement and practical advice. Her insightful 
comments at different stages of my research were thought provoking and helped me 
focus my ideas. Dr. Grace Lartey provided encouragement for use of correct grammar 
and consistent notation in my writings. Her skillful statistical knowledge ensured the 
rigor of this study. Dr. Judy Davison contributed an understanding of research theory as it 
relates to this study. I am grateful to her for holding me to a high research standard and 
enforcing strict validation for each research result, thus, teaching me how to do research.  
 
 
  v 
CONTENTS 
I. STATEMENT OF THE PROBLEM 
 Introduction………………………………………………………………………..1 
 Pharmacy Education………………………………………………………………2
 The Problem Defined……………………………………………………………...9 
 Purpose of the Study……...……………………………………………………...11 
 Research Questions…………………………………………………....................13 
 Significance of the Study………………………………………………………...15 
 Limitations of the Study………………………………………………………….17 
 Definitions of Terms……………………………………………………………..18 
 Summary…………………………………………………………………………21 
II. REVIEW OF THE LITERATURE 
 Introduction………………………………………………………………………24 
 Health Professions……………………………………………………………….25 
 Accreditation…………………………………………………………………….34 
 Professional Associations………………………………………………………..51 
 Degree Classifications…………………………………………………………...57 
 Elevation of Clinical Doctorate as Entry-Level Degree………………………....69 
 The Current Study……………………………………………………………….87 
 Summary…………………………………………………………………………90 
III. METHODOLOGY 
 Introduction………………………………………………………………………93 
 Research Design………………………………………………………………….94 
  vi 
 Role of the Researcher………………………………………….……………….97 
 Population and Sample…………………………………………………………..98 
 Research Questions……………………………………………………………..102 
 Instrument Development………………………………………………………..102 
 Expert Review of Research Instrument………………………………………...103 
 Procedures………………………………………………………………………105 
 Data Analysis…………………………………………………………………...107 
 Trustworthiness and Validity…………………………………………………...109 
 Ethical Considerations…………………………………………...…………......111 
 Summary………………………………………………………………………..112 
IV.  RESULTS 
 Introduction……………………………………………………………………..116 
 Methodological Considerations………………………………………………...117 
 Results…………………………………………………………………………..121 
 Summary…………………………………………………………...…………...202 
V. DISCUSSION AND CONCLUSIONS 
 The Study in Brief………………………………………………………………211 
 Discussion………………………………………………………………………215 
 Recommendations………....................................................................................288 
 Conclusions……………………………………………………..………………294 
REFERENCES…...………………………………………………………...…………..301 
APPENDIX A: Interview Schedule Mapped to Research questions……..…….….…...321 
APPENDIX B: Document Analysis Protocol….……………...………………………..326 
  vii 
APPENDIX C: Interview Schedule……………………...……………………...……...328 
APPENDIX D: Information to Expert Panel Members…………..…………..………...332 
APPENDIX E: Letter to Study Participants………………………………….….……..336 
APPENDIX F: Consent Form…….………………………..…………………………..339 
APPENDIX G: Summary Outline…………….………………………………………..342 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
  viii 
A CASE STUDY ON PHARMACY TO EXPLORE THE PERCEPTIONS OF 
PHARMACY LEADERS AND POLICY MAKERS ON THE BENEFITS, RISKS, AND 
ALTERNATIVES OF THE DOCTORATE AS THE ENTRY-LEVEL DEGREE IN 
HEALTH PROFESSIONS 
 
Heidi M. Crocker   May, 2013           352 Pages 
Directed by: Stephen Miller, Beverly Siegrist, Grace Lartey, and Judy Davidson  
Educational Leadership Doctoral Program                            Western Kentucky University 
 The clinical doctorate is an emergent trend in many health profession disciplines. 
Collier (2008) projects continued momentum toward higher degrees for entry into 
practice and advancing the field in health professions. There has been minimal research 
on how the trend of doctoral education in health professions will affect health professions 
education, delivery of services, and interdisciplinary relationship among health care 
providers, or the wider society (Freburger, King, & Slifkin, 2008).  
 This research focused on the transition to the clinical doctorate in one profession, 
Pharmacy, retrospectively examining the inception and enactment phase of the Pharm.D. 
The study provides important insight into the perceptions of the leaders and policy 
makers who were involved in the changes that led to the Doctor of Pharmacy as the 
entry-level degree for the practice of pharmacy. The qualitative methods of data 
collection, primarily 14 high-quality interviews, allowed the researcher to search for 
commonalities and patterns related to this policy mandate: development and 
implementation phases in both the educational institutions and the practice of pharmacy.  
 The findings from this research provide evidence that these leaders are confident 
that establishing the Pharm.D. as the sole entry into pharmacy practice was the right 
decision for the profession, but acknowledge that requiring the Pharm.D. was only the 
starting block, that more work remains to maximize the knowledge, skills, and abilities of 
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the Doctor of Pharmacy in the U.S. healthcare delivery system.  
 The discovery of 18 patterns and 71 attendant themes documented the 
implementation of the Pharm.D., with major changes at four levels: health professions 
education, delivery of services, interdisciplinary relationships, and society as a whole. 
Decisions at each level acted as building blocks for modifications at the next level, but in 
a non-linear fashion. Changes that resulted at each step necessitated constant reflection 
and on-going improvements, but the profession continues to move forward. 
Recommendations derived from this empirical investigation provide extensive guidance 
to leaders in other healthcare disciplines who are contemplating the clinical doctorate as 
the entry-level degree into practice. Many of the anticipated outcomes at the time of the 
mandate were inaccurate, and numerous findings were unanticipated. 
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CHAPTER I 
STATEMENT OF THE PROBLEM 
 
 
Introduction 
 
 Over the past decade, clinical doctoral programs in health profession disciplines 
(i.e., physical therapy, nurse practitioner, and occupational therapy) have proliferated in 
the midst of both support and controversy among educators, professional organizations, 
practitioners, administrators, and third party payers. Many accrediting agencies for these 
disciplines are implementing a clinical doctorate as the entry-level degree into practice. 
This degree is focused on gaining depth and experience in clinical knowledge and skills, 
unlike the Doctor of Philosophy (Ph.D.) that focuses on research (Freburger, King, & 
Slifkin, 2008).   
 Extensive literature is available within each specific health profession that 
explains the rationale and requirements needed for programs leading to that degree, such 
as the Doctor of Physical Therapy and the Doctor of Nurse Practitioner, a dearth of 
published work addresses how this trend will affect health professions education, delivery 
of services, and the interdisciplinary relationship of health care providers. To address this 
gap, this research is a qualitative study of how the transition to the clinical doctorate in 
one profession, Pharmacy, was perceived during the establishment and implementation 
phase of the Doctor of Pharmacy. Pharmacy is useful for this study because the transition 
to the Doctor of Pharmacy (Pharm.D.) as the profession’s entry- level degree began over 
20 year ago and was implemented in 2003; thus, so it is probable that the effects of the
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change have become manifest. Leaders in health profession disciplines who are 
contemplating the clinical doctorate as the entry-level degree into practice must examine 
the potential benefits of the degree, the risks associated with transitioning to the new 
degree, and the alternatives available to changing the educational requirements necessary 
to enter the profession (Freburger et al., 2008). The dialogue occurring in many health 
professions may be enhanced by the query of other professions that have moved toward 
doctorates to discover any commonalities in pursuing a higher entry-level degree. 
Specifically, what can other health professions learn from a study of this process for 
pharmacy, the area with the longest history for this journey? 
Pharmacy Education 
 In 1989 the American Council on Pharmacy Education (ACPE) mandated that the 
Doctor of Pharmacy (Pharm.D.) would be the entry-level degree for a licensed 
pharmacist effective with students graduating after January 1, 2003. This decision 
provided the opportunity to expand and increase the pharmacist role in the rapidly 
changing health care system (American College of Clinical Pharmacy, 2000). The 
American Association of Colleges of Pharmacy (AACP) Commission to Implement 
Change in Pharmaceutical Education was established in July 1989 to develop a series of 
recommendations to guide pharmaceutical education as it evolved to meet the changing 
demands of the profession, the health care system, and society (Commission to 
Implement Change in Pharmaceutical Education, 1997a). The Commission issued a series 
of background papers and position statements that outline the fundamental missions of 
pharmacy practice and education (Commission to Implement Change in Pharmaceutical 
Education, 1997a); the educational requirements including curricular content and 
outcomes (Commission to Implement Change in Pharmaceutical Education, 1997b); the 
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endorsement of the Doctor of Pharmacy as the sole degree for entry into practice 
(Commission to Implement Change in Pharmaceutical Education, 1997c); the 
responsibility of pharmacy educators for scholarship, fellowships, and graduate and post-
graduate education and training (Commission to Implement Change in Pharmaceutical 
Education, 1997d); and commitment to the preparation of graduates proficient in 
pharmaceutical care in a rapidly changing healthcare system (Commission to Implement 
Change in Pharmaceutical Education, 1997e). These historical documents provide insight 
into influences on the policies, standards, and regulations that govern pharmacy 
education and the profession. 
 The accreditation requirement for the Pharm.D. was another step in the 
furtherance of pharmacy education that began with the four-year Bachelor’s degree 
mandate in 1932 (Cohen, 2008). Throughout the 20th century, the AACP and other 
national associations collaborated on numerous study projects surrounding the scope of 
practice and internal policy issues within pharmacy that led to the conclusion that clinical 
practice constitutes the essence of pharmacy (Elenbaas & Worthen, 2009). Professional 
leaders saw potential in clinical practice as the basis of professional philosophy and 
directed their attention toward educating members of the healthcare industry and society 
about the expansion of knowledge, skills, and abilities of the pharmacy professional. In 
addition, standardization of pharmacy education to incorporate clinical and patient 
interaction experiences with the mechanics of pharmaceuticals would become necessary.  
 The debate regarding the implementation of the Doctor of Pharmacy as the entry-
level degree occupied pharmacy organizations and leaders for so long that some sectors 
of the profession neglected other issues that were critical and equally as important to the 
advancement of the profession (American College of Clinical Pharmacy [ACCP], 2000). 
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According to Elenbaas and Worthen (2009), a six-year professional course of study was 
first proposed in 1948, and the University of Southern California instituted the entry-level 
six-year Pharm.D. as its sole professional degree two years later. Throughout the 1960s, 
1970s, and 1980s the field moved toward the adoption of patient-centered practice as a 
unifying philosophy of practice. Concomitantly, the role of the pharmacist was visualized 
as, and the professional mission evolved to, pharmaceutical care, moving the professional 
focus from product-oriented to patient-oriented. In the early 1990s professional leaders 
and pharmacy educators endorsed pharmaceutical care as its new professional mission 
(American College of Clinical Pharmacy [ACCP], 2000). The 1992 mandate by the 
American Association of Colleges of Pharmacy (AACP) that the Pharm.D. would be the 
sole entry-level into practice was approved without much debate. The Accreditation 
Council for Pharmacy Education (ACPE) demonstrated support of the mandate with 
implementation deadlines for institutions to establish programs and the revised Pharm.D. 
standards that went into effect in 2000 (Cohen, 2008). Cartwright and Reed (2005) 
believed that academic programs could not be mandated into greatness; moving forward 
with the Pharm.D. merely as an exercise in compliance rather than a commitment to the 
goals and vision of the Pharm.D. could result in less than desirable outcomes. 
 Retrospectively, the adoption of the pharmaceutical care mission and the mandate 
of the Doctor of Pharmacy as the entry-level degree were commendable steps for the 
profession, but these changes alone are not sufficient to transform professional practice 
(ACCP, 2000). Since these landmark decisions were adopted, various task forces have 
been formed to analyze important aspects of implementation such as competencies that 
must be built into every Pharm.D. program, development of efficient bridge programs for 
practitioners, and ongoing dialog of key stakeholders (Cartwright & Reed, 2005). The 
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AACP Janus Commission was established in 1995 to examine the health care 
environment. The commission was charged with identifying, analyzing, and predicting 
changes within the environment that were likely to influence pharmacy practice and 
pharmaceutical education. The Commission reported to the AACP, through several 
background papers and position statements, both opportunities and threats that were 
perceived as present in the environment at that time (Janus Commission, 1997). The 
American College of Clinical Pharmacy was convinced that the changes in United States 
health care delivery, economic growth, education, and health management systems that 
occurred during the 1990s had “set the stage for meaningful transformation of the 
profession” (Janus Commission, p. 995).  
The Clinical Doctorate 
  A common goal of the clinical doctorate across disciplines is to produce a more 
autonomous practitioner (Freburger et al., 2008). The professional and academic 
accrediting associations play a central role in the decision regarding entry-level 
requirements into practice by setting standards that are referenced by states when 
accrediting programs and licensing practitioners (Bollag, 2007). Since the 2003 
implementation deadline, a few articles have been written in pharmacy literature 
exploring whether doctoral education fits the profession’s purpose and identity, 
especially at a time of limited resources and economic uncertainty (cf. Freburger et al., 
2008; Siler & Smith Randolph, 2006).  
 Advocates of the clinical doctorate propose that the elevated degree will improve 
quality and professionalism of care. Some support the position that transformation of a 
profession is rooted in the dramatic demographic changes in society, scientific progress, 
and technological advances in the health care industry (Collier, 2008). Others decry the 
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validity of the clinical doctorate and suggest the professions are elevating the degree in 
order to help practitioners provide service autonomously from physician referral and 
allow for potential increased reimbursement rates for services (Siler & Smith Randolph, 
2006). Some opponents argue that the additional time requirements and financial cost of 
education are unnecessary and will result in a shortage in the labor force (Freburger et al., 
2008).  
Theoretical Perspective 
 The theoretical framework for this qualitative study is grounded in changes in 
health behavior, which can be defined as “the actions of individuals, groups and 
organizations, as well as the determinants, correlates, and consequences, of these actions-
which include social change, policy development and implementation, improved coping 
skills, and enhanced quality of life” (Parkerson et al., 1993, p. 30) related to health. The 
most common health behavior theories found in this field are the Transtheoretical 
Model/Stages of Change, the Social Cognitive Theory, and the Health Belief Model 
(Painter, Borba, Hynes, Mays, & Glanz, 2008). Applying elements of these theories in 
the exploration of potential determinants of behavior may increase understanding of the 
individual, interpersonal, group, organizational, and community levels.  
 The current focus is the professional leaders’ and policy makers’ perceptions of 
the benefits, risks, and alternatives of the Doctor of Pharmacy as the entry-level degree 
during the decision-making process. The Transtheoretical Model (TTM) divides the 
process of change through a progression of stages from pre-contemplation, in which there 
is no intention to change behavior, through motivation and intention to change behavior 
stages, ending in a maintenance stage that incorporates the uptake of the new behavior 
(Kraft, Sutton, & McCreath, 1999). Di Noia and Prochaska (2010) suggested that the 
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decisional balance construct of TTM provides a framework for understanding the 
decision-making process as individuals progress through these stages.  
  Social Cognitive Theory (SCT) provides a framework for understanding how 
environment and social influences impact the beliefs and cognitive competencies, and in 
turn affect a person’s behavior (IDEA, 2006). The central concept of SCT is that self-
efficacy, belief in the ability to execute a behavior, is directly linked to outcome 
expectancies. Outcome expectancies, expecting that engaging in certain behaviors will 
produce desired outcomes, motivate behavior change and are critical in the development 
of intentions to take on a certain behavior (Williams-Piehota, Sirois, Bann, Isenberg, & 
Walsh, 2011). According to Williams-Piehota et al., “once intentions are formed, efficacy 
expectations provide the chief motivation to initiate and maintain behavior change (p. 
23). 
 The Health Belief Model provides an understanding that a person’s predicted 
behavior is a process of cognitive decision-making and is dependent on the person’s 
perceptions of the seriousness, susceptibility, benefits, and risks of the situation (Fingeld, 
Wongvatunyu, Conn, Grando, & Russell, 2003). The probability that someone will take 
action to change a behavior is influenced by the perceived threat of a situation and the 
expectations about outcomes (Redding, Rossi, Rossi, Velicer, & Prochaska, 2000). 
Exploring the perceptions of stakeholders during the decision-making process may 
predict the course of action needed for successful implementation and maintenance of the 
behavior change. 
 For this study, the Social Cognitive Theory and The Health Belief Model are too 
limited, focusing on individuals. In contrast, the Transtheoretical Model (TTM) is 
applicable for both individuals and to the collective response of the individuals in the 
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institutions affected by the change. Therefore, TTM is selected to frame this work. 
 The literature on the Transtheoretical Model indicates the existence of 
fundamental barriers or concerns that underlie a complex organizational change process. 
An example could be the degree required to enter into a profession (Brazeau et al., 2009a; 
Greenwood, Suddaby, & Hinings, 2002; Siler & Randolph, 2006). These essential issues 
directed the study’s research agenda and served as the framework for the investigative 
study. One problem is that changing the professional philosophy does not guarantee that 
all stakeholders, such as the health care system, third party payers and the patient base, 
will embrace the necessary changes to transform the practice of pharmacy to match the 
philosophy.  
 A second problem is that the education system must be remodeled and advanced 
to a professional doctoral level that will prepare graduates to be competent in 
pharmaceutical care and function as professionals in a changing health care system and 
economic climate (Brazeau et al., 2009a). In a climate of rising health care cost and a 
chronic shortage of qualified health profession educators, this presents a daunting task for 
educational institutions and program administrators.  
 A third problem surrounds the increased emphasis toward inter-professional 
collaboration in health professions education and practice. For successful transformation 
of pharmacy practice, other health disciplines such as medicine and nursing must accept 
that the clinical doctorate degree provides insurance that graduates are prepared for 
educational and professional roles in other health science education programs and 
interdisciplinary practices (Brazeau et al., 2009b). 
Empirical Perspective 
 The AACP Commission to implement change in pharmaceutical education states 
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in Position Paper 3 that there is a societal need for pharmaceutical care to be the practice 
model of pharmacy in the 21st century (Commission to Implement Change in 
Pharmaceutical Education, 1997c). Position Paper 3 provides evidence of substantial 
support from pharmacy educators and professionals for the change to the “doctor of 
pharmacy (Pharm.D.) as the sole degree for entry into pharmacy practice” (p. 7). The 
commission identified issues and barriers that this substantial change would likely 
generate for schools and colleges of pharmacy as well as the practice of pharmacy overall 
during the implementation phase of the change.  
 The Commission did not, however, address how this philosophical change would 
be translated into the rapidly and continuously evolving health care system (Janus, 1997). 
Eckel and Kezar (as cited in Cartwright & Reed, 2005), suggested that the ingredients for 
successful change are strong administrative support, a collaborative process, a motivating 
vision, persuasive and effective communication, long-term orientation, rewards and 
incentives, and necessary supporting structures. The transformation of pharmacy practice 
from a product-oriented to a patient-oriented profession is an encompassing process, 
requiring collaboration from all segments of the profession and an inclusive approach for 
adoption (ACCP, 2000). The pharmacy profession has adopted the philosophy that 
pharmaceutical care will be the practice model in the 21st century and the transition to 
the Doctor of Pharmacy as the entry-level degree is now complete.  
The Problem Defined 
 Many of the accrediting agencies are mandating the new advanced degree 
requirements, and most are establishing standards and student outcomes to guide the 
institutions in the transition. However, resources to support design and implementation of 
the curricular changes necessary to comply with the new standards are not the domain of 
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the accrediting agencies, and state funding levels for higher education have been falling 
due to widespread economic hardships. In addition, the changes require a strong rationale 
and sufficient resources to gain acceptance and prevent opposition as well as the potential 
argument of degree creep from members of the health care system and society (Clement, 
2005). 
 Rapport, Stelzner, and Rodriguez (2007) provided information on the external 
forces that are behind the progression of the clinical doctorate as an entry-level degree 
that pertains to all disciplines undergoing the same transformation. Entry-level education 
refers to the degree or educational level at which a person is deemed prepared to enter a 
given profession. One external force required is a shift in the culture of health care and 
method of service delivery to a system that emphasizes an understanding of patient belief 
systems, integrated study and intervention, and advocacy for patients as required for best 
practices (Threlkeld, Jensen, & Royeen, 1999). Threlkeld et al. (2009) addressed the 
dissemination of this information by discussing the observed trend in other healthcare 
fields that has resulted in the transition to clinical doctorate education programs, as well 
as the clinical doctorate degree as a means of entering the profession.   
 The influence of the external force of the doctoring profession is a key concept in 
the discussion of clinical doctorates. Several studies are cited in medical literature 
pertaining to the characteristics of the doctoring profession, one that comes with the 
award of a clinical doctorate degree (Benoit, Mohr, & Shabb, 2004). This sparks a new 
arena for investigation on the general topic of the clinical doctorate. Benoit et al. (2004) 
provide enlightening information on academic program transition, curriculum design, and 
implications for one area of concern specific to this discipline, i.e., school-based physical 
therapy.    
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 Understanding the experiences of the physical therapy profession during the 
transition to a doctoring profession provided valuable knowledge and guidance for 
leaders of other health care disciplines that are involved in this organizational change 
within the profession. These types of major change agents have an influence on every 
aspect of a profession including the educational programs, best practices, and governing 
bodies. However, one should be mindful that each situation is unique and each discipline 
will respond to these changes differently. It is important to learn from the experiences 
shared and refer to these case studies for perspective, but it is equally important not to 
rely on the experience of one single institution for a template on how to proceed through 
the change. 
 The complexity of today’s healthcare environment demands that new practitioners 
have knowledge, skills, and abilities that need to be addressed at multiple levels. How the 
clinical doctorate practitioner blends into the delivery system is unknown because these 
changes are in their infancies. The transformation in healthcare education to the clinical 
doctorate is happening at an accelerated rate, and multiple disciplines are trying to adjust 
to the changes. Although the disciplines may have different orientations, the similarity of 
process suggests that studies exploring these different institutional changes would be 
beneficial to the larger field of healthcare professions, with the sharing of results and 
resources providing useful information to all of the specific fields.        
Purpose of the Study 
 The issues laid out in the previous section have yet to be addressed adequately 
with respect to empirical evidence. Almost all of the writing in this field has been 
relevant commentary and opinion, position papers, and results of commission 
investigations such as the five position papers written by the AACP Commission to 
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Implement Change (1997a, 1997b, 1997c, 1997d, 1997e) and the White Paper: A Vision 
of Pharmacy’s Future Roles, Responsibilities, and Manpower Needs in the United States 
(American College of Clinical Pharmacy, 2000). The limited empirical studies give 
inadequate information on how the transition to the clinical doctorate was implemented, 
specifically the challenges and barriers that were faced to secure a successful transition. 
In addition, limited empirical studies are available that provide details on the outcome of 
the transition on the profession, especially the educational programs, best practices, and 
governing bodies. This study directly addresses this general lack of understanding, 
particularly from the perspective of stakeholders who were pivotal in the decision to 
change the requirement for entry-level education for pharmacy. 
 Thus, the purpose of this qualitative study is to understand the perceptions of 
professional leaders and policy makers regarding the benefits, risks, and alternatives of 
the clinical doctorate as an entry-level degree for pharmacists. Semi-structured interviews 
with the leaders and stakeholders who were pivotal in making decisions regarding the 
academic accreditation mandate to implement the new Pharm.D. constitute the database. 
This allowed the researcher to retrospectively evaluate the process of transitioning from 
the master’s level to the clinical doctorate level, the risks accompanying the switch to the 
new requirements, and alternatives to the transition that could result in satisfying the 
philosophy and mission of the profession.  
 The subjects interviewed in this study were all participants in key policy groups 
that were involved in the decision to mandate the Pharm.D. as the entry-level degree for 
the profession of pharmacy. The four stakeholder groups included: (a) Commission to 
Implement Change in Pharmaceutical Education, (b) the Janus Commission, (c) the 
AACP Board of Directors, and (d) the ACPE Board of Directors. Therefore, the central 
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research question for this study can be stated as: “What are the current perceptions 
(benefits, risks, and alternatives) of key policy makers in the pharmacy profession who 
participated in the decision to require (by January 1, 2003) the clinical doctorate 
(Pharm.D.) as the entry-level degree for practitioners?” 
Research Questions 
 The decision to implement the Pharm.D. as the entry-level degree into pharmacy 
practice was influenced by numerous stakeholders who represented various groups. 
These groups made independent decisions that, collectively, resulted in the final decision. 
The following research questions are framed within the context of the wider milieu 
depicted in Figure 1.  
 1. What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
      a.  health professions education? 
      b.  delivery of services? 
      c.  interdisciplinary relationship of practicing clinicians? 
      d.  societal and economic landscape of the health care industry? (Cost-  
 benefit) 
 2. What is the transferability of an entry-level clinical doctorate as related to 
 professional opportunities?  
Specifically, these empirical questions represent the perceptions of the key members of 
the four organizations most instrumental in the decision to move toward the Pharm.D. as 
the entry-level degree to practice pharmacy. 
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Stakeholders  ⇔ Categories of Influence ⇔ Educational Factors  ⇔ Health Professions  
                        Outcomes 
 
Accrediting Agencies         Institutions of   Entry-level degree   Accreditation conferred 
           higher education 
 
Institutions           Economic costs/benefits  Time to degree   Clinical doctorate  
  
Academic Leaders         Academic policies  Program quality   Pharm.D.   
Professionals          Professional societies/  Credentials    Professional status/influence 
                 employment 
 
Students          Universities   Clinical training requirements Certification 
 
Consumers          Healthcare/society  Patient education   Local pharmacist 
Figure 1. Institutional and organizational factors relating to preparation for pharmaceutical professional practice. 
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Significance of the Study 
 As conversation about and movement toward the clinical doctorate in the health 
professions has gained momentum, leaders in the various fields need to understand key 
policy and operational issues as well as complications that are likely to arise during the 
transition to these new degrees. There is little to guide these decision makers with respect 
to an empirical track record.  
 The one exception to this lack of experience is the field of pharmacy, which made 
the decision to move toward the Pharm.D., with full implementation by January 1, 2003. 
Because that process is now sufficiently institutionalized, studies of the transition could 
provide useful guidance to stakeholders in the other health profession fields.  
 To the author’s knowledge to date, the current study constitutes the only research 
on the benefits and risks of the degree and alternatives associated with increasing the 
educational requirements necessary to enter the profession. The literature indicates that 
there are fundamental barriers or concerns that underlie a complex organizational change 
process such as the degree required to enter into a profession (Brazeau et al., 2009; 
Greenwood et al., 2002; Siler & Randolph, 2006). These essential issues directed the 
study’s research agenda and served as the framework for the investigative study. Beyond 
the groundbreaking retrospective nature of this work, the following represent specific 
contributions to the field. 
 First, the nature of the study focused primarily on the emic voice (the view of the 
individual inside the decision-making role). This study tapped members of the four key 
policy bodies involved in the decision to require the clinical doctorate as entry-level for 
practice in pharmacy. Because the researcher was a chiropractor with educational 
responsibilities, this outsider’s view facilitated taking the etic perspective as well 
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(Danquah & Miller, 2007; Gall, Borg, & Gall, 1996). Further, chiropractic is sometimes 
thought of as “outside” the traditional healthcare disciplines and as less qualified than 
regular doctors. This outsider position, however, allowed the researcher to take a less 
biased perspective than those whose training comes from within one of the traditional 
healthcare disciplines.  
 Second, the qualitative approach to the study enabled the researcher to gain in-
depth accounts about the long-term effects of this landmark transition in the education of 
healthcare professionals in pharmacy. Most of the pharmacy research cited has been 
commentary and opinion, position papers, and commission/investigative reports. 
Understanding personal perceptions and reflections from key individuals could provide 
unique insight to assist current policy makers in the transition to the clinical doctorate for 
additional health professions. 
 Third, this study is explicitly retrospective. Seldom do studies go back in time to 
reflect on the effects of policies after they have been implemented for a number of years. 
This approach can provide detailed information on how the transition to the clinical 
doctorate was implemented and how the outcome has affected the profession, especially 
educational programs, best practices, and governing bodies.  
 Fourth, previous research studies have not provided in adequate empirical 
evidence on the specific challenges and barriers faced during the transition to the 
Pharm.D. or the outcomes of the transition. In this study, the interview process provided 
the opportunity for the subjects to expound on the particular challenges or barriers that 
influenced the decision. For example, there were many conflicting opinions were voiced 
in publication about how the Pharm.D. would affect the delivery of service (American 
College of Clinical Pharmacy, 2000). Now, 20 years after the mandate, the changes in the 
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delivery of pharmaceutical services and the trade-offs that have come with the transition 
to the Pharm.D. can be identified. 
 Finally, two important topics were addressed in this study that could only be 
explored only after the mandate had been implemented for a number of years. First, has 
the new professional philosophy of “pharmaceutical care” evolved into the best practice 
model for the practicing pharmacist of the 21st century? Has the Pharm.D. allowed for 
expanded professional opportunities for the pharmacist? Second, how has the general 
population and society as a whole responded to the advanced knowledge, skills, and 
abilities of pharmacists? The retrospective nature of this study allows those questions to 
be directly addressed. 
Limitations of the Study 
 This study seeks information about the perceptions and insights of key individuals 
involved in the development and implementation of the Doctor of Pharmacy using 
qualitative data collected from semi-structured interviews. These data represent rich 
descriptions of the internal and external issues contemplated as described by the key 
individuals. However, several limitations to the research follow. 
 First, the fact that the researcher has a clinical doctorate in another health 
profession discipline, chiropractic, is a bias. The researcher needs to control voice, tone, 
and reactions to responses to questions as pharmacy leaders and policy makers are 
interviewed. Caution must be exercised to assure that personal feelings or insights 
specific to chiropractic are not embedded in the questions, nor in the interpretations of the 
data. 
 Second, it is anticipated that the interviewees will have some views that are 
similar, particularly if they served on the same committee during the discovery phase. 
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Some may feel obligated to support the decision that was ultimately approved and not 
fully disclose personal perceptions of the internal and external conflicts that were 
involved. 
 Third, this study is limited to the pharmacy profession. The external and internal 
policy issues for consideration when creating a clinical doctorate in pharmacy are not 
likely to transfer across disciplines with absolute fidelity.  
 Fourth, the population and actual samples are limited to the members of the 
AACP Commission to Implement Change in Pharmacy Education, the Janus 
Commission, the AACP Board of Directors, and the ACPE Board of Directors who 
served from 1989-2002. The population was chosen via purposeful, critical case 
sampling. This does not allow for a complete picture of the pharmacy profession. Cost 
and time considerations prevent extending the study to include stakeholders from other 
segments of the profession.  
 Fifth, the qualitative design of this study presents a limitation, in that qualitative 
research, due to the small sample size, has decreased generalization of findings to other 
health professions disciplines contemplating transitioning to the clinical doctorate. In 
addition, since the author provides interpretation of the results, the findings are subject to 
interpretation by other researchers.       
Definitions of Terms 
 The terms in this section are directly related to the research that is cited 
throughout this study. All are commonly used in the healthcare professions. 
 Accreditation Council for Pharmacy Education (ACPE). The ACPE is the 
accreditation agency of professional degree programs in pharmacy and providers of 
continuing education for pharmacists (ACPE, 2012, para. 1).   
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 Accreditation governing bodies. United States higher education is governed by 
the private, non-governmental accreditation industry, a self-regulation mechanism for 
higher education to verify quality standards in education through a peer-evaluation 
process. The peer-evaluation process is accomplished by national, regional, and 
specialized private, non-profit organizations called “accreditation agencies” that develop 
their own quality standards and processes to evaluate institutions and programs. The 
majority of these organizations have full- and part-time employees to carry out the day-
to-day operations but rely heavily on volunteers with a stake in accreditation to execute 
the accreditation process. The governing body and decision-making commission of an 
accreditation agency is comprised of appointed or elected members that representing 
higher education faculty and administrators, practitioners in specific fields, and members 
of the public (Council on Higher Education Association, 2010b, p. 1).   
 American Association of Colleges of Pharmacy (AACP). The AACP is a non-
profit organization that represents and advocates pharmacy education in the profession of 
pharmacy (ACPE, 2012, para. 1). 
 American College of Clinical Pharmacy (ACCP). The ACCP is a professional 
organization comprised of members from multiple health professions that are committed 
to advancing clinical pharmacy and pharmacotherapy as the practice model for pharmacy 
(ACCP, 2012, para. 1).   
 Clinical or practice doctorate. This doctorate is a professional degree that focuses 
on clinical competencies required to practice and the utilization and translation of 
research into practice (Fraher, 2007, slide 3). 
 Degree creep. This term refers to mandating higher degrees or credentials than 
are necessary for entry into a field or profession. This phenomenon occurs when factors 
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external to scope of practice are perceived to represent additional education and new skill 
requirements as necessary without supportive data (Loochtan, 2011, slide 8). 
 Delivery of services. Delivery of service refers to the quantity and quality of 
resources defined within a scope of practice provided to those who need it, when needed, 
and with minimal waste. This is accomplished systematically by groups of trained 
individuals who enable people to receive health care (World Health Organization, 2012, 
para. 2). 
 Doctor of Pharmacy (Pharm.D.). A Pharm.D. is the first-professional degree 
required for the entry into pharmacy practice. Completion of the Doctor of Pharmacy 
curriculum from an accredited institution is required to sit for the North American 
Pharmacist Licensure Examination (NAPLEX) (Oregon State University, 2012, para.1). 
 Entry-level degree. This degree is granted with the knowledge, skills, and abilities 
required for entry into clinical practice and/or become licensed to practice (Fraher, 2007, 
slide 4). 
 Health professions. Health professions are occupations are competency-based in 
knowledge and skill sets to deliver specific services in the health care system (Copnell, 
2010, p. 64). These occupations are defined as professions because of a specific body of 
knowledge and skills, extensive education and certification, established scope of practice, 
and ethical principles (Hampton & Hampton, 2004, p. 1050). 
 Maturation of discipline. As the scope of a field advances, proper preparedness 
for entry-level into the field requires additional education and acquisition of new skill 
sets (Loochtan, 2011, slide 15). 
 Pharmaceutical care. This term refers to the patient-oriented, outcomes-based 
pharmacy practice that requires interdisciplinary collaboration to promote health, prevent 
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disease, and design a safe and effective drug therapy regime for improved quality of life. 
The primary elements include the profession is medication-related, the care is provided 
directly to the patient, defined outcomes that will improve the patient’s quality of life are 
expected, and the provider accepts responsibility for the outcomes (American Society of 
Health Pharmacists, 1996, p. 258). 
 Research doctorate. A Doctor of Philosophy (Ph.D.) degree is a post-graduate 
terminal degree that emphasizes knowledge and skills in conducting research (World 
Education Services, 2010, para. 10).  
Summary 
 A number of health professions are strategically in transition toward 
implementation of advanced degrees, a trend that has precipitated debate among 
educators, professional organizations, practitioners, administrators, and third party 
payers. Recent growth in clinical doctorates in the health professions, such as pharmacy, 
physical therapy, and occupational therapy, is motivated by professional associations 
advocating raising entry-level programs to the doctoral level, specifically those that 
prepare graduates for practice in the respective profession (Bollag, 2007). The decision to 
change the entry-level requirements into a profession has wide-ranging consequences and 
should spark discussion and incorporate perspectives of all stakeholders such as 
employers, educators, professionals, the public, regulatory agencies, and policy makers 
(Fraher, 2007).  
 Health profession disciplines that are contemplating the clinical doctorate as the 
entry-level degree into practice must examine the potential benefits of the degree and the 
risks and alternatives associated with increasing the educational requirements necessary 
to enter the profession (Freburger et al., 2008). It is important to note that clinical 
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doctorates are professional degrees focused on clinical competencies required to practice, 
not research degrees such as the Ph.D. that focus on conducting original research and 
scholarship. It may be beneficial to query other professions that have moved toward 
doctorates to discover any commonalities in pursuing a higher entry-level degree.  
 In the attempt to modernize the pharmacy practice from a product-oriented to a 
patient-oriented profession, considerable changes are necessary regarding professional 
development, scope of practice, regulation, pay modernization, and the development of a 
competency-based workforce (Copnell, 2010). The pharmacy profession adopted the 
philosophy that pharmaceutical care is the practice model for the 21st century, and the 
Doctor of Pharmacy is warranted as the entry-level degree into practice, effective in 
2003. For this philosophy to become practice, the stakeholders have and must continue to 
embrace the transformative changes if the practice of pharmacy is to match the ideals 
inherent in the Pharm.D.  
 This study is a qualitative study of how the transition to the clinical doctorate in 
one profession, pharmacy, was perceived during the establishment and implementation 
phases of the Doctor of Pharmacy. Pharmacy was chosen because the transition to the 
Doctor of Pharmacy (Pharm.D.) as the profession’s entry-level degree began over 20 
years ago and was implemented in 2003, so it is probable that the effects of the change 
have manifested. Given the rapidly changing environment in the United States healthcare 
system, a retrospective study of the decision to move to the Pharm.D. from the 
perspective of key stakeholders could be very instructive for related healthcare 
professions currently pursuing or considering the move to the required clinical doctorate 
for entry to practice. Thus, the central research question for this study is: “What are the 
current perceptions (benefits, risks, and alternatives) of key policy makers in the 
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pharmacy profession who participated in the decision to require (by January 1, 2003) the 
clinical doctorate (Pharm.D.) for practitioners?”
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
 
Introduction 
 The purpose of this study is to discover the perceptions of pharmacy leaders have 
about the clinical doctorate and its effect on health professions education, the delivery of 
services, the interdisciplinary relationship of health care providers, and the relationship 
between the degree and increased professional opportunities. Pharmacy is useful as a case 
study because the transition to the Pharm.D. as the entry-level degree into practice was 
implemented in 2003, so the effects of this change on the profession are identifiable. The 
adoption of pharmaceutical care as the professional mission and the academic mandate of 
the Pharm.D. as the entry-level degree were monumental, but these changes alone are 
insufficient to transform professional practice to match the philosophy.  
 This study is a qualitative study of professional leaders’ and policy makers’ 
perceptions of the benefits, risks, and alternatives of the doctor of pharmacy as the entry-
level degree, both during the decision-making process and regarding the transferability of 
the Pharm.D. degree for professional opportunities. Semi-structured interviews were 
designed to examine these issues at the individual, interpersonal, group, organizational, 
and community levels. The population consists of four stakeholder groups: the AACP 
Commission to Implement Change in Pharmacy Education, the Janus Commission, the 
AACP Board of Directors and the AACP House of Delegates from 1989-2002.  
 This review centers on research and policy related to clinical doctorates in the 
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health professions. Included is information on the structure and dynamics of professional 
agencies and educational institutions, aspects of degree classifications, and theories and 
studies on the elevation of clinical doctorate as an entry-level degree. The literature is 
derived primarily from the physical therapy, occupational therapy, nurse practitioner, and 
pharmacy disciplines that address issues and concerns that have risen in the transition to 
the clinical doctorate. The remainder of this chapter provides details of this literature. 
Included are sections devoted to Health Professions, Accreditation, Professional 
Associations, Degree Classifications, and the Elevation of Clinical Doctorate as 
Entry-Level Degree. The chapter concludes with a Summary. 
Health Professions 
 Health professions represent a cluster of careers involved, directly or indirectly, 
with practitioners regarded as experts in the respective field being key to patient 
wellbeing. The educational process among the disciplines is diverse, as are the licensing 
requirements to enter practice, the state regulated scope of practice, and the role within 
the complex healthcare delivery system.   
Disciplines 
 A health profession refers to an area in which trained practitioners exercise skill 
and judgment or provide service for the prevention or improvement of the health of an 
individual or the treatment and care of a person who is injured, sick, or disabled (Health 
Professions Act, 1996). According to the American Medical Association (AMA), there 
are more than 80 careers in health care and 8,400 accredited educational programs in 
those health care fields (American Medical Association [AMA], 2012). Their respective 
associations govern each health profession, and the educational programs are accredited 
by the respective health professions education accrediting agencies.    
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Prerequisites 
 Each health profession has identified competencies for which one must be 
properly educated and trained to execute in order to perform specific job responsibilities 
within the occupation (Head, 2004). In addition to being formally educated and 
technically trained, a health professional must demonstrate proficiency of the identified 
competencies through a nationally validated examination process. The scope of practice 
of a health profession is determined at the state level. Each state government has a 
division that establishes the rules and regulation of practice within that state. Head 
acknowledged that many employers may require their own minimal standards of 
education and training above and beyond the state defined scope of practice.  
 Academic. There is no consistency within health professions regarding the 
required academic degree to enter into practice. Some disciplines such as medicine, 
chiropractic, and dentistry have demanded the first professional doctorate for entry into 
practice since the their inception (Clement, 2005). Some professions such as physical 
therapy and pharmacy elevated the entry-level requirements over time, starting with the 
bachelor’s, master’s, and currently the doctorate. Still other disciplines such as nursing, 
require a lesser degree for entry into practice but offer advanced educational 
opportunities for entry into advanced practice.  The Association of Schools of Allied 
Health Professions (ASAHP) (2012) published a position paper to identify some of the 
distinctions between the entry-level clinical doctorate (i.e., Doctor of Physical Therapy 
and Doctor of Pharmacy) and advanced practice doctorates such as those in nursing and 
occupational therapy. The rationale for the ASAHP position statement was a lack of clear 
distinctions between the types of doctorates, the absence of any defining guidelines 
regarding required credits for practice, and the expressed concerns of many allied health 
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educational leaders about the increasing number and types of doctoral-level programs 
that are emerging across disciplines. Phelps and Gerbasi (2009) concluded, “the doctoral 
degree is likely to become the most common entry-level degree” (p. 21).   
 The level of entry to practice and the content requirements of health professions 
education programs are guided by educational accreditation agencies. Phelps and Gerbasi 
(2009) investigated the accreditation requirements for practice doctorates in 14 healthcare 
professions and found considerable differences in terms of their standards and the type of 
information they provided. Most of the accrediting agencies examined had reframed their 
standards from specific curricular requirements to competency or outcome-based, but no 
consistent standards were found between professions. LaBelle (2004) indicated that 
credential inflation is a factor in the increase in professional doctorate programs resulting 
in master’s degree requirements for professional practice being replaced by the doctorate 
degree, especially in healthcare. This is supported by Royeen and Lavin’s (2006) 
prediction that “within less than a generation, the majority of health care practitioners in 
allied health and advanced practice nursing will be degreed at the level of the clinical 
doctorate” (p. 105).   
 Licensure. Most health professions try to ensure the quality of new professionals 
by requiring graduates of accredited programs to pass a licensing exam (Siler & 
Randolph, 2006). As mentioned earlier, a health professional must be formally educated, 
technically trained, and demonstrate proficiency through a nationally recognized 
examination process (Head, 2004). Each health profession has an educational credential, 
or entry-level degree, that plays an important role in the process to be licensed to practice 
within the discipline. These internal benchmarks provide a foundation for the external 
influences on education and credentials (Head, 2004). 
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 In the United States, each state has jurisdiction over the standards and 
requirements for a practitioner to be licensed in their particular state. Licensing of health 
professionals, regulation of practice standards, and disciplinary actions are administered 
by a division of the state government. For example, the state of Virginia has the 
Department of Health Professions (Health Practitioners Monitoring Program, 1986) 
established within the executive branch. The governor appoints the Director of the 
Department of Health Professions and establishes a board of health professions that is 
represented by all disciplines. In addition, each discipline has a representative board, such 
as the Board of Pharmacy and the Board of Physical Therapy. Together, this department 
is responsible for a plethora of powers and duties listed in the Code of Virginia 54.1-
2505, ranging from the establishment of requirements for individual disciplines to the 
regulation and enforcement of laws that pertain to each profession.  
 The state regulatory agencies work closely with the education accrediting 
agencies when developing a profession’s scope of practice within the state. According to 
Hawkins, Roemheld-Hamm, Ciccone, Mee, and Tallia (2009), significant differences are 
found from state to state in health regulatory systems, depending on their perspectives 
and perceived roles. The current model for many state medical regulatory agencies is a 
“punitive, non-differentiated approach” to health professional performance problems. 
Each state medical licensing and board-certifying agency uses their own taxonomies to 
organize complaints against health professionals. Hawkins et al. found that 
communication problems with patients are the most important issue leading to complaints 
to state medical boards, and the most frequent and concerning complaint was providers 
not “conforming to minimal standards of medical practice” (p. 230). The authors 
addressed concerns about inadequate study methods for measuring communication skills 
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of health professionals and limited educational/remedial resources to address competency 
standards complaints. Hawkins et al. concluded that a national approach to health 
professionals study would promote a consistent framework for defining provider 
competence and performance in support of continued improvement of the health 
professions workforce. Head (2004) explained that the National Commission on Allied 
Health, developed by the U.S. Department of Health and Human Services, routinely 
conducts reviews of issues, problems, and potential solutions that pertain to education 
and the supply and distribution of allied health professionals, providing recommendations 
and alterations to scopes of practice and licensure standards. 
 The move toward national regulatory standards has been gaining momentum in 
the healthcare industry. Wakefield (1999) addressed the influence of technology on the 
health care delivery system.  She noted that practice across state lines is happening in 
situations such as nurse triage in an emergency from two states away, a rural-based 
physician consulting with a physician at a major research institution, or a hospital 
establishing a web-site to provide health-related information across the globe. These 
examples are restricted by the diversity in the scope of practice acknowledged by each 
individual state. The Pew Commission (O’Neal and the Pew Health Professions 
Commission,1998) emphasized that the goal of health professional regulation, “to 
establish standards that protect consumers from incompetent practitioners” (p. 84), will 
be best accomplished in the future if states enact uniform scopes of practice for each 
health profession. The Commission (1998) offered the recommendation that Congress 
pass legislation to facilitate professional practice across state borders.  
Institutions 
 The passage of the Affordable Care Act (ACA) in March 2010 was the beginning 
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of the United States’ effort to transform the health care system, and higher education 
institutions have an important role in the process (Kirch, 2011). Not only do institutions 
of higher education provide health insurance for employees and students and frequently 
become involved in the delivery of health care, they face the complex challenge of 
educating the next generation of health professionals. Kirch proposed that, as the nation 
experiences a greater demand for health care services, colleges and universities must be 
prepared to train more health professions than ever before. Not only must higher 
education institutions produce the necessary number of health professionals, they must 
ensure that the entry-level workforce is prepared to meet the demands of the health care 
system of the 21st century. 
 Structure. Major changes are taking place within the U.S. health care system, 
with strong implications for health professions education. Engel (2000) suggested that the 
magnitude of anticipated changes still ahead challenge institutions to prepare their 
students to become adaptable and develop the skills necessary to be active participants in 
managing the inevitable change in the health care industry and in society at large. He 
pointed out that educational institutions are charged with providing the quantity of 
professionals to meet the healthcare needs of our society, but the economic imperatives of 
the institutions must be balanced with the cost incurred to educate the professional and 
the available career prospects. “Even now there are countries with an increasing number 
of doctors who are either underemployed or unemployed, while the cost of educating 
doctors continues to escalate” (Engel, p. 39). 
 Planning for the future resources is complicated by the dramatic changes 
happening within the individual health professions. Engel (2000) noted that most health 
professionals are educated at the university level, and an increasing number are at the 
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graduate and doctoral level.  Educational institutions must stay abreast of the reshaping 
roles and responsibilities of members of many health professions and the revisions in the 
entry-level requirements and scope of practice that result. Clark (1999) stated that 
educators must anticipate current and emerging trends affecting the knowledge and skill 
requirements of health professionals, and they have the responsibility to design and 
implement educational programs that prepare the students for future practice settings. 
Two major trends transforming health professions education are the advent of 
community-academic partnerships and the evolution of interdisciplinary health care 
teams (Clark). These developments require new educational methods involving service-
based learning and interdisciplinary collaboration. This is completely opposite from the 
traditional methods in which disciplines were kept isolated and the focus was 
autonomous research. Clark suggested that these tendencies have important implications 
for the competencies of the graduates of health professions schools and are one reason the 
professional doctorate is emerging as the entry-level degree for many health professional 
disciplines.    
 Dynamics. Huisman and Naidoo (2006) noted that, as many elements of the 
institutional infrastructure have adapted to the changing environment of higher education, 
the traditional doctorate (Ph.D.) has remained untouched. The authors explained this 
resistance to change because the doctorate is one of the few remnants of the “classical 
university” (p. 4); and the concept of proposing alternative doctorates, such as the 
professional doctorate, may be considered too radical of change. Nair and Webster (2010) 
concluded that change is often difficult in fundamentally conservative professions such as 
health care and education.  
 In the past 30 years, schools of health professionals have been increasing the , 
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number of doctoral faculty due to internal and external pressure. Clement (2005) linked 
the trend for an increase in doctoral prepared faculty to the regional and specialty 
accreditation requirements specifying the terminal degree in the preparation of faculty 
and requesting increased scholarly research. Many of these professions are considering 
transitioning to the clinical doctorate and it is expected that faculty be at or above the 
level they are teaching. One measure of faculty development and quality improvement is 
increasing numbers of doctoral prepared faculty (Clement, 2005).  
 Raising the level of entry for practice from a master’s to a doctorate requires 
analysis of the potential impact on educational programs and institutions. Clement (2005) 
argued that a strong rationale is needed to neutralize opposition regarding degree creep 
and an approved design and process for programmatic and curricular changes. Degree 
creep refers to the gradual increase in academic requirements necessary to enter a 
profession without justified increased knowledge and skill content demonstrated in the 
program (Loochtan, 2001). Clement emphasized that the transition will be associated 
with many hurdles during implementation. Changing from a graduate to a professional 
degree involves procedural transitions that have impact on students, faculty, clinical 
affiliations, other health care programs, and institutional policy and resources. 
 In 2005, the Higher Learning Commission (HLC) of the North Central 
Association of Colleges and Schools set up a task force to study the trends and growth in 
professional doctorates and the responses from academic institutions to these degrees 
(Higher Learning Commission, 2006). In the 2006 final report to the HLC Board of 
Trustees, the Commission stated that in health care professions “there is an obvious need 
to create capacity to educate practitioners and those who will primarily be educating 
practitioners” (p. 8) and that the professional doctorate should be considered as a degree 
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level within the hierarchy of U.S. degrees to fulfill this need. The Commission also noted 
the importance of national consistency in defining and evaluating professional doctorates 
and that this can only be accomplished only by the collaboration of the institutional 
accreditation bodies, the educational institutions, and the respective profession. 
 Role and responsibilities. As health professions restructure the requirements for 
entry into practice and the scope of practice, one role of the institution is to develop 
distinctions between the different levels of education and their relationship to levels of 
professional practice (Davis & Burnard, 1992). The development of the professional 
doctorate addresses the importance of research that is work-based focused and will 
develop “tradable knowledge,” which is a complement, not a replacement, to the 
theoretical focused research associated with the Ph.D. (Fenge, 2009). As a result, doctoral 
education is attracting new groups of learners, individuals who are looking for ways to 
achieve new insights and practice development but not wishing to pursue careers in 
academia or research (Bourner, Bowden, & Laing, 2001). Fenge suggested that it is 
essential for more practitioners to engage in professional doctoral programs to improve 
the research aptitude and capabilities of practitioners. Tennant (2004) stated that the 
challenge for universities is not to distinguish between the Ph.D. and the professional 
doctorate, but the transformation required to meet the needs of career professionals 
outside the traditional academic structure.   
 Barnett (as cited in Davis & Burnard, 1992) noted that one responsibility of 
education is to develop the professional. This suggests that education may be involved in 
the development of critical thinking and reflective skills that were once thought to be 
cultivated only through experience in professional practice. The translation of knowledge 
into professional action by encouraging students to develop skills, utilize knowledge, and 
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reflect on circumstances in critical ways is central to professional education (Davis & 
Burnard, 1992). The process of developing knowledge and skills does not evolve in linear 
fashion, but in a cyclic framework that is “reflected in Dewey’s model of learning from 
experience” (Davis & Burnard, 1992, p. 1399). Because the cycle of learning is a 
continual process, it becomes the responsibility of the educators to develop students as 
life-long learners who constantly revisit areas of knowledge and practice through a series 
of “study loops” (p. 1399).  
 Liao, Wang, and Chai (2007) reported that the current and future trends in health 
professions education include evidence-based practice, problem-based learning, 
informative technology, and advanced degrees for entry-level practitioners. It is the 
responsibility of the institution to develop academic programs that comply with the 
requirements and guidelines set forth by the accreditation agencies and, at the same time, 
provide the core curricula that satisfy the objectives of clinical practices that are 
established by the professional workforce (Liao et al., 2007). The nature of clinical 
education requires almost constant curriculum revision and expansion of essential content 
to maintain the currency of best practices within the health professions (O’Sullivan, 
Carter, Marion, Phol, & Werner, 2005). The institutional role to produce entry-level 
practitioners who are academically prepared and technically trained to enter into a 
profession is complicated and complex and requires strategic planning and educational 
reform.   
Accreditation 
 Academic accreditation is a complex system that has transformed from a simple 
concept of establishing educational quality assurance into a loosely coupled web of 
collaborative processes that attempt to assure and improve the quality of educational 
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institutions and programs.  Grounded in the values and beliefs common to higher 
education, accreditation in the United States has evolved in response to the rapidly 
changing environment in higher education. In order to understand the current landscape 
of academic accreditation, insight into the historical perspective is imperative. This 
section provides the foundation for exploration of the current conditions, developing 
trends, and the future climate of accreditation in the United States and its position in the 
global arena of education.   
History of Academic Accreditation 
 For more than 100 years, accreditation is the only organized means for 
establishing and assuring quality education to the larger public. Starting with the 
establishment of the New England Association of Schools and Colleges in 1895, 
accrediting agencies began forming as membership organizations whose mission was to 
provide the foundation for self-regulation as a means of identifying institutions of higher 
education that offered honorable educational quality (Brittingham, 2009). During the 
industrial revolution, the number of higher education institutions rose rapidly, and the 
diversity of the types of institutions expanded. The accreditation agencies served society 
as the primary authorities on determining which schools were legitimate quality higher 
education institutions.  
 The Flexner Report was published in 1910 and provided a scathing report on the 
quality and educational standards of medical schools in the United States. The report 
sparked the initiative to develop educational standards for medical programs and 
systematic review processes for these programs. Other professions, educators, as well as 
the public noticed this overhaul of United States’ medical education. The professions and 
educators responded by developing voluntary self-regulation processes of quality 
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assurance and quality improvement (Council on Higher Education Association, 2010b). 
The public responded by supporting the private organizations that developed the external 
quality review systems, resulting in the accelerated growth of the mission-oriented 
approach to accreditation in existence today (Brittingham, 2009). A succession of 
associations have been formed to coordinate the complex accreditation process. The 
CHEA, established in 1996, is the current private organization that coordinates 
institutional and programmatic accreditation in the United States (Eaton, 2009). 
 After World War II, the Servicemen’s Readjustment Act of 1944, known 
informally as the G.I. Bill, support for returning veterans added another layer to the 
evolving accreditation landscape. A number of new institutions were established, and the 
quality of a few was questionable. The government required a strategy to guarantee that 
the federal student financial assistance and other federal funding followed students to 
legitimate institutions of higher education. Instead of developing a new system of its 
own, the government depended on the private, self-regulating accrediting agencies as the 
primary reliable authority on the legitimacy of higher education institutions and 
programs. This has been in effect since the Reauthorization of the Servicemen’s 
Readjustment Act in 1952. States followed the lead of the federal government, making 
the accreditation system the gatekeeper for both federal and state funding (Schray, 
2006a).  
 The relationship between the accreditation industry and the federal government is 
a notable example of a successful public-private partnership (Schray, 2006a). The private 
accrediting organizations provide external peer review of institutions and programs for 
quality assurance. The federal government ensures that taxpayers and recipients of 
student aid funds are attending quality institutions and participating in legitimate 
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programs. By working together, the accreditation-federal government relationship has 
established a reliable and effective process to provide access to one of the highest quality 
higher education systems in the world (Council on Higher Education Association, 2002). 
In countries where educational accreditation is primarily controlled by the government, 
accountability standards are robust, but institutional autonomy and accessibility is 
limited. In the United States, the historic self-regulated accreditation system has allowed 
for institutional autonomy and greater accessibility, but accountability to societal 
stakeholders is weak (Hunt, 2009).    
 Between 1950 and 1965, the accreditation industry established structure and 
standards for the important service it provided for students, society, higher education 
institutions, and the public interest. The foundation of accreditation is rooted in three 
primary values and beliefs about higher education: the importance of institutional 
mission, the principle of institutional autonomy, and the essential role of academic 
freedom (Eaton, 2009). During this time, the structure included three types of accrediting 
organizations: regional, national, and specialized. The regional accrediting organizations 
are divided into six regions of the country and review entire institutions, the majority 
being degree granting and nonprofit. National accrediting organizations oversee primarily 
non-degree granting and for-profit institutions. Most of these institutions are focused on a 
specific mission such as business or faith-based (Eaton, 2009). Specialized accrediting 
organizations operate nationally and review programs that produce professionals 
requiring licensure. The specialized accrediting agencies work closely with state 
regulators on materials of licensure of individuals and professional standards.   
 Concurrently, a standardized accreditation process was established that included 
five key components: a mission-based approach, standards, a self-study prepared by the 
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institution, a peer-review site visit with report and a periodic review process, and a 
decision that is made by a commission (Brittingham, 2009). The accreditation standards 
were developed and the fundamentals of today’s accreditation process were implemented. 
First, institutions and programs conduct a self-study and prepare a written summary of 
their performance based on the standards of a particular accrediting agency. This 
document undergoes a peer review to test the reliability of the report and serves as the 
foundation for the on-site visit that occurs next. A visiting team, comprised of a 
commission of volunteer peers and public members, reviews the physical setting of the 
institutions and programs. Members of this decision-making commission will take action 
to affirm accreditation for new institutions and programs, reaffirm accreditation for 
established institutions and programs, or reject accreditation to institutions and programs 
(Council on Higher Education Association, 2002). The final component is that the 
institutions and programs must continue an on-going external review process. The review 
cycle may vary depending on the specific standards set by the accreditation agency and 
recommendations of the appointed commission. 
 The accreditation process is performed by 81 recognized private, non-profit 
organizations (Council on Higher Education Association, 2006a). Both the CHEA and 
the federal government, by virtue of the U.S. Department of Education, formally 
recognize these accreditation organizations (Schray, 2006a). The criteria for recognition 
and the outcomes of recognition used by the non-governmental coordinating agency 
CHEA, and the criteria for recognition and the outcomes of recognition used by the 
federal government, are different.   
 As mentioned above, the private, non-governmental accreditation industry was 
established as a self-regulation mechanism for higher education to verify quality 
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standards in education through a peer-evaluation process. The peer-evaluation process is 
accomplished by national, regional, and specialized private, non-profit organizations 
called “accreditation agencies.”  The agencies develop their own quality standards and 
processes to evaluate institutions and programs. The majority of these organizations have 
full- and part-time employees to carry out the day-to-day operations but rely heavily on 
volunteers who have a stake in accreditation to execute the accreditation process. The 
governing body and decision-making commission of an accreditation agency is 
comprised of appointed or elected members representing higher education faculty and 
administrators, practitioners in specific fields, and members of the public (Council on 
Higher Education Association, 2010b). Primary funding comes from annual dues from 
institutions that are accredited and fees that institutions pay for the accreditation 
appraisal.   
 For more than 50 years, this self-regulating accreditation industry has been 
coordinated by a non-governmental coordinating agency. In 1974 the Council on 
Postsecondary Accreditation (COPA) was formed as a result of a merger between the 
Federation of Regional Accreditation Commissions of Higher Education (FRACHE) and 
the National Commission on Accrediting (NCA).  FRACHE represented the regional 
accreditors, and the National Commission on Accrediting, founded in 1947, represented 
the national and specialized accreditation agencies (Department of Education, as cited by 
National Association of State Administrators and Supervisors of Private Schools 
[NASASPS], 2011). COPA members voted to dissolve in 1993 due to tensions among the 
membership, the result of the problems that faced higher education throughout the 1980s 
and 1990s (Council on Higher Education Association, 2010c). A temporary entity, the 
Commission on Recognition of Post-secondary Accreditation (CORPA), was established 
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to continue the recognition of accrediting agencies until a new national organization for 
accreditation could be established (NASASPS, 2011). According to the Council on 
Higher Education Association (2010b) website, CHEA utilizes a recognition process that 
confirms accreditation agencies evaluate an education institution on five standards: 
 • advances academic quality; 
 • demonstrates accountability; 
 • encourages purposeful change and needed improvement; 
 • employs appropriate and fair procedures in decision-making; and 
 •  continually reassesses accreditation practices. (p. 2) 
 The outcome for an accrediting agency to receive recognition by CHEA is the assurance 
that the accreditation process that they employ promotes quality, integrity, and 
consistency.    
 The federal government utilizes the non-governmental accreditation to identify 
institutions eligible to receive federal student financial assistance and other federal funds 
(Schray, 2006b). According to the U.S. Department of Education (2011b) website: 
 The U.S. Secretary of Education (Secretary) is required by statute to publish a list 
 of nationally recognized accrediting agencies that the Secretary determines to be 
 reliable authorities as to the quality of education or training provided by the 
 institutions of higher education and the higher education programs they accredit. 
 (Part 602.1, para. 1) 
 The Accrediting Agency Evaluation Unit, under the auspice of the Office of 
Postsecondary Education and the National Advisory Committee on Institution Quality 
and Integrity (NACIQI), was established within the Department of Education to execute 
the federal responsibilities in accreditation (Council on Higher Education Association, 
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2006b). The criteria for recognition by the U.S. Department of Education are defined in 
Title 34 of the Code of Federal Regulations, with the most recent update effective July 1, 
2010 (Department of Education, 2011a). The accrediting agency that applies for federal 
recognition must demonstrate that the accreditation process employed effectively 
addresses the institution or program in the following areas: 
 • success in student learning outcomes related to the institution’s mission; 
 • curricula; 
 • faculty; 
 • facilities, equipment, supplies; 
 • sufficient fiscal and administrative resources; 
 • sustainable student support services; 
 • transparent recruiting and admission practices, academic calendars, catalogs, 
grading, and advertising tools; 
 • details of objectives and measures of programs offered; 
 • disclosure of student grievances available to agency; and 
 • record of compliance of institutional responsibilities under Title IV of the 
Higher Education Act, based on the most recent updates. (Schray, 2006a, Federal 
Government Recognition section, para. 4) 
 When the application for recognition is submitted to the U.S. Department of 
Education by the accreditation agency, the NACIQI will make a recommendation to the 
Secretary of Education regarding recognition. The secretary, in view of the Committee’s 
recommendation, makes the final designation concerning recognition (U.S. Department 
of Education, 2011a). Funding for the CHEA recognition process is acquired through fees 
charged to the institutional members. The federal government recognition process is 
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funded through congressional budget allocations to the Department of Education (Eaton, 
2009).  
 The Higher Education Act (HEA) was signed into legislation in 1965 with the 
goal of strengthening American colleges and universities. The Higher Education Act of 
1965 was a response to concerns for more higher education opportunities for lower and 
middle class families, the lack of proficient instructors in emerging areas of study, the 
need for improved library resources at institutions, and the important role universities 
play in dealing with community development issues such as poverty and economic 
growth (Council for Opportunity in Education, 2003). This piece of legislation governs 
federal financial aid programs, institutional aid programs, and regulations that apply to 
colleges and universities as a prerequisite for awarding federal funds. The HEA section, 
Title IV: Student Assistance, addresses elements that pertain to federal student aid, 
including institution and program accreditation requirements. The HEA was reauthorized 
in 1968, 1972, 1976, 1980, 1986, 1992, 1998, and 2004. Each reauthorization included 
changes to regulations related to the relationship between accreditation and the 
disbursement of federal funds. The amendments focused primarily on increases in 
institutional and program accountability measures. Accreditation is the targeted path in 
which study procedures and accountability reports can be collected. According to 
Brittingham (2008), “The newly re-authorized HEA, or Higher Education Act, has 
approximately 100 new reporting and record-keeping requirements for colleges and 
universities” (p. 36, emphasis in original). The strengthening control of the accreditation 
process through governmental policing has raised concerns that the non-governmental, 
voluntary process of institutional accreditation, historically unadulterated, may be in 
jeopardy. The convoluted relationship between the private accreditation industry and the 
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federal government has implications on many levels that are too vast for discussion in 
this chapter. Key references in this area include Brittingham (2008) and Graca (2009). 
 In the past two decades, a fervent interest has occurred in questions being asked 
about higher education. Critical questions related to accessibility, affordability, 
accountability, and quality have implications for the accreditation process and 
expectations because of its vital role in the American higher education community 
(Schray, 2006b). Accreditation is the primary method of quality assurance in higher 
education, serves as a gatekeeper to federal and state funding, and promotes 
accountability to the larger public. As tensions mounted in the higher education climate, 
accreditation became the target for any public discord and the buffer for the friction 
between institutions maintaining autonomy and increasing government regulations 
(Wergin, 2005). The accreditation system has been criticized for being “cumbersome, 
expensive, secretive, and outdated” (McMurtrie, 1999, p. 41) in a time when education is 
experiencing a rigorous transformation.   
 The assumption is that accreditation guarantees quality. Many researchers are 
suggesting that, during the accreditation era, the quality of higher education had been 
slipping. The 2003 National Study of Adult Literacy reported that millions of American 
adults possessed below minimum standard reading abilities (Neal, 2008). This is one 
example of the mounting problems faced by the education industry. Suggestions began to 
surface that evaluation by the government, institutions, and the public sector of the 
accountability structure of the U.S. educational system may be warranted. An audit of the 
current accreditation system, such as the Flexner Commission conducted on U.S. medical 
education, may result in solutions to some of the accountability loopholes for a more 
contemporary update to the system.      
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 In 2005, as a response to the escalating interrogation, Secretary of Education 
Margaret Spellings formed the Commission on the Future of Higher Education. The 
Commission was established to initiate a national dialogue on the future of higher 
education and charged with “examination of how we can get the most out of our national 
investment to ensure that our higher education system continues to meet our nation’s 
needs for an educated and competitive workforce in the 21st century” (Schray, 2006, 
para. 1). The Commission placed the status of accreditation high on the agenda and 
launched an exhaustive audit of the current system and initiated conversation with the 
accreditation community and higher education stakeholders on improvement strategies 
for the accreditation process and expectations. 
 Published in 2006, the Spellings Commission report, A Test of Leadership: 
Charting the future of U.S. Higher Education (Commission on the Future of Higher 
Education, as cited in Bardo, 2009), was successful in the mission to initiate a national 
dialogue on the future of higher education and identified key concerns that warrant 
improvement throughout the higher education landscape. The report was highly critical of 
the current accreditation system and projected little confidence or conviction in 
accreditation as a force for quality in the future (Eaton, 2009). According to Bardo, the 
report calls for action and provides recommendations on five themes regarding the future 
of accreditation: 
 • the balance between government regulation and peer study; 
 • study of student learning; 
 • credit transfer between institutions; 
 • transparency of accreditation; and 
 • due process in accreditation. (p. 48) 
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The Spellings Commission report “has been taken as a major wake-up call for both 
higher education and the regional accrediting bodies” (Bardo, p. 48). He suggested that 
this report, along with two emerging trends - the concern with higher education costs, 
productivity, and outcomes from all stakeholders and the paradigm shift to outcomes 
based studies - are the provocation for significant transformation in accreditation.  
 Higher education and accreditation leaders heeded consideration for the 
Commission’s criticisms and recommendations. The Council on Higher Education 
Association (2010b) acknowledged that the Commission identified important concerns to 
be addressed for the accreditation process and its role as a force for quality. The 
accreditation industry and higher education, with the support and guidance of CHEA, 
have made progress in addressing the concerns stemming from the Spellings commission 
and are creating a culture of evidence, study, and accountability (Bardo, 2009).   
 Judith Easton, President of CHEA, expressed caution regarding the Commission’s 
call to nationalize quality standards. She proposed that movement toward federalization 
of a single set of standards and benchmarks for quality assurance would override the 
importance of self-regulation and escalate the public distrust in the autonomy of higher 
education (Council on Higher Education Association, 2010b). According to the American 
Council on Education (ACE), accreditation was one of the most controversial topics in 
the 2008 HEA reauthorization (American Council on Education, 2008). Congress 
asserted itself more directly into the accreditation process through amendments made 
related to the accreditation recognition process, the establishment of quality standards, 
and federal student aid provisions (Bardo, 2009). Because of the connection to Title IV 
financial aid and accreditation, institutions will be required to revise their organizational 
structure and must allocate additional resources on study, reporting, and accountability 
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measures.   
 In 2008 the institutions and accreditation agencies began their own investigation 
into the current accountability structure. The Council for Higher Education Accreditation 
launched the CHEA Initiative, a multi-year national conversation on the future of 
accreditation (CHEA, 2012). Many charges were related to this initiative, but the primary 
one was to gather information to prepare for the anticipated reauthorization of the Higher 
Education Act in 2012 (CHEA, 2010a, para.1). Through extensive dialogue with a 
plethora of stakeholders, eight issues about the future of accreditation were identified:  
 • advocacy for accreditation; 
 • accreditation’s relationship with the federal government; 
 • accreditation and accountability; 
 • accreditation’s relationship with state governments; 
 • the relationship between institutions and accrediting organizations; 
 • the relationships among accreditors; 
 • international activity; and 
 • the growth of the for-profit sector. (CHEA, 2010a, para. 5) 
Initially, the participants acknowledged that changes were warranted in accreditation 
policy and practices but were interested in incremental changes over time. As the CHEA 
moves forward with this initiative, the action plan development phase will begin with 
many more national conversations. 
 Concurrently, the Higher Education Opportunity Act of 2008 (HEOA) was 
passed, resulting in increasing governmental pressure with regard to accountability from 
accreditation (CHEA, 2010c). The intensifying legislative activity created a sense of 
urgency for action by the participants in the Initiative’s conversation. The focus shifted to 
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concerns about the relationship between the federal government’s expectations and the 
role of the accrediting organizations in compliance. The framework for action plans for 
the most relevanct issues in accreditation and higher education are being developed in 
preparation for the next reauthorization of the Higher Education Act in 2013. 
 The accreditation industry has been functioning with the same mission and 
processes for over 50 years. A profession or industry that is proactive in self-regulation 
and self-study establishes a more superior position in public opinion than one that is 
forced into regulations and demands from authority. In that sense, accreditation is 
beneficial to all stakeholders: institutions, students, and the general public. On the other 
hand, the United States and the global educational system are experiencing a paradigm 
shift in accountability measures, and it seems a perfect time for reflection and evaluation 
of the current U.S. accreditation system. The issues that have surfaced through public 
discourse, the Spellings Report, and the CHEA Initiative may result in a first-order 
change in the accreditation industry. Unless a major unexpected shift in course occurs, 
the identified issues will be incorporated into the accreditation process, and the leaders in 
higher education and accreditation will be required to respond to the requirements. The 
tensions between the federal government and accreditation and higher education 
communities for balance of power require constructive negotiations and collaboration to 
establish a structure that is best for the U.S. educational system and the citizens. 
 Academic accreditation. Academic accreditation is a complex system that has 
evolved from a simple concept of establishing educational quality assurance into a 
loosely coupled web of collaborative processes. According to the Council on Higher 
Education Association (CHEA, 2010c) website, “Accreditation is the primary means of 
assuring and improving the quality of higher education institutions and programs in the 
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United States” (para. 1). In order to understand the landscape of academic accreditation, 
several facets should be addressed. A historical perspective will provide a foundation for 
exploration of the current conditions, developing trends, and the future climate of 
accreditation in the United States regarding its position in the global arena of education.   
 Structure. The decentralized and complex accreditation structure in the United 
States is unique compared to most countries, which is reflective of the decentralized and 
complex structure of U.S. higher education (Eaton, 2009). Brittingham (2008) suggested 
that the American quality assurance system stands out in three factors: 
   • accreditation is a nongovernmental, self-regulatory, peer review system; 
   • nearly all of the work is done by volunteers; and 
   • accreditation relies on the candor of institutions to assess themselves against a 
set of standards, viewed in the light of their mission, and identify their strengths and 
concerns, using the process itself for improvement. (p. 10)  
 The CHEA (2010c) website lists four types of accrediting organizations in the 
United States. Regional accreditors focus on public and private, non-profit and degree-
granting, two- and four-year institutions. The eight regional accreditation agencies 
service both higher education institutions and K-12 institutions. The national faith-based 
accreditors examine religiously affiliated and doctrinally-based institutions, mainly non-
profit and degree granting. National career-related agencies accredit primarily for-profit, 
career-based, single-purpose institutions. Programmatic accrediting agencies focus on the 
specific programs that are housed in the higher education institutions, such as health 
professions, law, and teacher programs.    
 Dynamics. The accrediting associations obtain their status through a recognition 
process that is similar to the accrediting process of its institutional membership. The 
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CHEA and the Department of Education (DOE) independently establish standards that 
must be met by the accrediting organizations in order to be recognized. CHEA 
recognition addresses the academic legitimacy of the accrediting agencies’ membership. 
The DOE recognition is required for agencies whose members seek eligibility for federal 
student aid funds (Eaton, 2009; CHEA, 2010b).  
 Over 100 years ago, accreditation began as a voluntary system and, theoretically, 
it still is considered a voluntary system. It is established that the accreditation emerged as 
a non-government controlled process, but an institution must be accredited to be eligible 
for federal financial support. This support may be viewed through student financial aid, 
grant monies, and research support, as well as other avenues. In today’s climate, federal 
student financial aid is in excess of $78 billion per year (Neal, 2008). If a college or 
institution were to lose accreditation, it may be a financial disaster.   
 Role and responsibilities. Academic accreditation specifies four major tasks in 
the mission: ensure quality assurance, provide access to federal and state funds, stimulate 
society’s confidence in higher education, and support transferability (Eaton, 2009). 
Another piece of the accreditation industry’s mission is to ensure quality improvement of 
higher education. Success in encouraging major innovation while maintaining quality is 
noted through the development of community colleges and the advent of student learning 
(CHEA, 2010c). Many states that carry out professional licensure require that graduates 
sitting for the examination for licensure have graduated from an accredited program. In 
addition, many states require that all professional programs offered at institutions within 
the state be accredited.  
 Accreditation of institutions and programs takes place on a continuing cycle that 
varies based on the situation. The cyclic process of developing standards, institutional 
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self-study, peer-review, and commission-based judgments ensure that accreditation in the 
U.S. is trustworthy, legitimate, and self-regulating as a process. Accrediting agencies 
provide legitimacy to organizations and schools seek out these bodies because 
accreditation enhances their reputations (Marion, 2005). To attain support from the public 
and private sector, schools must be perceived as creditable or legitimate. “Institutionalism 
is the process by which systems achieve legitimacy” (Human & Provan, as cited in 
Marion, 2005, p. 282). 
 Standards. A trend that is emerging in educational environments is that of 
accountability. Accreditors are accountable to the institutions and programs that comprise 
the membership. They also are accountable to the general public and government who 
have a large stake in the quality of higher education in America (Eaton, 2009). The 
CHEA website notes that one of the ways that accreditation serves students, society, and 
the public interest is by being responsive to the current climate of accountability. The 
current focus on student outcomes, institutional performance, greater transparency, and 
transferability are concerns being addressed in the established standards and study tools 
utilized by the accrediting bodies. A new generation of study tools, such as the Collegiate 
Learning Study, provides institutions with constructive feedback on how the students 
have performed and how the institution is performing in comparison to similar colleges 
and universities (Brittingham, 2009). The current U.S. accreditation system provides a 
starting block toward a consequential accountability system, but major modifications will 
need to be arranged. Rothstein, Jacobsen and Wilder (2005) suggested: 
 The American accreditation system includes many elements that could   
 easily be adapted for accountability purposes….Regional associations could 
 specify state-endorsed cognitive and behavioral outcomes, and the associations 
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 could develop measurement tools to assess whether schools actually contribute to 
 these outcomes - not only whether they follow appropriate instructional practices, 
 but whether satisfactory student learning is actually achieved. True accountability 
 would make accreditation mandatory, not voluntary; outside intervention and 
 remediation would have to accompany serious warnings that might lead to loss of 
 accreditation. (p. 629)    
 Important changes have been taking place in the accreditation model for K-12 
schools worldwide, but in the United States there are some concerns that are surfacing 
(Bernasconi, 2004). The eight regional accreditation agencies have set standards that are 
qualitative in nature and generally equitable. Questions arise because of significant 
variances in the accreditation processes between the eight recognized regional agencies. 
In addition, the accreditation policy at the state level varies considerably across the 
United States. Some states do not require accreditation, a few require regional 
accreditation, and many have created their own state accreditation standards and 
processes (Bernasconi, 2004). Although a wide variety of thoughts on the accreditation 
process abound, the general trend in K-12 and higher education has been movement away 
from inputs or resources to focusing on outputs, processes, and effectiveness 
(Brittingham, 2009).   
Professional Associations 
 Professional associations are not-for-profit organizations established to benefit a 
particular profession. Carver (2006) notes that professional associations have a dual role 
of representation and regulation. The mission of a professional association may 
encompass a variety of objectives that seem conflicting in nature. The intention of 
endorsing professionalism of the highest integrity and advocacy for the individuals in the 
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profession appears at odds with the responsibility to protect the public interest by 
regulating the members (Friedman & Phillips, 2004). In addition, professional 
associations function as bureaucratic organizations and lobby for the professional interest 
in legislative concerns (National Institutes of Health, 2011).  
Structure 
  Watkins, Drury, and Bray (as cited in Friedman & Phillips, 1996) explained that 
the traditional governing structure for non-profit organizations is based on committed 
involvement of volunteers organized into large executive boards, complex committee 
structures, and a diverse membership. The governance is charged with determining 
mission, establishing strategy, and implementing policy in response to needs and 
expectations of the membership (Friedman & Phillips, 1996). The main source of income 
is membership dues, which implies that the members own the association. Carver (2006) 
cautions that this is overly simplistic because of the complex responsibilities of the 
association to both the members and the public. Friedman and Phillips (1996) pointed out 
that over the past two decades, members are demanding expanded services and greater 
support, while requesting the association advocate for the profession on government 
initiatives. Watkins et al. (as cited in Friedman & Phillips) argued that the traditional non-
profit model of a large governing board, an overabundance of committees, and 
ceremonial decision-making processes are unable to adapt to these changing 
environments.  
 Kushner and Poole (1996) suggest no single governance structure is ideal for all 
associations, but that structural function is associated with organizational effectiveness. 
Structural dysfunction with the association governance may result in organizational 
failure. Bradshaw, Murray, and Wolpin (1992) posited that the size of the governing 
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board and the complexity of committees is not directly related to organizational 
effectiveness. Brown and Iverson (2004) argued that traditional governance model of 
non-profit organizations correlates with minimal proactive strategic planning. Murray 
(1996) suggested that, if an organization fails, it is not due to unfitting governance 
structure but may be because of unsuitable implementation of the model. Carver (2006) 
concluded that the governance structure of an organization is determined by history and 
circumstance. It is possible that the history and circumstances can produce structures that 
interfere with effective governance, especially in a complex and changing environment. 
Dynamics 
 Professional associations fundamentally operate as service organizations that 
provide opportunities for participation and product benefits to their customers, who are 
referred to as the membership (Gruen, Summers, & Acito, 2000). For these organizations 
to be effective, a healthy, committed relationship must be present between the association 
management and membership. Gruen et al. (2000) explained that these relationships are 
bound agreements based on economic investment by members through payment of dues 
and membership renewal in exchange for the benefits and professional opportunities 
supplied by the association. As other non-for-profit organizations, professional 
associations rely on volunteers to participate in the governance and delivery of services 
available to the membership. Bhattacharya (1998) pointed out that members can help the 
organization by volunteering time and donating money to support the mission of the 
organization. In the United States there are over 80,000 registered professional 
organizations representing a variety industries, professions, causes, and interests (Gruen 
et al., 2000). Bhattacharya reported that, in 1994 the top 50 organizations that sold 
individual memberships represented some 165 million people. In 2010 23 professional 
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associations and societies represented the pharmacy profession (Professional Societies 
and Associations, 2010).  
 Wilson (1995, p. 341) identified an extended list of variables that have theoretical 
and empirical support to influence relationships: 
 • commitment; 
 •trust; 
 • cooperation; 
 • mutual goals; 
 • interdependence/power imbalance; 
 • performance satisfaction; 
 • comparison level of the alternative; 
 • adaptation; 
 • nonretrieveable investments; 
 • shared technology; 
 • summative constructs; 
 •structural bonds; and 
 • social bonds. 
  Wilson (1995) suggested that commitment in relationships is the most important 
variable for the sustainability and future of institutional viability. In an attempt to 
understand the levels of membership commitment, Gruen et al. (2000) turned to research 
in organizational behavior and identified three categories of membership behaviors that 
are indicative of a committed relationship in membership markets: the retention rate, the 
extent of participation, and membership coproduction (p. 36). The retention rate refers to 
the percentage of members who renew their membership annually and is related to the 
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level of member satisfaction (Bhattacharya, 1998). The authors found that, if members 
have mutual goals and support the mission of the association, motivation to renew is 
present.  
 The extent of participation by members is reflective of the quality of members 
that are committed to the organization. Gruen et al. (2000) claimed that the most 
important aspect of membership quality is member participation (p. 36), which denotes 
the average usage of benefits offered by the association.  
 The second indicator of quality membership is coproduction (Gruen et al., 2000), 
which is the extent of membership involvement in the production of products, delivery of 
services, and association leadership. Early in the relationship, members tend to participate 
by being primarily consumers of products offered by the association. Over time, the 
development of trust and friendship, supported by quality products and services, results in 
stronger and valuable relationship. Morgan and Hunt (1994) believed that when 
commitment and trust are present, outcomes of efficiency, productivity, and effectiveness 
flourish. Gruen et al. argued that in committed, long-term membership relationships, 
customers become more involved in governance and participate in the coproduction and 
value creation of the organization. Wilson (1995) suggested that, when both parties give 
“non-retrievable investments” (p. 342), an increase is seen in value creation and stronger 
structural bonds. Morgan and Hunt (1994) suggested that cooperation and collaboration 
in professional networks are required by members of a profession for the profession to be 
competitive and effective in the global market (p. 20).  
Role and Responsibilities 
 Professional associations represent the interests of the membership and regulate 
the standards and strategic development of the profession. Greenwood, et al. (2002) 
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suggested three reasons that professional associations are important in the 
institutionalization of a profession: to provide the construct and management of intra-
professional regulation, to act as a negotiating or representative agency, and to monitor 
compliance with institutional norms. Decision making within a profession about 
boundaries, membership, and behavior can be a political process (Dezalay & Garth, 
1996). Professional associations provide a venue where stakeholders from the 
professional community interact and discuss competing interests. From the interactions 
and discussions, understanding of reasonable conduct and behaviors of the professional 
community are established (Greenwood et al., 2002).  
 The professional association represents the membership in interactions with 
external stakeholders and communities regarding the intra-professional agreement. 
Through negotiations with other stakeholders and the membership, the characteristics are 
shaped and redefined into the identity and distinctiveness of the profession. Once 
professional belief and practices are established, the professional associations play an 
important role in advocating value and monitoring compliance of institutionalized 
practices by the membership. This regulatory function is sustained through routines such 
as training and education, professional development, and disciplinary actions 
(Greenwood & Hinings, 1996).  
 Greenwood et al. (2002) also suggested that associations play an important role in 
times of deinstitutionalization or change within a profession. They suggested:  
  associations can legitimately change by hosting a process of discourse through 
 which change is debated and endorsed: first by negotiating and managing debate 
 within the profession; and, second, by reframing professional identities as they are 
 presented to others outside the profession. This discourse enables professional 
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 identities to be reconstituted. (p. 59) 
 Lalonde, Menendez, and Perron (2010) posited that health professional 
associations have the knowledge, skills, and abilities to be leaders in the campaign for 
practice change and improvement, to influence the remodeling of service delivery, and to 
advocate for policies that protect society. Strong associations may be able to identify 
barriers present in the community and promote innovative ways to address them. Lalonde 
et al. identified commonalities among these professional associations: 
 • develop and promote standards of care and innovative practices; 
 • assume leadership in the establishment of standards of education, practice, and 
professional competency studies; 
 • participate in training programs and continuing education activities; 
 • act as technical advisors in national working groups; 
 • promote collaborative practice; and 
 • work with government and other stakeholders in developing, implementing, 
monitoring, and evaluating health policies and programs. (p. 2134) 
 Professional associations have important regulatory roles and responsibilities and 
contribute to the institutionalization and legitimization of a profession. Greenwood et al. 
(1996) found that associations play a vital role when a profession is going through a 
change process. Professional associations are important during the deinstitutionalization 
and reframing of a professions’ identity. Macpherson (2010) recommended that 
professional associations review and refine their services that align with the needs and 
expectations of the membership. Macpherson surveyed educational leaders and found 
they want the professional associations to provide services related to professionalization 
of the industry, instead of acting as a representative of the industry.   
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Degree Classifications 
 Higher education leaders, government officials, and business executives have 
been engaged in detailed discussions about learning, calling for an increase in the 
proportion of Americans with high-quality degrees and credentials (Hebel, 2010). Mark 
Bouchard, chairman of the Salt Lake City Chamber of Commerce’s effort to improve 
education in Utah stated, “Education is the greatest single asset we have in society today” 
(cited in Hebel, 2010, p A4). The Lumina Foundation on Education is a leader in the 
efforts to increase higher education attainment rates in the United States. The challenge, 
“Lumina’s Big Goal,” calls for the proportion of the U.S. population that holds a high-
quality postsecondary degree or credential to be 60% by 2025 (Lumina Foundation for 
Education, 2010, p. 1). Lumina believed “the value of degrees and credentials--both for 
the individual and society as a whole--ultimately rests on the skills and knowledge they 
represent. The quality of the degree or credentials has well-defined and transparent 
learning outcomes that provide clear pathways to further education and employment” (p. 
1).  
 In the workforce, job applicants are partially evaluated on their credentials. The 
decipherment of the wide range of academic degrees, training certifications, and licenses 
to practice is a challenge for employers (Nemec & Legere, 2008). Society has a strong 
reliance on paper credentials, and no meaningful system exits to interpret their 
significance. Contreras (2004) suggested that reliance on degrees does not serve a public 
interest and that there is a difference between a degree and a skill set or knowledge. 
Contreras argued that we are inundated with degrees that have been devalued, and degree 
programs that get longer and longer are not producing graduates with greater skill sets or 
knowledge. 
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Academic Degrees 
 The academic degree is described as a cultural artifact and a symbol of American 
postsecondary education (Glazer-Raymo, 2005). In the United States, academic degrees 
come from many sources, and the nature and function of the degree may be perceived 
differently from source to source. An academic degree is a title conferred by universities 
and colleges when successful completion of courses has been achieved as determined by 
the degree-granting institution (Random House Dictionary, 2005). The institution and 
individual programs within the college or university should hold accreditation from a 
reliable and nationally recognized accreditation agency (Nemec & Legere, 2008). 
According to the National Center for Education Statistics (NCES), the academic degree is 
sought after in ever-increasing numbers across every demographic. The NCES reported 
that, in 2006, more than 2.9 million academic degrees were conferred in the United 
States. They estimate this number will reach nearly 3.5 million by 2017 (National 
Association for Educational Statistics, 2008). The academic degree allows the student to 
proceed through the hierarchy of academic endeavor from bachelor’s, master’s, and 
doctor’s degrees or into the workforce. 
 Baccalaureate. In the United States, a bachelor’s degree is the foundational post-
secondary award, usually requiring three or four years of study (Random House 
Dictionary, 2005). The Common Data Set of U.S. Higher Education Terminology (2010) 
defined a bachelor’s degree as: 
 an award (baccalaureate or equivalent degree, as determined by the Secretary of  
the U.S. Department of Education) that normally requires as least four years but not more 
than five years of full-time equivalent college-level work. This includes ALL bachelor’s 
degrees conferred in five-year cooperative (work-study plan) programs. Also, it includes 
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bachelor’s degrees in which the normal four years of work are completed in three years. 
(n.p.) 
 The program content and completion requirements for a baccalaureate degree are 
not consistent among degree granting institutions, which may interfere with the 
transferability of course credits. In the 1998 Statement to the Community: Transfer and 
the Public Interest, the CHEA inquired about the transfer process and academic quality 
and began a campaign to organize the process. They acknowledged that student mobility 
and opportunities in higher education depend in part on successful transfer of credit 
(CHEA, 2002).  
 In response to the changing economy, there is increasing demand for 
baccalaureate-level education for certain jobs that never before required these credentials 
(Ruud, Bragg, & Townsend, 2010). The need to respond to workforce demands has 
placed academic institutions in a position of workforce development. Ruud, Bragg, and 
Townsend explained that this situation has given rise to a new and innovative degree 
known as the Applied Baccalaureate. Supported by the Lumina Foundation for 
Education, the authors used telephone interviews and document analysis to better 
understand why “the degree was emerging as a means to facilitate baccalaureate 
completion for adults who accumulated some college credits but failed to obtain a degree 
and for adults who had not enrolled in college” (p. 138). They found that many states 
indicated a dedication to general baccalaureate attainment within their state. The 
Kentucky Council on Postsecondary Education, as cited in Ruud et al. (2010), 
implemented the Double the Number campaign to “double the number of bachelor’s 
degree holders in the state by 2020” (p. 140). Ruud et al. suggested that these types of 
initiatives have brought together community colleges and traditional institutions to 
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develop the Applied Baccalaureate from a desire to enhance the states’ overall 
baccalaureate attainment rates. 
 Postbaccalaureate. Storr noted (as cited in Glazer-Raymo, 2005) that in the early 
years of American higher education, the baccalaureate was the only earned degree 
awarded following completion of a course of study. The master’s degree was a conferred 
honorary degree awarded at commencements and graduation ceremonies. In 1851 Henry 
Tappan, president of the University of Michigan, instituted the Masters of Arts (M.A.) 
and Masters of Science (M.S.) as earned degrees aligned with the undergraduate 
baccalaureate and the research doctorate, the Doctor of Philosophy (Glazer-Raymo, 
2005). Master’s programs emerged as the degree of choice in professional fields, while 
the research doctorate was the degree of choice for those pursuing a career teaching in the 
expanding higher education system. In 1909 the newly established Association of 
American Universities (AAU) declared a need for organization of postbaccalaureate 
education and called for a definition of purpose of the master’s degree, resulting in the 
hierarchy of academic degrees that we understand today. The hierarchy of academic 
degrees begins with the undergraduate baccalaureate as the foundational degree and a 
pre-requisite for advancement to higher levels of education. Postbaccalaureate, or 
graduate academic degrees, are granted at the master’s level as a free-standing 
professional degree, and the research doctorate is the gold standard in the graduate degree 
hierarchy (Berelson, 1960).   
 Master’s. During the 20th century, there was persistent promotion of higher 
academic standards in graduate education occurred. The Association of American 
Universities (AAU) study of the master’s degree in 1909 and the 1910 Flexnor Report on 
medical schools made the standardization and professionalization of graduate education a 
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priority. As academic leaders struggled to establish standards and structure, a rapid 
expansion was seen of professional fields and proliferation of diverse master’s programs 
in professional and academic fields, leading to a potentially chaotic situation (Thelin, 
2004).   
 In the 1960s the Association of Graduate Schools declared that the master’s 
degree needed to be “rehabilitated, revitalized, resuscitated, refined, and readjusted” 
(Glazer-Raymo, 2005, p. 9). The American Council on Education responded by forming 
the Committee on Academic Degrees in 1962 charged with investigating the proliferation 
of master’s degrees in professional and academic fields. Recommendations for 
standardization and professionalization were made from various stakeholders, including a 
proposal by Stephen Spurr, then president of the University of Texas at Austin, that 
suggested a one-year academic master’s, a two-year professional master’s, a three-year 
professional, and a four-year doctorate (Spurr, 1970). In 1973 the Council on Graduate 
Schools proposed that the ideal master’s degree program consists of:  
 Preplanned and coherent sequence of lectures, seminars, discussions, and 
 independent studies or investigations, designed to give the student the 
 opportunity to learn from original sources in the library, from studies 
 conducted in the laboratory, through creative scholarship (whether research 
 or professionally oriented) and through research or professional practice in 
 the field. (as cited in Grazer-Raymo, 2005, p. 11) 
 Colleges and universities began to adapt the degree in response to a growing 
demand for advanced education for entry into professional work, compared to merely a 
step toward the Ph.D. path. O’Brien (1992) explained that the transformation occurred at 
the institutional level, with master’s degree programs being adapted to offer subject 
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specialization, professionalization, and career development. Conrad, Haworth, and Millar 
(1993) summarized the findings of a Council of Graduate Schools’ sponsored study of 
master’s degrees, establishing that the degree is recognized as a significant, and often 
terminal, credential for managing entry into and advancement within many professions.  
 The growth in practitioner-oriented education has expanded the landscape of 
master’s level education. Educators have developed various strategies to meet the 
changing landscape at an institution-by-institution basis, making the standardization and 
professionalization of the master’s degree more complex (O’Brien, 1992). Haworth, 
Conrad, and Polster (2012) stated that a national database is not maintained to track or 
investigate master’s degree programs, providing little understanding about the general 
purposes, quality, and value of the master’s degree and master’s education in the United 
States. 
   Doctorate. The purpose of doctoral education is to prepare an individual with 
mastery of advanced knowledge, scholarly research skills, and the ability to apply theory 
to practice in the discipline in which the degree is earned (Clement, 2005). Two main 
classifications of doctorate degrees are the research doctorate, named a Doctor of 
Philosophy (Ph.D.), and the professional doctorate that traditionally was a “pre-service” 
high-level degree that served a role in the preparation for entry into a profession.  
 The research doctorate has traditionally been regarded as the highest degree on 
the hierarchy of academic degrees and understood and recognized internationally. 
However, in many fields today, especially the natural sciences, the post-doctorate has 
become implicitly the terminal degree in these areas, and employment without this 
holding is highly unlikely. In large part this is because the post-doctorate often serves as 
an apprenticeship toward participating in and then acquiring the funding necessary to set 
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up one’s own lab to continue research in some specialized aspect of cutting edge 
investigations (Cook, Irby, Sullivan, & Ludmerer, 2006). 
 The professional doctorate is diverse across a broad array of disciplines and has 
important structural and conceptual differences that vary from country to country 
(Neumann, 2005). In recent decades, the professional doctorate has become increasingly 
popular, especially in Australia and the United Kingdom (Bourner, et al., 2000; Jolley, 
2007). Professional doctorates are not new to U.S. higher education, but in the past 
decade a new category of professional doctorates is emerging, particularly in health care, 
that is creating confusion regarding their classification in doctoral education (Task Force 
on the Professional Doctorate, 2006).  Jolley indicated that much of the confusion 
surrounding doctoral education can be attributed to the differences in nomenclature 
between the countries. He summarized the scenario: 
 In the first half of the 20th century the U.S. began a proliferation of professional 
 doctorates, which were designed as pre-professional qualifications. In this way, 
 the U.S. MD is not an equivalent of the Ph.D. or even the British MD either in 
 design, level, or a preregistration qualification. In Australia, however, the 
 expanding portfolio of professional doctorates has always been intended for the 
 population of qualified professionals. Should this not be confusing enough, it 
 must also be appreciated that by the 1920s, the US Ph.D. had begun to incorporate 
 a significant teaching element, introducing a degree of similarity (and confusion) 
 with the post-qualifying professional doctorates in the rest of the world. (p. 227) 
Allen, Smyth, and Wahlstrom (2002) argued that the independence of study associated 
with the Ph.D. is undesirable for many individuals, but they do desire the internationally 
recognized Ph.D. award. 
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 In the United States, the first Ph.D. was conferred at Yale University in 1861, 
while the first professional doctorate, the Doctor of Education (Ed.D.), was awarded at 
Harvard University in 1921 (Bourner et al., 2001). Neuman (2005) suggested that the 
original intention was that the professional doctorates would be an alternative to the 
research doctorate and viewed as “complementary” (p. 183) in some fields such as 
education. Scott, Brown, Lunt, and Thorne (2004) believed the emergence of the 
professional doctorate was in response to the changing roles of the university and society 
in the production and use of knowledge, pressures for more diverse and professionally 
relevant programs, and the expansion of higher education. The authors linked the recent 
proliferation of professional doctorates to the demand from professions and workplace 
requirements for increased skills and knowledge; the emphasis on “evidence-based” 
practice; and new understandings about knowledge creation, form, and production. 
Bourner et al. suggested that the professional doctorate can be seen as “the coming of age 
of work-based learning” (p. 74). Brown and Lauder (2001) contended that national 
prosperity in a competitive global economy depends on upgrading the knowledge and 
skills of the workforce.  
 Scott et al. (2004) proposed that the growth in the professional doctorate parallels 
the increasing criticism of the traditional Ph.D. in terms of its narrow focus, the limited 
skills acquired by candidates, and its isolation in general from the workplace. The status 
of the Ph.D. is being challenged by the increased availability of doctoral degrees (“Ph.D.-
-club or history?,” 2004). Brown, Hesketh, and Williams (2003) suggested that a 
knowledge-driven economy is a strong force in the rise of mass higher education, 
especially for the terminal doctorate. This is documented by the increase of doctoral 
programs and new degrees that have risen in the past decade. These “knowledge 
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workers” expect to command high levels of general and specialized skills when they 
leave the university with graduate qualifications (Brown et al., 2003, p. 110; Tennant, 
2004). Neumann (2005) concluded that the individual student, not standard curricular 
content, should be responsible for initiating any connection between workplace and 
research. “In general the lack of involvement of professional doctorate programs in 
industry, workplace or profession was striking” (Neumann, 2005, p. 185).  
 Park (2005) contended that traditional Ph.D. programs are responding to the 
criticism by transforming the structure and content that can muddle the distinction 
between the Ph.D. and the professional doctorate. Traditionally, no explicit national 
standards or guidelines existed for doctoral education as a whole, but that is a current 
topic in higher education today. Neumann (2005) found the structure of educational 
programs and learning outcomes were similar between the Ph.D. and professional 
doctorates, and fundamentally the two doctorates are interchangable. The major 
differences were the target population and selection criteria for students (Jolley, 2007; 
Neumann, 2005). “The only distinction between the two would be the award name and 
the students’ choice to best meet their career needs at any given time” (Neumann, p. 185).  
 Entry-level doctorate. The first professional doctorate was originally introduced 
as a “pre-service” high-level credential that was instrumental in the preparation for entry 
into a profession. Programs of study were offered in professional schools and 
universities, incorporating a substantial element of coursework and research related to 
professional practice. The discipline of study was identified in the degree title (i.e., M.D., 
J.D., Pharm.D.). A first professional degree is a first degree, not a graduate degree, even 
though it incorporates the word doctor in the title (NCES, 2008). The National Center for 
Educational Statistics classified first professional degrees “as those awarded after 
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completion of academic requirements to begin practice in the following professions: 
chiropractic (D.C.); dentistry (D.D.S. or D.M.D.); law (LL.B or J.D.); medicine (M.D.); 
optometry (O.D.); osteopathic medicine (D.O.), pharmacy (Pharm.D.); podiatry (D.P.M., 
D.P., Pod.D.); theology (M.Div., M.H.L., B..D, or Ordination); or veterinary medicine 
(D.V.M.). Royeen and Lavin (2006) distinguished between the entry-level clinical 
doctorates and post-professional clinical doctorates that were first introduced in 
pharmacy’s transition to the entry-level Pharm.D. Several disciplines are present within 
the health professions such as physical therapy, nurse practitioner, and occupational 
therapy that are elevating the entry-level degree required to practice to a doctorate level.    
 Clinical. In the past decade, several doctoral programs have emerged, notable in 
the area of health care. These often are referred to as clinical doctorates or practicing 
doctorates but are not the same thing as a research doctorate or a professional doctorate in 
title or content. Clarity in terminology is relevant in discussions related to the context of 
the clinical doctorate (Royeen & Lavin, 2006). The authors posited that, in our society, 
the term doctor is notably associated with a physician. This means:  
 The nature of the degree needs to be clearly communicated to the public for 
 whom they care and that professionals identify themselves as physicians, nurse 
 practitioners, physical therapists, occupational therapists, and so on instead of 
 using the term doctor as if it were synonymous with one professional group. (p. 
 102)  
 Inconsistency is found among the diverse programs related to length, rigor, 
content, or ultimately the usefulness to the person who achieves them. Some serve as a 
license to practice, while others may be the terminal practice degree for advanced 
practice (Royeen & Lavin, 2006). In general, many professional doctoral candidates have 
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experience in or are currently working in their professional fields. The programs are 
primarily focused on the application of theory and knowledge to specific, professional 
problems, rather than trying to create new theories or knowledge, as in the Ph.D. track. 
Royeen and Lavin (2006) explained, “the clinical doctorate refers to knowledge and skill 
needed to deliver complex and advanced service/care within the scope of practice of a 
health care professional” (p. 102). Lester (2004) revealed that the practicing doctorate 
requires conceptualizations that are not defined by academic research and the generation 
of knowledge. Graduates of a clinical doctorate will be able to serve as practitioner-
researchers. More importantly, graduates of a clinical doctorate will be capable of high-
level thinking: “thinking and action needed to create significant and considered change 
and development in complex practical situations” (Lester, 2004, p. 762).  
 Certification. Certification is a voluntary process by which a non-government 
entity, such as professional association or credentialing body, awards recognition to an 
individual who demonstrates completion of standardized criteria (National Organization 
for Competency Assurance [NOCA], 2006). It is a method that a profession or 
occupation uses to differentiate among its members based on predetermined standards for 
knowledge, skills, and competencies (Nemec & Legere, 2008). The majority of 
certification programs are classified as either attendance-based or study-based 
certifications, or a combination of both.  Attendance-based certification programs require 
individuals to complete a certain amount of instructional time, but no formal study is 
demanded (Nemec & Legere, 2008). Study-based programs require participants to 
complete a formal evaluation that demonstrates the acquired knowledge, skills, or 
competencies. In addition, NOCA (2006) described an academic certification or 
“curriculum based certification” (p. 7) as completion of a series of courses, each with its 
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own completion requirements that can be demonstrated by official transcripts.   
 Over the past decade certifications have grown rapidly in vendor-specific 
technologies (Varhol, 2000). An example in health professions is in diagnostic imaging. 
These types of certification ensure that the vendor product is utilized correctly and 
consistently based on standard implementation. These certifications may add new skills 
for an individual but are not a foundation to build a career (Varhol, 2000).   
 Licence. License and licensure is the mandatory process by which a government 
agency, typically at the state level, grants permission for an individual to legally engage 
in a profession or occupation (Nemec & Legere, 2008). A license is a method of ensuring 
that a person has been deemed worthy to engage in an occupation before the public. 
Elevation of Clinical Doctorate as Entry-Level Degree 
 A controversial issue facing many disciplines in the health professions is the 
rapidly precipitating movement toward establishing the Clinical Doctorate to be the 
entry-level degree into practice. This is not a new topic of discussion among the leaders 
in the professions. Douglas (2005) suggested that the conversation of the doctorate of 
nursing has been debated for over 25 years but really gained momentum in October 2004 
when the American Association of Colleges of Nursing (AACN) adopted a position 
statement: “The AACN calls for a transformation of the education appropriate for nurses 
who will be practicing at the most advanced level” (p. 6). Griffiths and Padilla (2006) 
claimed that the proposal of the Doctor of Occupational Therapy (OTD) surfaced in 1993 
as the accumulation of a 40-year debate (p. 541) and has progressively gained support 
from the American Physical Therapy Association (APTA). In 2005 the APTA vision 
statement included “that all physical therapy services will be provided by doctors of 
physical therapy by the year 2020 (Massey, as cited in Griffiths & Padilla, 2006, p. 541). 
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 Swanchak (2010) claimed that the main controversy around the elevation to the 
clinical doctorate as an entry-level degree is related to the reasoning or motivation of the 
individual seeking the degrees. Many health professions are somewhere in the 
progression of transitioning toward awarding clinical doctorates as first degrees, citing 
the necessity for advanced knowledge and skills to be effective in the rapidly changing 
and complex health community (Swanchak, 2010, p. 12). As Ellis (2007) noted, the 
professional doctorate for the health and social care professions is a “product of its time” 
(p. 2272), but there is minimal empirical or theoretical information can be found on the 
effects of this evolving situation. William Siler and Diane Randolph (as cited in 
Dickerson & Trujillo, 2009) examined arguments for and against the elevation of the 
professional degrees to the clinical doctorate. According to Dickerson and Trujillo 
(2009), “Their conclusion was that neither universities or professional organizations 
objectively evaluate clinical doctorates and they suggested that an external study, such as 
the Flexner Commission, should be done to establish uniform criteria” (p. E47). Studying 
the experiences of other health professions that have successfully made the transition to 
the clinical doctorate, such as pharmacy and physical therapy, may be helpful (Cartwright 
& Reed, 2005). 
 Within the past two decades, several new doctoral programs have been created in 
the health care fields. Collier (2008) considered that the workforce shortage in many 
health professions has educational institutions and policy makers trying to address the 
rapidly changing needs of the health care system. The health workforce dynamics are 
important in understanding the health care environment, and credentialing requirements 
are an underlying theme among many health professions. Collier (2008) reported that 
employers and educational leaders have expressed concern about the increasing degree 
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levels in several health professions, especially as it relates to the cost of health care and 
other health systems dynamics.  
 Referred to as clinical doctorate, professional doctorate, or practicing doctorate, 
most of these new programs do not possess the same content or title as the research 
doctorate in the specific discipline, nor do they consistently follow the historical model of 
the “1st professional doctorate,” as defined by the National Center for Educational 
Statistics (NCES) (Higher Learning Commission, 2006, emphasis in original). The NCES 
model concludes that the course of study for a first professional degree is typically three 
years of study post-baccalaureate (NCES, 2008). According to the Higher Learning 
Commission (2006), the various professions have defined the essence of each program, 
but “there seems to be no obvious consistency among the various degrees as to length of 
study; rigor, substance, or content of the program; or the ultimate utility of the degree to 
the person who earns it” (Higher Learning Commission, 2006, p. 1). For example, 
Kontogianes (2004) described an innovative program that has been established to address 
the shortage of pharmacists in Oklahoma. Instead of having to complete the baccalaureate 
degree first and then transfer for the additional three years for the doctorate, this unique 
program “takes the student seamlessly from high school to the doctorate in six years” 
(Kontogianes, 2004, p. 47) by allowing the student to receive an associate degree and 
then transfer directly into a doctoral program at a four-year university.  Kontogianes 
(2004) declared that the need for pharmacists is so great that these programs must be 
developed quickly and must promptly produce properly trained and competent 
pharmacists.  
 The recent emergence of the clinical doctorate primarily falls into two categories: 
those that have changed the entry-into-practice level for new graduates through the 
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accreditation process of educational programs, and those that allow for advance practice 
beyond the entry-level (Collier, 2008). Collier suggested:  
 Even in the absence of a mandate from the profession or its educational program 
 accreditation group, there has been rapid movement to the clinical doctorate due 
 to market forces of educational programs competing for potential students. (p. 7) 
 Various stakeholders are involved in this high profile debate: professional 
organizations, employers, educational leaders within and outside of the professions, and 
regional accreditation agencies. Those that support the transition to the clinical doctorate 
focus on the expanded knowledge base, technological advances, and expanded clinical 
experiences (Collier, 2008). Opponents to the move to the clinical doctorate are 
concerned about the creation of greater workforce shortages, increased educational costs, 
and public confusion with the number of new types of “doctors.” Some who strongly 
oppose the elevated entry-level degrees believe the move to is to gain professional power 
rather than a response to market demand (Collier, 2008). 
 The decision to move to the clinical doctorate level may pose problems for the 
institutions that have offered the master’s degree program but do not have doctoral-
granting authority or the transition does not parallel the university mission. When 
institutions decide to create a new doctoral program, they must ask the regional 
accreditation agency to extend the college or university accreditation to include the new 
professional doctorate. So many variables and variations are associated with this new 
educational trend that the quality assurance agencies do not have reliable or valid 
evaluation tools to ensure quality assurance of the clinical doctorate programs.  
 In 2005 the North Central Association of Colleges and Schools established a Task 
Force on the Professional Doctorate and charged the committee to study the current 
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trends and expansion in program creation of the professional doctorate and provide 
recommendations of the best ways to provide quality assurance. The Task Force initiated 
a national discussion in various forums, and the recommendations were organized into 
three major concerns: Institutional context, core characteristics of program content, and 
shared quality assurance. The Higher Learning Commission (2006) accredits colleges and 
universities not specific programs; therefore, the primary focus is on the capacity of the 
institution to construct and support effective programs that award a professional 
doctorate. The Higher Learning Commission (2006), together with other accreditation 
bodies, defines core characteristics of a professional doctorate program based on uniform 
competencies from those who practice the profession across the nation.  Although the 
specific program content is accredited by specialized accreditation agencies, the 
institutional accreditation bodies evaluate how well the new degree program is fulfilling 
the core characteristics and uniform competencies that have been established. The Task 
Force on Professional Doctorates emphasized the importance of the Higher Learning 
Commission to collaborate with professional and specialized accreditation bodies in the 
establishment of standards for professional doctorate programs.  
 While it is so vitally important that conversations be held with specialized 
 accrediting bodies, the Task Force agreed that institutional accrediting bodies 
 should not defer to specialized agencies if they conclude that the profession’s 
 degree is lacking in the substance or rigor appropriate to a professional 
 doctorate. (Higher Learning Commission, p. 12) 
  Pharmacy 
 Over the past 150 years, pharmacy education in the United States has evolved 
from an apprentice model to a six-year professional doctorate degree. The incremental 
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changes that occurred were prompted by changes in pharmacy practice and public 
expectations and by academics in an attempt to move the practice forward (Cohen, 2008). 
The issues of the appropriate curricular content, length of study, and degree name have 
been the subject of considerable debate in the profession throughout the 20th century.  
 Theoretical perspectives. During the 19th century, pharmacy education occurred 
through the apprentice model, mainly because very few university programs existed. In 
the report that transformed medical education, Abraham Flexner concluded that 
pharmacy was “an arm added to the medical profession, a special and distinctly higher 
form of handicraft, not a profession” (Cohen, 2008, p. 103). According to Buerki (1999), 
the first discussions about establishing a uniform structure of pharmacy education 
occurred around 1870 within the American Pharmaceutical Association (APhA) and in 
the late 1890s within what is now called the American Association of Colleges of 
Pharmacy (AACP). The accreditation mandate of a four-year Bachelor’s degree as a 
minimum requirement for pharmacy practice was achieved in 1932. Momentum to 
standardize and improve pharmacy education continued until World War II. Cohen 
explained that, during the depression, the public perceived pharmacists “as retailers and 
in great oversupply” (p. 104). This prompted academics to call for increased science and 
rigor in pharmacy programs versus training in retail and management, a conversation that 
continued until the 1970s (Buerki, 1999; Cohen, 2008). Concerns about curriculum, the 
state of the profession, and the public and government image of pharmacists were 
studied, analyzed, and changed on a steady basis for the next 30 years. Finally, in the 
early 1990s there was consensus that the professional practice model should be 
“pharmaceutical care” and the Doctor of Pharmacy be established as the sole entry-level 
degree into pharmacy practice (Buerki, 1999; Cohen, 2008).  
  75 
 The success in achieving a professional doctoral level education will enable 
pharmacists to be prepared to serve in a variety of practice settings as well as be agents of 
change in the complex healthcare system (Brazeau et al., 2009a).  Holland and Nimmo 
(1999a) proposed an innovative model to assist pharmacy leaders facilitate practice 
changes in the current complex and diverse pharmacy environment. They believed that, 
in order to maximize change in pharmacy practice, three interrelated components must be 
fulfilled by leadership: creation of an environment conducive to a new form of practice, 
availability of appropriate training for practitioners, and motivational strategies of 
practitioners to change. Holland and Nimmo (1999b) suggested that two main factors 
contribute to individual pharmacists’ responsiveness to a change in practice:  their 
personality and their professional socialization. “Professional socialization is the process 
by which a student or young practitioner acquires the roles, behavior, and attitudes 
expected of a member of the profession involved” (Goldenson, as cited in Holland & 
Nimmo, 1999c, p. 2459). Faculty members, preceptor/internship experiences, and fellow 
students influence this socialization. Holland and Nimmo (1999b) concluded that the 
proposed practice model requires changes in responsibilities and duties that may not be 
compatible with a pharmacist’s personality, resulting in a resistance to change. Therefore, 
professional re-socialization to the newly established roles, behaviors, and attitudes 
expected by a doctor of pharmacy is vital for the professionalization of pharmacy. 
 In 2008 the Curricular Change Summit leaders recommended that the focus of 
pharmacy education programs must continue toward a professional doctorate level and 
that graduates should and will remain in community practice (Brazeau et al., 2009a). 
Cohen (2008) suggested that the community pharmacist is a key individual who can 
provide patient care and education on medications, improving the quality of patient’s 
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lives. One concern is that the current system of reimbursement for pharmacists is 
primarily based on dispensing prescriptions. Cohen (2008) stated that a “large statistically 
sound study” (p. 107) documenting the important role the pharmacist plays in patient care 
is necessary to alter reimbursement methods. “Ultimately for pharmacists to realize their 
full potential in our system serious reform and altered payment systems are needed that 
will recognize the value of time spent in patient care and not just dispensing” (Cohen, 
2008, p. 107). 
 In addition, Cohen (2008) expressed that, although pharmacy practice and 
pharmacy education have embraced the patient care practice model, confusion exists on 
the part of the public and other health care providers as to the expected standards across 
the profession of pharmacy. Many accept the value pharmacists add in patient care, 
especially in hospitals and clinic settings, while others continue to view pharmacists as 
commercial retailers and not as a true health care professional. “Until we get uniform 
acceptance from patients, providers, and health care payers of the value that pharmacy 
brings to health care there will be debate and controversy about the curriculum and the 
future” (Cohen, 2008, p. 108). 
 Empirical investigations. In 1946 the American Association of Colleges of 
Pharmacy (AACP), together with other national associations, conducted a survey that 
focused on the internal issues of the pharmacy profession. The Elliott survey, named after 
the primary investigator Edward C. Elliott, found that members of the occupation 
believed there was a professional nature of pharmacy, but that the public perception was 
much less (Elenbaas & Worthen, 2009). Elliott’s report, the General Report of the 
Pharmaceutical Survey (as cited in Elenbaas & Worthen, 2009), concluded that the four-
year curriculum of pharmacy education was not sufficient to provide the scientific 
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content required of the profession and the general education component of a post-
secondary education. The recommendation was to move to a six-year degree program 
that would make possible the granting of a professional doctorate.  
 Pharmacy educators had mixed response to the Elliott survey; some agreed the 
changes were necessary and others were strongly opposed to any curricular 
modifications. In 1948 the AACP published a position paper that supported the doctor of 
pharmacy degree for six years, specifying two years of pre-pharmacy followed by four 
years of professional education (Kendig, 1948). In 1950 the University of Southern 
California was the first college to commence the entry-level six-year Pharm.D. degree 
program, dissolving the Bachelor of Science program. The University of California San 
Francisco (UCSF) in 1955 and the University of Michigan in 1961 followed this 
inauguration (Elenbaas & Worthen, 2009). It would be many years before other 
institutions would follow these leaders in the development of entry-level Pharm.D. 
programs. 
 Several years after the Elliott survey, the Millis Study Commission on Pharmacy 
investigated pharmacy from an external societal perspective rather than an internal 
perspective such as the Elliott survey (AACP, 2000; Worthen, 2006). The focus of the 
Millis study, conducted between 1973-1975, was to gather perceptions “for what should 
they be educated” (Worthen, 2006, p. 5). The final report, Pharmacists for the Future, 
suggested that pharmacists should be trained with other health professionals at the 
bedside of the patient, not behind the prescription counter isolated from the clinical 
aspect of medicine (Worthen; Elenbaas & Worthen, 2009). This introduction to “clinical 
pharmacy” was met with mixed responses from educators and professional leaders. These 
results were supported by the 1967 study by the Task Force on Prescription Drugs that 
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investigated the impact of extending outpatient prescription coverage to Medicare 
patients (Worthen, 2006). The Task Force concluded that the perception of the 
pharmacist “is viewed by many people as simply transferring pills from a large bottle to a 
small one--counting tablets, typing labels, and calculating the price” (Task Force on 
Prescription Drugs, 1967, p. 19). On the other hand, the Task Force commended those 
pharmacists who were providing direct patient care, including accompanying doctors on 
hospital rounds and managing patient use of medication. According to Elenbaas and 
Worthen (2006), throughout the 1970s and 1980s the clinical pharmacy concept was 
becoming rooted in the practice model and the movement of the Pharm.D. as the entry-
level professional degree was gaining steam, but the two were not synonymous.  
 The issue of the six-year curriculum leading to the Pharm.D. as the entry-level 
degree into pharmacy practice was at center stage for pharmacy education leaders for 
over three decades, beginning with the 1950 report of the Pharmaceutical survey. In 1981 
the American Pharmacists Association (APhA) conducted an exhaustive review of 
pharmacy education that concluded with the recommendation that the six-year Pharm.D. 
should be the entry-level credential into practice (Miller, 1989). As the AACP president, 
Miller formed the Commission to Implement Change in Pharmaceutical Education and 
charged the Commission to develop a strategic plan to establish standards for pharmacy 
education in the 21st century. A few months later, the American Council of 
Pharmaceutical Education (ACPE) announced the accreditation mandate that established 
the Pharm.D. as the sole entry-level degree into pharmaceutical practice, with 
implementation for the entering class of 2000 (Commission to Implement Change in 
Pharmacy Education, 1997a).  
 The AACP Commission to Implement Change in Pharmaceutical Education 
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convened over three years and produced a series of background papers and 
recommendations. The third background paper recommended that AACP support the 
Pharm.D. as the sole entry-level degree, and in 1992 the AACP House of Delegates voted 
in favor of the professional doctorate as the sole entry-level (Commission to Implement 
Change in Pharmacy Education, 1997a). One year later, the ACPE issued revised 
accreditation standards and guidelines for the Pharm.D. degree programs. Curriculum 
Standard 8 stated that students must be prepared for the “emerging roles that ensure the 
rational use of drugs in the individualized care of patients” (ACPE, 1993, p. 15). One 
more accreditation standard revision in 1997, which included the implementation date of 
2000, finally solidified the 47-year professional debate that began with the 1950 Elliott 
Report that had called for a six-year professional doctorate as the sole entry-level degree 
in pharmacy. 
 Boyden (2006) conducted a qualitative study for the purpose of understanding the 
motivations behind the decision to mandate the entry-level Pharm.D., the benefits 
associated with the transition, and the future of pharmacy education. The investigation 
included case studies of two selected pharmacy schools that had distinct experiences in 
the degree changeover process. Through extensive interviews with leaders of the two 
institutions, Boyden (2006) concluded that the chief motivations that led to the adoption 
of the entry-level Pharm.D. as the sole degree were degree uniformity across the 
profession; the gain in prestige with a title of doctor; and “the appropriateness of giving 
those with a minimum of six years of intensive, challenging didactic and experiential 
education a high-level, terminal degree” (p. 160). In addition, Boyden stated that 
graduates who engage in clinical and therapeutic settings have greatly benefited from the 
entry-level Pharm.D. decision but those who practice as community pharmacists have not 
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had opportunities to utilize the advanced knowledge and skill sets they acquired. 
 At the 2008 AACP Curricular Change Summit, the focus was on the transition 
from educating pharmacists with a product focus to educating pharmacists to provide 
patient-centered care (Brazeau et al., 2009b). Although the Accreditation Council for 
Pharmacy Education (ACPE) Standards 2007 defined the expanded and expected 
professional competencies, AACP President Yanchick stated in his address at the 
Summit, “We must transform pharmacy curricula away from a baccalaureate-level focus 
to a professional doctoral-level focus” (Brazeau et al., 2009b, para. 2). Brazeau et al. 
(2009b) summarized the conversations that occurred at the 2008 AACP Curricular 
Change Summit in a list of recommendations for consideration by the AACP and its 
member institutions related to the future of pharmacy education: 
 • educational programs must provide opportunities to the changing health care and 
 economic climate;  
 • graduates must: 
  • do their part to make health care more beneficial and cost effective, 
  • embrace information technology, 
  • have the skills and confidence to be adaptable and flexible to changes in 
 their professional careers,  
  • take responsibility for continued professional development, 
  • be willing to work collaboratively, 
  • engage their communities, 
  • be leaders and advocates, 
  • be culturally competent, and 
  • assume the responsibility to address society’s needs. 
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 Cooksey, Knapp, Walton, and Cultice (2002) presented data from the 2000 
National Pharmacist Workforce Study that described a “dynamic shortage of 
pharmacists” (p. 182) reported to be apparent as early as 1998. The shortage is a result of 
several factors including: an increase in prescription drug use, expansion of pharmacists’ 
roles and nontraditional job markets, limited use of automation, inefficiencies in the 
workforce, and greater numbers of female pharmacists who tend to work fewer hours 
than men (Cooksey et al., 2002). The 2009 National Pharmacist Workforce Study was 
focused on examining the association of the Pharm.D. degree with time spent dispensing 
medication and patient care (Kreling et al., 2010). The data showed that pharmacists who 
practice in community settings spend the majority of time on dispensing activities, 
regardless of the educational degree. In hospital settings, more time was allotted for 
patient care for pharmacists with a Pharm.D., and pharmacists with a B.S. degree handle 
the dispensing activities. Kreling et al. (2010) suggested that the current trends, such as 
the increasing age of the population and continued increase in prescription drug use, 
indicate a need for pharmacists practicing in community practice settings. What continues 
to be unclear is how the need for patient care from pharmacists will grow, especially in 
community settings.  
 Other Health Profession Disciplines 
 The growth in clinical doctorate programs is rooted in the changing 
demographics, scientific developments, and technological advances in health care. 
Primary health care providers such as pharmacists, nurse practitioners, occupational 
therapists, and physical therapists are necessary partners in promoting health and 
preventing disease. Health professionals must be educated in diverse knowledge and 
skills that were not previously considered within their scope of practice, but are now 
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identified as critical to understanding the healthcare needs of society. 
 Nurse practitioner. Purdue University School of Nursing (PUSON) has been a 
leader in the development of innovative curricular opportunities in the Doctor of Nurse 
Practitioner (DNP) program. Drs. Wall, Novak, and Wilkerson (2005), faculty at 
PUSON, share the developmental process experience so that other schools may benefit 
from the experience as they develop their own DNP programs. Many schools of nursing 
are in various stages of development or implementation of DNP programs. This article 
provides a step-by-step process of development of a unique program that uses 
interdisciplinary resources to result in highly qualified providers. This case study 
provides insight into important elements of development process, student demands, 
curriculum design, and program evaluation that can be generalized to institutions that are 
developing clinical doctorate programs in other allied health disciplines. The most unique 
feature of this program, making this case study a valuable resource, is the 
interdisciplinary collaboration that is supported at a variety of levels (Wall et al., 2005, p. 
401). The charge of improving the integration of health disciplines and reengineering the 
health delivery system has been given to leaders at all levels of health care. Each 
university setting will have opportunities for collaboration with multiple disciplines, 
many within their own institutions; Wall et al. (2005) provide examples of places to 
explore those prospects.  
 The DNP program at PUSON provides a curriculum from post baccalaureate to 
doctorate that emphasizes interdisciplinary collaboration among faculty, hospitals, 
community leaders, and state, national, and international health care administrators (Wall 
et al., 2005, p. 397). Collaboration with other disciplines in a variety of settings, 
including Ph.D. researchers, emphasizes an integrative approach to patient care and 
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provides opportunities for evidence-based practices in clinical care delivery, patient 
outcomes, and systems management (AACN, as cited in Wall et al., p. 397).  
 Occupational therapy. Another healthcare discipline contemplating the 
transformation from a master’s degree to a clinical doctorate as the entry-level degree is 
occupational therapy. As of January 1, 2007, the Accreditation Council for Occupational 
Therapy Education (ACOTE) granted accreditation only to post-baccalaureate programs 
(Griffiths & Padilla, 2006). The decision to offer a master’s or Doctor of Occupational 
Therapy (OTD) is at the institutional level. In their 2006 study, Griffiths and Padilla 
provide linkage to the influences leading to this decision in occupational therapy and 
other healthcare disciplines such as pharmacy, nursing, and physical therapy.   
 The purpose of the study was to explore the decision-making status at institutions 
regarding the selection of an OTD as a viable part of their program. Debate has occurred 
within academic and practice circles about the relative value of the Doctor of 
Occupational Therapy over the master’s degree (Griffiths & Padilla, 2006, p. 540) but 
there is no professional consensus on the value of the inflated degree. A multifaceted 
survey was conducted to identify factors being considered in the decision-making process 
at academic institutions regarding the inclusion of a Doctor of Occupational Therapy 
degree into the program. The survey packet sent to academic program directors of all 
institutions that offered entry-level occupational therapy programs in the United States 
was based on a similar study conducted regarding the entry-level Doctor of Physical 
Therapy (Domholdt, Stewart, Barr, & Melzer, 2002).  
 The results were the identification of several factors that both support and impede 
the decision for institutions to incorporate the OTD into the program, with the majority 
leaning toward supporting its inclusion of the OTD. The study did not reveal a clear 
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understanding of the perceptions of the academic program directors toward the idea of 
developing an OTD program. The perception of academic leaders on the value of the 
clinical doctorate as an entry-level degree is an important research opportunity in all of 
the disciplines faced with this decision.  
 The identification of these factors provides an historical record of the 
considerations that institutions can judge when deciding on the feasibility of a program 
that is transitioning from a baccalaureate to postbaccalaureate. This is transferable 
information across disciplines faced with a similar situation. The portion of this article 
that held the greatest value was the history of clinical doctorates (Griffiths & Padilla, 
2006, p. 541). In this section, the authors looked to research from several healthcare 
disciplines and articulately conveyed commonalities between the professions related to 
the entry-level requirements. Explanation of the various academic degrees relevant to the 
discussions provided a solid foundation for a complex and nomadic situation.   
 Physical therapy. The University of Colorado Physical Therapy program took 
over seven years to transition from the master’s degree in PT to the doctoral degree 
(Rapport et al., 2007). The researchers found: 
 While appreciating the external forces creating change, and the professional 
 momentum within physical therapy to transition to a doctorate degree (i.e., the 
 DPT), the faculty at the University of Colorado became committed to the redesign 
 of overall program philosophy and curriculum as part of this change. (p. 66) 
 Parallel to the colloquy of the clinical doctorate has been dialogue about the 
increasing interest in developing a viable alternative to the research focused degrees of 
Doctor of Philosophy in several of the health disciplines (Wall et al., 2005). The clinical 
doctorate, also called the practicing doctorate, offers students a degree that centers on 
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evidence-based practice. Melnyk and Fineout-Overholt (as cited in Wall et al., p. 397) 
defined evidence-based practice as: 
 a problem solving approach to clinical practice that integrates 1) A  systematic 
 search for and critical appraisal of the most relevant evidence to answer a burning 
 clinical question; 2) One’s own clinical expertise; and 3) Patient preferences and 
 values. (p. 397) 
Scholars have reported that it can take up to 20 years before scientific findings become 
part of bedside practice (Wall et al, 2005). Clinical doctorate programs that focus on 
interdisciplinary, evidence-based learning attempt to take “transitional knowledge” (Wall 
et al., p. 397) from research centers to practicing providers and may significantly reduce 
that timeframe.  
 This concept of interdisciplinary collaboration also is a central theme in the case 
study reported by Rapport et al. (2007). This report directed attention to a new Doctor of 
Physical Therapy program (DPT) at the University of Colorado at Denver and Health 
Science Center (UCDHSC). By summarizing the process used in the transition from a 
master’s degree program to the DPT degree program at UCDHSC, the authors 
highlighted the curricular changes that have taken place in most physical therapy 
education programs as they have made this transformation. One of the most significant 
changes has been to provide opportunities for interdisciplinary collaboration. The ability 
to collaborate and interact on an effective team includes an underlying assumption that 
the members have a knowledge base regarding each other’s disciplines, preparation, and 
expertise so that they can contribute to the efforts of the team (Utley & Rapport, as cited 
in Rapport et al., 2007, p. 63).  
 The transition to the clinical doctorate in health professions has prompted debate 
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about its impact on the availability and quality of health care, especially in populations 
that are underserved (King, Freburger, & Slifkin, 2010). Supporters of the change claim 
that it is necessary because of the complexity of health care and that the additional 
training will meet the demands of this complexity. Opponents argue that the added costs 
to students may eventually lead to decreases in practitioner supply. King et al. (2010) 
shed some light on the future delivery of services by exploring how the Doctor of 
Physical Therapy (DPT) is affecting the PT workforce and the allocation of services.  
 The purpose of this study was to observe how the shift to the clinical doctorate is 
affecting rural communities and to identify issues for future research (King et al., 2010, p. 
25). The exploratory analysis of key stakeholder perspectives on the relationship between 
the DPT and the supply and quality of physical therapist was approached via a semi-
structured telephone interview. The interviews with three key stakeholder groups--
physical therapist education program directors, directors of PT departments at rural 
hospitals, and presidents of state PT associations--provide quantitative and qualitative 
data related to the impact on the supply and quality of physical therapy in rural areas so 
to date.   
 The results indicate that the stakeholders interviewed perceived the current PT 
shortage in rural communities has not been impacted as a result of the DPT growth (King 
et al., 2010). Overall, the opinions were diverse, at times conflicting, and indicative of 
future investigation into the impact of the DPT on rural communities. Study limitations 
include the small, purposive sample of stakeholders and the problem that the operational 
construct of “quality of care” (p. 33) was not clearly defined in the related questions. An 
interesting outcome is that several of the findings suggest opportunities for collaboration 
between the educational institutions and the rural hospitals. Some of the disparities 
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between perceptions of the program directors and the hospital administrators show a need 
for improved communication. In addition, there may be a mutually beneficial alliance 
between the educational programs and the rural hospitals. The DPT programs need sites 
to provide the students with clinical experiences, and the rural hospitals need help. 
Relationships with educational programs may assist the rural hospitals with recruitment 
and exposure to the latest evidence in practice (p. 33).   
 A commonality discovered in the three independent and diverse studies reviewed 
in this section is collaboration (King et al., 2010; Rapport et al., 2007; Wall et al., 2005). 
The studies approach the concept of collaboration as it relates to different disciplines, 
various scenarios, and numerous groups. The two case studies related to curriculum 
design (Rapport et al., 2007; Wall et al., 2005) provide program developers with models 
that can be used as examples. The content of the curriculum will be unique to a specific 
discipline, but the context of a health professions training program is similar in many 
ways.  
The Current Study 
 This qualitative study is an attempt to understand the perceptions of professional 
leaders and policy makers regarding the Pharm.D. as the entry-level degree to practice. 
The limited published empirical studies provide little information on the challenges and 
barriers that were faced during the transition to the clinical doctorate. The purpose of this 
study is to evaluate retrospectively the benefits of transitioning to the clinical doctorate 
level, the risks that accompany the new requirements, and alternatives that were 
considered to satisfy the philosophy and mission of the pharmacy profession.    
Guiding Theory 
 The theoretical framework for this qualitative study is grounded in the 
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Transtheoretical Model (TTM) of health behavior change. The decisional balance 
construct of TTM provides a structure for understanding the decision-making process at 
the individual, interpersonal, group, organizational, and community levels. TTM divides 
the process of change through a progression of stages: pre-contemplation; motivation and 
intention; change behavior; and, finally, maintenance. 
 In 1999 the Quality of Health Care in America Committee of the IOM published a 
report that addressed the issues of the decentralized and fragmented nature of the U.S. 
healthcare system, specifically the nation’s epidemic of medical errors (IOM, 1999). The 
IOM (1999) concluded that faulty systems, procedures, or situations that lead individuals 
to make mistakes cause the majority of medical errors. The report laid out a roadmap by 
which government, health care providers, industry, and consumers can work together to 
design a safer healthcare system.  
  Selected milestone decisions in pharmacy, such as transforming the philosophical 
mission to pharmaceutical care and altering the entry-level requirements to the Doctor of 
Pharmacy, constitute important steps in the complex change process that has transformed 
the pharmacy profession. Changing the professional philosophy does not guarantee that 
all stakeholders, such as the healthcare delivery system, governing bodies, or the public, 
will embrace the necessary changes to transform the practice of pharmacy to match the 
philosophy. The Institute of Medicine (IOM) (2001) stated that due to the rapid changes 
occurring in the U.S. healthcare delivery system, a gap is evident in its ability to translate 
new knowledge and skills of practitioners into the best practice model. The IOM (2001) 
also noted that the health care needs of society have changed and bringing “state-of-the-
art care to all Americans in every community will require a fundamental, sweeping 
design of the entire health care system” (p. 2).  
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 The educational system must be remodeled and enhanced to prepare the Doctor of 
Pharmacy for the advanced knowledge, skills, and abilities necessary to fulfill the new 
role and responsibilities associated with the new practice model. The importance of 
adequately preparing the workforce to make a smooth transition into a newly designed 
healthcare system is paramount. The way health professionals are trained to meet the 
health care needs of society will need to be overhauled (IOM, 2001).  
 In addition, successful transformation of pharmacy practice will require that other 
health disciplines such as medicine and nursing must accept that the Pharm.D. provides 
assurance that graduates are prepared for the expanded roles and responsibilities 
associated with direct patient care. The expanded role of the pharmacist in patient care 
will require changing the structure and processes of the environment in which health 
professionals and organizations function (IOM, 2001).  
Relation to Recent Empirical Work 
 This study is a retrospective investigation on how the one decision, to change the 
entry-level degree in pharmacy, in a multifaceted change process, affected the other 
ingredients necessary to make the transformation successful. At the core of the 
pharmacy-degree changeover are the leaders and stakeholders, including but not limited 
to, professional organizations, employers, and educational leaders within and outside of 
the professions, accreditation agencies, and society who debated, advocated, publicized, 
and voted for or against the monumental decision to change the requirements for the 
entry into the pharmacy profession (Boydeen, 2006). In order to understand their 
perspectives, key participants were interviewed. Members of the AACP Commission to 
Implement Change, The Janus Commission, the AACP Board of Directors, and the 
ACCP House of Delegates were chosen for their important participation in the decision-
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making process. Their hindsight provides a unique perspective of the benefits, risks, and 
alternatives that were contemplated during the establishment and implementation of the 
Pharm.D. mandate. In addition, their longevity in the pharmacy profession gives them a 
perspective on the transferability of the Pharm.D. for extended professional opportunities. 
 This study of perceptions of the influences, desires, and politics behind the 
decision-making process--as well as the influence this decision has had on healthcare 
education, delivery of services, and society as a whole--will serve pharmacy education, 
offer knowledge and guidance to other health professions contemplating the transition to 
the clinical doctorate, and contribute to the existing literature. This study builds on and 
will advance the field with respect to the limited number of empirical investigations in 
the process of elevating required entry to the doctorate in healthcare fields. Specifically, 
although much has been published, very little has been based on empirical evidence. The 
current study helps to rectify that deficit.  
Summary 
 This study is an exploration into the perceptions of pharmacy leaders have about 
the Pharm.D. and its effect on health professions education, the delivery of services, the 
interdisciplinary relationship of health care providers, and the relationship between the 
degree and increased professional opportunities. This qualitative study was designed to 
examine these issues at the individual, interpersonal, group, organizational, and 
community levels through semi-structured interviews. The review of the literature centers 
on research and policy in relation to clinical doctorates in health professions, primary 
physical therapy, occupational therapy, nurse practitioner, and pharmacy disciplines.  
 Health professions encompass a plethora of careers that are involved, directly or 
indirectly, with patient care. Each health profession is unique in its governing structure, 
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educational requirements, regulatory processes, and educational institutional options. The 
current and future trends in health professions education and workforce provide insight 
into the state of our rapidly changing health care system. The future workforce is 
dependent on the academic training of the professional. 
 Academic accreditation is a complex system that is the primary method of quality 
assurance for educational institutions and programs. The private, non-government, self-
regulated accreditation industry has been the standard for over 50 years. As the primary 
means of quality assurance in higher education, accreditation serves as a gatekeeper to 
federal and state funding and promotes accountability to the larger public. Over the past 
two decades, the climate of higher education is changing, and accreditation has become 
the target for any public discord and the buffer for friction between institutions 
maintaining autonomy and the increased demands for accountability and government 
regulation.  
 Professional associations play an important role in endorsing professionalism of 
the highest integrity, advocating for individuals in the profession, and protecting the 
public interest by regulating the members. These associations fundamentally operate as 
service organizations for their customers, referred to as members. The involvement and 
participation of the members is reflective of their commitment to the organization.  
 The academic degree required for a professional to enter the workforce has 
become a much debated issue among higher education leaders, government officials, and 
business executives. Efforts to increase higher education attainment rates in the United 
States have opened up dialogue regarding the definition and transparent learning 
outcomes that are associated with paper credentials. The reliance of society on paper 
credentials is complex because there is no single system exists to interpret their 
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significance. 
 In health professions, there is a rapidly precipitating movement is seen toward 
establishing the clinical doctorate as the entry-level degree into practice. Many health 
professions are somewhere in the progression of transitioning to the clinical doctorate as 
the first degree, but there is minimal theoretical or empirical information is available on 
the effects of this evolving situation. Looking at the experiences of health professions that 
have successfully made the transition to the clinical doctorate may be helpful to other 
professions contemplating the transition. The factors identified in the decision-making 
process in occupational therapy or pharmacy may serve as a template for other 
professions that are moving through the same decision-making process. The transition 
from a baccalaureate program to a post-baccalaureate program in any discipline may 
warrant different content, but the dynamics of the change process are likely to be parallel. 
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CHAPTER III 
 
METHODOLOGY 
 
 
Introduction 
 
 A shortage exists in academic literature related to the benefits, risks, and 
alternatives to the clinical doctorate as the entry-level degree in health professions 
education. Studies on the transition to the clinical doctorate in individual disciplines, 
although limited, emphasize the importance of understanding the complexity of the 
change process. LaBelle (2004) indicated that the master’s degree is being replaced by 
the professional doctorate for entry into practice, especially in healthcare. Ellis (2007) 
stated that the transition to the clinical doctorate as the entry-level degree in health 
professions is a “product of its time,” (p. 2274) insufficient theoretical or empirical data 
is found on the effects of this evolving situation. Swanchak (2010) suggested that the 
advanced knowledge and skills necessary to be effective in the rapidly changing and 
complex healthcare system require expanded education for all health professionals. 
Collier (2008) recognized that there are various stakeholders involved in this debate: 
professional organizations, employers, and educational leaders within and outside of the 
professions, accreditation agencies, and society as a whole.  
 This chapter provides a description of the research methods used in this study, 
including the research design, description of the population and sample, instrumentation, 
procedures for data collection and analysis, as well as the issues of validity and ethics. 
Using the Transtheortical Model of Health Behavior Change and a qualitative method, 
the overall research question that guides the study was, “What are the current perceptions 
(benefits, risks, and alternatives) of key policy makers in the pharmacy profession who 
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participated in the decision to require (by January 1, 2003) the clinical doctorate 
(Pharm.D.) as the entry-level degree for practitioners?” 
Research Design 
 The purpose of this study is to gain understanding of the perceptions of the 
decision makers who were involved in the changes that led to the practicing doctorate as 
an entry-level degree for pharmacy. For this research, a qualitative case study will be 
conducted on the establishment and implementation of the entry-level doctorate in the 
pharmacy profession. Qualitative design allows inquiry on the detailed knowledge of the 
processes by which the series of events took shape and how these processes affect 
stakeholders (Weiss, 1998). The evaluation involves an oral account of individuals who 
were instrumental in the decision-making process through semi-structured interviews.  
 The role of the researcher in qualitative research is one of a spectator of an 
occurrence. Observing the emic (the participant’s view), while maintaining the outsider 
viewpoint (etic perspective), the researcher is able to record the data as well as 
consolidate and organize the findings (Danquah & Miller, 2007; Gall et al., 1996). Stake 
(1978) stated: 
 What is happening and deemed important within those boundaries (the emic) is 
 considered vital and usually determines what the study is about, as contrasted 
 with other kinds of studies where hypotheses or issues previously targeted by the 
 investigators (the etic) usually determine the content of the study. (p. 7)  
“Qualitative data analysis requires understanding, digesting, synthesizing, 
conceptualizing, and reconceptualizing the description of feelings, behaviors, 
experiences, and ideas” (Macnee & McCabe, 2008, p. 28). This retrospective perspective 
on the experiences, observations, and opinions of key participants in the transformational 
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entry-level degree changeover in pharmacy is most reliably collected and best analyzed 
through qualitative case study methods. 
 For this study specifically, using a qualitative research design to collect 
demographic data and interviews of 14 key individuals from four specific groups allowed 
the researcher to collect thoughts, beliefs, and reflections in relation to the decision- 
making process. Creswell (1998) offered several characteristics of qualitative 
methodology procedures that serve this retrospective study: it is interactive and 
humanistic, building rapport and credibility with the interviewees, and it is emergent and 
multi-faceted. Taking a holistic, panoramic perspective approach to this investigation 
results in lessons learned and the identification of remaining questions (Creswell, 2003). 
Case Study Methods 
 Case studies as a research method offer insights that may not be achieved with 
other qualitative approaches. Yin (2009) suggested that the case study method be chosen 
when the research questions start with “who” or “why,” the researcher has little control 
over the variables, and it is necessary to focus on a contemporary event. According to 
Yin: A case study is an empirical inquiry that investigates a contemporary phenomenon 
in depth and within its real-life context, especially when the boundaries between 
phenomenon and context are not clearly evident. (p. 18) Case studies are carried out so 
that one can gain further understanding and certain audiences will benefit (Stake, 1978). 
Stake believes that “its best use appears to me to be for adding to existing experience and 
humanistic understanding” (p. 7).  
 The unit of analysis, or the basis for the case, is crucial. Case selection is 
determined by the research purpose, questions, and theoretical content; but other 
constraints can have an impact on case selection (Rowley, 2002). External constraints 
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such as accessibility, resources, and time available will influence the unit of analysis.  
 According to Stake (1995), the type of case study depends upon the purpose of 
the inquiry. An instrumental case study is used to provide insight into an issue, an 
intrinsic case study is undertaken to gain a deeper understanding of the case, and the 
collective case study is the study of a number of cases in order to inquire about a 
particular phenomenon. As discussed in Chapter I, the topic of the Pharm.D. as the entry-
level degree for the practice of pharmacy was first initiated in 1948. Changing the degree 
requirements for pharmacy practice was a topic of conversation for a variety of 
stakeholders at multiple organization levels for over 40 years. To investigate this 
phenomenon from the initiation of the conversation to the decision, and finally the 
implementation, was too vast for this study. Based on the purpose of this research, the 
research questions, and the theoretical content, the researcher established boundaries to 
narrow the unit of analysis of the case. The four limited, but critical, stakeholder groups 
and the timeframe produced explicit bounds for this instrumental case study, 1989-2002, 
wherein, the case represents a vehicle for understanding a complex issue.  
 Case study research constitutes both quantitative and qualitative sources, typically 
triangulating data sources such as direct detailed observations, interviews, and document 
analysis. Triangulation comprises evidence from various sources to collaborate the data 
or finding (Rowley, 2002). The primary method of data collection for this bounded case 
study consisted of semi-structured interviews. A document analysis was conducted prior 
to the interviews to provide the researcher had a clearer understanding of how each 
subject fit into the decision-making framework when the full interview was conducted. 
The data analysis and the semi-structured interviews were conducted to strengthen the 
data by providing a triangulated design. 
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Role of the Researcher 
 In the qualitative case study framework chosen for this study, the researcher is the 
primary instrument of data collection, interpretation, and analysis. The role of the 
researcher in case study research follows that of a non-participant observer (Creswell, 
2003; Yin, 2009). In the non-participant role, the researcher attempts to remain objective 
and sustains some level of distance, while at the same time cultivating interpersonal 
rapport in the relationship with subjects in order to elicit rich, optimal data.   
 Yin (2009) suggested that the researcher must be able to ask good questions and 
interpret the responses, be a good listener, be adaptive and flexible in various situations, 
have a firm grip on issues being studied, and be unbiased by pre-conceived notions. In 
developing the interpersonal rapport and relationship with the participants, the 
researcher’s biography is implicated in the production of knowledge, allowing for 
subjective influences incorporated in the data (Hughes, 2012). Coffey (as cited in 
Hughes, 2012) suggested the researchers should be conscious of how case study research 
and narrative writing “reproduce and implicate selves, relationships, and personal 
identities” (part 2, para. 6).  
 Reflexivity is acknowledgement of ways in which the researcher’s biography 
influences the data collection findings. Throughout the process, the researcher needs to 
aware of personal biases that can be derived from social characteristics, previous personal 
and professional experiences, or education and interests that could influence the data 
(Malterud, 2001, pp. 483-484).  
 In this study, the researcher acknowledges possible biases that could have 
influence in the interpretation of the interview responses. First, the researcher holds a 
Doctor of Chiropractic (D.C.) degree. This clinical doctorate is the entry-level degree to 
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the practice of chiropractic. The chiropractic profession established the D.C. degree as 
the entry-level into practice from the inception of the profession in 1895, unlike 
pharmacy that is transitioning from a master’s degree to a doctorate degree as the entry-
level degree many years after the beginning of the profession.  
 Second, the researcher has responsibilities in chiropractic education and the health 
care delivery system. These experiences provide knowledge in the issues and concerns in 
health professions education and the U.S. healthcare system from a chiropractic point of 
view. 
 Third, the researcher made a professional career change after 20 years in private 
practice in chiropractic to a career in academics, specifically in health professions. In this 
professional transition, the researcher experienced limitations in professional 
opportunities that were specifically related to the Doctor of Chiropractic degree being a 
first professional degree, as compared to a terminal degree in a profession as defined in 
academic nomenclature. 
 Finally, the reviewed literature, particularly the opinions and commentary, was 
heavily weighted toward the negative consequences of the transition to the Pharm.D., 
specifically the hardships on the academic institutions, and the phenomenon of degree 
creep. The researcher is unaware of any empirical data that address the influence the 
Pharm.D. has had on health professions education, delivery of service, interdisciplinary 
practice, or society as a whole.  
Population and Sample 
 Patton (2002) suggested that qualitative investigations typically focus on 
relatively small samples to permit inquiry and explanation of a situation in depth (p. 46). 
Purposeful sampling of a small group of individuals may provide a wealth of information 
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that pertaining directly to the questions being studied (Patton, 2002). Critical sampling 
permits the selection of subjects that allow for logical generalization and relevancy to 
other cases. The population constituted those individuals who were members 
of/participated in four domains: AACP Commission to Implement Change in Pharmacy 
Education, the Janus Commission, the AACP Board of Directors and AACP House of 
Delegates from 1989-2002, and the Accreditation Counsel for Pharmacy Education 
(ACPE) board of directors form 1989 - 2002.  
 The American Association of Colleges of Pharmacy (AACP) is a national 
organization representing the interests of pharmacy education and educators (About 
AACP, 2012). The membership includes all accredited colleges and schools, individual 
faculty, students, and organizations directly connected to pharmacy education. The board 
of directors is a body of appointed members who oversee the activities of the AACP and 
act on behalf of, and is subordinate to, the AACP’s full assembly.  
  The Commission to Implement Change in Pharmaceutical Education was created 
as part of ACCP’s strategic plan for educational change to foster assurance that the 
pharmacy profession was positioned to be a vital and unique force in health sciences as 
they moved into the 21st century (Buerki, 1999). AACP President William Miller 
appointed the commission, charging it with developing a long-term strategic plan that the 
ACPE, the Association, and its members could implement over the next decade. Miller 
(1989) outlined specific responsibilities of the commission, including: articulate a 
mission of pharmacy practice, grounded in philosophy and theory of pharmaceutical 
practice, that would serve as the framework for pharmacy education; provide 
recommendation regarding the types of manpower necessary to fulfill the mission; define 
the values and needs of employers of pharmacy graduates; determine the parameters of 
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an entry-level pharmacy practice degree; establish a timeline of the process of pharmacy 
education; suggest changes in accreditation standards to the ACPE; and prepare a time 
table for implementing any major changes (Buerki, 1999, p.181). The commission was 
instructed to develop an implementation plan that was based on previous studies and 
current environment factors affecting pharmacy practice and education. 
 The Janus Commission was formed in 1996 to assist the Commission to 
Implement Change and the AACP Board of Directors with identifying healthcare 
environmental factors, both historically and futuristically, that were potential threats and 
opportunities for the pharmacy profession. This “think tank” was charged with 
scrutinizing the landscape of pharmacy and analyzing changes in the healthcare system 
that may influence practice, education, and research (Buerki, 1999). The Janus 
Commission (1997) defined the environment as: 
 Encompassing the health care delivery system, health professions education, the 
 academic health center and research enterprise, and its related social, economic, 
 and political forces that impact these three areas. (p. 2) 
The Commission convened throughout 1996 and 1997 and submitted a report 
summarizing the issues discussed at the meetings and offering a series of 
recommendations for consideration by the AACP board of Directors. 
 Two months after the AACP established the Commission to Implement Change in 
Pharmacy Education, the Accreditation Council on Pharmacy Education (ACPE) 
declared its intention to “propose revisions in accreditation standards in keeping with 
changes in pharmacy practice and pharmaceutical education” (Buerki, 1999, p. 181). 
ACPE is the national agency for the accreditation of professional degree programs and 
continuing education in pharmacy. The board of directors is derived from the AACP, the 
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American Pharmacists Association (AphA), the National Association of Boards of 
Pharmacy (NABP), and the American Council on Education (ACE) (ACPE, 2012). The 
ACPE concluded: 
 Based upon the Council’s analysis and study of current practice developments, 
 future practice developments, future practice challenges and the corresponding 
 educational preparedness needed, the Council foresee the time when the 
 accreditation standards will focus upon a doctor of pharmacy program as the only 
 professional degree program evaluated and accredited. This new direction may 
 become adopted as soon as the year 2000. (Nona, 1990, p. 203) 
 The sample consists of key individuals from various stakeholder groups that 
constituted the four realms involved in the decision-making process such as members of 
the accreditation agency, representatives of the profession, agents from the professional 
advocacy domain, delegates from the educational field, and individuals from the general 
public who were involved during this period. These individuals formed the philosophical 
leadership necessary to change the profession (Janus Commission, 1997).  
 Guba and Lincoln (as cited in Weiss, 1998) suggested that the criteria should 
allow for selection that represents maximum variation to ensure the broadest scope of 
information is collected. The selected sampling strategy allowed for a straightforward and 
accurate assembly and analysis of data. For this study, a purposeful, critical case 
sampling of key individuals involved in the decision-making process of the changeover to 
the entry-level professional degree are studied. The investigation into a phenomenon that 
occurred over 20 years ago is limited because some individuals are unavailable (i.e., 
death, ill-health, retirement, etc.). The final sample size netted 14 high quality interviews. 
Availability and willingness of participants determined the final set of interviews. The 
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researcher originally contacted 43 individuals from the four target policy groups. The 14 
of 43 represent a 33% agreement to participate for the critical case sampling procedure. 
Research Questions 
  The research questions guiding this study were introduced in Chapter I and are 
included in this section for convenience of the reader. These guided the construction of 
the Interview Schedule (Appendix A).  
 1.  What are the benefits, risks, and alternatives of the elevation of requirements 
to an entry-level doctorate degree on: 
 a.  Health professions education? 
 b.  Delivery of services? 
 c.  Interdisciplinary relationship of practicing clinicians? 
 d.  Societal and economic landscape of the health care industry? (Cost-  
 benefit) 
 2. What is the transferability of an entry-level clinical doctorate related to 
professional opportunities? 
Instrument Development 
 Qualitative research design includes four primary methods of acquiring data: 
interviews, surveys, observations, and review of documents pertinent to what is being 
studied. In this research, the curriculum vita of the subjects was utilized to provide 
historical information and demographics of the individuals that participated in the 
decision-making process. Review of these documents provided objective information (see 
Appendix B, Document Analysis Protocol), but the ability to seek in-depth meaning to 
thoughts and feelings of the participants is limited. The interview process allows for more 
in-depth query into the subjective responses of the participants and the ability to 
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illuminate the responses given.    
 An interview schedule was developed based on relevance to the research 
questions, the specific role group, literature in the field, and theoretical considerations. 
Specifically, questions were developed as a method to assess individuals’ perceptions 
regarding the benefits, risks, and alternatives on health professions education, delivery of 
services, interdisciplinary relationship of practicing clinicians, and the societal and 
economic landscape of the health care industry. In addition, the interview schedule 
assessed the individuals’ perceptions of the transferability of the entry-level clinical 
doctorate related to professional opportunities (Appendix C). The interview schedule 
consists of 27 open-ended questions. 
 The process by which the researcher developed this study served as a frame of 
operation and included all the necessary elements in the conduct of case study research. 
Stake (1995) proposed a series of necessary steps for completing a case study in order to 
increase the reliability of the research, including posing research questions, gathering 
data, data analysis, and interpretation. The researcher developed a purpose and rationale 
for the case study, established the significance of the phenomenon of interest, and 
developed specific research questions and the unit of analysis.  
 The researcher’s dissertation chair provided initial feedback on the content of the 
specific research questions. Subsequently, the other members of the dissertation 
committee gave feedback. Finally, the author’s chair provided one last round of input; 
those revisions were submitted with the IRB human subjects application. 
Expert Review of Research Instrument 
 Burns and Grove (2005) suggested that, to ensure validity, individuals with 
expertise should examine interview questions for appropriateness, accuracy, and 
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suitability. Following approval from the Institutional Review Board at Western Kentucky 
University, a review of the instrument for appropriateness, accuracy, and suitability was 
conducted. A content expert reviewed the interview schedule to ensure construct validity 
of the survey. No changes were made as a result (Appendix C). A qualitative expert 
provided feedback on the interview schedule to enhance expert validity, and no changes 
were made as a result. Collectively, these individuals possess expertise in healthcare 
education, pharmacy, and qualitative research methods.  
 Each of the members of the Expert Panel were sent a letter briefly explaining the 
study and requesting review and comments. The instrument draft and a review form with 
specific questions were included (Appendix D). The content expert familiar with the 
transition to the clinical doctorate in the health professions is Dr. Mary Lavin from St. 
Louis University School of Nursing. The qualitative research methods expert is Dr. Judy 
Davison from Western Kentucky University. (At a later date, subsequent to serving as a 
qualitative research methods expert, Judy Davison was added as a member of the 
dissertation committee.) Their combined expertise offers a complete study of the 
instrument for the research, providing support for content validity. 
 By identifying any deficiencies in design or procedure problems, alterations can 
be addressed before the larger study (Patton, 2002). In lieu of a pilot study, a review of 
the final interview schedule was conducted utilizing the content expert from the St. Louis 
University Doctor of Nurse Practitioner program, Dr. Mary Lavin. She provided feedback 
regarding the instrument and a baseline for the length of time for the scheduled 
interviews was obtained. She noted that the questions were specific to individuals who 
were involved in the decision-making process and estimated that the interviews would 
require 50-55 minutes to complete. No additional changes were made to the interview 
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schedule following this final review. 
Procedures 
 In general, procedures were consistent with a case study approach. For this 
investigation, semi-structured interviews were the primary method. Creswell (1998) 
suggested that recording devices should be used to capture and transcribe all of the 
comments in the interview process. Additionally, note taking by the interviewer provided 
a back up for technical difficulties and also provided information on the overall content, 
emotions, body language, and voice inflection that can help to interpret the actual 
transcript. Burns and Grove (2005) advised the interviewer to establish an environment 
comparable to that of a comfortable conversation. The researcher should adhere to the 
questions, be respectful of the time involved, be courteous to the participants, and avoid 
offering advice or asking questions that are not pertinent to the study (Creswell, 1998).   
 The investigator collected data utilizing the following procedures. An interview 
schedule was developed and mapped to the research questions. An introduction letter 
(Appendix E) was sent via electronic mail to the 43 individuals identified in the 
population/sample section provided contact information. Respondents who agreed to 
participate were sent the formal consent form (Appendix F). Individuals were requested 
to return the informed consent form, along with their curriculum vitae. Once the consent 
form and CV were obtained, the date/time of the interview was scheduled. Those who did 
not respond to the initial email within seven working days were sent a second email 
requesting their participation. In addition, the introductory letter and the consent form 
were sent via postal service.  The respondents who returned a signed consent form were 
contacted via email or telephone to schedule the interview. They also were asked to 
provide the researcher a CV prior to the interview date. 
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 Two individuals responded to the initial email and declined to participate. The 
researcher sent an email thanking them for their response, expressing how valuable their 
input would be to the study, and offering contact information in case they changed their 
mind. Both individuals changed their mind and accepted the invitation to participate.  
 Each participant in this study was required to sign an informed consent form. 
According to Gall et al. (1996), the researcher is required to inform each participant of 
the details of the study, the opportunity to withdraw consent without penalty, approval for 
recording the interview, and notification if other individuals will have access to the data.   
 Fourteen interviews were conducted. These represent the collective retrospective 
set of perceptions, reflections, and opinions of the selected participants. These individuals 
were chosen due to roles they played or their professional positions at the time of the 
pharmacy degree changeover. The dates of the interviews ranged from May 16, 2012 to 
June 15, 2012. All participants requested a telephone interview. The interview 
appointment was scheduled for approximately one hour, in which the researcher and the 
subject would be able to talk uninterrupted and where responses to the interview 
questions could be recorded.  
 The curriculum vitae provided background information to enhance the quality of 
the interview (see Appendix B for data gleaned from the CVs). A reminder email was 
sent two days prior to the scheduled interview for confirmation of date, time, and contact 
number. The telephone interviews were recorded through Clear Captions, a telephone 
captioning service for qualified Mac/PC/mobile users. Stacy Swenck transcribed the 
recorded interviews, and a transcript was sent to the researcher for review, editing, and 
adoption. The researcher also took contemporaneous, hand-written notes as back up in 
case of technical failure in the recording process. As indicated in the participant letter, the 
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individuals were ensured confidentiality prior to beginning.  
Data Analysis  
  The data analysis process took steps to offer a description of the uniqueness of 
this scenario. The specific analytic techniques utilized are consistent with the literature on 
qualitative methods generally (e.g., Patton, 2002), as well as studies that parallel the 
current investigation with respect to examination of key informants from a restricted 
population (e.g., Boydeen, 2006; Thomas, 2010). The process of qualitative data analysis 
is dynamic, beginning during data collection (Merriam, 2002). As the researcher 
examined notes and transcripts collected, interview excerpts were sorted and coded into 
categories that demonstrate trends or commonalities among the excerpts. Integration of 
the excerpts allows the researcher to develop a clear story of the specific case.  
 The two primary data sources for this study were (a) individual curriculum vitae 
and (b) transcripts from the interviews with the four stakeholder groups. A Document 
Analysis Protocol (Appendix B) was developed to facilitate the examination of the CV 
obtained from each subject. An analysis of the interviews provided detailed descriptions 
of the individual perceptions that were present within the larger narrative. The first step 
in analysis is a holistic reading of the transcripts. After determining a sense of the overall 
landscape of the data, the interviews were coded into categorizes.  
 Yin (2009) suggested that every case study should include an analytic system that 
guides the decision regarding what will be analyzed and for what reason. In this case 
study, the researcher utilized techniques from grounded theory in the search for any 
commonalities and patterns inherent in these common excerpts. During the first reading 
of the transcripts, the researcher wrote reflective remarks within brackets that were 
directly entered into the interview transcripts. This placed the researcher’s perceptions 
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and thoughts into a visible form to allow for a deeper and more general sense of what is 
happening.  
 The second reading of the transcripts focused on open coding (Creswell, 1998) to 
identify and categorize general categories that are repeated in the transcripts. The 
researcher color-coded the data, and the development of these categories and 
subcategories emerged as themes, patterns, and commonalities.   
 During the third immersion into the transcripts, the researcher utilized axial 
coding (Creswell, 1998) to document patterns that coincide within the data collected from 
the semi-structured interviews. A map of how the interview schedule related to the 
research questions is attached as Appendix A. The transcripts were independently 
analyzed and recorded on a matrix that was framed by the interview schedule as it related 
to the research questions. For example, five interview questions are on the interview 
schedule related to Research Question 1, section a. The interview transcripts were 
analyzed across these five questions collectively. Five questions on the interview 
schedule related to Research Question 1, section b. The transcripts were analyzed across 
these five interview questions collectively. This was repeated for Research Question 1, 
section c; Research Question 1, section d; and Research Question 2.  
 For triangulation purposes, two types of data--the individual curriculum vitae of 
the subjects and the 14 interviews (from the four stakeholder domains)--provided data 
that reflected different windows into the perceptions of key individuals regarding the 
benefits, risks, and alternatives to the Pharm.D. as the entry-level degree into pharmacy 
practice. 
Trustworthiness and Validity 
 The literature that was reviewed made it clear that the effects of the entry-level 
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Pharm.D. degree changeover had yet to be fully captured and analyzed. Each person 
identified as a leading participant was interviewed to inform this investigation. The 
combined knowledge gathered via a review of the literature, document analysis, and 
detailed parsing of the interview provides the study with a high level of credibility, 
authority, and validity. Merriam (2002) noted that issues of internal validity, reliability, 
and generalizability constitute the trustworthiness of a study. In qualitative design, errors 
that affect trustworthiness can occur with either data collection or analysis. It is important 
that the research be rigorous in utilizing a scripted protocol for data collection and a 
defined method of analysis to ensure reliability and validity. Both of these were clearly 
articulated and followed in this study. Merriam (2002) identified eight strategies for 
promoting validity and reliability: (a) triangulation, (b) member checks, (c) peer 
review/examination, (d) researcher’s position or reflexivity, (e) adequate engagement in 
data collection, (f) maximum variation, (g) audit trail, and (h) rich, thick descriptions. 
 Triangulation was utilized by collecting background information from the CV of 
the participants and confirming that the information collected during the interview was 
indicative of the thoughts and feelings of the participant. The two qualitative methods 
were combined to provide a more complete set of findings than could be gleaned through 
the administration of one of the methods alone.  
 A review of the process and interpretation of data was completed by Dr. Stephen 
Miller, the researcher’s dissertation chair, in effect serving as an informal external peer 
review/examination (audit). This process of evaluation involving a qualified individual 
within the relevant field improves quality, upholds standards, and increases the 
trustworthiness and validity of the findings. 
 Regarding reflexivity, the researcher was attentive to her relationship to the study 
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(a healthcare professional with a background in chiropractic) with regard to adversely 
affecting the results. An effort was made throughout to maintain a critical self-reflection 
of biases.  
 As the primary instrument for data collection, the researcher was intensively 
engaged in both data collection and data analysis. The focus on saturation with the 
content of the interviews facilitated the search for common themes and concomitant 
attention to outliers or lack of similarities. This prolonged involvement and familiarity 
with the case is crucial for validity and reliability. 
  In order to ensure maximum variation of perspectives, the full range of 
participants from the four target policy groups (population) was included. The office of 
the Executive Secretary of the AACP identified the population base from the AACP 
Board of Directors, Janus Commission members, and the Commission to Implement 
Change members. The Executive Staff at the ACPE identified the ACPE Board of 
Director members. From this larger group a census was conducted among those still 
available. The return rate on the census (33%) ensured the researcher of a representative 
cross sample.  Specifically, maximum variation was assured by selecting a critical 
purposeful sample of key individuals.  
 An audit trail was maintained by providing a detailed accounting of the research 
methods and procedures used in tracking the responses to items from the interview 
schedule and research questions. Steps were taken from the start of the research project to 
present a transparent description of the development and reporting of the findings.   
 The data collection procedure used was limited to personal interviews. 
Inaccessibility to certain key participants could have resulted in an unavoidable limit to 
the richness and scope of the study, but results of the high quality interviews will allow 
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the reader to decide whether the findings are transferable to other disciplines transitioning 
to the clinical doctorate as the entry-level degree.  
 In summary, the researcher addressed seven of Merriam’s (2002) eight strategies 
to ensure credibility and trustworthiness of her analysis--triangulation; peer 
review/examination; researcher’s reflexivity; adequate engagement in data collection; 
maximum variation; audit trail; and rich, thick descriptions. Triangulation was satisfied 
by the use of more than one approach to the investigation in order to enhance confidence 
in the ensuing findings. Subjecting the author’s research to peer review/examination 
ensured a higher level of trustworthiness and validity to the findings. The researcher’s 
reflexivity permitted the understanding of how knowledge, beliefs, and values may have 
come into play during the research process. As the primary research instrument, the 
researcher maintained adequate involvement in the data collection process. Attention was 
given to maximum variation sampling to ensure the broadest range of information and 
perspectives available. An audit trail of the research steps taken during the investigation 
is documented in a transparent report. The researcher provided thick, rich descriptions to 
allow the readers to determine if the situation described in the study applies to the 
reader’s situation.  
Ethical Considerations 
 The researcher was diligent in her efforts to guarantee that all aspects of this 
research study met the standards for ethical research, including the federal rules for 
studies involving human subjects. The Human Subjects Review Board (HSRB) from 
Western Kentucky University required completion of an on-line certification course in 
human subject research. Both the researcher and dissertation chair, as required, 
completed this training. To ensure Protection of Human Subjects, application was made 
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to the Western Kentucky University Institutional Review Board for approval to conduct 
the study. Every effort was taken to follow all procedures regarding protection of 
confidentiality and respect for persons (consent process). All data were handled and 
stored in accordance with recommendations by Wiebe, Eurepos, and Mills (2010). 
Summary 
 This chapter recognizes the methodological concerns involved in the investigation 
into the benefits, risks, and alternatives to the Pharm.D. as the entry-level degree into 
pharmacy practice. The purpose of this case study is to gain insight and knowledge that 
fills a gap in the current theoretical or empirical data on the effects of this transition. 
Description of the research methods used in this study, including the research design, 
description of the population and sample, instrumentation, procedures for data collection 
and analysis, as well as issues of validity and ethics constitute this chapter. 
  The research design was a qualitative case study that allowed for inquiry into the 
detailed knowledge of the transition to the Pharm.D. as the entry-level degree into 
pharmacy practice and the perceptions from key individuals on how this decision affected 
stakeholders. Triangulation was achieved by examining two sources of data with two 
different procedures. Background and demographic information on the participants was 
collected via each individual’s CV via document analysis. The Interview Schedule was 
the primary source of information, focused on the emic perspective of the subjects using 
a semi-structured interview format.  
 In qualitative research, the researcher’s role is central. In this study, the researcher 
took primary responsibility for the interpretation, based on analyses that were guided by 
the strategies of ground theory coding. Throughout, the author remained cognizant of her 
own background and biases - that of a healthcare professional from a somewhat 
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marginalized specialty, chiropractic - with respect to the traditional disciplines. That 
background is complemented by her current work in higher education and the 
methodological skills of the academic doctorate.  
 The thoughts, beliefs, and reflections of 14 key individuals from the four target 
policy groups constituted the primary data regarding the decision - making process to 
require the clinical doctorate in pharmacy. These individuals--including leaders of 
professional associations, educators, accrediting agencies, and professionals--were 
centrally involved in requiring the Pharm.D. as the entry-level degree to practice. Case-
study strategy of inquiry guided the research design and data collection (Creswell, 2003; 
Yin, 2009), with the goal to obtain multiple perspectives from the four policy 
groups/commissions. 
 The population for this bounded case study consisted of 43 individuals who were 
participants in four stakeholder domains: AACP Commission to Implement Change in 
Pharmacy Education, the Janus Commission, the AACP Board of Directors and AACP 
House of Delegates from 1989-2002, and the ACPE Board of Directors. A census of this 
purposeful, critical case population resulted in a final sample consisting of 14 key 
individuals (33% return) from the various stakeholder groups who constituted the four 
realms that were involved in the decision-making process.  
 The research questions were constructed following a survey of related studies. 
Specific questions were designed to elicit information on the retrospective perceptions of 
the stakeholders in the field of pharmacy who were involved in the decision to require a 
clinical doctorate (Pharm.D.) as the entry-level degree to practice as a professional. This 
involved modifying questions from previous studies to focus on this historical decision, 
as no investigations were found that examined the long-term effects of this milestone 
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decision in the healthcare professions.  
 Qualitative research design, protocols for case study research, and the 
Transtheoretical Model of Behavior Change provided frameworks for the development of 
the Document Analysis Protocol and the Interview Schedule. The document analysis 
provided objective information about the subjects (applied to the subjects’ CVs). The 
interview schedule was developed to gain in-depth knowledge regarding the perceptions 
of the respondents on the effects of the Pharm.D. and the transferability of the entry-level 
clinical doctorate related to professional opportunities.  
 The research conducted in this study is consistent with the elements of case study 
research. The components of the study included the development of a purpose and 
rationale, establishment of the significance of the issue, the development of specific 
research questions, the unit of analysis (the bounded situation/decision as instrumental 
case), and protocols for data collection and data analysis. 
 The Institutional Review Board at Western Kentucky University approved the 
study; and the instruments were reviewed for appropriateness, accuracy, and suitability. 
Both a content expert and a qualitative expert both examined the interview schedule to 
ensure validity. No changes were made to the instrument based on the expert review. 
 The procedures for this study were consistent with case study research. The 
primary method of data collection was the semi-structured interviews, in which the 
questions were mapped to the research questions. The 43 individuals who constituted the 
population were sent an introduction letter via electronic mail in April 2012. Initially 
seven responded that they would be unable to participate, but two decided to participate 
after a follow-up letter was sent. Those who did not respond were sent the same 
introduction letter by U.S. Postal mail. Three letters were returned for invalid address. 
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Twenty-one individuals did not respond to any method of contact. This resulted in 14 
subjects constituting the final sample.  
 All subjects completed an informed consent form and were asked to include a 
current CV when they returned the informed consent form. Telephone interviews were 
conducted May 16, 2012 - June 15, 2012 and were recorded, transcribed, reviewed for 
accuracy, and analyzed. 
 The data analysis process began during data collection. As the researcher received 
the completed transcriptions, review of the documents was started. The analytic system in 
this study included utilizing the document analysis protocol to retrieve objective 
information on the subjects as well as using open and axial coding methods to search the 
transcripts for commonalities and patterns that recurred in the interviews. 
 The collective knowledge gathered by review of the literature, document analysis, 
and in-depth study of the interviews provided the study with a high level of 
trustworthiness, reliability, and validity. The researcher worked diligently to ensure that 
this study met the standards of ethical research, including the protection of human 
subjects, confidentiality, and respect for persons.
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CHAPTER IV 
 
RESULTS 
 
 
Introduction 
 The clinical doctorate is an emergent trend in health professions. In some 
disciplines, the practicing doctorate is an advanced degree that is available for 
experienced professionals. In other disciplines the clinical doctorate is the sole entry-level 
degree to practice. In many cases, this transition is precipitated by the educational 
accrediting agencies implementing a clinical doctorate as the entry-level degree into 
practice, surrounded by both support and skepticism among educators, professional 
organizations, practitioners, administrators, and third party payers.  
 The individual health professions have explained the rationale and requirements 
necessary for clinical doctorate programs leading to the respective degree, but there is 
little information is available about how this movement will affect health professions 
education, delivery of service, interdisciplinary relationships among healthcare 
professionals, or society in general. Leaders and policy makers in health profession 
disciplines that are facing this transition should consider the benefits, risks, and 
alternatives to changing the educational requirements necessary to enter the profession. 
This study focuses on how the transition to the clinical doctorate as the entry-level degree 
in one profession, pharmacy, was perceived during the inception and implementation 
phase of the Doctor of Pharmacy. 
 The purpose of this study was to provide insight into the perceptions of
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professional leaders and policy makers regarding the benefits, risks, and alternatives to 
the Doctor of Pharmacy degree as the entry-level degree into pharmacy. Pharmacy is 
appropriate for this study because the transition to the Doctor of Pharmacy (Pharm.D.) as 
the profession’s entry-level degree was mandated in 1992, with complete implementation 
in 2003. Now, after 20 years, it may be insightful to see the effects of the change on the 
profession. All of the leaders and stakeholders in this study were pivotal in making 
decisions regarding the academic mandate to implement the Pharm.D. Each participant 
reflected on past experiences and articulated current perceptions related to the effects of 
the decision to go to the Pharm.D. as the sole degree into to pharmacy practice. 
 The remainder of this chapter details the results of this study. Specific sections 
addressed include methodological considerations and findings, which are organized 
according to the research questions. The chapter concludes with a summary.   
Methodological Considerations  
 This is a qualitative case study that involves an oral account of individuals who 
were instrumental in the decision-making process through semi-structured interviews. 
The researcher observed the participant’s view (emic perspective), while maintaining an 
outsider viewpoint (etic perspective). The researcher established the unit of analysis by 
narrowing the population to four limited, but critical, stakeholder groups and the 
timeframe of 1989-2002, to represent a means to understand a complex case. The four 
stakeholder groups included members of the AACP Board of Directors, the Commission 
to Implement Change in Pharmacy Education, the Janus Commission, and the ACPE 
Board of Directors. 
 The population consisted of 43 key individuals from the four stakeholder groups 
that constituted the four realms involved in the decision-making process regarding the 
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Pharm.D. as the sole entry-level degree to practice pharmacy. Availability (deceased, ill, 
retired) and willingness of participants determined a final sample size of 14 high quality 
interviews. The 14 of 43 represent 33% participation for the critical case sampling. Of the 
43, 28 were still available. The final sample involved 50% of those who could, at this 
point, have participated.  
Instrumentation 
 The curriculum vitas of the subjects in this study were reviewed for objective 
information and demographics of the individuals participating in the decision-making 
process (see Appendix B, Document Analysis Protocol). This is inconsistent with the 
consent form signed by each participant. The consent form states that a content 
questionnaire would be sent to all participants prior to the interview. In lieu of the content 
questionnaire, the CV represented objective information on each participant, a tackic 
taken based on the suggestion of one of the respondents. This post-hoc change was 
approved by the IRB. 
 The interview questions were developed as a means to assess the individuals’ 
perceptions of the benefits, risks, and alternatives on health professions education, 
delivery of services, interdisciplinary relationship of practicing clinicians, and the societal 
and economic landscape of the healthcare industry. In addition, questions were created to 
assess the individuals’ sense of the transferability of the entry-level clinical doctorate 
related to professional opportunities. The interview schedule consisted of 27 open-ended 
questions based on relevance to the research questions, the specific role group, literature 
in the field, and theoretical considerations. The dissertation committee also gave 
feedback on the development of the instrument. After preliminary drafting of the 
instrument was completed, the dissertation chair provided additional input.    
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Procedures 
 The procedures for this research were consistent with a case study approach. After 
receiving approval from the Human Subjects Committee at Western Kentucky 
University, the research instrument and the Interview Schedule were examined for 
content and clarity by two educators, one in health professions education and one in 
qualitative research. The Expert Panel Members provided valuable feedback to the 
researcher. Each panel member completed the Expert Review of Interview Schedule 
(Appendix D). The expert panel members noted no significant changes. In lieu of a pilot 
study, the content expert and the author’s dissertation chair reviewed the final interview 
schedule one last time. 
 Fourteen interviews were conducted, representing the collective retrospective set 
of perceptions, reflections, and opinions of the selected participants. All the interviews 
were conducted by telephone and were completed in approximately one hour. Once the 
conversations began, the subjects expressed great passion and enthusiasm to voice their 
views and opinions. Respondent 10 said, “Your proposal and thesis topic is really much 
needed. I think it is great.” Because of the eagerness of the subjects to share information, 
several of the interviews exceeded the scheduled time, some lasting up to two hours in 
length. The intense curiosity was further demonstrated when a respondent contacted the 
researcher several months after the interviews, inquiring to as when the study would be 
published and requesting the opportunity to read the final product.    
 The interviews were recorded and transcribed. In addition, the researcher took 
contemporaneous hand-written notes as a backup in case of technical difficulties. Each 
interview began with the researcher confirming the confidentiality of the conversation, 
just as it was explained in the written participant letter.   
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Data Analysis 
 Using a purposeful, critical sample matrix as detailed in Chapter III, two primary 
data sources were used for this study: the individual curriculum vitae and the transcripts 
from the interviews with the four stakeholder groups. A Document Analysis Protocol 
(Appendix B) was utilized to examine the CV of each subject for objective background 
information to enhance the quality of the interview. In this case study, techniques rooted 
in grounded theory were utilized to search for any commonalities and patterns in the 
interview transcripts (Creswell, 2003; Yin, 2009). The specific analytical techniques 
involved the researcher collecting notes and transcripts. The interview excerpts were 
sorted and coded into open codes (themes) that demonstrated trends. These open codes 
were collected into axial codes (patterns) that the researcher identified among the data. 
Integration of the trends and themes allowed the development of a holistic story of the 
specific case. 
 Each of the 14 participants’ responses to the interview questions were read, 
reread, and analyzed for commonalities and themes that were presented in the transcripts. 
The first reading was a holistic analysis to obtain an overall sense of the landscape of 
data. The second reading of the data focused on open coding (Creswell, 1998) that 
identified general categories that were present in the data, as well as subcategories that 
were identified as commonalities and patterns present in the themes.   
 The third examination of the transcripts focused on axial coding (Creswell, 1998) 
to document patterns that overlap within the data collected from the semi-structured 
interviews, specifically how these professional leaders viewed the benefits, risks, and 
alternatives to the clinical doctorate as the entry-level degree into pharmacy practice. The 
transcripts were analyzed independently and recorded on a matrix that was structured on 
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how the interview schedule related to the research questions (Appendix A). Finally, the 
interviews can be classified in terms of the type of information that the content 
represents.  
Results 
 The results are organized by the research questions and constitute the framework 
for exploring the meaning of the responses. Each subpart of the research question is 
repeated in bold for the convenience of the reader. The actual interview questions from 
which the question is derived are repeated immediately after the sub-research question; 
for simplicity, the abbreviation for the Interview Schedule is (IS). 
 The sample consisted of a small number of prominent key individuals from the 
four stakeholder groups. It would be impossible to provide a description of the 
respondents without compromising their identity; therefore, the researcher assigned a tag 
label to the feedback from each research subject, displayed as Respondent 1, Respondent 
2, etc., for all 14 participants. 
 This is a study of phenomena that occurred over 20 years ago, and the 
respondents are subject to two biases: recall and confirmation. Recall of specific details 
and dates may be difficult after a long period of time. People tend to remember things 
that confirm their beliefs and forget things that do not. The researcher made attempts to 
minimize both recall and confirmation bias during the interview process. At the 
beginning of each interview, the interviewees were asked if they preferred to start telling 
a story, with the researcher interjecting to remain within the content frame or if the 
researcher should ask specific questions. All participants decided to tell a story, and the 
researcher interposed to keep track of content and monitor the time. The researcher 
remained open to any unexpected and significant findings that emerged from the 
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interviews. 
 Finally, a note on organization of content is apt. Throughout, both patterns (and 
themes) that the author identified are done in bold (bold italics) to alert the reader to their 
centrality to the story that unfolds as the results are reported. Although themes were 
identified in a prior search of the data (open coding), the patterns that the researcher 
subsequently discovered as larger organizing structures that encompassed two or more 
themes (axial coding) are presented first, with the themes for that pattern presented within 
the content of description of each pattern. Together, these patterns and their respective 
themes facilitate telling the story of these respondents’ retrospective on the decision to 
mandate the Pharm.D. 
 In order to give a holistic account, the author intermixed contextual information 
from interviews with background information from Chapters I and II. Information from 
the interviews generally provided the content for the introductory context following each 
research question and set of Interview Schedule queries. To the extent that background 
information from Chapters I and II was necessary to complete their story, that 
information is presented in square brackets for the convenience of the reader, thus 
making explicit that the information did not derive from the interviews. In addition, 
information from respondent interviews was handled in three ways: overall interpretation 
of an issue by the researcher, direct quotations, and direct paraphrases.  
 A summary outline (Appendix G) was created in order for ease of the reader to 
view the entire chapter in a holistic content. Each pattern is presented in bold, and its 
offspring themes are presented in bold italic. The last two patterns did not fit directly 
under any of the research questions and are addressed as additional findings. 
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Research Question 1a  
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate on: 
  
 a. health professions education? 
  
 IS1. In general, what benefits do you think the Pharm.D. has had on pharmacy 
 education? 
 
 IS2. To what extent has the curriculum/knowledge base changed for students? 
 What have been some of the trade-offs for changes in the curriculum/knowledge 
 base for students?  
 
 IS3. The entry-level degree into pharmacy practice changed from a master’s to a 
 Pharm.D. Why was the Pharm.D. chosen instead of a Ph.D? How did this change 
 the structure of the educational programs? Were more clinical hours required or 
 length in program? Have institutions made the necessary changes?  
  
 IS4. Educational institutions had the responsibility of creating new Pharm.D. 
 programs that satisfied the accreditation requirements. One controversy of the 
 changeover has been the charge of “degree creep.” Do you feel that programs 
 have been successful in elevating the educational experience to the level 
 anticipated?  
 
 IS5. Was there a formal, structured plan developed to assist educational 
 institutions through challenges associated with the transition? What resources 
 have been available to institutions and program leaders in regard to establishing 
 curricular changes, faculty credentials, funding sources to implement the change, 
 etc?    
 
 First pattern: Historical accounts leading up to the ACPE mandate. There 
was a slow, gradually growing understanding that the practice of pharmacy both in 
hospitals and in community settings should be patient-care based. Because of the 
uncertainty and magnitude of the changes, this process was going to require 
comprehensive and explicit dialogue among all stakeholders. [The respondents are 
people who took the leadership position to move the educational requirements that 
subsequently become, hopefully, a catalyst that moves the profession. They were 
advocating to better serve both patients and the community, in hopes that tomorrow they 
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will appropriately utilize the knowledge base and the skills that pharmacists have.] 
Eventually, the knowledge base of the pharmacist will be recognized as unique and 
certainly much more comprehensive as it relates to pharmaceutical sciences and 
pharmacotherapy more so than any of the other health professions.  
 The majority of respondents recounted that the Commission to Implement Change 
guided the profession as to how the transition was going to work. The colleges set into 
place the design for the development and subsequent acceptance of this change in policy 
by the body at large. Then, a series of reports from the commission were disseminated to 
all the colleges in the country. This information and policy statements guided discussion 
among faculty at each of the institutions. Each pharmacy school used the internal process 
for curriculum change to debate the wisdom, or lack of wisdom, in accepting these 
changes. A vote eventually was taken by the AACP Board of Directors to accept each of 
these position papers as a process to implement the change. This happened over a number 
of years, finalized in 1992. The commission was reappointed in 1992 and dealt with some 
additional issues as well; thus, this development went over a long period of time.  
 Theme: The decision-making and implementation timeframe was a constructive 
process; but it was very controversial, and there was a lot of anxiety about it. The 
ACPE could see how people could get in trouble with drugs, and the pharmaceuticals 
were becoming more and more problematic. Their use was more complex and the current 
healthcare system was not adequately addressing patients’ needs with regard to drug 
interactions and complications.  
 This has been a very divisive topic for 50 years. Considerable discussion was held 
on going to the entry-level Pharm.D. as the only entry-level degree. At the beginning, 
people thought it would be a smooth transition. In 1989, when the accrediting body for 
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pharmacy (ACPE) made the pronouncement that all schools would need to go to the 
Pharm.D. and change the curriculum, people pointed to the law profession. This was the 
way the legal profession changed to the Juris Doctor. Everyone received a jurist doctorate 
and things did not seem to miss a beat. But that was not the case in pharmacy. 
Respondent 3’s acknowledgement of the “messy” change was echoed by Respondent 10, 
who recalled: 
 This was a very contentious process. I make this statement from the standpoint of 
 I’ve been fortunate enough to have a very long career as a practicing health 
 professional as a pharmacist. I think I saw that side of it and I also have been in 
 the academic environment for about 30 years now. I have a view from both 
 worlds and my assessment has been, as to some extent is true today, that this has 
 been a very contentious process with pharmacy. 
 
There continues to be many battles by schools to decide how to implement and fund the 
change and how to find the faculty and the sites for the experiential portion of the 
curriculum. Not everyone was on board with each school, nor within the association. The 
conversation surrounding changing the entry-level degree included extensive change at 
several levels, and numerous individuals struggled.  
 Theme: Many respondents believe that pharmacists are the most 
underappreciated health profession. The pharmacists’ contributions to healthcare are 
undervalued because they are invisible to the public. Respondent 11 believed that this 
philosophy goes back a long time ago and that pharmacists sometimes are their own 
worst enemy: 
 I first realized this after I graduated from college and became a pharmacist. I was 
 drafted a couple months later and served in the Army for a couple of years. Being 
 a pharmacist was unappreciated by the U.S. military. We were not officers. 
 Anybody that they sent to Houston for six weeks, they thought they could turn 
 into a pharmacist. I sort of had a chip on my shoulder about that for the rest of my 
 professional career.  
 
 When the issue of pharmacists being commissioned in the military was being 
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 debated in Congress, there was growing pressure to change it. At the same time, 
 California was operating with the Pharm.D. degree and other colleges across the 
 country were gradually instituting the Pharm.D. It may not have been the only 
 degree issued but there were a lot of people working on the Pharm.D. and they 
 had a lot more clinical experience.  
  
 A disconnection had occurred between some views about pharmacy practice 
within academia and within the world of pharmacy practice. Numerous strong exceptions 
were present at the time, so the environment was not uniform. However, there was an 
expansion of interest in the accreditation body for pharmacy education. With the 1970s 
came the early Pharm.D., although California had moved earlier. The majority of the 
country, however, began implementation during the early 1970s. Schools began training 
the Pharm.D., and also was the add-on Pharm.D.; but these were mostly in institutional 
(hospital) settings.  
 The ACPE pushed change; some of the schools were in favor, some were not. 
Schools were faced with an enormous investment and intensive work to change courses 
and curriculum. They first started adding hours to the curriculum. Respondent 12 
recalled: 
 I remember that a bachelor’s degree at University of Ohio for liberal arts required 
 116 hours and pharmacy needed 160 hours. So pharmacists were earning a lot 
 more than a B.S. degree and were not being recognized for it. They kept adding 
 hours to it so by the 1970s, there was not any profession with a course 
 requirement as rigorous to become a pharmacist with a bachelor’s. People would 
 get a master’s with fewer hours. It should have been a doctorate. 
 
  Not all respondents supported the sentiments that pharmacists are becoming more 
recognized as key players in healthcare delivery. A number of respondents [5, 7, 10, 12] 
believe that pharmacists have not traditionally been accessible to the public and that they 
fill prescriptions from behind the counter. Respondent 7 painted this picture: 
 In Washington, DC, go down near Congress and observe the pharmacy 
 environment. Every pharmacy is very chain drugstore oriented, very few 
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 independent representatives that do patient care. If the decision makers are not 
 seeing pharmacists as healthcare providers, we have a tremendous issue. If the 
 policy makers were serviced by a competent pharmacist either saving their lives 
 or actually see a pharmacist intervene and make a difference, they might 
 appreciate the knowledge, skills, and abilities. 
  
Respondent 10 illustrated a similar thought: 
 Education is a relative concept. Some of the most educated people I know don’t 
 have a lick of common sense. You may be talking to one of those today but no 
 pharmacy has done a good job of helping patients understand regardless of how 
 educated those patients are. We have not done a job that is any good at all letting 
 them know what we do for them as a profession and that is my problem because 
 in my mind it is another opportunity. When a pharmacist is behind the counter, 
 behind the computer, or in the basement of a hospital people have no idea what 
 value is there. 
 
Respondent 5 said:  
 Here is the challenge: The members of society that interact with community 
 pharmacists hardly see them. They may have a draft window that they can talk to 
 the pharmacist but can’t approach them. Most of the time folks say there is no 
 exposure to individuals who have more than minimal skills. There is the 
 perception of the pharmacists being trained or educated or having the skills to 
 provide direct patient care…in some situations, yes and in some situations, no. 
  
 Some practice leaders are beginning to change their operations because people are 
beginning to perceive the value that is out there. [Historically, people have seen 
pharmacists as merchants, not healthcare providers.] Society is beginning to see that 
pharmacists have the ability to provide pharmaceutical care to the people who matter. 
Many respondents [3, 6, 7, 9] are of the opinion that they see that we do have an 
important role in trying to conserve some of the costs in healthcare.  
 Theme: There is still debate whether pharmacy education should focus on 
patient care or the product. Schools that are closely related to medical students lean 
toward patient care. One respondent noted that the top ranked pharmacy schools are on 
medical campuses. At an AACP meeting, Dr. Layla Esposito, then with the Health and 
Human Services, was discussing the proliferation of schools all over this country 
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[Respondent 6]. The question was posed as to why we have not observed the 
establishment of colleges of pharmacy at these outstanding colleges of medicine and 
health centers across the country. Respondent 6 conveyed her response, “Of course, 
because it is too expensive if you do it right.”  Those not on a medical campus have a 
more difficult time securing training sites for experiential learning that really expose 
students to working with healthcare teams. An interesting observation was that our top 
ranked medical schools do not necessarily have pharmacy schools associated with them, 
but most of the state medical schools do [Respondent 6]. Many private or proprietary 
pharmacy schools do not follow this model.  
 Second pattern: For this transition to be uniform and organized, it had to 
stem from the accreditation bodies and the educational profession. Curricular 
changes in pharmacy education were necessary for successful conversion to the 
doctorate level. 
 Theme: During the transition, many schools revisited their clinical curriculum 
in making changes because those 7-10 years sustained a major overhaul in 
accreditation standards. The timing was right. Some schools had to address their 
approach to clinical training because the ACPE standards changed; they needed to sync 
with the accreditation standards. The ACPE demanded re-evaluation of the curriculum; 
many schools had their feet held to the fire because of financing. The accreditation 
agency is evaluated by the Board of Education every five years. Schools have to do a 
self-study, as does the accreditation agency, and send it to the United States Department 
of Education (USDE) for review. During the Bush and Obama administrations, the USDE 
came down harder on the accreditation agencies to ensure that they hold programs to their 
standards. Much of what programs do for accreditation stems from what the Department 
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of Education is demanding, i.e., accountability for education. All of the colleges of 
pharmacy in the U.S. are autonomous. There were 70+ colleges of pharmacy when this 
was occurring and when this started with the 1989 ACPE mandate. If all the colleges did 
what they wanted, we [Respondent 4, 8] would have a hundred different curriculums and 
there would be chaos and lack of uniformity. The outcome would have been a clear 
disaster for the American public.  
 It was a very stressful time for institutions: teaching two curriculums at the same 
time. The B.S. program was expiring, and they were adding in the Pharm.D. This was 
stressful on faculty, with considerable angst as far as curriculum revision; content 
changes; cutting hours and courses; and, hence, faculty, etc. Administrators were under 
pressure as well. Some schools conducted a bottom-up approach; some used a top-down 
approach. Some schools were more effective than others. The intention--why the school 
was implementing the program--was reflected in the success of the transition. Respondent 
10 provided another example of the nationwide debate: 
 One example was the University of Illinois, where Walgreens is headquartered. 
 They were hammered as a public university because of their movement to the all 
 Pharm.D. program. The private universities that I have been affiliated with had a 
 much easier time of this because of how those universities are structured. I am not 
 saying one is better than the other. They were just different.  
 
 For many years, people responded and said, “You want me to do this, I’ll do this,” 
not embracing the idea of why. ACPE started asking schools to do certain things, 
pressing the issue of improvement until the schools had to embrace the idea of upgrading 
the quality of the program. At first, the classes were 10-12 students at a time. The schools 
built in working with medical students and with physicians. They developed an 
understanding of what a pharmacist can do. Concomitantly, research was increasing and 
this needed to be incorporated into the coursework. Schools really expanded the practice 
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of patient care, ensuring that the patient had the best use of drugs. That trend continued 
and expanded through the 1980s. A paper on pharmaceutical patient care really changed 
the landscape, describing how patients with chronic diseases in community pharmacies 
presumably could get patient care, obtain monitoring of their medications, and have 
access to the necessary intervention (Manasse, 1989). The pharmacist would make sure 
patients received the optimal benefits from their medications.  
 At the same time, Respondent 13 explained that the Pew Commission (Institute of 
Medicine, 1999) was tracking drug misadventures and medical errors and documenting 
how excessive drugs were being used and are to this day. Throughout this period and into 
the 1990s, external racket and unease in the healthcare environment flourished: that 
pharmacists could do even more, yet, were not allowed to exercise those skills.  
 Theme: In order for the pharmacist to take on the responsibilities associated 
with drug management, pharmacy education would need to be revamped. Drug therapy 
was becoming patient-specific, based on effectiveness of the drug as related to genetics 
and metabolism. The pharmacist was in a much better position to possess global 
knowledge of all the drugs available to treat patients but lacked the hands-on clinical 
experience with what the drug was doing with actual patients. Reading about the 
statistics, research papers, and pharmacological theory was not the same as on-the-
ground, problem solving with patients about how to avoid problems and maximize the 
benefits within the entire system known as pharmaceutical care [Respondents 8, 12]. 
Pharmacokinetics had become increasingly important, especially since it seemed that the 
pharmacy profession could not continue with the status quo, just taking orders from 
physicians to ensure that the patient got the right product. In effect, the pharmaceutical 
industry had taken over the process of producing medications, via manufacturing, that the 
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pharmacist had done prior to WWII.  
 [The recommendation to the academic community to convert from a Bachelor of 
Science program to a six-year Doctor of Pharmacy degree was made in 1948 after the 
Elliott survey was completed and presented to the AACP. At the time it was presented, it 
was a four-year Bachelor of Science program in pharmacy. After much discussion 
regarding the proposal, which the academic community rejected, a compromise was 
struck, leading to the five-year Bachelor of Science degree. The pharmacy school at 
UCSF in 1954 made the decision to convert to the Pharm.D. program.]  Regarding the 
project at UCSF, Respondent 3 commented that it was something that made a difference 
and could apply to the whole profession: “It was slow…. [I]t took years to get beyond 
just the beginning idea [that] the pharmacist as a clinician had merit.” 
 Many Pharm.D. graduates in the 1980s and 1990s had spent 9-10 years in college 
getting this credential, and a number of them ended up on college faculties. Some went 
into industry, but they were still underappreciated except at big [research] institutions. So 
many ended up being unhappy. After the rigors of their education, there was 
dissatisfaction that many pharmacists felt a sense of underemployment. Respondent 12 
illustrated the environment at the time: 
 I do not remember the dates/times until we get into the 1990s, but there was 
 continued discussion and presentations by the academic community to move to 
 the Pharm.D.…[which]was continually met with resistance to change by 
 academic people. Discussions over the Pharm.D., I recall very clearly at the time, 
 there were 21 different schools of pharmacy that had some type of Pharm.D. 
 program with different kinds of variations. It was never really a consensus if you 
 will about the academic[s]. [C]hanging was in the profession itself about this 
 Pharm.D. degree and stuff. Questions about the role pharmacy plays and the 
 clinical applications needed to be answered and [these] were factors that led to the 
 long-term evolution which took 50 years to get the Pharm.D. as the single entry-
 level degree. 
 
 Theme: Concern was expressed over which degree was appropriate. The 
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respondents were unanimous in the opinion that there was minimal discussion regarding 
whether the degree should be a master’s, Ph.D., or a Pharm.D. Many felt that if this was 
going to be a degree to be used by practitioners in healthcare delivery, a clinically 
oriented non-Ph.D. degree would probably better serve their needs. A master’s is a 
graduate degree; a Pharm.D. is a professional degree in line with the M.D., D.D.S., etc. 
This made sense. [The Elliot report in 1948 suggested a six-year program for the 
pharmacy degree so pharmacy moved to a five-year degree.] It was labeled “a bulging 
bachelor’s.” The general consensus of respondents was that, in order to position their 
profession properly, a single entry-level degree to enter practice was necessary. 
Regarding the influence of pharmacists compared to decision makers in other healthcare 
professions, the practicing doctorate was needed in order to put them on a similar level of 
knowledge base, talent, and skills. 
 The other aspect of that certainty related to concerns dealing with the boundaries 
of the degree. Honorific titles have meaning that is embedded in the culture beyond the 
question as to whether the individual credentials say Ph.D. or Pharm.D. The letters that 
represent a credential are truly trivial in the total scheme of things. However, they are far 
more important to specific role groups whose identity is symbolized by that insignia. 
Specifically, university faculty were inclined to cling to that which makes them 
distinctive if not distinguished, i.e., the title after their name. Respondent 5 expanded on 
this situation: 
 It is pretty easy to think of a large group of individuals, these being academics, 
 most of whom have, at some point in time, earned a Ph.D. after their name, 
 squabbling about why in the world are we thinking about giving up this prized 
 nomenclature to individuals that are clearly our inferiors.  
  
 Theme: A large group of individuals, these being academics, opposed to the 
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doctorate as the entry-level degree into pharmacy. To avoid all of the conversation, we 
[Respondents speaking here] basically had this degree be something that would be far 
less controversial. This doctorate relates to the clinical setting rather signifying that it is 
based on original research intended to advance the knowledge of humankind, which is the 
realm of the traditional Ph.D. 
 Theme: The biggest curricular change was the addition of the one year of 
experiential work. The overall educational process shifted from predomintely organic 
and medicinal chemistry to physiology, pathophysiology, pharmacology, and 
therapeutics. Students are not just learning structures, but are learning structures in the 
context of pharmacology of drugs. It is a different kind of experience. There are practical 
labs that simulate actual patient care experiences. The entire fourth year is experiential, 
where pharmacy students are exposed to practitioners, a year where the student spends a 
month on several specialty rotations such as family practice, internal medicine, 
cardiology, community practice, etc. [Respondents 6, 12]. Another label for students in 
these rotating experiences is preceptor; in education they are called student teachers.  
 The practitioners mentor the students; this is important because we need to 
prepare pharmacists to possess the confidence in themselves to approach physicians 
professionally and in an engaging manner to be part of the decision-making process and 
the patient care team. Some schools have introductory practice experiences for the first 
through third years so students are attending school and having practical experience the 
entire time until they graduate [Respondents 6, 14]. In order to provide pharmaceutical 
care, students must be able to talk and listen to people; thus the skills of writing, talking, 
listening, problem solving, and thinking outside the box are important. This is a very 
powerful combination and is true for all professional occupations.  
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 Not everyone was sold on how the clinical aspect of the Pharm.D. played out.   
Respondent 12 was an outlier on the benefits of the experiential component: 
 I do more of the clinical education or Pharm.D. program, the clinical education 
 piece. You can really get my blood pressure up on how we do clinical education, I 
 think it is a waste of time. 
  
 My criticism of pharmacy education is the experiential piece. I am tired of having 
 students coming to my class and say the three out of the eight rotations were a 
 total waste of time. To send students to CVS pharmacy while in college and call 
 that community pharmacy rotation, which is suppose to be clinical and have a 
 little counseling. This is what is happening throughout the country and meanwhile 
 in the last 10-12 years, we have increased the number of pharmacy schools and 
 the number of students without having the clinical capacity to take care of it.     
  
 Third pattern: When converting to the Doctor of Pharmacy degree program, 
many institutions experienced internal resistance related to universities and their 
educational programs. Isolated situations were noted where the institutions found it 
difficult to make the transition because of abundant resistance. Many of these were not 
research environments. The pharmaceutical accreditation body had increased its 
expectations of research activity, largely to support the scholarship by Doctors of 
Philosophy. A handful of proprietary schools have had a difficult time. The culture of 
these schools is what primarily drives the thought process, led by the composition of their 
board, which from the beginning, was, “I am here because I am a pharmacist” 
[Respondent 6] and not an academic scholar. That mentality proved difficult to accept 
during the transition to professional practice, and many of these individuals still struggle 
with it.  
 Theme: The state universities, in many cases, were much more research 
focused and research intensive, with NIH or FDA funding, and that is viewed 
positively across the country and internationally. The private universities are more 
focused on educating a student to be a solid citizen in the community. Their two-year 
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focus on liberal arts has remained the same, i.e., trying to have a student finish with a 
well-rounded perspective of how a citizen should act in society. This is an inherent 
component. Respondent 10 provided an example: 
 One example was the University of Illinois, where Walgreens is headquartered. 
 They were hammered as a public university because of their movement to the all 
 Pharm.D. program, but the private universities that I have been affiliated with had 
 a much easier time of this because of how those universities are structured.   
  
 Theme: Schools that established the educational model of the 
Pharm.D./medical school had an easier time with the transition. Many private schools 
went through what was called the add-on Pharm.D. They had a B.S. program and added 
content to satisfy the basic accreditation requirements for the Pharm.D. Most respondents 
perceived that interdisciplinary training was a key factor in the success of the transition in 
many schools. Respondent 1 explained that, at his affiliated school, medical students are 
trained that, in case of a drug question, a pharmacist answers that question. We hardly 
teach pharmacology to medical students anymore. Respondent 8 illustrated his situation 
with collaborative education: 
 We do not have a medical school at this institution but we work closely with a 
 state medical school and are part of their basic science of their medical curricula. 
 We have become part of the medical complex but we have to rent space from the 
 medical school. This required more faculty as well, so I had to raise tuition. It was 
 a hard sell, but we were able to accomplish that.  
 
 This specialization of content is a problem for many health professional schools. 
Most medical schools accept that they cannot teach everything they want in their 
curriculum, yet the logistics related to the sheer number of students is overwhelming. The 
thought of getting 140 pharmacy students together with 200 medical/nursing students into 
one integrated curriculum is a daunting prospect, even if all three groups are in the same 
university. For schools that are not linked through a common institution, and often not 
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even by contiguous geography, daunting becomes nearly impossible. Respondent 14 
explained his experience: 
 Nursing did not want the Pharm. D. They were taught that only nurses can teach 
 nurses and nurses have the responsibility for the medication. Many nurses that I 
 knew did not want the pharmacist second-guessing them so to speak. But this is 
 changing. When pharmacy was going to the all Pharm.D., the nursing association 
 would not support us.    
  
 Theme: It was a struggle to create another position called clinical faculty. This 
position was necessary because of the inclusion of the experiential component that was 
added to the curriculum. This new position had just as rigorous requirements for 
promotion as did the basic science faculty, but they did not have the obligation to do as 
much federally funded research as the basic scientist. What is the status of the individual 
who is a professor in the area of pharmacy practice at institution A versus a professor of 
pharmacology and toxicology at the same university? We would hope that it is a simple 
answer that they enjoy equivalent status but the answer is twofold. Respondent 14 
illustrated the dilemma of clinical faculty: 
 When I was at a different research institution the Pharm.D. were prohibited from 
 chairing a dissertation committee. I think that has changed now, but then that was 
 true.   
  
 Theme: Originally, a shortage of clinical faculty in the Pharm.D. programs 
existed. A major challenge for the programs was obtaining additional clinical faculty. 
When Pharm.D. programs first started proliferating, there were not enough qualified 
instructors were available to fill faculty positions to train the prospective students. Back 
in those days, over half of a Pharm.D. class went out and got academic jobs at other 
institutions because you [Respondents 1, 8, 9, 14] needed these kinds of people if you are 
going to do this kind of curriculum. So they would do residencies and then go out and 
have academic jobs. That was a big thing.  
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 The ACPE Commission to Implement Change in Pharmacy Education 
recommended that all programs include a clinical science minimum in the pharmacy 
school curriculum that was patterned after medicine. The clinical science faculty would 
be those with bedside manners as well as experience in the laboratory [Respondent 8]. 
Schools utilized some of their own faculty but had to look for additional clinical 
instructors with practice experience. This was a challenge because all of these programs 
had to develop a year of clinical experiences and all needed experienced faculty. 
Ultimately, creating another position called clinical faculty proved difficult. 
 In the early 1970s when Nixon was president, an infusion of federal money into 
health education occurred. Money was available to hire more clinical faculty if the 
institution converted to more clinical education. This concept was fostered by the 
profession and is now under debate for its effectiveness. The question under deliberation 
is whether schools need more clinical sciences and practice-based research or increased 
theoretical focus. Pressures exist within universities to obtain federal grants, and the 
effects of this on staffing clinical faculty are apparent. Respondent 12 noted: 
 In my most recent experience, we find busy practitioners in different practice 
 settings and less and less of the full-time paid higher clinical faculty. They have 
 outsourced the benefits of clinical faculty and moved the positions over to get 
 research faculty because of the pressure on public universities to get federal 
 grants.  
  
 Theme: An issue faced by the schools is how to treat these new academics in 
terms of getting them promoted. This issue depends on the culture of the university that 
we have called University A. They were going into academic institutions, and the 
traditional way for promotion in academic institutions is research funds and publications. 
That is what is happening with new faculty members. Local pharmacists want to teach 
clinical pharmacy and to spread the word. Respondent 1 said: “That is not easy, it was not 
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even easy here because we are a strong research institution so to get our clinical people so 
that they could start competing at the academic level took some doing. We actually 
initially put them on a different trajectory that they weren’t on a tenure-track. That has 
changed over the years. They have developed their programs at UCSF and USC in CA.” 
Clinical professors are on a different track than academic professors. Tenure-track faculty 
are required to publish and bring money into the university. Clinical track faculty publish 
in a different way but are not on tenure track…[as a] one-year continuing contract, maybe 
after time, a three-year contract. Respondent 2 shared his experience: 
 I remember when the first Pharm.D. was hired at my institution in 1972. It was 
 like who are these people and what the hell are they talking about. Although what 
 you have learned is different, must be applied differently, but the degree 
 qualifications are equivalent. 
  
 Now, I would say that people on the Ph.D. track have a different understanding of 
 how to operate and solve problems. To me there is a commonality that they can 
 write better than others. If you have done a dissertation, you understand what it 
 takes to be a reasonable writer and defend things with logic…. That is a 
 difference. There is no such animal in professional doctorate programs. A 
 capstone project is as close as they get and you cannot do that without going 
 fulltime. 
   
 Theme: Within the schools and colleges of pharmacy, the biggest opposition 
was the basic science faculty. These faculty are scientists who were focused not 
necessarily 100% on teaching; their work also included research, which was how they 
were promoted. That was what gave them credibility within the scientific community. 
Then, suddenly, they hear of this group of people in a new department called pharmacy 
practice who do not have a Ph.D. Many had a Pharm.D. or even a master’s, yet somehow 
they were supposed to be considered to be professors just as those with their Ph.D. All 
the time and struggles to train for and then conduct the work of scientists were being 
discounted. So, within these schools there was a fair amount of contention between the 
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basic science component and the pharmacy practice constituent. Respondent 12 thought 
that academics do not like change, and some people see no reason for all graduates to 
have the Pharm.D. degree. They still argue the case that maybe there should be a 
Bachelor of Science in pharmacy.  
 Fourth pattern: Institutions making the conversion to the Doctor of 
Pharmacy degree were met with external resistance with respect to the practice of 
pharmacy. 
   Theme: Opposition was present within the profession as well as within the 
universities. Not one organization speaks to pharmacy in the U.S., such as the ASHP and 
the ACCP. Approximately 37 were intent on doing it the right way. A few of the 
professional organizations did not support the Pharm.D. until after the Millis Commission 
in the mid-1970s [Respondent 12]. The ACCP was opposed because they began as a 
group of pharmacists who were involved in some great things. The Pharm.D. was going 
to negatively impact the image. 
  The strongest opponents were the medicinal chemists; many were very 
conservative and certainly resistant to change. Some even had family traditions based in 
the medicinal practice. It was not uncommon to hear that one’s grandfather was a 
pharmacist and he did it this way, and my father was a pharmacist and he did it this way, 
and this is the way I was educated and the way I want to educate my sons and daughters. 
Respondent 3 illustrated this situation: 
 Opposition was mostly internal. I do not recall a lot of discussion from AMA or 
 any other practice groups. The biggest groups were the NACDS, which I ended 
 up resigning the presidency of that organization because I would not speak out 
 against the bill. 
 
 The AACP attempted to initiate discussions across the country with the various 
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professional organizations, knowing that not everyone would agree but trying to achieve 
some consensus to move forward. The AACP felt that a natural ally would be the 
American Society of Health Systems Pharmacist (ASHP), but the organization was not a 
supporter. The AACP’s theory was to identify those with whom they could work because 
they might , in some cases, make an impact such as a medical school, or they may impact 
a decision maker at a national level such as NIH or FDA [Respondent 10]. The AACP 
was successful in forming alliances because some really driven members in the 
professional organizations were committed to finding as much support as possible. Many 
individuals were committed to making the Pharm.D. work, rather than institute 
regulations to boost their egos; but they really felt it was best for pharmacy and therefore, 
was going to be the best thing for patients. So how, then, can we [Respondent 10] pull in 
these amazing folks and identify those within Walgreens, CVS, and Rite Aid who might 
support the mandate during deliberations? 
 Some individuals still see no reason for the all-Pharm.D. degree. A divergent 
opinion from a few respondents was that the whole discussion from the beginning in the 
1970s, 1980s, and reaching a crisis point in the 1990s, was all about the initials behind 
someone’s name. It was not about trying to help patients with what they need, such as 
drug management, advice, and information, to be healthy in the U.S. As Respondent 10 
noted: 
 A friend of mine in Oklahoma said you know this organization strongly opposed 
 it [the all-Pharm.D.] but I will tell you today that we have found out that it is the 
 best thing that  happened to pharmacy. I about fell out of my chair. 
 
 Theme: Many of the people who held a Bachelor of Science degree (B.S.) in 
pharmacy as the main credential for a lifelong practice as a registered pharmacist were 
facing a dilemma. The ticket to beginning a practice in pharmacy is a license. It doesn’t 
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matter whether you possess a Pharm.D. or a B.S.; the license is required. This constitutes 
passing a standardized examination that is recognized by each of the 50 states. Many with 
the B.S. degree in pharmacy felt they would be viewed as second-class citizens. The B.S. 
pharmacist worried about losing prestige and faculty positions. 
Respondent 7 illustrated how this trend continues today: 
 I remember having a discussion with one of our faculty this year about the 
experiential portion of our curriculum. I asked him to come into the office to discuss it 
because he had then a very strong opposition to it and it was clear. So finally he said what 
you make is a very good argument but I come from a very very poor family and I cannot 
see adding another year of education or another whole year of paying tuition. I just can’t 
see the value of additional training especially in the clinic. It does not make any sense. 
Respondent 6 echoed Respondent 7 with this story: 
 In the early 1980s, the institution that I was affiliated with supported the Janus 
 report and implemented the Pharm.D. degree in 1984. I was the dean and was 
 trying to raise financial support for the Pharm.D. program. I pledged to the folks 
 at the pharmacy school, the president, and the pharmacists in the state that this 
 state might not be among the first to have a Pharm.D. program, but that we would 
 not be among the last.  
 
 The pharmacists with B.S. degrees in that state were of the opinion that they were 
 going to get grandfathered in. I said: “Why I don’t think I’m going to be able to 
 do that boys.” I had a little battle. That would be a violation of academic integrity, 
 academic fraud. To that there was a lot of opposition. This was a very difficult 
 time. The AACP was following it very closely. 
 
Those opposed felt that the retail pharmacist would be put out of business unless all were 
grandfathered, but to do that would defeat the purpose of a Pharm.D. Those opposing the 
blanket waiver argued that a degree is granted by an institution which, based upon 
specific requirements completed, grants a degree; and no one has the authority to grant a 
degree to somebone who has not done the work.  
 In the end, a lot of practicing pharmacists had to adjust. Many of these smaller 
pharmacies had been in the family for generations and were now being bought by chain 
stores. They were just trying to survive this era of consolidation, and this was another 
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blow to them. They had an antiquated degree (the baccalaureate) and felt their profession 
was abandoning them. In contrast to these personal struggles, many of the advocates 
focused on the abstract notion of the “greater good,” trying to explain the value of the 
degree enhancement and the value to the profession that enhances everyone. If 
pharmacists were to continue to get paid high salaries for essentially pouring pills out of a 
big bottle into a little bottle, eventually the state board of pharmacy would not extend a 
license [Respondent 8]. So, unless the profession elevated its work to reflect the 
education, thus adding value to society, that profession would disappear.  
 Most of those affected understood the broader argument; some went back and 
received the Pharm.D. degree, mostly the young practitioners. Ultimately, the rationale 
that society absolutely needed a group of professionals who understood the actions and 
interactions of drugs carried the day, i.e., that the complexities among so many drugs are 
complicated and advanced education is necessary for adequate understanding. Drugs are 
so much a part of everyone’s lives that members of this society cannot deal with it by 
themselves. People need help; they need educated advice, so a theoretical foundation is 
essential. Then that foundation had to be developed into a curriculum that included not 
only content, but also the process of problem solving and communication. Respondent 11 
expressed these thoughts: 
 I have been a pharmacist for 60 years, so I have gone across the spectrum. You 
 may not believe this but I have practiced side-by-side with pharmacists that had 
 six weeks of formal training, some with one year, some with two or three, and 
 some had ten years of formal training.  
 
 The pharmacists that were bachelor of science pharmacists including myself, had 
 to pass the test after we went through all of this self-imposed educational work on 
 how to better serve our patients. I was 67 years old or something like that, but we 
 were committed to our practices. 
  
 This continues to evolve since we bought our own pharmacy in 1965. We have 
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 one building, one facility. My son and his wife are pharmacists. They run the 
 place. We have the building with a group of physicians and other practitioners. 
 We are close to major cities that have dozens of specialists and we try to serve 
 them by having a respectful relationship. We have a super Walmart here. So 
 the fact that we are employing six pharmacists speaks of our service and 
 reputation. 
 
 Theme: The B.S. pharmacists said “wait a minute”; soon people will be asking 
for a Pharm.D., and we are not going to be considered for some positions. Respondent 
3 noted that the decision makers knew they would make the B.S. pharmacists unhappy 
because they did not want to feel that they were being slated as second-place citizens. 
Respondent 10 expanded on this issue: 
 One of the issues was that many of the people that had a bachelor of science 
 degree in pharmacy as the main credential for practice, who had a life as a 
 registered pharmacist, were feeling slighted [and] felt that they were being short-
 changed. They believed that the B.S. degree, which gave them the ability to 
 pass the licensing exam recognized by each of the 50 states, was no longer 
 suitable. So this looks like I will be a 2nd class citizen now to somebody who gets 
 the degree of doctor and they are still a pharmacist like I am. Why should they be 
 viewed more positively or differently?  
 
Pharmacists with the B.S. degree have found it difficult to practice at the higher level 
[Respondent 8, 10].  
 Theme: The ability for pharmacy practice to evolve is dependent on the 
opportunities that exist in community and hospital practice settings. The 
responsibilities and duties of pharmacists are expanding in the work-place 
environment, but very slowly. In some states, pharmacists now have been providing 
immunizations. Not all states are at this point, but the influence has been instrumental in 
changing some states [Respondent 5]. The people who formulate such rules of practice 
are situated within the professions. But even as they extend their professional reach, they 
resist including anything that will inhibit them from continuing what they already are 
doing. Respondent 14 illustrated the importance of state governance and scope of 
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practice: 
 We work in a collaborative practice with agreements with both physicians groups 
 and pharmacy groups [who] sit down together and are supported by state and state 
 board of pharmacy. We have a state pharmacy congress that meets on a regular 
 basis and I think we are the stimulus for changes in the scope of practice for 
 pharmacy. We are putting together recommendations for a bill to the next 
 legislative session here that will greatly broaden the scope of practice. 
 Pharmacists will be recognized for their ability to manage patients. It is going to 
 come, but it is slow.  
 
 I tell our students that when they graduate, it is their duty to join the local, state, 
 and national organizations and volunteer for committee work, run for office 
 within the next 10 years so they can control it and they can change [it]. Go to the 
 state meetings and see the leaders who are getting ready to retire. If you want 
 change, you have to be involved.  
 
  [In 1989, the ACPE mandated the Pharm.D. as the entry-level degree for a 
licensed pharmacist, providing the opportunity for the profession to expand and increase 
the pharmacist role in the rapidly changing healthcare system. The role of the pharmacist 
was visualized as patient-oriented, the mission of the pharmaceutical profession 
eventually being adopted as pharmaceutical care, moving away from the historical 
product-oriented responsibilities. The mandate for the Doctor of Pharmacy as the entry-
level degree, and the concomitant pharmaceutical mission, were credible steps for the 
advancement of the profession; but there were many external influences existed for 
successful implementation, one being the healthcare environment. As a result of the Janus 
Commission’s investigation into the changes occurring within the U.S. healthcare system, 
the ACCP was convinced that the changes in the U.S. healthcare delivery system, 
economic growth, education, and health management systems had set the stage for 
transformation of the profession (Janus Commission, 1997).]  
 The work environment has been changing with more and more of the better 
positions going to the Pharm.D. graduates. At the same time, students are attending 
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school during the greatest biomedical and pharmaceutical information, both prescription 
drugs and over-the-counter products that has ever existed. Practicing pharmacists will 
face difficulties if there is too little time to teach all of the necessary knowledge and 
skills. 
 When asked if the profession has been successful in becoming primary 
pharmaceutical care providers, Respondent 5 said: “The question is if the whole 
profession changed to pharmaceutical care, which pharmacists are qualified?” For 
example, if a student graduated from pharmacy school five years ago and went to work 
for a chain drugstore and had adjusted well to filling prescriptions day in and day out, 
some certain skills gained while in school have been lost. Even though the profession has 
a term pharmaceutical care, the care part is not played up that much. It then creates a 
perception that pharmacists are not trained or educated to provide primary care.  
 Theme: The respondents unanimously agreed that the primary external 
opposition came from the chain drugstores and owners of regional chains.  The major 
employers of pharmacists were those against the Pharm.D. The chains lobbied hard with 
considerable funds targeted legislatively. Rhetorically speaking, these larger employers 
argued for stepping back and looking at this process: Let’s have open forums, open 
dialogue, and discussion [Respondent 3]. But this strategy was not embraced.  
 One major opposition came from the National Association of Chain Drug Stores 
(NACDS), which entity is made up of CVS, Walgreens, Right Aids, the large grocery 
stores, etc. The chain pharmacy community was adamantly opposed to extending the 
length of education because it would cost more to hire pharmacists, and they were losing 
workers because of the negative environment. They spent millions of dollars fighting it 
[Respondents 3, 8]. At one point, the president of USC received a letter from the NACDS 
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suggesting that they reconsider moving back to a bachelor’s degree [Respondent 10]. In 
the state of Maryland, an incredible fight was occurring in the legislation to get the 
Pharm.D. approved in higher education [Respondents 9, 13]. The stories go on and on.  
 To double the contentious environment, a member of the NACDS served on the 
AACP board at the time. That is when things became heated. The chain drugstores 
adamantly opposed the situation, and now they embrace and support it.  
Respondent 14 demonstrated this change of position by the chain drugstores: 
 At the last chain drugstore meeting in Florida a couple of months ago, the people 
 from the top were all saying how we need to make sure our pharmacists are away 
 from that dispensing mode and taking care of patients in improving outcomes. I 
 have never heard that before now. I think they are changing, but they have a long 
 way to go.  
  
  Many consumers do not appreciate what a pharmacist can do for them as a 
healthcare provider because they enter a large chain pharmacy and bypass cigarettes, past 
alcohol and garden supplies, finally to reach the pharmacy. The public image of 
pharmaceutical care is all too often viewed as a product, not a healthcare service 
[Respondent 14].  
 Some chain drugstores such as Walgreens, CVS, etc., now have patient care 
groups; nurse practitioners and pharmacists combine their expertise with the traditional 
chain drugstore, becoming more of a health center. The industry has a long way to go 
because the public does not appreciate the advancements in pharmacy education. Also, 
they do not understand what the new knowledge has done to make them healthier and 
less likely to experience adverse drug reactions or be put in the hospital because of poor 
adherence or interactive drug therapy [Respondents 8, 14].  
 When the University of Maryland went all Pharm.D. in 1993, the arguments 
among the university, community, and across the state of Maryland were parallel to those 
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occurring at the national level. Indeed, many of the chain drugstores in Maryland bitterly 
opposed the school’s effort to go all Pharm.D. They were afraid that if Maryland, a major 
flagship school, was able to go all Pharm.D., it would undermine the efforts to stop the 
national movement toward the all Pharm.D. [Respondents 9, 13]. For a few years, this 
became a focus of the political discussions around pharmacy education. The transition at 
the University of Maryland did not occur immediately. The request for an all-Pharm.D. 
program failed a few of times before the University voted to accept the curriculum for the 
Pharm.D. At the time, Maryland was the only school in the state to offer a Pharm.D. 
degree. There are now three: the flagship institution, a small liberal arts school, and 
University of Maryland Eastern. Respondent number 13 illustrated the chain drugstore 
opposition: 
 I remember in maybe 1994, in Maryland and the CVS went to state legislature to 
 propose a bill that the University of Maryland College of Pharmacy would have 
 its curriculum forever (I am paraphrasing but that is basically what it said). So 
 they loaded all of us on a bus and took us down to Annapolis and Baltimore and 
 had us go talk to legislators about the profession. I remember it was my 
 introduction to the legislative process. I walked into one legislator and gave him 
 my spiel and he said that is all very nice but already traded my vote on that 
 issue. It is a change effort and I think it just took a political front. We pretty much 
 felt that we were in charge of our school, but the truth is we weren’t you know. 
 
 Fifth pattern: Recognition that the impact on students and the entire 
educational experience was an important factor in both the decision and 
implementation of the professional doctorate in pharmacy. Many opponents 
[Respondents 3, 7, 12 speaking] thought having everyone on the six-year program would 
dilute the quality of training. If one looks at the old five-year program, a student may 
have about six months of experiential learning so the six-year program added about six 
more months of experiential and six months of didactic learning. The six years provides a 
good background, with the baseline of competency that the pharmacists need for general 
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practice. For those graduates who want to specialize in a certain area of pharmacy 
practice, a residency is the appropriate route. This is where people learn to practice. It is 
not possible to train an infectious disease specialist or a cardiology specialist in six years.  
 Theme: A student can’t go through this program without going full time and 
having a structured curriculum. Students move through as a class core, and the 
socialization of the class cohort yielded one of the most powerful benefits that was 
unexpected [Repondent 3]. Students are systematically and deliberately chosen with the 
likelihood of being successful, so you end up with a cohort of people who represent a 
narrow band of intellectual goals and concomitant curriculum. When they spend 40+ 
hours a week together for four years, they learn how to work together. We used the term 
Problem-based learning module, but small-group inquiry takes it to a new level. One 
begins to realize how important it is to work together, and the outcome is an individual 
who is better equipped to work in any environment because they understand the value of 
working together. That is an abstract idea.  
 Theme: There is a sense that, to differentiate themselves now, new graduates 
have to get residencies or certifications. Having only a Pharm.D. now simply means you 
are a pharmacist. It doesn’t carry the distinction that it did back when the programs were 
small with 200-300 people graduating a year. The issue now under debate is that one has 
to have a residency. Not all respondents were pro-residency because it is cost-prohibitive 
to put all students through a residency [Respondents 2, 5, 12]. 
 Theme: The type of student attracted to pharmacy is part of the problem. 
Consider Meyers-Briggs: a pharmacy student is typically going to be structured, want to 
know what the outcome is going to be, “tell me what I need to learn and I will do it.” 
Respondent 6 said: “It is incumbent upon us to do a much better job of preparing our 
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graduates to be independent, self-disciplined learners, critical thinkers, and problem 
solvers.”  
 Many curriculums still use the “talking head method” of educating students 
because there is only enough time to address 20% of the necessary knowledge base. It is 
unfair to tell students what they are supposed to know; we need to teach them how to 
learn and how to go about the learning process. Respondent 6 expressed this concern: 
 Since I graduated from high school 50 years ago, the changes in history and 
 English have not been much, added new ideas, but pretty much the same. How 
 much has changed in science and of course, pharmacy? So, it is incumbent upon 
 our bright listeners to stay on top of what is going on in order to be a factor in 
 taking care of their patients and to be effective in working in a constantly 
 changing environment. 
 
 Prior to the Pharm.D., the typical recruit was a student who did not like to work 
with people. They preferred to be behind the counter and fill prescriptions. Today, we see 
a totally different attitude, and they want to help people. Some respondents [1, 8, 13, 14] 
believe that one benefit for the Pharm.D. in pharmacy education is the recruitment of a 
better-rounded student, ones who are passionate about providing care to patients and are 
focused on what they can do to help people, better utilize their pharmacy education, and 
teach patients how to be healthy.  
 Many schools have made changes in the admission standards. All respondents 
affiliated with a pharmacy school [1, 3, 4, 5, 6, 7, 9, 10, 13, 14] noted that 50% of the 
total application and admission process in their programs is grade or test based. The other 
50% considers students and what they have done to participate in community related or 
organizational activities, leadership, and communication skills. Those abilities weigh 
very heavily in most admission processes. Respondent 4 said their application process 
requires interviews and essays to evaluate communication skills; but once they get there, 
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it is lost.  
 Candidates for admission in pharmacy programs had sufficient time in 
undergraduate systems to become fairly well rounded, but usually the pre-professional 
programs are heavily weighted on science. When they get to pharmacy school, although 
it is a competitive program, it is just pharmacy. They have little knowledge in sociology, 
economics, etc., that is needed to enhance the education. The educational system of 
pharmacy is starting to recognize this and requiring these courses for admission.  
Respondent 4 explained why this is a problem: 
 You may not hear this from anyone else, but I think we teach too much drugs and 
 diseases and do not teach enough about how they are involved in the sociology of 
 healthcare. Students are part of this situation because they don’t like the other 
 stuff. They like and are interested to learn about [a] disease and how it is treated. 
 So the contextual content of a pharmacy education is kind of downplayed even by 
 the faculty. [L]ets learn more about drugs and diseases and a little bit on how to 
 communicate. 
  
 Sixth pattern: The changes in pharmacy education curriculum as related to 
academia have been an evolution, not a revolution. In the 1950s there were four-year 
degrees, five-year degrees, and some Pharm.D. programs in California. We [Respondents 
1, 3, 9, 14] had degrees that, originally designed to be honored at 50 hours, were moving 
toward 120 hours. In 1962 it was mandated as a five-year degree program that included 
one semester of experiential education equaling about 150 hours. At this point, pharmacy 
was a “bulging baccalaureate” [Respondent 3]. The length of time to completion had 
increased because individuals felt the need to increase ideas and add content into the 
curriculum. We had some schools of almost 280 credit hours. It was truly a six-year 
Pharm.D., which meant we had to make some type of change.  
 The same respondents knew they were going to have trouble. Leaders understood 
that they needed to be informed because the suggestion was to change the educational 
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model. One concern was whether the curriculum would be watered down because the 
Pharm.D. would now be the generalist degree. Some argued that keeping students in 
school longer for these experiences would be too expensive. We went to the students, and 
they said it was important. 
 When discussing curriculum, institutions should be encouraged not to focus not 
on credit hours but think instead about the endpoint competencies that graduates need 
when they leave. What should they be able to do in the patient care environment and then 
work backwards to determine what is needed in the curriculum. Respondent 14 illustrated 
curriculum changes: 
 Our curriculum is drastically different than many pharmacy schools. It is all team-
 based small-group active learning. Faculty in medicinal chemistry, pharmacology, 
 pharmaceutics, and the clinical faculty are all together working with the students 
 to look at how they approach and solve problems about patient care.  
 
 Theme: The ACPE developed the add-on Pharm.D. to allow B.S. pharmacists to 
upgrade their credentials. [The ACPE and AACP believed] that institutions needed to 
have continuous education programs that assist those who want to do this work but don’t 
have the skills. This will bring them to the level where they can be recognized and paid 
for their services. Thus, because the argument that the already-licensed B.S. pharmacists 
had some validity, programs were developed that allowed these professionals to go back 
to school for training online, weekends, etc., to get the Pharm.D. Conflict revolved 
around the nature of the curriculum that would prepare such an individual (older 
pharmacist with less than a Pharm.D.) to help resolve, accommodate, or at least interact 
professionally in a manner consistent with the best practice standards and the current 
critical problems that the nation faces: giving students experience with illnesses and 
concomitant use of drugs, managing this ominous availability of drugs [Respondents 6, 
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14]. 
 Theme: The complexity of drug interactions is rising and it is necessary to 
educate pharmacists to reflect this with skills in patient counseling. Over 50% of 
patients take medications, yet educators don’t seem to want to be engaged in counseling 
patients at the student level. Pharmacy programs need a different kind of student and 
mission. We [Respondent 3] have ended up bragging about the highest GPA when they 
enter - the brightest students. But what happens when we follow the student through the 
professional education program? 
 Theme: The changes wrought by the new Pharm.D. required extensive debate 
about and changes in pharmacy curriculum and instruction. The establishment of the 
Commission to Implement Change in Pharmacy Education was the turning point in 
pharmacy education. [The first of seven background papers written by the Commission 
(1997a) focused on curriculum and instructions]. Through all of this, we [Respondents 1, 
6, 8, 9, 14] were able to develop the overall degree, with the Pharm.D. as the generalist 
degree and residencies after graduation that would allow students to concentrate in a 
particular specialty area. Huge changes occurred in the curriculum. The curriculum has 
been in the process of evolving over many years as the nature of professional practice 
changed. Respondent 3 illustrated the curricular debate: 
 At the 1988 ACPE meeting in Monterey, CA, the president and CEO of NACDS
 came to the council and discussed that we needed to add three additional courses, 
 computer statistics and geriatrics were two. I agreed that they needed to be there 
 and asked what we could take out of our present program to make room. The 
 comment was we couldn’t find anything that we really want to take out. We feel 
 like it would make our foundation unstable to take some of these [current classes] 
 out. I said that  we have a problem because we have [to put] these additional hours 
 into an already bulging bachelor, and to honor a B.S. degree is frankly a bunch of 
 BS. That is what kind of kicked the pot over.  
 
The institutions were given eight years to prepare to do this because the first class was in 
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2000. Once most of them bought into the new degree, they needed funding to increase the 
number of practice facilities in addition to rearranging the content and sequences of 
courses.  
 Debates over curriculum are the most important but also the most difficult. What 
can be taken out, why should this and that be put in, how is this to change? The excision 
of material becomes personal to the faculty who have are so dedicated to the courses that 
they teach. Academic arguments over curriculum are among the most vicious of all 
academic disagreements. Respondent 4 illustrated the discourse in academic arguments: 
 Everyone stands in a circle, points their rifle inward, and shoots. The reason why 
 it is so almost hateful is because the arguments are so important to the individual. 
 Because when anyone outside this circle looks at it, the person outside the circle 
 realized the arguments are so vicious because the stakes are so small…. [Y]ou 
 know for the individual whose 12 lectures are going to be removed from the 
 curriculum. Anybody outside would be like ‘get a life’ and get on and do some 
 other things that are maybe far more important than this, but those 12 lectures 
 sometimes represent the life of the individual and the self-esteem of the 
 individual.  
 
 Theme: The Commission to Implement Change did not approach this 
conversation from the standpoint of whose material was going to be deleted. It was far 
more concerned with how the program could obtain what was needed or a curriculum 
to reflect the nature of the practice of the profession, and to do this in a reasonable 
period of time. The commission was looking at the amount of basic information, pre-
professional information that was advancing that which was necessary for the pharmacist 
to know and needed to learn and master by the practitioner. The amount of information 
was growing at such an enormous rate that we [Respondent 4] were looking at the best 
way we could fit this into an efficient timeframe. It ended up being a minimum of two 
years pre-professional education and four years of professional education. This new six-
year program was a simple jump from a baccalaureate degree to a professional doctorate 
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degree.    
 Theme: The combination of new requirements in content and knowledge for the 
Pharm.D., as well as necessity of background understanding of science, has led some 
schools to institute a pre-pharmacy program requirement of up to three years. 
Compounding the staffing issues for the new clinical instructors were the assessment 
program requirements that had been driven by the Department of Education [in that 
state]. On paper, pharmacy schools made these changes appear positive because it was a 
mandate [Respondents 7, 11]. Yet, the amount of effort put into making the changes 
varied widely because of so many new assessment demands. By the time program leaders 
had implemented one, something new was on the table.  
 More and more schools are making the three-year pre-pharmacy mandatory. In 
some schools it was four years and then three to four years of professional programs 
because one cannot teach everything that a student needs to know. In today’s society, it is 
equally as important for graduates of educational programs in the health professional 
fields to possess a good basic education as well as science and math, but this means 
ending up with three to four years of pre-professional studies [Respondents 6, 7, 11, 12]. 
Add the whole load of the pharmaceutical program and you end up with eight years to 
graduation. 
 Theme: One result of institutions being required to bring in additional qualified 
people to implement the revised programs has been a rise in tuition. Tuition hovers 
around 20k/year, but there are a lot of private schools that are much higher. Students are 
graduating with horrendous bills, $100,000 or more debt from their education. Several 
respondents [6, 9, 12, 14] commented that higher education does has little sensitivity to 
the rising costs of education. Respondent 14 had the idea: “I would love to see some type 
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of loan forgiveness for pharmacists. If they could get part of their loan forgiven if they 
practice 3-5 years in an underserviced area.” Respondent 12 said: 
 As long as they keep having the number of applicants, they do not really care. I 
 had these discussions with associate deans on campus and I have four grandkids 
 and am gasping on how my family is going to get these kids through college.  
 
 Theme: Not one grand scheme, template, or module exists to follow. A formal, 
strategic plan was not developed to assist institutions through this paramount change 
process. [The ACPE established the mandate in 1989 that in 10 years every school had to 
be a Pharm.D. program, but the AACP did not sustain that position until the middle of the 
90s when the Commission to Implement Change (1997c) published the third round of 
papers. The Commission to Implement Change in Pharmacy Education was appointed by 
the AACP in 1989 and 1992 (Buerki, 1999). The commission was comprised of academic 
personel and was charged with determining the specifics of the curriculum change 
process and content. The Commission’s background papers (1997a, 1997b, 1997c, 
1997d, 1997e) basically came out and recommended that it was time to go to the 
Pharm.D. degree.] This second paper (AACP, 1997b) was a tentative foundation for the 
transition. Respondent 3 illustrated the scenario: 
 As you look at the ACPE original declaration in 1989 stating that they would 
 move forward with the plan to implement the Pharm.D. as the entry-level degree 
 to be credited. There had been a lot of conversation going on that led to that 
 decision and it was inclusive conversations. The ACPE did not just wake up one 
 day and say we want to do this. These discussions revolved around where the 
 profession should be and what it could be. This took a change in 
 acknowledgement and it was messy.  
 
No direct financial support was available from professional organizations to individual 
schools because professional organizations just don’t have that kind of money 
[Respondents 2, 9]. Each individual school was given the freedom, relatively speaking, to 
devise the new Pharm.D. curriculum and overall program and to develop the specifics as 
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they saw fit, as long as their particulars were consistent with the overall parameters of the 
new Pharm.D. as set fourth by the ACPE [Respondent 10]. 
 On the other hand, there was support from the accreditation agency, ACPE. 
Documents were related to the standards, the structure of the curriculum, and a fairly 
lengthy timeline was in place to give the schools the opportunity to develop the 
programs. The AACP was out in front in reform efforts. The association assisted schools 
with both curricular reform and faculty development. The AACP was very active in 
providing seminars and intellectual support to the schools regarding when and how to 
move to the Pharm.D. program [Respondent 2]. There certainly was a lot of 
encouragement and cheerleading efforts to persuade schools to pick up the pace and 
move this as rapidly as possible. 
 Research Question 1b 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
  
 b. the delivery of service? 
 IS6. The profession adopted the mission of “pharmaceutical care” as more 
 comprehensive, going beyond dispensing medications. Do you think the 
 profession has been successful in becoming primary pharmaceutical care 
 providers?  
 
 IS7.  How have the state regulatory agencies accommodated the advanced 
 knowledge and skill base of the pharmaceutical professional? Have they expanded   
 the scope of practice and revised the licensure requirements?   
 
 IS8. How has the distribution of services been affected? For example, what affect 
 has the Pharm.D. had on rural or underserviced communities?  
  
 IS9. There were many opinions voiced in publications about how the Pharm.D. 
 would affect the delivery of service. Some reported that, with the increased 
 autonomy, the  pharmacist would have direct patient contact and be the primary 
 manager of the patient pharmaceutical needs. Others reported that with the 
 increase in knowledge and skill, the new Pharm.D. would focus on increased 
 financial opportunities and move away from direct patient care. Now, 20 years 
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 after the mandate, how do you think the delivery of  pharmaceutical services has 
 changed? 
 
 IS10. In hindsight, what roles and responsibilities of the pharmacy profession 
 have been most affected by the Pharm.D.? Which elements of professional 
 practice have benefited from the degree change and which ones did not change as 
 anticipated? 
 
 [The debate regarding the implementation of the Doctor of Pharmacy as the entry-
level degree was accompanied by many opinions voiced in publications about the effect 
of the Pharm.D. on delivery of service. The six-year professional course of study was 
first proposed in 1948, and two years later the University of California was the first 
school to institute the entry-level Pharm.D. as its sole professional degree. Immediately 
following was the University of California San Francisco in 1954. Through the next three 
decades, the field moved toward the adoption of patient-centered practice as the 
philosophy of pharmacy practice, but the transition was not consistent across the 
country.] 
  Seventh pattern: The success of the transition from product-based to 
patient-based pharmaceutical care is inconsistent throughout the U.S. healthcare 
system. [Before WWII, the pharmacist compounded many prescriptions. The 
pharmacist’s major function was to take herbs and add some chemicals, combining the 
raw material into a concoction for which the physician wrote out a recipe on a 
prescription pad. Respondent 8 explains that function was taken over by the 
pharmaceutical industry after WWII.] 
 Theme: With the introduction of the Pharm.D., the role for the new clinically-
trained pharmacist expanded rapidly in hospital settings. After the primary role of 
blending various pharmaceuticals into a prescription was taken over by the large drug 
companies, many pharmacists in the retail setting now were simply taking a piece of 
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paper they could hardly read and making sure that the patient got the dosage that the 
physician wanted the patient to take. In the 1940s, hospital pharmacy was not very well 
developed, although it had become more prominent by the time of the AACP meetings in 
the 1980s. With the introduction of the Pharm.D., specifically what UCSF and the other 
programs that emulated them had done, the potential of the pharmacist to add real value 
especially in the hospital setting, was visible. But the value of the pharmacist role was not 
envisioned in the community setting. Respondent 10 commented on this transition: 
 The University of Michigan went all Pharm.D. 20 years before the mandate. It 
 differentiated itself from a marketing perspective from other schools in Michigan, 
 such as Wayne State University. There was a very large enrollment in the 
 baccalaureate programs in pharmacy at UM. Being a research and comprehensive 
 university, the  decision was made to decrease class size and go all Pharm.D., with 
 a clinical focus. I don’t have solid data on where the graduates specifically went 
 to practice, but would be willing to bet that a much higher proportion of graduates 
 from UM ended up in hospital practice. 
 
 Theme: The advancements in the delivery of services and the scope of practice 
are dependent on geographic location. In different regions of the country, particularly on 
the west coast which led the Pharm.D. movement, a significant change has occurred in 
the delivery of pharmaceutical services. By the mid-1990s some schools in the Midwest 
and in the Boston area also had committed to the Pharm.D. as the sole degree. The 
Pharm.D. markedly changed the status of pharmacy in California, but that is not 
necessarily true across the country. It is mandated in California that a pharmacist who 
fills the prescription must give advice to the patient. In Boston, hospitals and health 
systems are now beginning to put in job descriptions statements such as “Pharm.D. 
preferred or required.” Respondent 2 summarized this geographic distribution: “The 
acceptance of the Pharm.D. has been somewhat based on geographic distribution. The 
Northeast was one of the slowest to make the transition.” 
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 [In 1998, the Pew Commission supported the goal that health professions 
regulation should be to establish standards that protect consumers and suggested this 
could best be accomplished if states enacted uniform scopes of practice for each health 
profession. The Pew Commission’s work suggests that there is still movement and 
conversation about the professional scope of practice at the state level and the people that 
can influence changes are in the professions.]  
 Theme: State regulations regarding the scope of practice of pharmacy are 
widely varied throughout the country and have a direct impact on the delivery of 
services. [In the United States, each state has jurisdiction over licensing of health 
professionals, establishment of the professional scope of practice, regulation of practice 
standards, and disciplinary actions against performance problems. The state regulatory 
agencies work together with educational accrediting agencies in the development of a 
health professions scope of practice.] The differences in state rules and regulations are 
dependent on the perspectives and perceived roles in the state healthcare delivery system. 
The most progress has been made in the laws at the state level that permit collaboration 
between the pharmacist and the physician [Respondent 10, 11]. Such regulations are 
usually accompanied by reasonable constraints in the way that they are written (but when 
available allow the pharmacists and physicians to get together in organizations where 
they know each other and gain confidence in each other). The whole idea of collaborative 
care is very effective and has been proven to help the patient save money in the long run. 
For example, in St. Louis if somebody wants to practice pharmacy in that metropolitan 
area (including Illinois), they have to have a pharmacy license in each state [Respondent 
10]. A few states have enacted collaborative steps to enhance collaboration in the field of 
pharmacy, such as these bordering states (Washington and Oregon, Kansas and 
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Nebraska), but these efforts have been slow to develop. Respondent 10 explains one-
reason that states resist collaboration: 
 It goes back to the Civil War and states’ rights. Each state wants to have their 
 own ability to do what they want to do within their state. There are national 
 guidelines that I guess are templates to work from that many states have followed, 
 such as the flu vaccine or hepatitis. Those kinds of things at the national level 
 form a template standpoint that have worked, but each state is always going to 
 have their individual ability to license people that practice medicine, pharmacy, 
 nursing, etc., within their borders. I don’t see that changing simply because of the 
 history and the way our country was started.  
  
 Theme: There appears to be a relationship between licensure, state 
governments, and the protection of salaries. Respondent 11 suggested that every state 
legislature is a little bit different, but the politics of changing the scope of practice have 
been the same. Several respondents [6, 9, 11, 12, 14] noted that since the first legislature 
ever convened in the U.S., the individuals that advocate licensures have varied from state 
to state, but that all are from the good old boys club; we [Respondent 11] are going to 
control the number of practitioners so everyone can make a lot more money. We are not 
going to hand out licenses to practice freely, no matter what the profession is. Illustrating 
this political environment, Respondent 11 stated: 
 In our state, I would like to believe that we are much smarter than the rest of the 
 world but we still have some of these scopes of practice issues come up. I was 
 involved for a few years and experienced lobbying for the chiropractors objecting 
 to the physical therapists’ ads in the yellow pages and the physical therapists 
 complaining about and lobbying against the chiropractors for the definition of 
 physician. In addition, there were organized lobbyist groups that represented 
 medicine that decided a long time ago that they would control nurses and the 
 nursing profession. And now [there is] the rise of the DNP. The horse is out of the 
 barn now and it is an evolving thing. 
 
 Theme: One issue that makes pharmacy unique is that it is the only profession 
in which two sets of licenses are required: the practitioner who has the license and the 
space or facility in which the pharmacist works. The pharmacy products, specifically 
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prescription drugs, are subject to their own set of rules and regulations by the FDA and 
the respective state board. That really became complicated in the 1960s with all the drug 
abuse issues [Respondent 12]. Then you get the drug enforcement agency’s account. At 
one time there were nine different government agencies that could have walked through 
the door at any hospital, come into the pharmacy, and poked their nose into the daily 
operations. 
 Eighth pattern: Finances play a major role in changing pharmaceutical 
practice. Chain drugstores cannot continue to grow the way that they have in the past 20 
years; they cannot expand the drug product distribution. The big chains have set up units 
within their big companies to explore how to define healthcare reform to provide services 
as well as product distribution. The chain drugstores are experimenting with that and 
pharmacies are at the height of this experiment [Respondent 11]. It is going to take a long 
time. 
 There is a gradual change but there remains a strong impact by the national 
drugstore chains. The chain drugstore business model confirms that we have incentives in 
the healthcare systems today to dispense more drugs, not necessarily to get value. That is 
the orientation that corporations take because the bottom line in business is the cost-
benefit. How much time for taking care of a patient with individual attention and how 
much is the reimbursement for that time? The majority of respondents [2, 3, 5, 9, 11, 12, 
14] are convinced that we are getting considerably more compensation than we used to 
but we are not getting enough. Respondent 7 stated: 
 The national associations need to stand up and promote us. People have collected 
 enough evidence to show the value pharmacists can do in saving lives and saving 
 money. What we really need is a good television show that features a pharmacist 
 out there saving lives. 
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 Theme: A primary player is the pharmaceutical industry. The drug industry 
continues to find ways to get its money and creates internal issues for providers of the 
delivery of medicine. When we [Respondents 2, 8, 11, 12] are talking about any hospital 
or community pharmacy, the largest financial item on the balance sheet is the cost of the 
drug products, which has hammered the pharmacy profession. As the healthcare and third 
party payer systems have changed, the dispensing fees and insurance reimbursement rates 
have continued to get constrained. Yet drug manufacturers continue to push for ways to 
maintain their profit margin. One method is to use their more extensible trade name to 
negotiate having the state government obtain rebates back to the states as long as you 
have physicians prescribe. Respondent 12 explains the complexity of the situation: 
 The latest news was just out in the last couple of days about President Obama, 
 when he went after his Affordable Care Act to deal with industry to get more 
 rebates back from them. But the pharmacy profession would and should not get 
 involved in negotiating prices from the government or with the pharmaceutical 
 industry. 
  
 Theme: The business model of the chain drugstores limits the roles and 
responsibilities of pharmacists in practice. [Two-thirds of our pharmacists today are in 
community pharmacy, in drugstores, and the majority of those are chains. The chain 
drugstore has the business model built around distributing drugs and competition in that 
market is restricted to that limited role.] All respondents were in agreement that the 
business model of the chain drugstores is because the revenue stream still is dependent on 
prescription filling. There is no real significant revenue stream that pays for ambulatory 
care, particularly in community pharmacy; there is not revenue to pay for clinical services 
[Respondents 5, 12, 14]. In order to make a profit, chain drugstores have to do what their 
business model says and that is to sell physical drug products; and in order to expand 
pharmaceutical care services, they have to be in a position to get paid for that. Right now 
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there is no good model to do pharmaceutical care in community pharmacy.  
 The current community practice model is very efficient and effective in 
accomplishing the limited role of dispensing prescriptions. Respondent 6 commented 
that: “the American public, any place in the U.S., can get just about any prescription drug 
that they want within 24 hours. It is an extraordinarily efficient and effective system for 
distributing drug products.” The pharmacist controls it under the law but really just works 
for these chain drugstores. 
 The hospital setting is different. Respondent 14 noted that there was a report out 
recently by the Surgeon General talking about the role of the Pharm.D., which gave 
strong support for pharmaceutical care and allowing pharmacists to take care of patients 
and dispense drugs. Respondent 4 stated: “Pharmacy education has changed dramatically 
and now pharmacy practice is in transition; how long it is going to take is unknown.” The 
profession has thought positively about the trend toward patient care and has been 
pushing this for a long time. All Respondents were in agreement that, historically, 
pharmacists have always been overeducated and underutilized. Respondent 7 illustrated 
this transition: 
 Pharmacists have always been linked to the product. We are moving beyond 
 selling  drugs. Sometimes I am optimistic and sometimes I am pessimistic. 
 Pessimism comes in at the whole healthcare system. It is already so expensive and 
 to add another X number of dollars for pharmacy services, you get a lot of 
 resistance. 
 
 Most graduates are in community practice [Respondents 5, 9, 12, 14]. That 
includes the vast majority who are going to practice in drugstores and do not practice the 
caliber pharmacy or the rigor of pharmacy that the pharmacist is capable of doing. So the 
majority involves dispensing medication, hopefully getting reimbursement and doing 
medicine-management therapy and helping patients with their medications.  
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 There is really no incentive for chain drugstores to change their mode of operation 
so those individuals are probably over educated for that practice, but the Doctor of 
Pharmacy degree has accelerated the transition for pharmacy practice at a higher level, 
namely the hospitals. Respondent 14 summed up the situation: 
 Sixty percent of our graduates end up in community pharmacy, especially chain 
 drug stores, which the majority of time is spent doing prescriptions and that is 
 going to have to change. I am convinced it is going to change. I think it is 
 changing rapidly as we speak. Go back to what the CVS people are saying they 
 want pharmacists to do. I think it is all tied to the whole debate about 
 transforming healthcare and the healthcare initiatives. I think there will be a 
 significant change in the healthcare delivery system because we are legalizing 
 many of our health professions as primary care providers. There is no way our 
 medical society can manufacture or graduate enough positions to take care of 90% 
 of the population. We have to look to other health professions and that is why I 
 think pharmacy’s decision to go to the Pharm.D. 10 years ago provides us with a 
 workforce with young graduates who are capable of providing primary care in the 
 community setting, especially in chronic care…[where they] are more capable of 
 providing acute-care in medical clinics or where you expect to see practice. 
  
 Theme: In the attempt to modernize the pharmacy practice from a product-
oriented to a patient-oriented profession, one concern was how pharmacists were going 
to get paid for the advanced services. Several respondents [5, 10, 13] commented with 
regard to the compensation system, with Medicaid and private third-party insurance 
programs. The conversation of payment was associated with a commodity. Management 
of Medicare Part D opened the door for pharmacy to capitalize on that. The price of a 
drug was the cost of the ingredients plus a fee. Now that is being ratcheted down further 
and further. Respondent 10 said, “where and what is the future if it gets down to two 
dollars for each prescription, all you are worth is $2.00.” 
 Theme: A limiting factor is that an organized system for compensation for 
services has not been established. [When the Healthcare Act was established, it was very 
contentious and is still being blocked. There was a movement toward reimbursement of 
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pharmacists for cognitive services, paying pharmacists for something other than what 
goes in a bottle and is given to the patient.] Several respondents [2, 5, 10, 13] noted that 
medication therapy management services became part of the conversation at the federal 
level, many of the pharmacy professional organizations, which were strongly 
independent, began to collaborate. Groups such as the National Community Pharmacist 
Association, the American Pharmacist Association, and the AACP came out with a 
positive, unified approval of identifying pharmacy in a different light.   
 The biggest asset is that those groups that were at loggerheads in the 1980s now 
realize that they can’t survive unless they work together. They should have done that in 
1989, but they are now and we [Respondent 10] are moving on, moving forward. Many 
respondents [2, 5, 12, 13] believe that pharmacists are still underappreciated by the U.S. 
healthcare system. The incentives to provide quality care and do it at the most reasonable 
price are all misplaced. For instance, the cost benefits of drugs and drug therapy have 
been analyzed, computed very narrowly and typically found on one drug regime versus 
another. There is no appreciation demonstrated when medicine is properly used. When 
drugs are properly managed, this decreases the amount of payment and creates a healthier 
person. In the current U.S. healthcare system, this approach does not provide incentive, 
nor is it factored into cost/benefit analysis. Pharmacists are involved in the process of 
ensuring that a prescription is not only the right drug for the patient, but also the 
appropriate dosage. An appropriate diagnosis becomes a different entity when you 
[Respondent 11] are looking at the appreciation (or, rather, lack thereof) for optimum 
healthcare demonstrated by the Blue Cross/Blue Shields of the world. Instead of making 
drugs cheaper and services cheaper, their emphasis on lowest cost medicines will 
increase the number of hospitalizations, necessitate more tests, etc. That is an example of 
 166  
how the incentives are on the wrong side of what makes sense, particularly long term.  
 I [Respondent 11] would say that 15 years ago the only physicians you talk to that 
were supportive of the single-payer system were the ones who were 30-35 years old. 
There were not any physicians that were 50 and older who supported a single-payer 
system. They finally figured out that the system is not as easy as they thought it was. At 
the same time, because we have the Doctor of Pharmacy or a doctor of this or whatever, 
that does not ensure that all of these doctors can walk on water. So we need to make sure 
we pay attention to the human side of care. Sometimes just a hand over a shoulder of a 
patient is the most important thing one can do. Respondent 11 added, “I am a big 
advocate for high-tech care but I am a bigger advocate for high touch care.” Respondent 
7 illustrated the reimbursement dilemma: 
 The pharmacist still needs to go into situations that we know we can get paid. 
 When I was in practice, the pharmacists made their money off of selling the 
 product. We doubled the cost and that was what we got for reimbursement. Then 
 some third party payers went  to the cost-plus fee and kept ratcheting down the fee 
 to the point where you have a very expensive drug and you are getting maybe two 
 dollars fee out of it. …[Originally] we give away our advice for free because we 
 made money off of the product. If we can figure a way to sell our advice, some 
 pharmacists have even opened clinics like this, where the patient comes in  and 
 they charge them on the basis of $15-20 an hour so they can help them with 
 medications,…kind of like a pharmacist program that we put together here at this 
 university. 
 
It is basically supply and demand. It is hard to put a finger on just where it came from but 
salaries went from roughly around $80,000/year back in the 1950s, went up a little bit, 
and now we are looking at 100-120K for pharmacist salaries. There was a shortage of 
pharmacists and so the practitioners were getting high salaries. At the time, $100K was a 
very high salary, higher than an engineer or any other graduate because the demand was 
high so we could raise tuition. The salary situation is the same now as it was then. The 
new pharmacist is being paid about the same as in 1990 [Respondents 7, 8]. 
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Some people are saying that it is worth figuring out how to get reimbursed for what 
pharmacists are giving to the patient.  
 The reimbursement methods for hospitals are different for the pharmacy portion. 
The savings on drugs are not reflected in the “patient outcomes” that indicate saving 
lives, etc. So there is no incentive to change anything. Reimbursement still relates to the 
product. Respondent 9 shared this current news, “Today’s Wall Street Journal has an 
interview with the CEO of Express Scripts talking about the cost structure and the value 
of pharmacies dispensing and that sort of thing.” Respondent 11 expressed these 
thoughts: 
 There has been a 40-50 year struggle to present to employers that they need a 
 public relations program. When the public goes to the local pharmacy, you cannot 
 find or communicate with the pharmacist. You do not see them. There was 
 one time where there was a Peoples drug store in Washington, DC. If we want to 
 really change the way people  perceive pharmacy, we need them to be present in 
 the Peoples drugstore in the poorest parts of DC.   
 
 Theme: The current third-party reimbursement model does not provide 
incentives for pharmaceutical care. There are other questions related to the acceptability 
of the Pharm.D. on services and the marketplace because no one has figured out a good 
way to pay pharmacists to do the things we want them to do and that they are prepared to 
do. The continuing big struggle is the difference between the distribution function of 
drugs in the marketplace and the provision of the Pharm.D. services [Respondent 5]. As 
newer and more expensive drugs enter, if a pharmacist cannot make money as a typical 
independent pharmacist filling prescriptions, that is a problem. More and more of the 
independent pharmacists are leaving and more chain drugstores are being established.  
 Several respondents [5, 8, 12] commented that, in terms of patient care or 
providing pharmaceutical services, it is difficult to see how a pharmacist in a work 
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environment that is built around efficient, cheap, prescription fees would work. It is 
designed to be a place for getting a lot of drugs to a lot of patients very effectively and 
efficiently, but it is not the place to get confidential health advice. To do that, they need 
to provide a consultation space, time for conferring with patients, and most of all, a 
scheme for reimbursement for those services. 
  Research Question 1c 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
  
 c. the interdisciplinary relationship of practicing physicians? 
 IS11. Compare the status of pharmacy as a field within the hierarchy of the health 
 care industry in regards to:  
  i. salary?  
  ii. prestige?  
  iii. supply and demand? 
 
 IS12. How has the interaction between Pharmacists and other autonomous 
 providers changed, e.g., medical doctors, osteopathic physicians, or dentists? Is 
 there more of a partnership? Any conflicts? 
 
 IS13. Once the clinical practice of pharmacy was established as the professional 
 philosophy, what type of strategic plan was developed to inform and educate 
 members of other healthcare disciplines about the expansion of knowledge, skills, 
 and abilities of the pharmacy profession? 
 
 IS14. Do you recall what opportunities and threats from other disciplines were 
 presented during the decision-making process? What strategies were implemented 
 to embrace the opportunities or counteract the threats? 
  
 IS15. Retrospectively, what are the trade-offs that have come from the transition 
 to the Pharm.D? To what extent do you think that was recognized as being an 
 issue at the time that the transition was first implemented? 
 
 [Literature on the Trans-theoretical Model (Kraft et al., 1999) suggested that 
fundamental barriers underlie a complex organizational change process, such as 
modifying the degree required to enter into a profession. One problem is that changing 
the professional philosophy does not guarantee that all stakeholders, such as other 
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healthcare practitioners, will embrace the necessary changes to transform the practice of 
pharmacy to match the philosophy. In the U.S. healthcare system, there is an increased 
emphasis toward inter-professional collaboration in health professions education and 
delivery of care. To ensure successful transformation of pharmacy practice, other health 
disciplines must accept that the practicing doctorate degree assures that pharmacists are 
prepared for educational and professional roles in other health science education 
programs and interdisciplinary practices.]  
 Ninth pattern: Professionals in the U.S. healthcare system are strongly 
resistant to change and seek evidence-based research that a change is necessary. 
With respect to how the other fields responded to the changes happening in 
pharmacy, evidence is growing that an interprofessional, team-based approach to 
patient care is the best practice model. Many respondents [1, 3, 9, 10] believed that 
physicians are beginning to trust that the pharmacists know what they are talking about 
because the pharmacist is now capable of managing patient needs regarding interactions 
among complex medicines. Doctors are seeing through research and data that what the 
pharmacy profession has been saying is right. Pharmacists are able to speak in a language 
that the physician understands and, so, there is a lot more respect between physician and 
pharmacist over clinical applications of drugs. Respondent 5 believed that there has 
always been respect related to dosage, but the physicians historically felt they were 
trained to prescribe and the pharmacist was trained to dispense. Those were the rules and 
everybody should stay in their role. Doctors are starting to figure out that there are people 
who have the expertise to help them. There are still conflicts with older doctors who were 
trained in other ways. They don’t want to move over and relinquish their authority, but 
some of them are starting to make that transition. 
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   Theme: The pharmacy profession did not have a strategic plan to inform the 
other stakeholders, but there is a constant, slow acceptance of the abilities of the 
pharmacist. All respondents concurred that there was no profession-wide accepted 
strategy for how to communicate these changes to the broader community of health 
professions, nor to the public. The thought was that, if the change was made at the 
educational level, the profession could wait to see if they (pharmacists, other 
stakeholders) appreciated it. Only then would the value of the change be known.    
 Over time, more and more schools, and then more and more students, were opting 
for the Pharm.D. degree. Clinical programs developed from the hospital side where they 
started back in the mid-1960s and continued. As these clinical programs became more 
wide spread, it became clear that hospitals were interested in hiring Pharm.D. graduates 
and not bachelor’s graduates. Thus, this became an employment issue. Respondent 13 
served on a Pew National committee in which multi-disciplines were talking about the 
roles of various professions in primary care and about workplace needs. By 1989, 18 
schools were termed the “early adopters” of the Pharm.D. as the sole degree into 
pharmacy practice. 
 During the decision-making process on how to have a successful transition in 
pharmacy practice, the leaders did not look very far ahead. The members of AACP 
believed that pharmacists needed to be educated differently to provide better patient care 
outcomes, but did not focus on cross-professional team-based care. Many of the 
respondents [1, 2, 3, 5, 9, 10] indicated that they are passionate about this conversation 
now, both on a local and national level. The profession needs to reclassify pharmaceutical 
care and help universities become more cross-disciplinary in their teaching efforts. The 
concept of collaborative practice requires the whole healthcare system to undergo change. 
 171  
Each health professional needs to step forward and be more involved in healthcare 
delivery as a member of the health team. That is where patient care is going to be, a team 
effort across professions [Respondent 14].  
 Yet, not all parties are changing their mindset to be consistent with the more 
extensive pharmacy education. There are some pockets where the pharmacist is paid to 
provide services but a very small percent. Illustrating this resistance, Respondent 4 
indicated: 
 The AACP strategic plan was that every school had its own strategic plan and it 
 was reviewed twice a year and readjusted. We did reach out to other professions 
 and we had nurses, physicians, audiologists, etc., come to our national meetings 
 and talk about things that were happening in their profession and they heard about 
 things that were happening in our profession. Equally important, the executive 
 directors of the AACP got together and had a lot of discussion. 
 
 The healthcare system and reform will require pharmacists to be more 
progressive. The pharmacy profession is working harder and more aggressively to obtain 
provider status [Respondent 6]. Each facility within the healthcare system must have the 
most efficient and most effective system for patient care and demonstrate continuous 
improvement. It is unreasonable to say that is how pharmacists operate and we are always 
going to do it this way [Respondent 8]. There is a constant search for a better way of 
improving outcomes. The outcomes are twofold: one is a patient-care outcome and the 
second is economic outcomes, but not at the expense of patient care outcomes. How do 
you structure this relationship among the intelligences that these individuals bring into 
the arena and actually set egos aside? What is it that this person or this group knows, 
what can they add, what value do they add to the position? If the position is 
diagnostician, they use a tool, they don’t probe on the patient to get a diagnosis, they 
utilize MRI, CT, etc. Respondent 3 expressed these thoughts: 
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 I did not think it was possible to be more resistant to change than the resistance I 
 experienced in academia. But, having been an administrator in a different era, the 
 healthcare system is so politicized, especially today, that I have little hope of 
 seeing that change radically in my lifetime. That is the next decade. I think this is 
 the most insurmountable problem and one that I certainly don’t have the skill or 
 the patience, nor did I ever have the personality, that would permit me in being 
 successful at doing that.  
 
 Respondent 6 explained the role the pharmacist plays on the healthcare team. He 
makes clear that patient care is a two-step process; you have to have a proper diagnosis in 
order to make an appropriate decision. The second cannot be correct if you make a 
mistake with the first. Pharmacy can do an excellent job of prescribing medicinal 
substances but may not be confident in the skills of diagnosis. Pharmacists are experts at 
medications, the proper use of them, in combination with other drugs, with certain foods, 
with particular laboratory tests. Does the physician know the multiplicity of conditions 
being treated by several doctors starting with the general practitioner and multiple 
specialists, often in different subfields and treating different ailments? How can any one 
physician make an educated decision about therapy or inclusion of another chemical in 
combination with a variety of other things and be confident about that without asking 
someone who has specific expertise about these complex interactions, i.e., the Pharm.D. 
trained pharmacist. Respondent 8 explained how this situation is changing: 
 Historically, the limiting factor in delivery of services was [that] the pharmacist 
 did not have the medical history of the patient. Now, most doctors have gone 
 electronic so the prescriptions are either faxed or sent electronically. The patient’s 
 records are electronic, so the pharmacist can obtain a valid medical history of the 
 patient, and that is part of pharmaceutical care. The primary limitation today is 
 that the patient is sent to more than one specialist, which is happening more as our 
 population ages. They end up with overlapping diagnoses and different types of 
 diseases, but each physician is not aware of the other specialist’s treatment plan. 
 My opinion is that the patient should go to a single pharmacist who is aware of all 
 diseases, diagnoses, and medications that are prescribed to the patient. We are 
 getting closer, it happens more and more frequently, but before the 1980s it was 
 rare. 
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  Theme: There is a trend in the healthcare delivery system toward a 
collaborative care model. Initially, a number of medical people strongly opposed cross- 
discipline collaboration. Physicians did not understand it. There were feelings that it 
could take away some of the doctor privileges or recognition. There also were financial 
aspects for the opposition because a number of physicians dispense drugs out of their 
family practices. Respondent 10 described the situation: 
 The thought was physicians now have these pharmacists trying to take 
 responsibilities for some of my patient’s care. That is my responsibility to take 
 care of patients. And nurses, with the movement toward the nurse practitioner 
 degree, are asking if the pharmacist is now going to touch patients? That is my 
 responsibility as a nurse. So those conflicts existed within pharmacy and also 
 existed externally with health professions. In my role, I viewed this as an 
 opportunity but some older physicians and nurses thought they were trying to take 
 something away from practice. Really we just want to help and benefit the  patient. 
 If we benefit the patient, it is going to help you and your role as the physician or 
 nurse. 
 
 The pharmacists who are trying to change the practice are working with other 
health professionals, a nurse practitioner or primary care physician, and are really excited 
about it. Many physicians are relying on the Pharm.D. to monitor the drug therapy, 
especially younger physicians. Respondent 3 shared a true story that emulates the 
situation: 
 A physician got a call at home one night. He had a pretty sick patient with kidney 
 problems. He prescribed an antibiotic. Anyone else would respond to this 
 particular antibiotic and it would be effective on the disease but it was not 
 working on this patient. The resident and the pharmacist on call conferred and 
 altered the dosage because they understood the doses and type of antibiotics that 
 were best for this complex situation. The next morning the doctor came forward 
 to the pharmacist’s office, really mad, and said that no one changes my doses and 
 swarmed all over this person. Later in the day, the doctor was big enough to come 
 back to the person and said I owe you an apology. He said my dose was way 
 under where it should be and yours was right on the button. The blood levels for 
 that patient are exactly where they should be.   
 
 Theme: Many respondents have confidence that physicians will rely more and 
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more on the information from the pharmacist. This happens a lot in hospitals and in 
places that are organized that way, such as the Indian Health Services, Kaiser 
Permanente, and situations where the professionals are equal partners [Respondents 4, 10, 
11]. In these circumstances, the professionals are all trying to find a solution to the same 
problem, the patient’s problem. Respondents provided examples of collaborative models 
that are being set up in situations like the Rocky Mountain health plans in Grand 
Junction, CO, and Group Health of Puget Sound in Washington State, in which the 
reliance is upon the pharmacist for medicinal therapy as an interdisciplinary member of a 
team with physicians and nurses. It does not happen as often in the community setting 
where the patients are getting their prescriptions from the chain drugstore and going to a 
private physician but it does happen.  
  Theme: The changing landscape in healthcare required a team-based 
approach, and the pharmacist was the best professional to manage the drug therapy. 
Physicians know a lot about the 25 drugs that they prescribed; but, as a rule, they did not 
know several thousands of drugs that were available. Patients were seeing specialists who 
gave them other drugs and they would have complications from drug interactions. 
Pharmacists were capable of being informed of all of the drugs, all of the complexities, 
and, especially, the possibility that it would be achievable to tailor a drug for an 
individual. 
 The innovators and leaders said pharmacy could do much more than it is currently 
doing. Pharmacists need to be much more involved in the outcomes of drug therapy 
intervention, especially when there is an error, mistake, or the potential for a mishap. In 
the 1970s, pharmacy students were being taught not to speak to patients or how to avoid 
speaking to patients. Respondent 13 shared thoughts on the diversity of pharmacy 
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practice at the time: 
 In the summers, I worked for a pharmacy in a rural community. They were taking 
 care of the whole community. There was another pharmacy in town, but not much 
 in the way of physicians. They kept records on 5x7 cards. If someone needed 
 something, the pharmacist would call the physician and tell them what to 
 prescribe over the phone. The pharmacists would do refills and make decisions 
 like that. They were really doing patient care back in 1970 in the community 
 settings. Not as formally as we do now.  
  
 There were people, primarily in education, who were highly visionary. Many 
understood that this, the chain drugstore dispensing prescriptions, was not the way 
pharmacy should be practiced. Respondent 13 continued: 
 I also worked at a chain drugstore where the clerk sold the drugs to the patient and 
 the patient really couldn’t talk to the  pharmacist. They had to stand on their 
 tiptoes, over the swinging door at the end of the counter, to take a peek at the 
 pharmacist. 
 
 Tenth pattern: Most patients need drug therapy and many physicians, 
nurses, and other health professionals are recognizing that there is somebody on the 
team who has expertise about medication therapy and not diagnosis.  
Understanding of the competencies and skill set of each individual on the 
interdisciplinary team needs to occur at the educational level. The respondents 
unanimously agreed with the idea is that it is great that the pharmacists know more than 
the physicians about drug therapy, because if the team is going to be successful, we need 
to use the skills of each and every person on the team. This raises the question of who is 
in charge. Many respondents said that it depends on the situation. A hospital pharmacist 
noted, “If you have a patient that needs to be anti-coagulated and the physician does not 
have the skills to do it, well the pharmacist had better be in charge if you see what I 
mean.” Respondent 10 put the collaborative care concept into perspective: 
 Whenever you have a team, whether it is a team of health professionals, 
 investigators on a research project, or whatever, there has to be some kind of 
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 hierarchy. I mean you have got a doctoral committee and somebody is the 
 chairman of the doctoral committee. You have to work out who has responsibility 
 for what and I think that is really the basics for all these collaborative tracks. As 
 we start moving into new territory, where you have pharmacists that are coming 
 in and, not only through their education, but by their behavior and by what they 
 know and what they can do, they are readily recognized by physicians and nurses 
 and everybody else that there is somebody here that knows what they are talking  
 about with pro-therapy and drug management.  
  
 Theme: Pharmacists lack the skills in physical assessment that are necessary 
for patient diagnosis but are experts on the drug management of disease. Several 
respondents [5, 8, 14] explained that, at the school with which they are affiliated today, 
the curriculum has a physical assessment component, but they are hardly ready to 
practice it. The students learn some skills in the first and second year of the program, but 
other than maybe taking a blood pressure and vital signs, they get very little experience. 
To become proficient at physical assessment it takes practice, practice, practice 
[Respondent 8]. There may be some exceptions out there, but they are rare. 
 Pharmacists do not have the skills that the caring professions, such as nurse 
practitioners, have to assess the patient’s problems. Once the patient is diagnosed, 
pharmacists have the skills and education to manage a chronic disease state such as 
diabetes, hypertension, or asthma. Those situations are going to increase. Many pharmacy 
programs do not teach a strong physical assessment component or create the image that 
here is a practitioner who is great at physical analysis and has this ability to manage or 
take care of problems. Especially at the chain drugstores, they don’t put pharmacists in as 
a practitioner. Respondent 3 defined that the role of the pharmacist is evolving toward: 
 Our role is to [be] as efficacious [at supplying/managing] drugs at the lowest cost 
 to that patient in a timely manner. We have been able to prove this in hospitals…, 
 talking to patients to understand the medications, what goes on with that 
 medication, and what they should be experiencing with the medication instead of 
 just being told by the doctor or the nurse.  
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 Theme: One way to change the face of a profession is to educate health 
professionals together, in a collaborative environment. Students from different 
disciplines would obtain a much clearer sense of what the contributions of others on the 
health professional team can be. Respondent 6 illustrated this with a personal story: 
 My physical therapist is my best friend. I am almost 80 years old and how in the 
 world would I exist without my PT. How could I hike up mountains? My PT 
 expects to see me at least once a month. My PT is extremely well educated and 
 understands what is going on. I would have no qualms whatsoever if this 
 individual were Dr. Jim instead of Jim.  
  
 Stakeholders in academia are talking increasingly about inter-professional 
education. Every school is supposed to have some kind of program that involves medical 
students and pharmacy students working or talking together for discussions on how to 
treat patients [Respondents 3, 9, 11]. That will produce change over time. There is more 
team-based education, with pharmacists joining physicians and nurses on rounds and 
similar activities, so when they graduate they are accustomed to working together. The 
other thing that is happening is that more and more people take residencies and are going 
to a higher level of clinical practice, working in situations where physicians and nurses 
are trained [Respondent 4]. They see the knowledge the pharmacists have and, when they 
graduate, they want to work with someone with the same knowledge. In addition, 
organizations such as Kaiser Permanente have pushed for inter-professional care 
[Respondents 4, 11, 13]. This is much better than it was 5, 10, or 15 years ago. This will 
continue to evolve and improve.  
 In education, conversation about inter-professional care revolves around the 
didactic portion of health professions but there is a lot more smoke than heat right now 
because there is so much to do. Everybody talks about it, we [Respondents 3, 4, 10] have 
talked about it for 40 years, and we are making progress, but boy is it slow! This creates a 
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sense of cynicism; will it ever be accomplished? When you have pharmacy students and 
medical students taking the same courses in pharmacology, there is an opportunity on 
these campuses where you have both types of training, didactic and clinical, with other 
allied health professionals. Students respecting each other and being educated together 
make a lot of sense. Respondent 3 illustrated: 
 When we create an experiential practice site, we put a pharmacy clinician in and 
 give them a year before they have any students to train. The institution comes up 
 with the office space. These people give their time to the institution by helping the 
 doctors and patients in that year begin to understand the pharmacist’s worth so 
 they can be an important part of the team. So when the students arrive, they are 
 already looked upon as professionals. 
 
 It is best to have the young men and women on the healthcare team be in a 
learning environment where they are associated with other professionals. “We want the 
other professionals to walk in there and say the words my clinical pharmacist” 
[Respondent 6]. The students have more confidence because the medicine questions are 
being asked of the clinical pharmacist. Training with the medical students is key, and 
when they get out into practice, the new MD wants to know where the pharmacist is.  
 Theme: There are more opportunities for the disciplines to be educated 
together. There is a huge difference in the education process for medical doctors, nurses, 
and pharmacists. Medical and nursing education focus primarily on diagnosis; there is not 
a great deal of medicine in their training. Respondent 4 suggested that the pharmacy 
school curriculum does not spend much time on physical assessment and it is not like the 
nursing profession or any other caring profession. More education on the ability to 
diagnose is necessary for that to be a part of the pharmacist role. The pharmacist can 
present information to the physician that may change the diagnosis, but they are not 
trained in the evaluation process that leads to a diagnosis.  
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 A lack of knowledge by most people in the healthcare system exists concerning 
all the drugs. The physicians know the drugs that they prescribe, the ones they were 
trained with in their residencies and internship programs; but they do not know anything 
except the basic facts. If you asked a physician the dosage forms, they would say go see 
the pharmacist [Respondents 5, 6]. At most institutions the disciplines are not being 
educated together in the basic sciences, but they are increasingly being educated together 
when they make their rounds, on clerkships, and on the clinical rotations, improving the 
respect between disciplines [Respondents 7, 11].  
 Many chain drug pharmacies now have nurses associated where you can get your 
flu shots; you don’t have to go to the doctor’s office anymore [Respondent 4]. The reason 
nurses are on board is primarily to give injections. Pharmacists are not trained to 
administer drugs directly, and nurses are there if something should go wrong, trouble 
breathing for example. Pharmacists are not trained to deal with those emergency type 
situations and the nurses can triage. The main point is that there is an overlap and should 
be more respect and trust amongst the three groups.  
 Respondent 10 commented that he always wanted to look at how the ACPE 
agenda was going to affect the most important person in all this, the patient. He noted that 
studies based in the hospital settings report that, if a pharmacist rounds with physicians 
there are fewer drug reactions, fewer medical errors. This research documents how 
working collaboratively can benefit the common good in general and, most important, the 
patient. Missouri has been one of the leaders in getting this collaborative model into play. 
Working within a cooperative environment allows the input of the pharmacist working 
with other health professionals for the betterment of the patient.  
 Although most of the respondents saw the Pharm.D. in a positive light, there were 
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a few outliers that never supported the societal need for the Pharm.D. Respondent 12 
illustrated this oppositional view: 
 I still have one or two faculty here, one is retiring this year that is still in 
 mourning that we went all Pharm.D. While I know he is a Pharm.D., he has been 
 here 36 years and was one of the first Pharm.D. faculty hired here. He has never 
 really accepted the fact [that we went all Pharm.D.]. He still thinks that it would 
 have been better for society if we didn’t do it. He felt the quality in the post 
 Pharm.D. program and the types of students coming back for the Pharm.D. were 
 really focused and passionate about patient care and changing practice. He felt 
 that there was not a societal need for all of our students to be Pharm.D. because 
 they would not be able to utilize the training that they would receive here in 
 patient  care when they left to go out and work.  
 
Research Question 1d 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
 
 d. societal and economic landscape of the healthcare industry (cost-benefit)? 
 IS16. How does the change to the Pharm. D. serve the greater good? 
 IS17. Think about the strategic plan that the Pharm.D. represented as a policy 
 change. Retrospectively, to what extent has the “turf” of the healthcare fields 
 changed due to the implementation of the Pharm.D? How much did the balance of 
 power between healthcare professionals actually change? How much did the 
 perceptions of prestige, professional scope of practice for pharmacists actually 
 change? 
 
 IS18. What is your perception on how the Pharm.D. is viewed by the general 
 public? Do you think that the general population is familiar with the advanced 
 knowledge, skills, and abilities of pharmacists?  
 
 IS19. What is your sense about the public’s perceptions about the prestige of a 
 Pharm.D.? The public’s sense of advanced degrees and the people who earn 
 them? The effects on society as a whole? 
 
 IS20. What is your perception about society and the need for more classifications 
 of credentials or degrees? 
 
 Eleventh pattern: The Pharm.D. has resulted in a gradual change in the 
practice and professionalization of pharmacy and the concomitant views of society. 
Right before the Commission to Implement Change in Pharmacy Education started 
meeting, the AACP made a very strong case that pharmacy’s value to society would be 
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greatly increased if pharmacists were capable of providing patients with pharmaceutical 
care. Respondent 8 pointed out that the only way for pharmacists to prepare for the 
responsibilities associated with pharmaceutical care was more clinical training. The only 
way to get more clinical training would be by putting more time in the educational 
process.  
 A fundamental question before the field is what should the pharmacy profession 
be doing to take care of patients at every single practice setting? Respondent 12 said that 
he tried to get students to write a paper that describes the professional role, set of 
functions, practice activities, and job descriptions of what they visualize themselves 
doing in practice before they graduate. Articulating what their practice should be and 
successfully achieving that would provide a strong impetus toward changing the overall 
perceptions of the professional role. Engaging the student in and about the profession and 
related issues, both nationally and state level, could have far-reaching consequences.  
 Theme: One of the underlying reasons for the transition to the Pharm.D. was 
that pharmacists wanted more responsibility, but there is a difference between 
increased responsibility and autonomy. Several respondents [1, 6, 13, 14] commented 
that one of the benefits of this transition is that Pharm.D. graduates have more of a 
professional attitude and appear to be satisfied with their career choice.  Respondent 12 
explained: 
 I believe very strongly that pharmacists have to be in a collaborative environment. 
 We cannot provide the best patient care by ourselves, not should we try to do it by 
 ourselves. I think it is dangerous for nurses, physicians, or any other discipline to 
 try to do everything. There is a point when they are getting out of their boundary 
 levels. Doctor  of pharmacy, doctor of physical therapy, doctor of nurse 
 practitioner…[T]hat is why I don’t think autonomy is the way to go. I think we 
 have to have respect for each other. I think we have a long way to go, but 
 everybody is on board with it. 
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When students come out, they have worked in several different environments for a year 
of experiential learning. The rotations add maturity as the students continue to grow. 
When they return for graduation, they have a sense of what they want to do, they 
understand what they know and don’t know; and, most important, they are prepared to 
interact with other professionals to defend their position for the benefit of the patient.  
Many graduates finish the Pharm. D. and continue on to residencies, add an MBA, go to 
medical school, while others go into practice as an expert generalist.  
 Theme: Pharmaceutical care services cannot be forced upon the public, but 
take a slow, steady change in perceptions and expectations of individual patients.  In a 
community, pharmacists are found to be high on a list rating trustworthiness and 
answerability. Respondent 1 noted that surveys have shown that people today know to 
talk to the pharmacist about drug-related concerns. If we asked whether all people in the 
community appreciate the pharmacist, probably not. People generally do so when there is 
a personal connection; a pharmacist has done something spectacular for a person’s 
parents or somebody in that family. The population is becoming quite knowledgeable 
about their conditions and diseases, but some of it can be very confusing and they don’t 
understand it. Respondent 4 illustrated this with a story:  
 I am playing Betty and I am talking to Mary, my neighbor.  
 Mary, you know I was in to see my pharmacist the other day and I brought in this 
 particular prescription that is to control my blood pressure. I needed a new  
 prescription and I went to Doc Smith; he wrote the prescription and I brought it to 
 my pharmacist. He took a look at this and said, you know you really shouldn’t be 
 taking this particular type of antihypertensive mediation right now because this 
 could cause some serious interactions. It could put you in the hospital and let me 
 call Doc Smith and see if we can work out something that might be better for you. 
 The neighbor says, “Geez, you know my pharmacist never says anything like that 
 to me about anything. I go in there and ask the clerk at the back of the 
 supermarket if my prescription is ready and she gives it to me. I give her $487.40 
 and go on my way. I don’t even know the name of the pharmacist”…. This 
 change occurs in a profession and it is not on the basis of academics. 
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 Respondent 8 referred to several focus groups of patients, put together by 
pharmacist associations and other state organizations, that were gathered to discuss 
various issues and promote literacy, especially with the aging population. Many patients 
obtain information on health care and drug management off the Internet and are 
misinformed. The purpose of these focus groups is to share experiences, referrals. Most 
importantly, these gatherings have been a powerful opportunity to inform the public that 
they can go to their pharmacist for help with their medications and healthcare needs. 
 Theme: When opportunities are present for pharmacists to practice to their 
fullest potential, society will benefit as a whole. Respondent 3 noted the root question as 
it relates to how to deal with this issue: “Do you wait until there is a clamor on the paths 
of society that demand pharmacists take a far more active role? Ensuring that we are 
getting the best possible benefit out of the therapeutic miracles that are available today in 
the form of new drugs. Or do we go ahead and by showing patients what pharmacists are 
capable of doing, let them make individual decisions?” 
 The majority of respondents [1, 2, 5, 11] were aligned with the individual 
philosophy that the pharmacy profession has been good to them. Many strongly believe 
that pharmacists have been good to patients and community. And many believe that they, 
as an individual, have been good for the pharmacy profession.  
  Theme: Opportunities to practice pharmaceutical care are still in their infancy. 
We [Respondent 3] can do all of this training but we are going to have to take full 
responsibility of presenting to the public at large what these new trained pharmacists can 
do. This is a process that occurs over time, through experience. Most consumers do not 
have a clear sense of the capabilities of the pharmacist in helping them retain or regain 
their health, although a far larger percentage of today’s population is aware of what 
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pharmacists can and are doing to achieve those ends. That was not the case in 1992, just 
20 years ago, because there are far more practitioners doing those things and they can do 
it because they have been well trained to do it [Respondent 5]. This is how the face of a 
profession is changed. One element of professionalism is that, when a profession expands 
the scope of practice, the process occurs through immersion. The transition of pharmacy 
practice from product-based to patient-based has been slower than anyone imagined, but 
it is happening [Respondent 2]. It is happening because of well-managed drug therapy. 
  Several respondents [2, 5,11] believe that if community pharmacists are given the 
opportunity, they possess the capability and are doing a good job providing clinical 
pharmacy services in the community. For example, the general practice of pharmacy, 
which is not primarily urban, is similar to chiropractic in that if you would go to a town, 
say 3000 people, there would be a pharmacy and there will be a chiropractor [Respondent 
2]. The idea of increased expectation of the pharmacist and practice, whether in a small 
town or urban city, comes from the subtle recognition that, if more accessible, people will 
ask them questions and trust them. This changes slowly. 
 Theme: The pharmacy profession, as a whole, has not been proactive in public 
relations. The health literacy of an individual seemed to be directly related to personal 
interaction with a pharmacist. Those who have experienced problems with their 
medication or have multiple diseases or complications have seen both the hospital and 
community setting where a pharmacist has really helped them with a dosage problem or 
drug interaction. That is where the public relations happen, with referrals [Respondent 
11]. The public is becoming aware that the pharmacist can play an important role in being 
a problem solver. 
 [Health literacy is a major problem in the U.S. It impacts seniors in our 
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community. It impacts those who are not well educated or who do not have the advanced 
degree in related fields. There are so many people that do not understand basic English or 
cannot read.] We [Respondent 2] need to go out and give patients a sheet of paper that 
talks to them about the drugs they are supposed to take, and when you think the job is 
done, you have to be there because they need the support. Respondent 10 noted that many 
of the things that have been done by the U.S. Public Health Service related to health 
literacy have been by utilizing pharmacists and promoting the intervention with the 
patient’s drug therapy. You can do all the right things from what you do as a profession, 
the preparation of the product, perfect education, but if the patients are not their own self-
advocates, all of what you do is really for naught. The way we [Respondent 10] talk to 
patients in the health professions, we lose communication through phrases such as HMG 
inhibitors; but if we communicate that this drug is going to help you control how much 
rubbish is in your bloodstream, most people might be able to understand that. Some 
people in the profession are critical of current practice because we don’t help people 
understand what they need to do to speak up, to be participants, to be active in their own 
healthcare.  
 Healthcare provision is an interesting phenomenon. It would be interesting to 
investigate why Walgreens has made the decision, at least in some of their stores, to end 
up changing the layout so that pharmacists are actually talking to and interacting with 
patients. Several respondents [5, 9, 11] surmised that this was because they are seeing a 
need in society. There has been a lot of effort on the part of the pharmacist, organizations 
that represent pharmacy, and individuals who think outside the box to increase 
appreciation of this fact. Consequently, these changes are beginning to resemble forward-
looking models of patient drug management with the pharmacist highly involved. These 
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changes are illustrated by Respondent 11:   
 Some of it is just because pharmacists are underappreciated or undervalued but I 
 do think it has changed. I like to describe the situation as we still have a long way 
 to go uphill to  reach the deserved stature in the healthcare world. When I look 
 back on where we were 5 years ago, 10 years ago, or 20 or 40, we have come a 
 long way to ensure pharmacists have a much higher role in the military and in the 
 U.S. healthcare system.  
 
Respondent 9 illustrated the opportunities for the young graduate: 
 
 We have been pushing for healthcare reform and we have to keep pushing 
 because it makes sense. I think the pharmacists who want to practice at the top of 
 their skills and [utilize their] holistic [training] are willing to move to rural 
 communities [where they] can find a very rich environment and certainly we have 
 graduates that have done that. It is not necessarily the underserved communities 
 but sometimes quite well off communities in urban areas where patients are 
 willing to pay for that kind of stuff out of pocket.  
 
Respondent 3 added to these comments:  
  
 Some graduates have a harder time taking a practice preparation degree and 
 incorporate that into his or her mode of work. Basically, some graduates look for 
 work in the wrong places.   
 
 Research Question 2 
  
 What is the transferability of an entry-level clinical doctorate related to 
 professional opportunities? 
 
 IS21. What is the transferability of an entry-level clinical doctorate related to 
 professional opportunities, in theory? and Empirically? 
 
 IS22. What opportunities have evolved to allow the pharmacy profession to meet 
 more effectively the healthcare needs of society since the Pharm.D.?  
 
 IS23. What are your perceptions about how the Pharm.D. has enhanced the 
 professionalization of pharmacists? How? Why? 
 
 IS24. The decision to transition from a master’s to a clinical doctorate begins with 
 the internal decision and a strong rationale by the profession that change is 
 warranted. What are some of the external forces that are behind the progression of 
 the clinical doctorate as an entry-level degree that pertain to all other disciplines 
 that are undergoing the same transformation? Based on your retrospective, what 
 are the trade-offs/conflicts that other disciplines may face? 
 
 IS25. Inevitably, policy change leads to latent and unexpected developments. 
 187  
 Retrospectively, what do you think was the biggest surprise that resulted from the 
 change to the Pharm.D.? The biggest disappointment? 
 
 IS26. The conversation of the clinical doctorate is occurring on a global level. The 
 UK and Australia are experiencing their own transformations within health 
 professions. Was the impact of the Doctor of Pharmacy on the professional on a 
 global level discussed during the decision-making process? Considerations such 
 as the equality of the scope of practice from country-to-country, educational 
 requirements, licensing processes, etc.? 
 
 IS27. Can you think of anything else that might be relevant? Anything on power? 
 Backlash? Positive effects? Other? 
 
 Questions related to the transferability of the entry-level clinical doctorate focused 
on professional opportunities available for the pharmacist in the current marketplace. 
Most respondents believe the options for pharmacists are expanding with the new 
knowledge and skill base. Respondent 9 explained that, when you look at a pharmacy 
degree at the science level, it is almost a dual major in biology and chemistry. Then you 
add to that the health related information, therapeutics, and everything else. In addition, a 
pharmacy student will have been required to take courses in management and public 
health. All of this overlies pre-pharmacy requirements that are at least two years and for 
the most part three to four years of general education.  
 Twelfth pattern: The Doctor of Pharmacy is well prepared for a larger area 
of professional practice and related careers, such as the pharmaceutical industry 
and prescription development. These graduates bring pharmaceutical skills related to 
formulating dosage that are invaluable in the industry [Respondent 8]. You have 
pharmacists in the medical services industry, both the state and federal governments, and 
in health departments, talking with physicians and policy leaders about new drugs.  
 Theme: Opportunities are expanding in hospital and community settings. Job 
offers go out saying Pharm.D. or experience in hospital setting. A B.S. pharmacist that 
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never worked in a hospital setting would not qualify for this job. We [Respondent 3] are 
seeing Walgreens, Safeway, and other chain stores put in clinics with a Pharm.D. and 
DNP; and the Pharm.D. is doing the counseling, while the technicians are actually filling 
the prescriptions. Respondent 3 explained: 
 It can happen when given the opportunity, which is key to this, because a lot of 
 pharmacists don’t, but when given the opportunity to allow the pharmacist to sit 
 down and talk to the patient about the medication the patient is so better about 
 compliance and the doctors in the community like it. But if they are not given the 
 opportunity and if they just sit there and do what they always did, and some 
 pharmacists are happy to do that….I say “lick and stick.” 
 
Theme: Pharmacy is a huge industry and Pharm.D.s are highly sought today 
throughout the field. Biotechnology companies that are conducting clinical studies are 
hiring pharmacists as the head of the clinical pharmacology department, a position 
historically held by medical doctors [Respondent 5]. The complexity of clinical 
pharmacology has evolved to the point that the regulatory agencies require these research 
companies to have the Pharm.D. because they feel it is important.   
 Thirteenth pattern: There were external forces behind the progression of the 
clinical doctorate in pharmacy and other professions that are contemplating the 
transition may want to address these factors. Many respondents [5, 9, 10, 13, 14] were 
cautious about giving advice, but they voiced the concern about trying to figure out what 
has been done, what is relevant and what is not, when something is new. Respondent 10 
said that the school of nursing has called upon the school of pharmacy from time to time 
about problems that pharmacy ran into and that the nursing school seems to be running 
into the same kinds of problems. The school of nursing has determined what exactly they 
are going to do, so maybe they can learn from the mistakes and successes that pharmacy 
went through.  
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  Theme: The respondents perceive this transition to be successful in pharmacy 
because all stakeholders were involved. The leaders in the four key stakeholder groups 
took time to meet with all associations, create standards, and obtain advice, reactions, and 
comments from all interested parties. The respondents stressed the importance of 
involving people who may not be viewed as allies, agreeing that all sides were gathered 
together to talk freely and openly, without reservation, without any kind of bitterness or 
hostility, to open and air out the issues. As people and stakeholders began to see what 
was and what was not happening, they bought into the idea. A few did not fully buy in to 
the mandate but were required to comply with the new regulations [Respondents12, 14]. 
The pharmacy leaders planned to take a long time from the beginning because they 
wanted all groups to have ownership. Respondent 4 said, “We wanted all stakeholders to 
buy into it before we finalized it.” Respondent 10 illustrated the importance of open 
dialogue: 
 I think it is really contingent between physicians and nurses. I find it unbelievably 
 positive that the nurses have gone ahead without physician support. I think that on 
 the very ground level of this you need to pull together and really talk about what 
 the issues are. If you are not one to agree with each other, get various components 
 together, get the nurse practitioner, county employees, B.S. nurses, and 
 professional associations involved. And by all means bring in leaders in the 
 physician domain. You might leave a discussion room with 80% agreeing and that 
 is better than leaving the room with 100 people with their own ideas of what they 
 want to do and how they are going to fight this.  
  
 Theme: The respondents agreed that other professions might want to take time 
to learn this process, because this process has worked well for pharmacy. It has been 
argued in many graduate programs that pharmacy can be used as a template. Many 
disciplines are saying we [Respondent 3] want to do what pharmacy has done. Since 
pharmacy moved to the practicing doctorate as entry into practice, the profession has 
been able to transform the practice of pharmacy in only a decade. There is still more 
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work to be done, but the accomplishments have been impressive. It is important to read 
what is available in the published literature about how this process worked, learn about 
the tasks and the steps it took to ensure that the key stakeholders were knowledgeable 
about what the profession was trying to do. Hopefully, what we [Respondent 6] were 
trying to do had a positive influence on the field.  
 Theme: If the various stakeholders in the educational institutions successfully 
implement change in the educational requirements, the graduates of the Pharm.D. 
programs will have a ripple effect through the rest of society due to their upgraded 
capabilities and professional practice. As schools of pharmacy change curricula, so too 
will professional organizations and their bodies. Broader changes will occur through the 
efforts of promising practitioners who have come through the more intense educational 
process. Repondent 4 illustrated the importance of the change process: 
 It will be a slow evolutionary change; it will not be a dramatic painful change. 
 Anybody who wants to accomplish this, who wants it to happen in 2-3 years, I am 
 talking about public acceptance and all that stuff will be grievously disappointed.  
 
 Theme: It is important for a profession to articulate clearly what the difference 
will be when the professional doctorate program is implemented and how that will 
translate to better outcomes for patients. Respondents used nursing as a profession that 
needs to address this as part of the larger policy discussions that accompany changes in 
required credentials. Respondent 6 noted:   
 Nursing has never had a single accreditation program. They have a hodgepodge of 
 nursing credentials; diploma graduates, baccalaureate graduates, graduate degrees, 
 Ph.D. Now they are going for the DNP. In our case, pharmacy, we have always 
 had, from the standpoint of pharmacy education, one comprehensive, across the 
 nation, accredited degree. It might be a four year degree, 1+ 3, 2+2, etc. and now 
 we have the 6-year Pharm.D. degree as the entry-level, but we still have that 
 consistency that nursing does not have. They are deciding if they are going the 
 direction of the DNP but they have all of these other levels of [the] nursing track 
 that they are dealing with and I don’t see them addressing those. It is another 
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 level. What they are anticipating is that the master’s program for nurse 
 practitioners or whatever will be replaced by the DNPs. The question is will their 
 credentials be consistent on that certification and will all of these small 
 institutions be able to move in that direction.  
   
 Theme: The intention of the profession to transition to the practicing doctorate 
should be to establish a role as part of a collaborative team with other healthcare 
professionals, not increase the professional autonomy. Respondents 3, 5, 13 focused on 
making sure to be out front on this and to be careful to look back. If there is nobody 
supporting you, such as other key health professions, the intentions of the change need to 
be reevaluated.  
 Fourteenth pattern: The biggest surprise from the establishment of the 
Pharm.D. as the sole entry-level degree has been the unexpected rise in pharmacy 
schools. At the time that pharmacy went all Pharm.D. in the early 1990s,  there were 74 
pharmacy schools. The general feeling at that point was that pharmacy educators were 
going to have a difficult time staying even in terms of the supply of pharmacists. There 
were certainly those that said as soon as you go all Pharm.D. the demand is going to go 
down and there will not be as many applicants in pharmacy schools. It was even 
suggested that the standards for new students would have to be lowered. In fact, the Pew 
Commission forecast that there was no need for nearly as many pharmacy schools, 
projecting that many pharmacy schools should close [Respondent 5]. But none of that 
happened. We went from 74 to 125 schools, with most of the new programs in private 
institutions. All respondents indicated that this surge in the actual number of both 
pharmacists and schools was clearly unexpected at the time that the changes were being 
contemplated.   
 Theme: During the transition period, leaders thought that this educational 
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change would decrease the number of applicants. This turned out not to be true. 
Initially, many schools thought it was not okay to expand to a six-year program, and they 
would just do something else. At the time, there was a shortage of pharmacists. 
Respondent 9 explained what happened: There were more applicants and new schools 
began to open. So basically, this decision has brought more people into the profession. 
Respondent 3 explained the scenario: 
 We have seen an increase in the number of pharmacy programs, especially in 
 private schools. There is still a demand for pharmacists and the schools see a way 
 to make a dollar. Our state program is the lowest tuition in all comparative 
 schools in the west region that are close to us. A lot of the private schools have 
 tuitions double ours. 
 
 Theme: In addition to the increased number of schools, the class size has grown 
as well. ACPE maintains statistics on the number of graduates before the mandate and 
after the mandate. These data, together with enrollment figures, will provide information 
about how many graduates there will be in three to four years from now [Respondent 5, 
9, 12]. That number is quickly going to double from the number of pharmacists that 
graduated 10 years ago. Respondent 2 shared these thoughts regarding the number of 
pharmacy students and programs: 
 Are we getting to the saturation point regarding the number of pharmacy schools 
 and the number of graduates who will be entering the marketplace? Do we have 
 access to sufficiently qualified alchemy, particularly those with a Ph.D. in 
 sciences that can teach these students?  
   
 Theme: There was the perception of uncertainty regarding the quality of some 
of the new schools and programs within existing schools that have been started in the 
past 20 years. The pharmacy schools that have opened in the last 15 years are 
dramatically different from the existing schools because they tend to be in schools that 
don’t have a history of doctoral education, and the culture of the school may not reflect 
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graduate education. Respondent 9 emphasized that the culture of the school is important 
for success, illustrating with this point: 
 Many of the new private institutions did not have any doctoral programs at all. 
 Some of which only had baccalaureate programs besides the pharmacy school. So 
 that was an unintended thing. There has been a fairly substantial amount of 
 opinions. My take is that we don’t have good information about the quality of 
 graduates because we cannot  measure the quality of anything in education.  
 
 Respondent 3 noted that all the things that go into a college learning experience 
have undergone radical change by the ACPE for the past 40 years. The issue of what we 
[Respondent 6, 14] call the product at the end of the training has been hotly debated. 
Because there was a shortage of pharmacists for a while, colleges got into the business of 
educating pharmacists. They are using the student loan initiative in order to do this, and 
now suddenly some of the pharmacists are not finding work as easily as they may have 
five years ago. Respondent 14 shared these thoughts: 
 I think we have too many pharmacy schools now. In May, we graduated 119 
 students and on the day of graduation we still had about 26 students who did not 
 have a good job. Now, some were waiting for the perfect situation, did not want to 
 relocate, and such. There are many rural and inner city urban areas that have a 
 void.  
   
  Many respondents [2, 3, 9] expressed apprehension because there is a different 
philosophy in most of the new schools that are being developed that may do harm to the 
profession. These new schools are not research focused and they hire people who 
basically do not want to do research. This may be shortsighted. The ACPE accreditation 
standards and guidelines do not stipulate that faculty need to be scholars, rather than 
focusing only on teaching; but it may be doing a disservice to the profession when that 
happens. Respondent 8 illustrated this concern: 
 They do not have the most respected deans and/or a large number of faculty. 
 Some don’t have a basic science program, one of the things that I was a very 
 strong advocate for on the commission. I felt the science education must be 
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 expanded as well because a pharmacist graduate needs to know all the drugs of 
 the day but they don’t know the drugs that will be available 10, 15, 20 years from 
 now. At one time you could ask a pharmacist if they know all of the drugs they 
 were dispensing and they would say “yes.” That is not true today. So you need to 
 know the science upon which the drugs are derived in order to know how the new 
 drugs are fitting into the overall disease process and you need to have a strong 
 basic science foundation in order to do that. I question whether some of these 
 new schools that is happening. Visiting professors, people that [in] come in and 
 give a few lectures and go back to their main institution, give a lot of their basic 
 sciences. Accreditation is supposed to take care of that, but I don’t think they do a 
 good job.  
  
 On the other hand, most programs that were already established at the time were 
successful in adding additional faculty, an additional year, and additional training so that, 
overall, the Pharm.D. is a much better educated pharmacist than was the baccalaureate 
[Respondent 8]. 
 Theme: The largest increase of new programs has been in private schools, 
many without the established culture of doctoral or health professions education. There 
is still a demand for pharmacists, and schools see an opportunity to make more revenue 
by establishing a new doctoral program. Respondent 2 illustrated this phenomenon: 
 Twenty-something institutions that have been ready in their minds to entertain the 
 idea of starting a pharmacy program have called me up [on this] and my little 
 tagline for what I do as a consulting practitioner is “make the right decision for 
 the right reason.” I help them understand what is involved not only financially, 
 but institutionally to incorporate a pharmacy school into their offering. 
 
 I ask the question, what prompts you to want a pharmacy school? And it often 
 comes down to that they have been searching for ways to increase their 
 institutional perception, the profile of the place. Most of these have been 
 traditional liberal arts schools and by traditional, I mean 3000-5000 students who 
 have no graduate education. Many of them have no other health profession 
 schools. So they are seeking to improve institutional image, which is a very 
 legitimate argument. It can be defended because they assume that it will increase 
 the undergraduate interest in health sciences and therefore bring an internal 
 pipeline into pharmacy. The problem is the accreditation agencies are putting the 
 screws on them. 
  
 Fifteenth pattern: The conversation about redefining the pharmacy 
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profession is happening on a global scale. The definition of pharmacy is becoming 
more uniform but we [Respondent 11] must understand, especially as we get into the 
third world countries, the uniform definition of education--or uniform definition of a 
healthy diet or a day’s work--is still evolving. The Internet is making so much available 
these days but believe it or not there are companies that distribute drug information and 
get paid for it. That becomes a factor in third world countries. There is much to be done 
in organizations like Rotary International, which do a great deal, for instance, the polio 
immunization effort, in that volunteers deliver services. Not always trained individuals, 
but the job is getting done so the legal definition of practice as is thought by so many 
state legislators is not as big an issue in third world countries.  
 Theme: Understanding the culture of a country and how that shapes the 
response to a major change effort is vital to professional change. In the overdeveloped 
countries, when you get into education, the scope of practices becomes part of the debate. 
Respondent 4 expressed these thoughts: 
 That is such a tower of Babel, that is a nice biblical reference, …that is something 
 that is such a quagmire that I don’t think it is a fruitful thing for a profession in 
 one country to try and emulate what the professionals do in the U.S. with what the 
 professionals might do, let’s say in a far eastern country because the culture is so 
 different and the way in which change occurs is so different. It is vital to 
 understand the culture and the change process. 
 
 I have had enough trial and tribulation dealing with the other side of my campus 
 here at  the University, rather than trying to change the nature of the practice of 
 pharmacy or education for that practice in let’s say Bangladesh.  
 
 Theme: On a global scale, the Pharm.D. is not equivalent around the world. 
The ACPE has opened several international initiatives and dialogue opportunities. 
Professional roles in healthcare in other countries are much more government controlled 
than in this country. A lot of countries will not have a Doctor of Pharmacy degree, but 
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they want to redefine what pharmacists do in the new healthcare arena such as China, 
Korea, Libya, and Saudi Arabia. Many of the European countries are eager to move 
pharmacy in a different direction. Respondent 14 said, “I don’t know one country that is 
happy with what the pharmacists are doing. They want to emulate what we have done 
here.”         
 In Europe and Japan, pharmacists are highly respected. Just last year, Japan 
increased the curriculum by a year and required all of the clinical aspects in the 
curriculum [Respondent 14]. The British system is different than the U.S.; one example is 
that pharmacists have the authorization to prescribe. It is a tenth the size of the U.S., and 
pharmacists have done similar things in Great Britain without having a Pharm.D. degree 
[Respondents 9, 11, 12].  It was changed within the provision of the law. UK differs in 
another respect: there is only one membership organization, the Royal Pharmaceutical 
Society that represents pharmacy in Great Britain. That group oversees the ethical 
components, the licensing departments, and the division that speaks for pharmacy. 
Australia made great changes to the scope of practice in the 1980s and 1990s with no 
resentment or kickback from anybody. They did it by working with physician groups, 
working with patients, and working within the pharmacy community. Big changes were 
made in Walgreens Australia and New Zealand because they focused on changing the 
face of the profession and how the profession is viewed [Respondent 11]. These countries 
were successful in expanding pharmacy practice by staying attentive to what needs to be 
done to help the profession, not focusing on the initials behind a name.  
 These discussions occurred in Scotland, Edinburgh, and Nottingham; and it really 
doesn’t have anything to do with credentials or initials [Respondent 11]. It has to do with 
what does the practice of pharmacy need to do in order to evolve. The assumption should 
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be that a Ph.D. doesn’t mean anything, but what matters is how a professional works 
collaboratively with other people [Repondents 3, 9, 11, 12]. The focus should be on how 
the profession needs to adapt and change.  
 Canada does not require a Pharm.D. but many Canadians come to the United 
States and earn the degree and then return to Canada to practice [Respondents 5, 14]. The 
conversation between the U.S. and Canada with regard to the inter-changeability of 
degrees is continuing. You have the accreditation group, American Council on 
Pharmaceutical Education now called the Accreditation Council on Pharmaceutical 
Education, because it is now worldwide. Academic sections and experiential sections of 
curriculum are being discussed; there is a flow of academics, especially in the English 
speaking countries, that are cross-pollinating educational issues such as research 
[Respondents 9, 14]. Other countries want us to accredit their programs.  
 We [Respondent 11] were concerned about the political implications of this 
situation. Federation of International Pharmacists is an organization where we 
[Respondents 9, 11] are working together, but much of this is related to changing the 
culture of the specific country and it’s a time-consuming process. So what we 
[Respondent 11] have done so far is acted as a mentor for the rest of the world. 
International students in our programs return home and help their country [Respondents 
3, 6, 9, 14]. One respondent explained that his university has had a program in Thailand 
for 20 years; faculty come to the U.S. to get both a Ph.D. and a Pharm.D. and go back in 
educational circles in Thailand. The conversation right now is what they need to do about 
expanding their political education and what kinds of degrees are important, given the 
culture of their country. It is the same conversation in Japan [Respondents 1, 12, 14]. A 
faculty member from my university is currently on a two-year assignment at the Japanese 
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Medical School in Tokyo. 
 At the WHO meeting in Washington, DC, one issue discussed was how to scale 
up and expand health profession education throughout the world. There are many 
countries where there isn’t any pharmacy at all. Respondent 12 illustrated the cultural 
aspect: 
 I have been to Japan four times, have had hundreds of Japanese students and I 
 never thought that they would change to the Pharm.D. I understand why they 
 would not change, because their culture is different I have authored part of the 
 Japanese textbook but 40% of the graduates will work for industry.  
  
 Respondent 14 supported cultural diversity: 
 I had a group in my office from Iraq that needed help designing their curriculum 
 to a Pharm.D. curriculum. It is difficult to consult unless you know the 
 prospective culture of  the country. We are behind China and Great Britain and a 
 number of countries in allowing pharmacists to be responsible in the delivery of 
 healthcare and their medicines. I think they have 10 schools in Canada and look 
 at their population. I am impressed what Canada has been able to accomplish in 
 the change in the pharmacy profession. 
 
 Respondent 8 shared this story about Thailand: 
 
 I consulted with a school in Thailand, the question was should there be a 
 Pharm.D. or baccalaureate degree. They finally concluded that the Pharm.D. was 
 what they needed, they had no clinical pharmacists whatsoever, so they came over 
 here for a while and took the knowledge back. European countries have stayed 
 with the pharmacy school model that we had before WWII that was really a 
 chemist in the neighborhood. These were people who knew chemistry of the 
 drugs that were able to put together concoctions that would not blow up [and] that 
 would help people. In Germany, they are called chemists. In France, they are still 
 in the compounding era. They are reluctant to change, but I think that they have 
 seen the value of the change to the Pharm.D. especially with the power of all of 
 these new drugs and genetics. I think there is some movement in that direction 
 and they have a huge advantage over us, their government pays for it--single 
 payer system. If a single payer decides that is the way it is going to be, then that is 
 it. Without it, there is constant question of who is going to pay for what and how 
 much. 
 
 Respondent 5 shared his experience in Malaysia: 
  
 The country of Malaysia now has eight pharmacy schools. Pharmacists play a 
 major role in hospitals, in rounds with the medical doctors to decide the choice in 
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 drugs that are going to be used to treat the patients, and [this] has spread into the 
 practice in communities. 
 
Additional Findings 
  
 The interview schedule included a large number of questions about various 
perceptions of respondents regarding the effect of the Pharm.D. degree. The author’s 
attempt to obtain insight regarding the research questions resulted in two themes that 
combined into one pattern not specifically addressed in the research questions.  
The ACPE started an international commission to investigate how other countries train 
pharmacists, actually putting together criteria on how to bring in patient care, or what that 
training would look like within the standards of the particular country [Respondent 3].  
 Canada has made the decision to go Pharm.D. by 2020. Because they will be 
going through some of this [change process], it is important to have dialogue and get the 
issues out on the table and then have people agree to a goal on where the profession 
should be headed and how to accomplish that through degree requirements for entry-level 
practitioners. Respondent 11 illustrated the global landscape: 
 I have been a member of the International Pharmaceutical Federation for a 
 number of years, served on the executive committee for at least four years back in 
 the 1990s. The role of the pharmacist in the healthcare system in the UK or in 
 Germany, the Netherlands, France, Italy, or most European countries is something 
 that most American pharmacists would aspire to reach that goal of responsibility 
 and respect. There is a difference in the educational systems. The title of Doctor is 
 one that is underappreciated by some and over appreciated by others. When you 
 look at the Canadian system for instance, at pharmacy education, they are moving 
 in concert with the accreditation council for pharmacy education and I think that 
 there is an effort to harmonize the way that people use the educational 
 experiences across the Eurozone. English speaking countries that were once under 
 British rule (Australia, New Zealand, etc.) particularly in the Southwestern Pacific 
 are significant players with the world health  care organization (WHO) and the 
 WHO is a little bit like the U.S. government. It is finally waking up to the role of 
 the pharmacist or the potential role of the pharmacist. But WHO has been 
 dominated by Swiss medical practitioners and the pharmacists in Switzerland 
 have recently achieved recognition.  
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 Sixteenth pattern: The Pharm.D. must rely on the pharmacy technician in 
the dispensing role in order to have time for patient care. One issue that is critical 
within pharmacy practice is the role of pharmacy technicians. If we [Respondents 11, 14] 
support the pharmacy technician to do a lot of the dispensing functions, this will allow 
more Pharm.D.s to conduct more clinical care.  
 Theme: The role of the pharmacy technician has created huge internal conflict 
for many years, and this continues to this day. Now, we [Respondent 3] are finally 
allowing technicians to be involved in dispensing prescriptions, but it took from the late 
1950s. There was increasing support during the 1960s, but it took until the late 1990s 
before this became legal because of the function of handling drugs. Pharmacists were 
against this trend because, although the theme was to be in the clinical role, the thought 
process was that if you bring in technicians who might replace me, they could put me out 
of work [Respondents 3, 6]. This was a primary concern to pharmacists who worked for 
chain drugstores. In these practice settings, the primary responsibility of the pharmacist 
was processing and dispensing drugs based on doctors’ prescriptions. 
 Theme: The profession needs to get technicians licensed, but the idea of 
accomplishing this in this country will require a daunting political battle. This is an 
issue of control, and currently the pharmacy technician is defined as supportive personnel 
[Respondents 11, 14]. For example, in Virginia the chain drugstores wanted to go to no 
limit regarding the technicians to pharmacist ratio (unlimited). Right now some states 
have a 10:1 ratio and some states have a 2:1 ratio [Respondent 13]. There has been 
resistance because, if a technician is the one who refills a prescription, what is the 
pharmacist to do? This, again, is primarily problematic to those who work in the large 
chains where there is essentially no role for clinical pharmaceutical practice in the 
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existing business model. The question becomes whether allowing the cheaper labor 
(technicians) to fill prescriptions frees the pharmacist and facilitates patient counseling. 
Or, does it become the impetus for cost saving and hiring fewer Pharm.D. pharmacists? 
 Seventeenth pattern: Location, age, and patient compliance affect access to 
and quality of healthcare. Although the following themes were not directly related to 
the research questions, they are important to understanding the holistic story of the 
transition to the Pharm.D. in pharmacy education. 
 Theme: One of the surprises has been the rather quick movement of 
pharmacists out of the inner cities. Respondent 12 stated that he has been sitting around 
curriculum meetings for 17 years. About five years ago, he realized that there was no 
civic duty. There are a growing number of drug-induced problems that have increased 
over the decades, especially in the under-served communities, but fewer pharmacists are 
assisting these neighborhoods. Respondent 12 expressed that he would like to see a 
tuition forgiveness program for new Pharm.D. graduates.    
 Theme: One out of every five Medicare patients ends up in the hospital because 
they do not take their medications correctly. Respondent 12 believed that pharmacy 
needs to be involved in building more clinical programs and hospitals, especially with 
Medicare. There are questions related to the acceptability of Pharm.D. on services and the 
marketplace because we [Respondent 3] still have not figured out a good way to pay 
pharmacists. Between the 1980s and 1990s our [Respondent 12] practice went from 63% 
to 80% of all patients being on some kind of fixed rate for reimbursement. Respondent 12 
concluded, “there has been effective resistance to change in academia, effective business 
models of the corporate members of the chain drugstores, and hospitals dealing with the 
declining revenues because of Medicare/Medicaid contracting.”    
 202  
Summary 
 The clinical doctorate is a trend in health professions, seen as either an advanced 
degree available for experienced professionals or as the sole entry-level degree to 
practice. This trend is encircled by both support and uncertainty from the numerous 
stakeholders that are involved. Limited literature is available on how this development 
affects healthcare education, delivery of services, interdisciplinary alliances in health 
professions, or the public in general, who constitute the patient-base. The purpose of this 
study was to examine how key professional leaders and policy makers perceived the 
transition to the clinical doctorate in one profession, pharmacy, during the establishment 
and implementation phase of the Pharm.D. This retrospective study provides insight into 
the effects of the change on the pharmacy profession and associated stakeholders. 
 This qualitative case study employed semi-structured interviews to obtain an oral 
account of individuals who were intimately involved in the decision-making process. The 
unit of analysis was established by limiting the population to four critical stakeholder 
groups and the timeframe of 1989-2002, in order to understand a complex case that 
spanned over 40 years. Of the 43 individuals who constituted the population, 28 were still 
available (15 were deceased, ill, retired). The 14 of 28 represent 50% of those who could, 
and were, willing to participate.  
 Triangulation included the review of the curriculum vita that represented 
objective information and demographics of the participants and interviews. The interview 
schedule consisted of 27 open-ended questions that were designed, based on the research 
questions, to assess the subjects’ perceptions of the benefits, risks, and alternatives of the 
Pharm.D. on healthcare education, delivery of services, interdisciplinary relationships, 
and the societal and economic landscape of the healthcare industry.  
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 The procedures were consistent with a case study approach. Fourteen interviews 
were conducted by telephone; and, although designed to be completed in one hour, 
several participants were compelled to continue the conversation, an indication of their 
enthusiasm for the subject. The researcher attempted to maintain confidentiality, as was 
explained in the participation letter. 
 Each participant told a story and the researcher only interjected to remain within 
the content frame, monitor the time, or ask a specific question. The findings were 
organized around the themes that the researcher found (open coding) and the patterns 
(axial coding) that represent several themes that come together. They are presented with 
the patterns first, with the themes for that pattern encompassed within the broader content 
of each pattern.  
 Research Question 1a focused on the benefits, risks, and alternatives of the 
elevation of requirements to an entry-level doctorate on health professions education. The 
first pattern represents the historical accounts leading up to the ACPE mandate. There 
was a slow, increasing understanding that the practice of pharmacy both in hospitals and 
in community settings should be patient-care based. Because of the uncertainty and 
magnitude of the changes, this process was going to require comprehensive and explicit 
dialogue among all stakeholders. For this transition to be uniform and organized, it had to 
stem from the accreditation bodies and the educational profession. Three themes 
constitute this pattern. First, the decision-making and implementation timeframe was a 
constructive process, but it was very controversial with a lot of anxiety about it. Second, 
many respondents believe that pharmacists are the most underappreciated health 
profession. Third, debate continues on whether pharmacy education should focus on 
patient care or the product.  
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 The second pattern was for this transition to be uniform and organized; it had to 
stem from the academic accreditation bodies and the educational profession. Major 
curricular changes in pharmacy education were necessary for successful conversion to the 
doctorate level. Five themes demonstrated this pattern. First, during the transition many 
schools revisited their clinical curriculum in making changes, because those 7-10 years 
sustained a major overhaul in accreditation standards. Second, in order for the pharmacist 
to take on the responsibilities associated with drug management, pharmacy education 
would need to be revamped. Third, Concern was expressed over which degree was 
appropriate. Fourth, a large group of individuals, these being academics, opposed the 
doctorate as the entry-level degree into pharmacy. Fifth, the biggest curricular change 
was the addition of the one-year experiential work.  
 The third pattern focused on the experience of internal resistance experienced by 
many institutions when converting to the Doctor of Pharmacy degree program. Six 
themes account for this pattern. First, the state universities in many cases were much 
more research focused and research intensive, with NIH or FDA funding; and that is 
viewed positively across the country and internationally. Second, schools that established 
the educational model of the Pharm.D./medical school had an easier time with the 
transition. Third, it was a struggle to create another position called clinical faculty. 
Fourth, there was originally a shortage of clinical faculty in the Pharm.D. programs. 
Fifth, an issue that the schools faced is how to treat these new academics in terms of 
promoting them. Sixth, within the schools and colleges of pharmacy, the biggest 
opposition was the basic science faculty.  
 The fourth pattern focused on the external resistance experienced during the 
transition to the Pharm.D. Six themes support this pattern. First, there was opposition 
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within the profession as well. Second, many of the people who held a Bachelor of 
Science degree (B.S.) in pharmacy as the main credential for a lifelong practice as a 
registered pharmacist were facing a choice, deciding on whether they wanted to put the 
energy (i.e, time, money, mental) into completing the add-on Pharm.D. or retire from 
private practice. Third, the B.S. pharmacists said “wait a minute,” concerned that they 
would lose potential employment to the Pharm.D. Fourth, the ability for pharmacy 
practice to evolve is dependent on the opportunities that exist in community and hospital 
settings. Fifth, the educational outcomes of the pharmacy curriculum limit the roles and 
responsibilities of pharmacists in practice. Sixth, respondents unanimously agreed that 
the primary external opposition was from the chain drugstores and owners of regional 
chains.  
 The fifth pattern is recognition that the impact on students and the entire 
educational experience was an important factor in both the decision and implementation 
of the professional doctorate in pharmacy. Three themes are associated with this pattern. 
First, a student can’t go through this program without going full time and having a 
structured curriculum. Second, there is a sense that, to differentiate themselves now, new 
graduates have to get residencies or certifications. Third, the type of student attracted to 
pharmacy is part of the problem.  
 The sixth pattern identified is that the changes in pharmacy education curriculum 
as related to academia have been an evolution, not a revolution. Seven themes constitute 
this pattern. First, the ACPE developed the add-on Pharm.D. to allow B.S. pharmacists to 
upgrade their credentials. Second, the complexity of drug interactions is rising, and it is 
necessary to educate pharmacists to reflect this in patient counseling. Third, the changes 
wrought by the new Pharm.D. required extensive debate about and changes in pharmacy 
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curriculum and instruction. Fourth, the Commission to Implement Change did not 
approach this conversation from the standpoint of whose or which instructional content 
was going to be deleted. It was far more concerned with how the program could get what 
was needed, i.e., a curriculum to reflect the nature of the practice of the profession and to 
do this in a reasonable period of time. Fifth, the combination of new accreditation 
requirements and the necessity of background knowledge has led some schools to 
establish a pre-pharmacy program. Sixth, one result of institutions being required to bring 
in additional qualified people to implement the revised programs has been a rise in 
tuition. Seventh, there was not one grand scheme, template, or module to follow.  
 Research Question 1b focused on the benefits, risks, and alternatives of the 
elevation of requirements to an entry-level doctorate degree on the delivery of service. 
The seventh pattern identified the success of the transition from product-based to patient-
based pharmaceutical care as inconsistent throughout the U.S. healthcare system. There 
are five associated themes. First, with the introduction of the Pharm.D., the role for the 
new clinically-trained pharmacist expanded rapidly in hospital settings. Second, the 
advancements in the delivery of services and the scope of practice are dependent on 
geographic location. Third, state regulations regarding the scope of practice of pharmacy 
are widely varied throughout the country and have a direct impact on the delivery of 
services. Fourth, there appears to be a relationship between licensure, state governments, 
and the protection of salaries. Fifth, one issue that makes pharmacy unique is that it is the 
only profession, where there are two operant licenses: the practitioner (pharmacist) and 
then the facility (the pharmacy).  
 The eighth pattern is that finances play a major role in changing pharmaceutical 
practice. Five themes constitute this pattern. First, a primary player is the pharmaceutical 
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industry. Second, the business model of the chain drugstores limits the roles and 
responsibilities of pharmacists in practice. Third, in the attempt to modernize the 
pharmacy practice from a product-oriented to a patient-oriented profession, one concern 
was how pharmacists were going to get paid for the advanced services. Fourth, a limiting 
factor is that an organized system for compensation for services has not been established. 
Fifth, the current third-party reimbursement model does not provide incentives for 
pharmaceutical care.   
 Research Question 1c focuses on the benefits, risks, and alternatives of the 
elevation of requirements to an entry-level doctorate degree on the interdisciplinary 
relationship of other professionals. Pattern nine is concerned with how other fields in the 
healthcare system responded to the changes happening in pharmacy; i.e., professionals in 
the U.S. healthcare system are strongly resistant to change and seek evidence-based 
research that a change is necessary. There are four associated themes. First, the pharmacy 
profession had no strategic plan to inform the other stakeholders, but there is a constant, 
slow acceptance of the abilities of the pharmacist. Second, there is a trend in the 
healthcare delivery system toward a collaborative care model. Third, many respondents 
have confidence that physicians will rely more and more on the information from the 
pharmacist. Fourth, the changing landscape in health care requires a team-based 
approach, and the pharmacist is the best professional to manage the drug therapy.  
 The tenth pattern is that most patients need drug therapy; and many physicians, 
nurses, and other health professionals are recognizing that someone on the team has 
expertise about medication therapy, apart from insights about diagnosis. Understanding 
the competencies and skill sets of other disciplines needs to occur at the educational 
level. There are three themes. First, pharmacists lack the skills in physical assessment that 
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are necessary for patient diagnosis, and there is still debate whether pharmacy education 
should focus on patient care or the product. Second, one route to change the face of a 
profession is to educate health professionals together in a collaborative environment. 
Third, there are more opportunities for the disciplines to be educated together. 
 Research Question 1d relates to the benefits, risks, and alternatives of the 
elevation of requirements to an entry-level doctorate degree on the societal and economic 
landscape of the healthcare industry (cost-benefit)? The eleventh pattern focused on the 
gradual change in the practice and professionalization of pharmacy and the concomitant 
views of society. Five themes add up to this pattern. First, one of the underlying reasons 
for the transition to the Pharm.D. was that pharmacists wanted more responsibility, but 
there is a difference between increased responsibility and autonomy. Second, 
pharmaceutical care services cannot be forced upon the public; rather, changes in 
perceptions and expectations of individual patients represent a slow, steady process. 
Third, when opportunities are present for pharmacists to practice to their fullest potential, 
society will benefit as a whole. Fourth, opportunities to practice pharmaceutical care are 
still in their infancy. Fifth, the pharmacy profession, as a whole, had not been proactive in 
public relations. The health literacy of an individual seems to be directly related to 
personal interaction with a pharmacist.  
 Research Question 2 focuses on the transferability of an entry-level clinical 
doctorate related to professional opportunities. The twelfth pattern identified the Doctor 
of Pharmacy as well prepared for related careers that do not require private professional 
practice, such as the pharmaceutical industry and prescription development. Two themes 
correspond to this pattern. First, opportunities are expanding in hospital and community 
settings. Second, pharmacy is a huge industry, and Pharm.D.s are highly sought today 
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throughout the field.  
 The thirteenth pattern is that there were external forces behind the progression of 
the clinical doctorate in pharmacy, and other professions that are contemplating the 
transition may want to address these factors. There are five related themes. First, the 
respondents perceive this transition to be successful in pharmacy because all stakeholders 
were involved. Second, the respondents agreed that other professions might want to take 
time to learn this historical progression because this process has worked well for 
pharmacy. Third, if the various stakeholders in the educational institutions successfully 
implement change in the education requirements, the graduates of the Pharm.D. programs 
will have a ripple effect through the rest of society due to their upgraded capabilities and 
professional practice. Fourth, it is important for a profession to articulate clearly what the 
difference will be when the professional doctorate program is implemented and how that 
will translate to better outcomes for patients. Fifth, the intention of the profession to 
transition to the practicing doctorate should be to establish a role in a collaborative team 
with other healthcare professionals, not increase the professional autonomy.  
 The fourteenth pattern identified the biggest surprise from the establishment of 
the Pharm.D. as the sole entry-level degree: the unexpected rise in pharmacy schools. 
Four themes correlate to this pattern. First, during the transition period, leaders thought 
that this educational change would decrease the number of applicants. This turned out to 
not be true. Second, in addition to the increased number of schools, the class size has 
grown as well. Third, the perception of uncertainty prevailed regarding the quality of 
some of the new schools and new programs within existing schools that have been started 
in the past 20 years. Fourth, the largest increase of new programs has been in private 
schools, many without the established culture of doctoral or health professions education. 
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  The fifteenth pattern regarding the conversation about redefining the pharmacy 
profession is happening on a global scale. Two themes justify this pattern. First, 
understanding the culture of a country and how that shapes the response to a major 
change effort are vital to professional change. Second, on a global scale the Pharm.D. is 
not equivalent around the world. ACPE had done several international initiatives and 
created dialogue opportunities.  
 There were additional findings that were not specifically addressed in the research 
questions. Pattern sixteen is that the Pharm.D. must rely on the pharmacy technician in 
the dispensing role in order to have time for patient care. This pattern is supported by two 
themes. First, the role of the pharmacy technician has created huge internal conflict for 
many years and continues today. Second, although technicians need to become licensed, 
accomplishing this in every state in this country will precipitate a daunting political 
battle.  
 The seventeenth pattern is that location, age, and patient compliance affect access 
to and quality of healthcare. Two themes constitute this pattern. One theme is that 
respondents were surprised at the rather quick movement of pharmacists out of the inner 
cities. The second is that one out of every five Medicare patients ends up in the hospital 
as a result of inappropriate drug management.
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 CHAPTER V 
DISCUSSION AND CONCLUSIONS 
 
The Study in Brief 
 Freburger et al. (2008) indicated that there has been minimal research on how the 
trend of doctoral education in health professions will affect health professions education, 
delivery of services, and the interdisciplinary relationship of health care providers. This 
study, a qualitative post hoc assessment on the transition to the clinical doctorate in one 
profession, pharmacy, was perceived by professional leaders and policy makers during 
the inception and enactment phase of the Doctor of Pharmacy will address this gap. The 
mandate of the Pharm.D. as the entry-level degree was established in 1992, so the effects 
of the change were explored retrospectively. Leaders in other health professions who are 
contemplating the clinical doctorate can examine these results for commonalities as they 
transition to the entry-level degree into practice.  
 Over the last 20 years pharmacy has adopted the professional philosophy of 
patent-centered practice known as pharmaceutical care. This is accompanied by the 1992 
ACPE mandate that the Doctor of Pharmacy will be the sole entry-level degree into 
practice. The implementation of these two monumental decisions required pharmacy 
education to be restructured, moving away from a product-based focus to patient-based 
education. Curricular changes, guided by the ACPE accreditation standards, were 
paramount in the transition to the Pharm.D. degree. The Pew Health Professions 
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Commission Report (1995) supported pharmacy in the redirection of its education away 
from dispensing medication to a more clinical role. Cartwright and Reed (2005) 
suggested that academic programs cannot be mandated into greatness and there must 
exist a commitment to the goals and vision of the Pharm.D. for success. The movement 
toward higher degrees in health professions, either for entry into practice or for advanced 
practice, will continue to gain momentum (Collier, 2008). 
 This continuing trend sets the central research question for this study, “What are 
the current perceptions (benefits, risks, and alternatives) of key policy makers in the 
pharmacy profession who participated in the decision to require (by January 1, 2003) the 
clinical doctorate (Pharm.D.) as the entry-level degree for practitioners?” Consistent with 
this question, the purpose of this study is to provide insight into the perceptions of the 
leaders and policy makers involved in the changes that led to the practicing doctorate as 
the entry-level degree for pharmacy. 
 The methodology for this study was grounded in literature pertaining to research 
and policy related to clinical doctorates in the health professions, the structure and 
dynamics of professional agencies and educational institutions, aspects of degree 
classifications, and theories and studies of the clinical doctorate as an entry-level degree. 
The literature was drawn from the physical therapy, occupational therapy, nurse 
practitioner, and pharmacy disciplines that address issues and concerns that have risen in 
the transition to the clinical doctorate. The empirical research questions were designed to 
investigate the overall central research question as noted above. Specific instruments, 
consistent with the research questions, included an Interview Schedule for the subjects 
and a Document Analysis Protocol for the obtained curriculum vitas.  
 For the analysis of this study, the researcher relied on both emic qualitative 
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methods and etic-based analytical techniques to uncover the complexities of this case. 
Qualitative methods of data collection and analysis, rooted in grounded theory, provided 
the researcher an opportunity for in-depth understanding of intricate factors that were 
common among the responses.  
 The development of the interview schedule was based on questions written by the 
researcher and those borrowed from similar instruments in previous studies. Of the 43 
members of the four stakeholder groups, 14 participated. Only 28 of the 43 members 
were available due to death, illness, retirement, etc. of the remaining 15; 14 out of 28 
resulted in 50% participation among those still available. Interviews were conducted with 
the 14 participants who represented members of the Commission to Implement Change in 
Pharmacy Education, The Janus Commission, the AACP Board of Directors, and the 
ACPE Board of Directors. The Document Analysis Protocol was developed specifically 
for this study. The combination of these instruments constituted the data representing the 
perceptions of the key leaders and policy makers.  
 The tools (Interview Schedule and Document Analysis Protocol) were used 
according to the descriptions found in Chapter III. This qualitative case study unfolded 
with a contact letter being emailed to the key individuals, followed by a consent form and 
request for the curriculum vitae. The interviews were arranged with those key individuals 
who chose to participate. In several instances, the subject was so enthusiastic about the 
opportunity to address these issues retroactively that more than a few interviews went 
considerably beyond the planned time allotment, up to two hours. Each interview session 
lasted approximately one hour, with follow up occurring when needed. Each session was 
recorded by the researcher and transcribed. The tools used for data collection were 
designed to retrieve pertinent information that could assist the researcher in critically 
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analyzing and reporting the meaning of the complex factors that revealed what was 
distinctive about the effects of the transition to the clinical doctorate in one profession, 
pharmacy. 
 In this case study, data analysis techniques to search for commonalities and 
patterns utilized were rooted in ground theory. First, the author conducted a general 
holistic reading of the transcripts. The interview transcripts were then sorted into themes 
(open codes) that demonstrated trends. These open codes were categorized into patterns 
(axial codes) that were identified from the data.  
 In Chapter IV, the data were organized with each separate Research Question 
(RQ) being listed, followed by the specific Interview Schedule queries for that RQ or 
sub-RQ. Then, the author examined all of the themes from the open coding, arranging 
them into patterns (axial coding) as they fit together.  
 For each RQ the results were then organized by the patterns that were identified 
by the researcher. Under each pattern, the relevant themes were listed and described, with 
prototypical quotes from the interviews to illustrate the themes and patterns. In this 
manner, the author synthesized the data from the interview transcriptions into a story, the 
researcher’s interpretation of the overall set of interviews that represented the subjects’ 
retroactive perceptions of the mandate to develop and implement the Pharm.D. as the 
entry-level professional degree to pharmacy. Finally, relating the “story” sometimes 
necessitated background information from Chapters I and II. Any such text was included 
in square brackets to alert the reader that this information did not come directly from the 
respondents. 
 The heart of this chapter is the Discussion, where the results from Chapter IV are 
reported (patterns and themes) and then synthesized. Those findings are then analyzed in 
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terms of their impact on the literature and issues in the field. Because there are many 
health professions moving toward the clinical doctorate and the literature is fluid, the 
author is aware that pertinent research may be published that was not available at the time 
of review of the literature. 
    The remainder of this chapter includes sections on Discussion, 
Recommendations, and Conclusions. The discussion section is organized by the two 
research questions and sub-questions. Each specific sub research question or research 
question is noted in bold. For each research question, the findings from the interviews of 
the four stakeholder groups and document analyses are organized by the larger patterns 
and the specific themes that comprise each pattern. These summary findings--patterns in 
bold and themes in bold italics--are then discussed in terms of relevant literature and 
leadership issues. 
Discussion 
 The literature review for this study reveals that most researchers try to justify the 
necessity of the clinical doctorate in individual disciplines within the health professions. 
Many health professions are in some phase of transitioning to the clinical doctorate as the 
entry-level degree, but there is limited theoretical or empirical information is available on 
the effects of this developing situation. Empirical research in pharmacy has typically 
focused on historical accounts that proceeded and were significant to the mandate of the 
Pharm.D. (cf. Elenbaas & Worthen, 2009; Kendig, 1948; Miller, 1989; Worthen, 2006). 
Others have studied the issue from the perspective of understanding the motivations 
behind the mandate (Boydeen, 2006; Brazeau et al., 2009b; Cooksey et al., 2002). The 
works collected by Kreling et al. (2010) addressed current trends in the U.S. society, such 
as the increasing age of the population and increasing prescription drug use, which 
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indicate a need for more pharmacist interaction in patient care.  
 One limitation in this body of knowledge is empirical research that explains how 
a major change effort--changing the educational requirements for a healthcare discipline--
affects the health professions education, delivery of services, interdisciplinary 
relationship with other healthcare providers, or society as a whole. A number of scholars 
have suggested that leaders in health profession disciplines who are contemplating the 
clinical doctorate as the entry-level degree into practice should examine the potential 
benefits, risks associated with the transition, and alternatives associated with changing 
educational requirements necessary to enter a profession (cf. Freburger et al., 2008; 
Greenwood & Hinings, 2002; Siler & Smith Randolph, 2006; Williams-Piehota et al., 
2011). These gaps in the literature clearly imply the need for more research on the trend 
of the clinical doctorate in the health professions. 
 A number of other questions can be raised about how changing the educational 
requirements of a profession influence the philosophy and practice of the profession. (cf. 
Head, 2004; LaBelle, 2004; Phelps & Gerbasi, 2009) Specifically, does changing the 
professional philosophy guarantee that all stakeholders, such as the healthcare system, 
third party payers, and the patient base, will embrace the necessary changes to transform 
the practice to match the philosophy? In an environment of rising health care cost and a 
chronic shortage of qualified health profession educators, how does changing the 
educational requirements impact educational institutions and program administrators? For 
successful transformation of a professional practice, all stakeholders need assurance that 
the clinical doctorate degree provides graduates who are prepared for educational and 
professional roles that are required. This retrospective study focuses on these questions 
by exploring the change of educational requirements in one profession, pharmacy, 
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through perceptions of key decision makers and policy makers. 
Research Question 1a 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate on: 
  
 a. health professions education? 
 The discussion to follow includes a brief summary of each entire pattern as laid 
out in Chapter IV. The related literature that correlates to each theme associated with the 
pattern is highlighted. This study differs dramatically from much of the literature because 
it includes empirical results (interviews) in contrast to the types of sources that 
predominated the wider literature. Most of that information represents policy-focused 
position papers or opinions. The analysis that follows emphasizes how this work is 
different, new, controversial, confirming, etc., as compared to the extant resources. 
 Appendix G contains the outline of all patterns and their respective themes, listed 
without text--to give a sense of how they relate to one another. This essentially highlights 
the big picture versus the details of each theme or pattern that are provided in the 
respective textual descriptions/interpretations. 
 Several respondents explained that the Commission to Implement Change, 
established in 1989, set the design and guided the profession in the transition to the 
Pharm.D. Discussions regarding potential educational requirements and a practice model 
were happening for many years prior to the mandate. Buerki (1999) noted that the first 
discussions about establishing a uniform structure of pharmacy education occurred in the 
late 1880s. Cohen (2008) explained the progression of the pharmacy education, starting 
as the apprentice model and moving to the four-year bachelor’s degree by an 
accreditation mandate in 1932. After WWII, there was increased momentum to improve 
  218 
the rigor of pharmacy, but it wasn’t until the 1990s that there was consensus that the 
professional practice model should be “pharmaceutical care,” and the Pharm.D. was 
established as the sole entry-level degree into pharmacy practice (Buerki, 1999; Cohen, 
2008).  
 The Commission to Implement Change published a series of reports that guided 
faculty and administrators at pharmacy institutions in debates over the wisdom, or lack 
of, in accepting these changes. Finally, in 1992, the AACP Board of Directors voted to 
accept the Commission’s position papers as a process to implement the change.   
 Theme: The decision-making and implementation timeframe was a constructive 
process, but it was very controversial with a lot of anxiety about it. The respondents 
recounted that, when the ACPE made the pronouncement that all schools would need to 
transition to the Pharm.D. and change the curriculum, people thought it would be a 
smooth transition. But the reality was the conversation required adjustments at numerous 
levels, and not everyone was on board.  
 One respondent referred to the timeframe as “messy.” Another respondent 
recalled it as a very contentious process. There was uncertainty and trepidation by 
schools to determine how to manage the process and find the necessary resources to fund 
it. Position papers and reports provide outcomes (cf. ACPE, 1993; American College of 
Clinical Pharmacy, 2000; Commission to Implement Change, 1997 a, 1997b, 1997c, 
1997d, 1997e), but the author is unaware of any published literature or documents that 
express the intensity of the debates. Thus, the details provided in Chapter IV as derived 
from these interviews constitute new information and insights to understanding the 
transition to an entry-level clinical doctorate in the healthcare professions. 
 Theme: Many respondents believe that pharmacists are the most 
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underappreciated health profession. The pharmacist’s contribution to healthcare is 
undervalued because they are invisible to the public. Many respondents believed that 
this philosophy is deep-rooted and multi-faceted. A respondent noted that pharmacists 
have been underappreciated for a long time, illustrated by his experience in the U.S. 
military when pharmacists were not commissioned officers. Enlisted soldiers were sent to 
a six-week training and were referred to pharmacists.  
 The American Medical Association (AMA, 2012) reported there are over 80 
careers in health professions, in which trained practitioners have influence on the 
prevention or improvement of the health of an individual. Head (2004) noted that each 
profession has identified competencies for an educational credential and trains 
individuals to perform specific job responsibilities within the occupation. But there is no 
consistency within health professions regarding the required academic degree that 
ensures these competencies are met prior to entering practice. One respondent recalled 
that pharmacy first started adding hours to the curriculum but did not change the level of 
degree, which complicated the situation.  
 This debate of pharmacists being commissioned in the military surfaced in 
Congress. Concurrently, there was confusion in pharmacy education because California, 
and a few other colleges across the country, were operating with the Pharm.D.; but there 
continued to be pharmacists practicing with a B.S. degree. The ACPE tried to move to a 
uniform degree at that time, but not all schools were in favor of it. 
 Cohen (2008) stated that there is confusion on the part of the public and other 
healthcare providers regarding the required standards across pharmacy education and 
practice. Many health professionals are accepting the value that pharmacists add in 
patient care but some individuals in almost all fields continue to view pharmacists as 
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merchants and not as a true health care professional. Boyden (2006) concluded that 
pharmacists who engage in clinical and therapeutic settings have demonstrated the 
advanced knowledge and skill set associated with the Pharm.D. degree, but those who 
practice in a community practice setting have not had the opportunity to utilize the 
acquired abilities to the maximum potential. The details provided in Chapter IV confirm 
that there was controversy, confusion, and debate surrounding the necessary educational 
requirements for a practicing pharmacist that needed to be addressed before the transition 
to a single entry-level degree into pharmacy practice could be successful. New 
information and insight were derived from these interviews related to the specific issues 
that surfaced during the transition to the Pharm.D., reflection on how these issues were 
addressed, and the concerns that are still not resolved. 
 Many respondents deem the community pharmacy business model at the root of 
the slow growth of patient-oriented care. The fact that the majority of community 
pharmacists are still inaccessible to the public, filling prescriptions from behind the 
counter, is not helping patients understand their capabilities or value. Pharmacists 
struggle with having to excel at dual identities. The healthcare professions necessitate the 
practitioner to be proficient in the science and technology of the profession but also must 
be talented in business and marketing to have a successful patient-oriented practice. The 
current business model in pharmacy, particularly for those employed in the large chains, 
does little to promote the vision and practice of patient pharmaceutical care. This 
comprehensive narrative is new information in the field, as the author found no previous 
studies that addressed this state of affairs. 
 Theme: There is still debate whether pharmacy education should focus on 
patient care or the product. The accepted wisdom to this theme is reflected in the 
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following summary. During the depression era, pharmacists were perceived as retailers 
and in oversupply. Cohen (2008) explained that this prompted academics to call for 
increased science and rigor in pharmacy education, replacing training in retail and 
management. Concerns about the curriculum, the state of the profession, and public and 
government perceptions of pharmacists were evaluated for the next 30 years. In the early 
1990s the consensus of pharmaceutical care as the professional mission and the elevation 
of the entry-level degree to the Pharm.D. were guides to transform pharmacy education 
away from product-oriented to patient-oriented (cf. Buerki, 1999; Cohen, 2008).  
 Providing more detail on this issue, the respondents concluded that this change 
has not been universal across pharmacy schools. Respondents expressed that programs 
that are closely related to medical campuses, which received exposure to greater 
opportunities of collaborative care, have been more successful in transitioning to patient-
based learning than others. One respondent suggested that a primary factor in the debate 
is the structure of the schools, observing that most state universities with medical 
campuses are affiliated with a pharmacy school, while many private or proprietary 
pharmacy schools do not follow this model. That respondent continued, noting that many 
of the top ranked medical schools in the U.S. do not have a pharmacy school associated 
with them. At a professional association conference, this respondent specifically asked 
Dr. Layla Esposito, program officer with the Health and Human Services, about this 
issue. She responded that it was too expensive to develop the collaborative health 
education model, if you do it right. This explicit information provides new insight into 
the complexities of discussions on changing the focus of pharmacy education. While it 
has been established that the professional mission of pharmacy has evolved to patient-
based practice, these respondents addressed the importance of interdisciplinary education 
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to concentrate successfully on patient-oriented learning. Therefore, to accomplish the 
transition to patient-based pharmacy practice, cooperation is required from many 
stakeholders to develop learning models that can provide the necessary resources and 
experiences. The details of the interviews in this study suggest a key limitation to that 
actuality, i.e., many stakeholders believe that a truly interdisciplinary learning model is 
cost prohibitive.   
 Second pattern: For this transition to be uniform and organized, it had to 
stem from the accreditation bodies and the educational profession. Curricular 
changes in pharmacy education were necessary for successful conversion to the 
doctorate level. Trends were occurring in the healthcare industry, specifically 
pharmaceutical care, that indicated a broader knowledge related to the management of 
drug therapy was necessary. In order for pharmacists to be the professional who has the 
knowledge, skills, and ability to be the expert in drug management, pharmacy education 
and pharmacy practice would both need to be restructured to meet the demands. There is 
very little literature that addresses this complex situation. 
 These findings represent work new to the field. The author was unable to find any 
other empirical retrospectives on how these curricular processes played out under the 
original mandate to change to the Pharm.D. and the concomitant responses of accrediting 
agencies and pharmacy schools.    
 Theme: During the transition, many schools revisited their clinical curriculum 
in making changes because those 7-10 years sustained a major overall in accreditation 
standards. The respondents were in agreement that the ACPE needed to set high 
curriculum standards for the Pharm.D. The timeframe when the B.S. program was 
phasing out and the Pharm.D. was being added was a stressful time for educational 
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institutions. The subjects emphasized that this was primarily stressful on faculty and 
administrators who were pondering curriculum revisions, content changes, or cutting 
hours and courses, hence, faculty. These results are partially in agreement with Davis and 
Burnard (1992), who found that, as health professions restructure the requirements for 
entry into practice and the scope of practice, educational institutions will be responsible 
for distinguishing between the different levels of education and their relationship to levels 
of professional practice.  
 Respondents explained that some pharmacy schools eagerly revamped their 
clinical curriculum in response to the ACPE mandate, while others waited until they were 
forced to comply with the new accreditation standards. Some schools took the bottom-up 
approach; some schools used a top-down approach. The interviews revealed that the 
intention and eagerness with which a school approached implementing the program was 
reflected in the success of the transition. 
 The transition at the institutional level was slow at first. Pharm.D. cohorts 
consisted of 10-12 students at a time. Program leaders built stronger relationships with 
medical schools and practicing physicians, expanding the practice of patient care and 
establishing a place for the pharmacist on the patient care team. Respondents 
acknowledged two events that propelled this movement. First, Manasse (1989) published 
a paper that described how patients with chronic diseases in community pharmacies 
could, and should, get patient care; and the pharmacist will make sure they receive 
optimal benefits from their medication. Second, the Pew Commission (IOC, 1999) 
reported on how excessive drugs were being used and the medical errors surrounding 
drug therapies.  
 Related to these findings, Siler and Randolph (2006) noted that most health 
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professions try to ensure the quality of the new professional by requiring graduates of 
accredited programs to pass a licensing exam. Educational credentials and degree 
requirements for entry into a health profession are guided by the accreditation governing 
bodies. The accreditation agencies report to the U.S. Department of Education and are 
accountable for the standards of the programs in which they grant accreditation.  
 In the U.S., colleges of pharmacy are autonomous. If each college had the 
freedom to create its own curriculum, without regulations to follow, it would further 
complicate pharmacy education and enhance the lack of uniformity in the licensing 
process.  
 Tennant (2004) suggested that universities are charged with constructing the 
transformation necessary to meet the needs of career professionals, not distinguishing 
between the Ph.D. and the professional doctorate. In a discussion paper, Liao et al. (2007) 
concluded that it is the responsibility of the institutions to develop academic programs 
that comply with the requirements and guidelines set forth by the accreditation agencies, 
as well as develop curricula that fulfill the objectives of clinical practice. 
 O’Sullivan and collegues were (2005) of the opinion that the nature of clinical 
education requires continual curriculum revision and expansion of core content to remain 
current in regard to best practices within the health professions. Producing entry-level 
practitioners academically prepared and technically trained to enter a profession is 
complicated and complex and requires strategic planning and educational reform. 
 The results of this study demonstrate empirically that pharmacy took strategic 
steps to expand and broaden the educational process for pharmacists. The details from the 
interviews reveal that the majority of institutions were proactive in making the changes 
necessary to the curriculum and were supported by the accreditation bodies and 
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professional associations. In 1989 the president of the American Association of Colleges 
of Pharmacy (AACP) formed the Commission to Implement Change in Pharmaceutical 
Education and charged the commission with developing a strategic plan to establish 
standards for pharmacy education in the 21st century. This was soon followed by the 
American Council of Pharmaceutical Education (ACPE) mandate that established the 
Pharm.D. as the sole entry-level degree into pharmaceutical practice (AACP, 1997). 
Pharmacy had adopted the professional mission of pharmaceutical care, so the focus was 
on the transition from educating pharmacists with a product focus to educating 
pharmacists to provide patient-centered care (Brazeau et al., 2009b). The ACPE has 
issued several revised accreditation standards and guidelines in 1992, 1998, 2002, and 
2007 for the Pharm.D. degree programs. The 2007 ACPE Standards defined the 
expansion and expected professional competencies. This study is distinctive because the 
author provides a retrospective view on the importance of the educational curriculum and 
the translation to clinical practice. 
 Theme: In order for the pharmacist to take on the responsibilities associated 
with drug management, the pharmacy education would need to be revamped. Several 
respondents noted that pharmacokinetics had gained an important role in pharmacy 
practice, and it was time to establish the pharmacy profession as a decision maker in drug 
therapy and patient management. This supports Kirch’s (2011) suggestion that, as the 
U.S. experiences a greater demand for healthcare services, colleges and universities must 
produce the quantity and quality of workforce prepared to meet the demands of the health 
care system. Respondent 3 credited the pharmacy school at UCSF for being in the 
forefront, proclaiming that the pharmacist as a clinician had merit. This new information 
confirms that establishing the first Pharm.D. program at UCSF made a difference and 
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could be applied to the whole profession. This provided the confidence that moving to the 
Pharm.D. as the sole entry into practice was the right decision for the profession. 
 The current study found that the educational sector is responsible for staying 
abreast of the process of remodeling roles and responsibilities of health professionals and 
the concomitant revisions in the entry-level requirements and the scope of practice. This 
is consistent with Clark (1999), that educators must anticipate current and emerging 
trends occurring in health professions, and that they have the responsibility to establish 
educational programs that prepare students for practice. 
 The decision was supported in the Institute of Medicine (IOM) (2000) statement 
that the new patient-based practice model for pharmacy would require the educational 
system to be remodeled for the advanced knowledge, skills, and abilities necessary to 
fulfill the roles and responsibilities of pharmaceutical care. Engel (2000) posited that the 
magnitude of anticipated changes that are ahead challenge institutions to prepare students 
to become adaptable and develop skills necessary to manage the changes in the 
healthcare industry and in society at large. Educational institutions are charged with 
providing quality professionals that will meet the healthcare needs of U.S. society, but the 
economic situation of institutions must be balanced with the cost incurred to educate the 
professional and the existing career prospects. 
 The details of these interviews show that the pharmacy profession understood 
that, in order to change the face of professional practice, revisions in the educational 
curriculum constituted the first step. Because U.S. educational institutions have the 
autonomy to establish their own curriculum, the boundaries and guidelines for the 
advanced knowledge, skills, and abilities needed to be established by the accreditation 
governing body and supported by the professional associations. This information differs 
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from other work in the field because it is based on empirical data as opposed to position 
papers, literature reviews, opinions, or commentaries. 
 Theme: Concern was expressed over which degree was appropriate. A 
consensus was found among respondents that there was minimal discussion regarding the 
degree necessary for entry into pharmacy practice. The leaders felt that the degree was 
intended to be used by practitioners, working in the healthcare delivery system; therefore, 
a professional degree in line with the M.D., D.D.S., etc., made sense. This confirms 
Fenge (2009), who argued that the professional doctorate emphasizes the importance of 
research that is work-based focused and will develop tradable knowledge that is a 
complement to theoretically focused research associated with the Ph.D.   
 The data are consistent with findings of the Higher Learning Commission (2006) 
that there was a substantial need for the professional doctorate as a level in the hierarchy 
of U.S. degrees to create capacity to educate practitioners, especially in the health fields. 
This parallels Fenge (2009) who posited that more practitioners need to engage in 
professional doctoral programs to improve the research capacity of practitioners. The 
outcomes of this study concur with Engle (2000) that most health professionals are 
educated at the university level, and many are moving to graduate and doctoral level for 
entry-level degrees. However, none of the three sources was based on empirical 
investigations, a statement that exemplifies the entire field.  
 Respondents were mindful of concerns with the boundaries of the professional 
doctorate degree. This concurs with Nair and Webster (2006) that this type of change is 
often difficult in conservative professions such as health care and education. Letters that 
represent a credential, i.e., Ph.D. or Pharm.D., are symbolic and maintain a status in 
certain circles, primarily in academics. Huisman and Naidoo (2006) explained that the 
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resistance to change regarding the professional doctorate is because the traditional Ph.D. 
represents the “classical university”; and proposing alternative doctorates, such as the 
clinical doctorate, is too radical. 
 Clement (2005) acknowledged that some professions, such as medicine and 
chiropractic, have demanded a clinical doctorate since their inception. Some, such as 
pharmacy, have elevated the entry-level requirements over time, most currently the 
clinical doctorate. Other professions require a lesser degree to enter practice but offer 
advanced educational opportunities for an advanced degree. Phelps and Gerbasi (2009) 
found considerable differences in the accreditation standards of healthcare professions 
that require the practice doctorate as the entry-level degree. LaBelle (2004) suggested 
that credential inflation is a factor in the increase in professional doctorate programs, 
resulting in master’s degree requirements for professional practice being replaced by the 
doctorate degree. The details provided by the respondents confirm Clement’s suggestion 
that changing from a graduate to a professional degree will require a strong rationale to 
neutralize opposition against degree creep and obtain approval for the programmatic and 
curricular changes. Clement argued that a strong rational is needed when raising the level 
of entry for practice from a master’s to a doctorate because of the impact on students, 
faculty, clinical affiliations, other health care programs, and institutional policy and 
resources. In addition, Loochtan (2001) noted that, without justification, the potential for 
degree creep is present. Contreras (2004) concluded that there are numerous degrees that 
have been devalued and also degree programs that continue to get longer while not 
producing graduates with greater skill sets or knowledge. The information provided in 
this empirical investigation confirms that pharmacy was experiencing longer degree 
programs, but the transition to the sole Pharm.D. degree put an end to much of the 
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confusion and provided guidelines for curricular change to ensure graduates obtained 
greater skill sets and knowledge. 
 Throughout the 1980s and 1990s, many Pharm. D. graduates had spent 9-10 years 
in college getting this credential. Some went into industry, but a number ended up on 
college faculties. Many respondents concluded that, wherever they were employed, many 
felt they were still underappreciated except at big [research] institutions. Thus, after the 
rigors of their education, there was a sense of dissatisfaction that many pharmacists felt 
after they became pharmacists, a sense of underemployment.  
 Ruud et al. (2010) believed that, in response to the changing economy, there is 
increasing demand for formal education and a degree for jobs that never before required 
those credentials. The requirement for academic institutions to respond to workplace 
demands has resulted in a position of workforce development. Brown et al. (2003) 
suggested that this knowledge-driven economy is a powerful influence in the rise of mass 
higher education, especially for the terminal doctorate. In addition, Thelin (2004) noted 
that the rapid expansion of professional fields and proliferation of programs in 
professional and academic fields has led to a chaotic situation. 
 The empirical results of this study indicate that the decision to require a clinical 
doctorate in pharmacy was filling a need that was identified in the healthcare industry. 
This differs methodologically from other studies that were based on position papers, 
literature reviews, and opinions; but it is consistent with those conclusions. 
     Theme: A large group of individuals, these being academics, opposed the 
doctorate as the entry-level degree into pharmace. One respondent explained that a large 
group of individuals, primarily academics, many of who were educated at the Ph.D. level, 
were resistance to the degree change. These results were consistent with Worthen (2006), 
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who indicated that the introduction to clinical pharmacy was met with mixed responses 
from educators and professional leaders. Further, Elenbaas and Worthen (2006) noted 
that the clinical pharmacy concept was becoming rooted in the practice model during the 
1970s and 1980s, and simultaneously the movement toward the Pharm. D. as the entry-
level degree was gaining steam. According to one respondent, there was a conscious 
effort to avoid conflict with the academic community. Leaders promoted this doctorate as 
relating to the clinical setting, differentiating it from a Ph.D. that is rooted in original 
research intended to advance the knowledge of humankind. Once again the findings for 
this study, while consistent regarding content, are distinct from the existing literature, 
primarily because of the methods by which data/conclusions were obtained and analyzed. 
 Theme: The biggest curricular change was the addition of the one year of 
experiential work. Many respondents believed it is vital for students to rehearse the 
duties and responsibilities associated with pharmaceutical care such as talking and 
listening to people, problem solving, and critical thinking. However, one respondent 
deemed this clinical education a waste of time, stating that the locations and 
environments of these on-site practice experiences are not fulfilling the learning 
objectives.  
 Luke et al. (2009) stated that experiential learning is designed to introduce the 
student to clinical cases that promote active learning, critical thinking, and in situ 
problem solving. The experiential component of the pharmacy education is an entire year 
where students are exposed to practitioners and various practice environments, improving 
the professionalization of the students and their clinical skills.  
 The author did not discover any empirical studies related to the effectiveness of 
the experiential component of pharmacy education with respect to student learning 
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outcomes or program learning objectives. As is the case throughout this literature, most 
of these studies are non-empirical, making the current study’s carefully crafted qualitative 
analysis stand out as the exception. 
 Third pattern: When converting to the Doctor of Pharmacy degree program, 
many institutions experienced internal resistance related to universities and their 
educational programs. There are numerous stakeholders involved in the transition to the 
clinical doctorate: professional organizations, employers, educational leaders at various 
levels, and regional accreditation agencies. Boydeen (2006) noted that, at the core of the 
change in the pharmacy degree are leaders who debated, advocated, publicized, and voted 
for or against the decision to transform the requirements for the ENTRY-LEVEL degree 
into pharmacy practice. Some schools had more difficulty with the transition. Beyond 
that, one respondent believed that the culture of these schools drives the thought process 
and response to change. Some academic leaders, for example, had created a culture that 
implied that pharmacy had been doing fine, thus questioning the reason for transitioning 
to professional practice and resisting the process.  
  Changing the professional doctorate to pharmaceutical care does not guarantee 
that all stakeholders, such as the healthcare delivery system, governing bodies, or the 
public, will embrace and transform the practice of pharmacy to match the philosophy. 
Collier (2008) concluded that those who support the transition to the clinical doctorate 
focus on the expansion of knowledge base, technological advances, and expanded clinical 
experiences. Those who opposed the move to the clinical doctorate were concerned about 
the creation of greater workforce shortages, increased educational costs, and public 
confusion with the number of new kinds of doctors. In addition to confirming the work of 
Collier, the current study goes beyond that, with new information on the culture of the 
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academic institutions, U.S. healthcare system, and how the public was influenced by the 
progression of these advances in the field of pharmacy.  
 Theme: The state universities, in many cases, were much more research 
focused and research intensive, with NIH or FDA funding, and that is viewed 
positively across the country and internationally. Although a few respondents 
acknowledged a difference in the transition to the Pharm.D., depending on the structure 
of the school (public or private, research or not), there was not consensus on who had the 
easier time with the transition. A respondent expressed his experience to be that the 
public  research focused institutions had a more difficult time than private institutions 
because of how those universities are structured. The respondents did not, however, 
expand on the complexities and importance of the accreditation process on the success of 
the Pharm.D. transition.  
 Conversation continues about the complexity of a new degree approval in the 
literature, but not specific to pharmacy and the Pharm.D. Much of this relates to the 
accreditation process. Institutions that have offered a master’s degree program but do not 
have doctoral-granting authority have run into greater complications. This requires 
approval from the regional accreditation agency to extend the institution’s accreditation 
to include the new professional doctorate. The educational trend toward the clinical 
doctorate has moved so rapidly that the quality assurance agencies do not have reliable or 
valid evaluation tools to ensure the institutional quality of specific programs. North 
Central Association of Colleges and Schools (2005) established a task force on the 
professional doctorate, but specific guidelines have not been finalized.  
 Several studies were policy-focused, with emphasis on governmental regulations, 
accrediting procedures, and institutional responses on a macro-level. Schray (2006a) 
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acknowledged the relationship between the accreditation industry and the federal 
government as a noteworthy example of a successful public-private partnership. Schray 
explained that the federal government uses the non-governmental accreditation to identify 
institutions that are eligible to receive federal student financial aid and other federal 
funds.  Similarly, Eaton (2006) noted that this relationship has yielded a reliable and 
effective process to provide quality assurance to one of the most respected higher 
education systems in the world. Likewise, Hunt (2009) explained the accreditation-
federal government relationship allows for a balance between institutional autonomy and 
accessibility with robust accountability standards to societal stakeholders. 
 Eaton (2009) noted that the federal government recognition process of 
accreditation agencies is funded through Congressional budget allocations to the 
Department of Education. The 1965 Higher Education Act (HEA) was designed to 
strengthen American colleges and universities. Each re-authorization of the HEA, most 
recently 2008, has included additional institutional and program accountability measures 
(American Council on Education, 2008). Bardo (2009) stated that, because of the 
connection to HEA Title IV financial aid and accreditation, institutions will be required 
to reorganize their structure and must allocate additional resources on assessment, 
reporting, and accountability measures. In 2008 the Higher Education Opportunity Act 
(HEOA) was passed, increasing the governmental pressure with regard to accountability 
from accreditation (CHEA, 2011). Brittingham (2008) argued that the strengthening 
control of the accreditation process through governmental policing has raised concerns 
that the non-governmental voluntary process of educational accreditation may be in 
jeopardy. The complex relationship between the private accreditation industry and the 
federal government, which in turn controls federal funding to institutions, is important to 
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the success of academic institutions and educational programs.  
 In contrast to these studies that are generally all macro and related to compliance, 
this research was more micro, based on empirical data (interviews) with much 
personalized retrospectives on these larger processes. This study provides details on how 
policies generalized to higher education influenced the process of the transition to the 
Pharm.D. and the institutional response to the mandate.       
 Theme: Schools that established the educational model of the 
Pharm.D./medical school had an easier time with the transition. One key factor in the 
success of the transition expressed by several respondents was collaborative 
interdisciplinary training. Concurrently, the conversation of team-based collaborative 
healthcare education was occurring in other health care disciplines.  Although the 
conversation of interdisciplinary education is occurring among many health disciplines, 
this study provides empirical data that the specialization of content is a problem for 
health professional schools. The respondents concluded that the logistics of integrating 
140 pharmacy students together with 200 medical/nursing students is overwhelming at 
the institutional level. A respondent explained that, at his affiliated school, integrated 
education has been accomplished. Another respondent said his institution does not have a 
medical school, but they have partnered with other universities, progressing toward more 
integrated learning.  
 An additional respondent gave details that get to the root cause of the difficulties 
establishing interdisciplinary education among health professions. At his affiliated 
institution, nursing did not want the Pharm.D. They were taught that only nurses could 
teach nurses, a mindset that permeates in other disciplines as well. However, a different 
respondent is confident that this is changing, but ever so slowly.   
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 Previous studies have emphasized the importance of interdisciplinary learning in 
other health professions. Wall et al. (2005) stated that the most unique feature of the DNP 
program at PUSON was interdisciplinary collaboration supported by all levels. Similarly, 
Rapport et al. (2007) highlighted that one of the most significant changes in the DPT 
program at the University of Colorado at Denver and Health Science Center has been to 
provide opportunities for interdisciplinary collaboration. In addition, Clark (1999) 
concluded that, in preparing students to work in health care teams, interdisciplinary 
practice signifies a higher order of integration of perspectives and collaboration necessary 
for effective patient-based care. Similar to these studies, this work confirms that 
interdisciplinary education is theoretically significant but adds that there are variables 
that prevent the implementation of interdisciplinary learning from becoming mainstream.     
   Theme: It was a struggle to create another position called clinical faculty. This 
position was necessary because of the inclusion of the experiential component that was 
added to the curriculum. Respondents concluded that this was a challenge at the 
institutional level, an issue that was handled differently at each individual school. Several 
respondents expressed that this was a significant concern in pharmacy schools. This 
finding represents new insights, with the author finding no literature that addresses this 
concern in pharmacy education or in other disciplines moving toward the clinical 
doctorate.  
 How the clinical faculty issues evolved can have very real consequences for 
practice. The hope that the status of a professor in the area of pharmacy practice or 
pharmacology at a specific institution would benefit from equivalent status did not hold 
for all institutions. A respondent said that, at one research institution, the Pharm.D. 
faculty were prohibited from chairing a dissertation committee. Such institutional 
  236 
realities reflect real differences in prestige and hierarchy within the academic world. It is 
noteworthy that this type of information about the resistance to change and the sometimes 
subtle yet powerful forms it took (such as differences in role structure and 
responsibilities) that are loaded with implications for stature, tenure and promotion, and 
even salary, in the academy--are never addressed in the policy-focused position papers 
and commentary that constitute the bulk of the writing pursuant to the transition to the 
Pharm.D.  
 Theme: Originally, a shortage of clinical faculty in the Pharm.D. programs 
existed. A major challenge for the programs was obtaining additional clinical faculty. 
Tennant (2004) suggested that universities are challenged by the transformation required 
to meet the needs of the professional doctorate outside the traditional academic structure. 
Expanding on this, respondents explained that the commission recommended that the 
clinical component of pharmacy education be modeled after medicine. Respondent 
perspectives of the situation pointed to a problem rooted in academic accreditation that 
was not evident in the author’s review of the literature.  
 One respondent explained that, when the early adopters were developing 
Pharm.D. programs in the 1970s, federal money was available to hire clinical faculty if 
the institution converted to more clinical education, but that did not last long. Evidence of 
dual track appointments are implicit in the interviews for this study. For example, at 
many institutions clinical faculty are not responsible for obtaining federal grant money, 
which is the responsibility of the research faculty. Conflicts loom because, at the same 
time, there is mounting pressure for institutions to get federal grants and do research. It is 
noteworthy that this type of information--about resistance to change and the sometimes 
subtle yet powerful forms it took (such as differences in role structure and 
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responsibilities) that are loaded with implications for stature, tenure and promotion, and 
even salary within the profession--are never addressed in the policy-focused position 
papers and commentary that constitutes the bulk of the writing pursuant to the transition 
to the Pharm.D.  
 Several respondents noted that pharmacy schools made the accreditation changes 
look good on paper because it was a mandate but put little effort into implementing the 
changes. One respondent shared that, at his affiliated school, the clinical faculty have 
been outsourced to busy practitioners in different practicing settings and are not full time. 
This is compliant with the accreditation standards, appears high-quality on paper, but 
allows the school to move position openings from department to department, allowing for 
more research faculty resulting in potential federal support. These actual examples of 
how the clinical positions were defined and treated relate back to the discussion on 
whether the experiential component of pharmacy education is effective in the student 
learning outcomes or program objectives. This study suggests that budget, expediency, 
and traditional views on research and tenure may have influenced the focus on clinical 
teaching per se.  
  In the early days of Pharm.D. programs, qualified clinical faculty were in short 
supply. Many respondents recall Pharm.D. graduates completing a residency and then 
obtaining academic jobs. The author found no theoretical basis nor empirical treatment in 
the literature on how this influenced the quality and/or quantity of programs, but the 
respondents recount this as being a major concern at the time.  
 Documented in the literature is that many professions are considering 
transitioning to the clinical doctorate, and it is expected that faculty be at or above the 
level they are teaching. Clement (2005) suggested that one measure of quality 
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improvement in professional programs is increasing numbers of doctoral prepared 
faculty. This required additional faculty who had practical experience and could be 
effective in the classroom. In pharmacy education, the ACPE accreditation standards 
require the clinical component and hence, the increase in clinical faculty. This study 
emulates these facts, but the findings expand the understanding that many schools were 
challenged, and still are, to find experienced faculty to fill these positions. Further, within 
the schools, tensions developed over the role definitions of these new clinical positions 
vis-à-vis their responsibilities, rank, and stature within the institution. The interviews 
suggest that these institutional conflicts sometimes held sway over concerns about quality 
of education.  
 Theme: An issue faced by the schools is how to treat these new academics in 
terms of getting them promoted. Respondents noted that this was a chief concern at the 
institutional level and dependent upon the culture of the university. Practicing clinical 
pharmacists were necessary in the academic setting, but the traditional norms of 
promotion in academic institutions are based on research funds and publications for 
which the practicing clinical pharmacist was not responsible. In addition, respondents 
emphasized the difficulty with this situation and the challenges to find solutions. 
Although the circumstances have improved with time and better understanding of how to 
operate, this issue remains a contentious topic at many institutions that have clinical 
training as part of the curriculum. This finding represents new insight into the internal 
struggles at the institutional level, with the author finding no information related to this in 
the literature. 
 Theme: Within the schools and colleges of pharmacy, the biggest opposition 
was the basic science faculty. Respondents indicated this was a major cause of discourse; 
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in contrast, the author found no empirical evidence of this in the literature.   
 Upgrading pharmacy education curriculum to Pharm.D. standards and retaining 
the resources to meet the needs of the new curriculum required a major change effort at 
the academic level, and many academics do not like change. The ACPE accreditation 
standards required that pharmacy programs establish a pharmacy practice constituent, and 
basic science faculty had difficulty understanding the role of this new entity or the 
consequences from their contributions. Respondents explained that basic science faculty 
did not identify with the Pharm.D. or value the increase in knowledge, skills, or abilities 
of the graduates. The details of the interviews expose that the discussion continues in 
academic circles today, with those who still see no reason for all graduates to have the 
Pharm.D.  
 Fourth pattern: Institutions making the conversion to the Doctor of 
Pharmacy degree were met with external resistance with respect to the practice of 
pharmacy. The respondents conveyed eagerness to address the issues related to the 
resistance present from external stakeholders regarding the transition to the Pharm.D. A 
few provided firsthand knowledge regarding the debates and dialogue that occurred 
during the sometimes personal confrontations that occurred. These reflective perspectives 
are detailed in the following themes and provide new particulars at the core of the issues.   
 Theme: There was opposition within the profession as well as that within 
universities. Several respondents emphasized that the AACP conducted a strategic 
crusade to initiate discussion with the professional organizations and stakeholders, trying 
to attain some consensus to move them forward with the Pharm.D. One respondent 
believed the AACP was successful in obtaining buy-in from many leaders within 
professional organizations who went back to the members and explained this was the best 
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thing for pharmacy, emphasizing that it was going to be the best thing for patients. This 
person clarified that not everyone agreed and some continued to campaign against the 
Pharm.D.; looking back many realized, however, that it has been the best thing that 
happened to pharmacy.  
 Another respondent commented that a few of the pharmacy professional 
organizations did not support the Pharm.D., most notably the National Association of 
Chain Drug Stores (NACDS). The literature provides considerable background for this 
theme. For example, professional associations have several complex roles: advocating for 
the individuals within a profession, protecting public interest by regulating these 
members, and representing the professional interest in legislative concerns (Friedman & 
Phillips, 2004; National Institutes of Health, 2011). Professional associations play an 
important role in times of change within a profession because they have the capability to 
initiate debate and endorsement, campaign for practice improvement, and advocate for 
policies that protect society (cf. Greenwood et al., 2002; Lalonde, 2010; Macpherson, 
2010).  In most situations members pay dues and membership fees in exchange for 
services, benefits, and professional opportunities (Gruen et al., 2000). Pharmacy is 
represented by about 37 unique professional organizations, each representing a particular 
segment of the pharmacy profession. This study provides new insights into the details 
surrounding the opposition from specific professional associations and how the debates 
were presented on a political platform. 
 Theme: Many of the people who held a Bachelor of Science degree (B.S.) in 
pharmacy as the main credential for a lifelong practice as a registered pharmacist were 
facing a choice. To be registered to practice, pharmacists must have a license. This 
requires completing a standardized examination, regardless of the academic degree, that 
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is recognized by each of the 50 states. The respondents expanded that when the Pharm.D. 
mandate was implemented; questions surrounding the B.S. pharmacist and licensing 
concerns were prevalent. The choice was stark: discontinue practice or update 
credentials. Opponents argued that grandfathering in the B.S. pharmacist would defeat 
having a Pharm.D., noting that an institution grants a degree based upon specific 
requirements completed. One respondent felt grandfathering would be a violation of 
academic integrity, academic fraud. This finding supports the Lumina Foundation on 
Education (2010) belief that the value of a degree--both for the individual and society as 
a whole--depends on the skills and knowledge that the credential represents. The quality 
of the degree rests on the learning outcomes that can lead to further education or 
employment.  
 The importance of the appropriate credentials is discussed in the literature. 
Employers rely on the credentials of job applicants, and it has become increasingly 
difficult to decipher the wide range of academic degrees, certifications, and licenses when 
they evaluate job applicants (Contreras, 2004; Nemec & Legere, 2008). In addition, the 
National Association for Educational Statistics (2008) stated that the academic degree is 
progressively more sought after in all demographics. An overarching problem is that 
program content and completion requirements are inconsistent among degree granting 
institutions, interfering with the transferability of course credits (CHEA, 2001). This 
study finds that many of the advocates of the Pharm.D. approached this conversation by 
focusing on the abstract notion of the “greater good,” concentrating on the value of the 
degree enhancement for the profession and therefore to society. This value stemmed from 
the fact that society needed a healthcare practitioner who understood the actions and 
interactions of the plethora of drugs available; i.e., the complexities associated with many 
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drugs require advanced education for adequate understanding. Most B.S. pharmacists 
understood this argument, going on to complete the add-on Pharm.D. requirements. The 
compassion that led the pharmacist into healthcare in the first place prevailed; people 
need help and they need advice. This study confirms that the theoretical foundation of 
patient-based pharmaceutical care is essential, and an educational curriculum that 
includes the process of problem solving and communication must be completed. An 
individual respondent summed up what B.S. pharmacists went through: 
 The pharmacists that were bachelor of science pharmacists including myself, had 
to pass the test after we went through all of this self-imposed educational work on how to 
better serve our patients. I was 67 years old or something like that, but we were 
committed to our practices. 
Such personal passion about the larger transition from dispensing medicine to 
pharmaceutical patient care represents new insight to the field and highlights the 
individual human costs and sacrifices that were made during this process. 
  Theme: The B.S. pharmacists said “wait a minute”; soon people will be asking 
for a Pharm.D., and we are not going to be considered for some positions. One 
respondent reflected that the decision makers were aware that making the B.S. 
pharmacists unhappy was a risk and hoped that alternative solutions could be made to 
make the transition easier. Another respondent expanded that the concern for many B.S. 
pharmacists was the uncertainty of their future. These outcomes provide new empirical 
data that supports Freburger et al. (2008), who warned leaders in disciplines 
contemplating transitioning to a new entry-level degree that the potential benefits, as well 
as the risks and available alternative, must be examined carefully. Beyond that, Elenbaas 
and Worthen (2009) noted that the AACP and other national associations collaborated on 
numerous projects surrounding the scope of practice and internal policy issues within 
pharmacy that led to the decision of the Pharm.D.     
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 Theme: The ability for pharmacy practice to evolve is dependent on the 
opportunities that exist in community and hospital practice settings. The 
responsibilities and duties of pharmacists are expanding in the work-place 
environment, but very slowly. Previously, the Janus Commission (1997) concluded that 
the U.S. healthcare delivery system environment was right for transformation of 
pharmacy practice. The Pharm.D. mandate and the change in the professional mission to 
pharmaceutical care were the first steps toward advancement, but external influences 
have slowed the success of the whole profession in becoming primary care providers. 
 Beyond this dated work from just after the 1992 mandate for the transition to the 
Pharm.D., respondents commented on two factors. One is limitation in the scope of 
practice from state to state. There is confidence that pharmacists will be recognized for 
their ability to manage patients, but it is in the hands of the next generation of 
pharmacists to be active in local, state, and national organizations to keep the momentum 
going forward. The second is the disconnect between academics and practice. The 
professional mission is pharmaceutical care, and the educational institutions are 
producing Pharm.D.s who have the knowledge, skills, and abilities to manage patients. 
However, if new graduates enter into a practice environment that is still product-oriented, 
they will quickly lose certain skills gained during the educational process. 
 Theme: The educational outcomes of the pharmacy curriculum limit the roles 
and responsibilities of pharmacists in practice. The author found no evidence of this 
theme by other researchers. The subjects commented on pharmacy education preparing 
the Pharm.D. to supply and manage drugs to patients with a variety of conditions. The 
educational process does not train the Pharm.D. to perform physical assessment or 
diagnostic skills to identify diseases. Respondents then emphasized that the necessity for 
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each healthcare profession having a narrowly defined role/expertise, interprofessional 
education and a collaborative care model of patient management follows.    
 Theme: The respondents unanimously agreed that the primary external 
opposition came from the chain drugstores and owners of regional chains.  According 
to the respondents, the opposition from the chain pharmacy community, especially the 
NACDS, was a primary force in the resistance to the Pharm.D. This supports Greenwood 
and Hinings (1996) that professional associations play an important role in times of 
deinstitutionalization or change within a profession. In addition, Friedman and Phillips 
(2009) noted that, over the past two decades, professional associations are becoming 
strong advocates for the membership on political issues and government initiatives. The 
respondents’ information illustrates this because the chain drugstores were becoming the 
primary employers of pharmacists and they were opposed to extending the length of 
education because it would cost them more money to hire the new Pharm.D. graduates. 
The NACDS was a strong voice, had a powerful lobby, and had the financial resources to 
fight this mandate. Respondents believed that the attempt to stop the national movement 
to the all Pharm.D. by the chain drugstores became the focus of the political discussion 
around pharmacy education for several years, providing empirical evidence on how 
influential the professional associations are during a time of change. 
  The review of the literature did not prepare the author for how the chain 
drugstore, through the political arena and business model, influenced the success of the 
Pharm.D. mandate. As previously mentioned, the thought was that if pharmacy changed 
the academic degree, it would take time for other health providers and the public sector to 
accept the new knowledge, skills, and patient care abilities of the pharmacy. A 
respondent noted that the products sold in most pharmacies (especially the larger chain 
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drugstores) reinforce the older image of pharmacy as product-based, not a healthcare 
service. 
 The respondents were polite in the conversation surrounding the chain drugstores. 
Many acknowledged that some are beginning to change their business model, developing 
patient care groups by combining nurse practitioners and pharmacists into a health center 
environment. In the same breath, the respondents believe they still have a long way to go 
and question the underlying intention of this gradual change in the business model. 
Several respondents mentioned that the traditional chain drugstore, even with a health 
center inside, is not helping the consumer understand how the pharmacist can help them 
become healthier and less likely to have adverse drug reactions or hospitalized because of 
their drug therapy. This is exacerbated because the nurse practitioner is the one with 
whom the patient interacts, not the pharmacist.  
 The chain drugstore sector was strongly opposed to the Pharm.D. and used their 
political and financial power to block it, so much so that the lasting imprint on the 
pharmacy profession may be one of distrust. This information goes beyond Carver (2001) 
who suggested that it is possible an organization, guided by history and circumstances, 
can interfere with effective governance, especially in a complex and changing 
environment. Dezalay and Garth (1996) noted that the decision-making process within a 
profession regarding boundaries, membership, and behavior can be a political process. 
These types of situations can have long-term consequences on relationships. Consistent 
with these citations, several respondents referenced the battle that the University of 
Maryland went through and paralleled their struggles with what was happening 
nationally. The respondents were reserved in providing details of the struggles 
experienced at Maryland. The author interpreted the reason for the respondents’ 
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reservation was that the wounds were still too raw for those involved to discuss.  
 Knapp (2011) provided a firsthand account of the trials and tribulations that 
occurred at the University of Maryland. After the initial meetings with the chain 
drugstore representatives, committee members employed by the chain stores resigned and   
scholarship contributions from chain drugstore owners declined. He concluded that the 
strong opposition of the chain drugstores, posturing as large impersonal corporations 
represented by lawyers and executives rather than pharmacy practitioners, was an ideal 
opponent. The heavy-handed tactics of MACDS helped the school to rally supporters 
who became active and vocal proponents for change” (Knapp, p. 699).   
 Fifth pattern: Recognition that the impact on students and the entire 
educational experience was an important factor in the decision and implementation 
of the professional doctorate in pharmacy. Respondents generally agreed that the six-
year Pharm. D. curriculum is necessary to provide a solid foundation of competency that 
a pharmacist needs for general practice, but many opponents suggest that the six-year 
program dilutes the quality of pharmacy training. This supports Lester (2004), who 
suggested that clinical doctorate programs focus on the application of theory and 
knowledge and produce graduates who are capable of high-level thinking, which is 
necessary to work in complex practical situations.  
 Neumann (2005) noted that traditionally there were no explicit national standards 
or guidelines for doctoral education as a whole but that it is a current topic in higher 
education today. The finding of this study strengthen Boyden’s (2006) conclusion that the 
two motivations that led to the Pharm.D. were uniformity across the profession and “the 
appropriateness of giving those with a minimum of six years of intensive, challenging 
didactic and experiential education, a high-level, terminal degree” (p. 160). One concern 
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with Boyden’s finding is that the Pharm.D. is an entry-level practicing doctorate, not a 
terminal degree. This study differs because the respondents indicated that there was 
clarity among the profession that the Pharm.D. was intended to be a practicing doctorate 
from the beginning.  
 The respondents in this study provided descriptions of their affiliated schools, 
reflecting a wide range of diversity in program content and length. Although the Higher 
Learning Commission (2006) works together with the accreditation bodies to establish 
core characteristics of a professional doctorate program, based on uniform competencies 
rooted in professional practice, decisions regarding curricular content, length of study, 
and experiential practice are left to the autonomous universities. In addition, Royeen and 
Lavin (2002) argued that there is no consistency among the different programs related to 
length, rigor, content, or the usefulness to the person who achieves them. This is true in 
the pharmacy profession, as is confirmed by the respondents in this study. One example 
is the description by Kontogianes (2008) of a unique Pharm.D. program that takes the 
student straight from high school seamlessly to the doctorate in six years. Other programs 
require a four-year B.S. degree as a prerequisite as a requirement for acceptance into the 
program.  
 Theme: A student can’t go through this program without going full time and 
having a structured curriculum. One area not discussed in the literature is how the move 
to the Pharm.D. would impact the student. Several respondents concluded that one 
benefit of the Pharm.D. is the improved professionalization of new graduates. One 
respondent believed this has been a powerful benefit to the profession, although it had not 
been expected. Students are exposed to the professional role, set of functions, practice 
activities, and job descriptions during the experiential portion of the educational process.  
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The time spent working together with the pharmaceutical cohort and exposure to 
deliberation with other professionals in the experiential portion has equipped the graduate 
to work in any environment because they understand the value of working together. This 
new insight could help increase both public and policy maker acceptance of the transition 
toward pharmaceutical patient care and the key role of the Pharm.D. graduates as this 
occurs. The reflective approach of this study resulted in novel facts that support O’Brian 
(1992), who explained that part of the transformation that occurred at the institutional 
level was that professional degree programs were adapted to offer courses in 
professionalization. 
   Theme: There is a sense that to differentiate themselves now, new graduates 
have to go through residencies or obtain certifications. A few respondents believed that 
a residency is not appropriate for all students, mainly because it is expensive. As 
previously mentioned, the respondents concluded that the six-year Pharm.D. curriculum 
provides the graduate a solid foundation for general practice. Other respondents consider 
six years to be not enough time to train an infectious disease specialist or a cardiology 
specialist. In order to specialize in a specific concentration, a residency is necessary. This 
finding relates to Collier (2008), who suggested that employers and educational leaders 
must consider the increasing degree levels and certifications as they relate to workforce 
dynamics and the cost of healthcare.   
 Theme: The type of student attracted to pharmacy is part of the problem. 
 The respondents universally agreed that many schools have made changes to the 
admissions process to recruit candidates who have the capability of being independent, 
critical thinkers and are passionate about patient care. Emphasis on leadership skills and 
the ability to communicate has increased, while dependence on test scores and grades has 
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decreased. Some respondents sense that, although schools are recruiting better-rounded 
students, as students go through the program they resort back to the old way of thinking, 
“tell me what I need to learn and I will do it.” 
 This disconnect can be attributed to the student motivation, but some respondents 
and authors from the literature place the responsibility on the faculty. The respondents 
that are affiliated with pharmacy programs believed that many curriculums are still using 
the “talking head method” of educating students, not teaching the students how to go 
about the learning process, how to become self-disciplined learners. One respondent 
emphasized that it is the educational institution’s responsibility to produce graduates who 
are independent, critical thinkers, and problem solvers. The complexities of medication 
and drug therapy are changing so rapidly that new graduates have to become lifelong 
learners. These findings support Holland and Nimmo (1999b), who identified two main 
factors that contribute to an individual pharmacists’ responsiveness to the change in 
practice: their personality and their professional socialization. Goldenson (as cited in 
Holland & Nimmo, 1999b) defines professional socialization as the process in which a 
student or young practitioner develops the roles, behaviors, and attitudes expected of a 
member of the specific profession. Faculty members, preceptor/internship experiences, 
and fellow students influence professional socialization.  
 Before the Pharm.D., a recruit typically did not want to work directly with people. 
Since the Pharm.D., the student is more interested in the sociology of healthcare, but is 
still more focused on learning about the science of disease and the pharmacology of 
treatment. As mentioned earlier, a respondent believed that an unexpected benefit of the 
Pharm.D. was the improved professionalization of new graduates, and many respondents 
shared this view.  
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 Holland and Nimmo (1999b) believed that the new patient-based practice model 
of pharmaceutical care requires changes in responsibilities and duties that may not be 
compatible with a pharmacist’s personality. As discussed, there has been a shortage of 
qualified pharmacists to fill the faculty requirements at many schools. The respondents 
concluded that new graduates are completing residency programs, where they just begin 
to learn how to practice and are then hired as clinical faculty. Several respondents 
expressed concern that limited practice experience by the new clinical faculty may be a 
contributing factor to the slow professionalization of the student. 
 Sixth pattern: The changes in pharmacy education curriculum as related to 
academia have been an evolution, not a revolution. Many respondents believed the 
turning point in the curricular advancement was the establishment of the AACP 
Commission to Implement Change in Pharmacy Education in 1989. The details of the 
interviews describe the attempt to improve pharmacy education over the years; but prior 
to the mandate, the focus was on the number of credit hours and length of the program 
instead of the quality of content in the program. These findings reinforce Elenbaas and 
Worthen (2009), who noted that curriculum improvements have been at the forefront of 
pharmacy education since the 1948 Elliott report concluded that the four-year curriculum 
was insufficient enough to provide the scientific content of the profession and the general 
education component of a post-secondary education. As the nature of professional 
practice changed, the conversation was framed primarily on the number of credit hours 
and not on outcomes or required competencies.  
 Theme: The ACPE developed the add-on Pharm.D. to allow B.S. pharmacists to 
upgrade their credentials. Respondents emphasized that a significant conflict surrounded 
the necessary content in an add-on Pharm.D. curriculum to prepare a licensed pharmacist, 
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with less than a Pharm.D., for best practice standards of the new pharmaceutical care 
model. The respondents provided actual details regarding the debate over the Add-on 
Pharm.D. For example, one respondent described that, at an age when he should have 
retired, he decided to complete the requirements for the Add-on Pharm.D. so he could 
continue in private practice. The author did not discover any theoretical or empirical 
studies in the literature that addressed the extent of this debate or the decision-making 
process that was finally agreed upon regarding the Add-on Pharm.D.  
 Theme: The complexity of drug interactions is rising and it is necessary to 
educate pharmacists to reflect this with skills in patient counseling. The trend toward 
having pharmacists with the skills to communicate and educate patients is still in its 
infancy. Respondents note that over 50% of patients take medications, and it is becoming 
increasingly important for new graduates to have the skills to communicate with patients 
about the dangers/importance of side effects or possible interactions with other 
medications. Some respondents believed the responsibility to teach patient-counseling 
skills rests in the Pharm.D. curriculum. This contributes to the reason why pharmacy 
programs are recruiting a different kind of student and establishing a new mission in 
educational outcomes, as this study addressed earlier. These insights are consistent with, 
but go beyond, the work of Brazeau et al. (2009b) who revealed that the 2008 AACP 
Curricular Change Summit centered on the transition from educating pharmacists with a 
product focus to educating pharmacists to provide patient-based care. This study finds 
that the magnitude of advancements in pharmaceuticals and drug management 
established a societal need for pharmacists to become patient-centered in order to help 
individuals understand the complexities of medicinal therapies.   
 Theme: The changes wrought by the new Pharm.D. required extensive debate 
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about and changes in pharmacy curriculum and instruction. Many respondents 
emphasized that the ACPE accreditation standards and the AACP Commission to 
Implement Change background papers were distributed to all Pharm.D. programs as 
guides to develop a curriculum that would be in compliance. The respondents noted that 
institutions were given eight years to prepare for the required Pharm.D. curriculum, 
which they felt was an ample timeframe. This created major conflict at the administrative 
and faculty level. As the respondents explained, debates over curriculum are always 
difficult, but when they are focused on significant changes in the course of study, the 
debates are some of the most vicious of all academic disagreements. One respondent 
believed the reason is because the arguments are so important to the individual faculty 
who are so dedicated to particular courses that they teach within the curriculum. The 
details of the interviews indicate that this debate is guided by emotion and subjectivity by 
the individual faculty, when it should be directed by policies and objectivity related to the 
best interest of the program and profession.  
 Discussions surrounding curriculum mapping and content are on a continuous 
cycle in the academy. Many facets go into the decisions regarding program content that, 
many times, make these conversations difficult and complex. The results of this study 
support that the discussions are guided by the objective standards set forth by the 
accreditation body. The accreditation process is the means of assuring and improving 
quality of educational institutions and programs in the U.S. (CHEA, 2010c).  
  The current study provides personal retrospective on the policy groups and 
commission papers that frame the transition to the clinical doctorate in pharmacy. The 
accreditation governing body is the Accreditation Council on Pharmacy Education 
(ACPE). The insights from this study support Eaton (2009), who stated that the 
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accreditation agency works together with state licensing boards and professional 
associations to set curriculum standards that are changed and improved based on the 
changes occurring in professional practice. In addition, data from the 2000 National 
Pharmacist Workforce Study described a “dynamic shortage of pharmacists” resulting 
from several factors including an increase in prescription drug use, expansion of 
pharmacist’s role in the job market, and limited use of automation (Cooksey et al., 2000, 
p. 182). Therefore, the AACP Commission to Implement change in Pharmacy Education 
developed a strategic plan to establish standards for pharmacy education in the 21st 
century (Miller, 1989). The same year the ACPE mandated the Pharm.D. as the sole entry 
into pharmacy practice, implementation beginning with the class of 2000.  
 The commission produced seven background papers, the first focusing on 
curriculum and instruction (AACP, 1997a). In 1992 the third background paper 
recommended that AACP endorse the Pharm.D. as the sole entry-level degree, resulting 
in the AACP House of Delegates vote in favor of the professional doctorate as the sole 
entry-level degree (AACP, 1997a). Soon after, the ACPE reworked that accreditation 
standards and guidelines for the Pharm.D. degree program. The standards have been 
revised in 1997 and 2007. Again, what is distinctive about the current study is the insight 
into how these changes were implemented and the resistance to change that inevitably 
accompanies major transformations and curriculum.  
 Theme: The Commission to Implement Change did not approach this 
conversation from the standpoint of whose material was going to be deleted. It was far 
more concerned with how the program could obtain what was needed or a curriculum 
to reflect the nature of the practice of the profession, and to do this in a reasonable 
period of time. The respondents emphasized that the Commission to Implement Change 
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attempted to focus on the objective guidelines for the transformation and remain neutral 
to the subjective decisions of the specific material that would be altered. This finding is 
new information that explains the commission’s approach to the debate. The responses 
supported the conclusion that, with the required knowledge of the Pharm.D. increasing at 
such a rapid rate, the big picture became how to fit that much education into an efficient 
timeframe. At the institutional level, this continues to be a challenge. At the 2008 AACP 
Curricular Change Summit, AACP President Yanchick stated, “We must transform 
pharmacy curricula away from a baccalaureate-level focus to a professional doctoral-
level focus” (cited in Brazeau et al., 2009b, para. 2).     
 Theme: The combination of new requirements in content and knowledge for the 
Pharm.D. as well as necessity of background understanding of science has led some 
schools to institute a pre-pharmacy program requirement of up to three years. The 
respondents noted that an increasing number of schools are requiring foundational 
courses for entry into the pharmacy programs. Because there are no accreditation 
standards or guidelines of what constitutes the pre-pharmacy curriculum, the length of 
time for completion ranges from none to three years. Several respondents stated that these 
prerequisites, plus the six-year pharmacy program, could total up to eight years before 
graduation. One respondent raised this concern regarding the length and cost of pharmacy 
education relative to the benefits and opportunities available in practice. Similarly, 
Freberger et al. (2008) argued that the additional time requirements and financial 
commitment of education are unnecessary, potentially leading to a shortage in the labor 
force. In addition, Engel (2000) acknowledged that educational institutions are charged 
with providing the quality of professionals that will meet the healthcare demands of our 
society, but the economic concerns of the institutions must be balanced with the cost 
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incurred to educate the professional and the career opportunities that are available. 
 Theme: One result of institutions being required to bring in additional qualified 
people to implement the revised programs has been a rise in tuition. The respondents 
indicate the ACPE accreditation standard of more clinical faculty is directly related to the 
increase in tuition of pharmacy education. The factors contributing to the rising cost of 
healthcare and the rising cost in education are two mainstream conversations in the U.S. 
Yet, the author discovered no studies that address this relationship in the review of the 
literature. All decisions about changing credentials and degree requirements involve 
trade-offs. These should be addressed explicitly; the current study represents a first step 
for this particular problem. 
 Theme: Not one grand scheme, template, or module exists to follow. A formal, 
strategic plan was not developed to assist institutions through this paramount change 
process. The respondents concurred that an organized plan was not devised to 
communicate these changes, neither to the broader community of health professions nor 
to the public. The change was made at the educational level, and the value of that change 
to other stakeholders could only be appreciated with time. 
 Over time, more students were opting for the Pharm.D. degree and more clinical 
programs were developed. The workplace response was seen primarily in the hospital 
setting, hiring more Pharm.D. graduates than bachelor’s graduates. One respondent 
served on a Pew National committee that was focused on the roles of various disciplines 
within primary care, workplace needs, and the changing climate of the healthcare 
delivery system. A different respondent explained that conversations leading up to the 
ACPE mandate were extensive and inclusive, both internally and externally. Dialogue 
centered on where the profession should be and what it could be. Accordingly, by the 
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1989 ACPE mandate that Pharm.D. would be the sole entry-level degree for pharmacy 
practice, 18 schools had already established the Pharm.D. programs; and pharmacy 
practice, at least in the hospital setting, was acknowledging the advanced degree. This 
same respondent noted that this required acknowledgement of the degree by many 
stakeholders, and it was messy.  
  Once the ACPE mandated the Pharm.D. and issued the revised accreditation 
standards, each institution had the freedom to develop the curriculum and overall 
program autonomously, as long as they were compliant with the parameters of the new 
Pharm.D. set forth by the ACPE. Some of the parameters, such as the addition of clinical 
faculty, were costly and there was no direct financial support to individual schools from 
accreditation agency or the professional associations. The respondents indicated that they 
are satisfied with the support that both the ACPE and the AACP gave academic 
institutions in the implementation of the Pharm.D.   
 Beyond earlier treatment at a more global nature, the current study provides much 
more detail and reflects back on events as they occurred. For example, O’Brien (1992) 
concluded that the growth in practitioner-oriented education has expanded the landscape 
of graduate and doctorate level education. This transformation occurred at the 
institutional level, at an institution-by-institution basis, making the professionalization of 
the graduate degree more complex. More recently, Eaton (2009) discussed academic 
accreditation defining four responsibilities in the mission: ensure quality assurance, 
provide access to federal and state funds, stimulate society’s confidence in higher 
education, and support transferability. Institutions accredited by the organization pay 
annual dues and fees to the accrediting agencies for the accreditation appraisal (Council 
on Higher Education Association, 2010; Schray, 2006a). In the U.S., the accreditation 
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process is rooted in self-regulation, relying on institutions to assess themselves against a 
set of standards (Brittingham, 2008; Eaton, 2009). In pharmacy, the ACPE gave support 
by providing documents related to the standards, the structure of the curriculum, and a 
significant timeline for completion. 
 According to Carver (2001), professional associations such as the AACP have 
dual responsibilities: representation of the particular profession and regulation of the 
profession. They are non-profit organizations funded by the investment of members 
through payment of dues and membership renewals and rely on member participation to 
fulfill these responsibilities (cf. Bhattacharya, 1998; Gruen, 2010; Morgan & Hunt, 
1994). During the timeframe 1989-2002, the AACP had strong, active, and dedicated 
members that resulted in an effective organization (Gruen, 2010; Wilson, 1998). 
Greenwood et al. (2002) concluded that, through the seven background papers, the AACP 
Commission to Implement Change in Pharmacy Education provided a strategic plan for 
the implementation of the Pharm.D. which represented the interests of the membership. 
This study supports that, once the professional beliefs and practices were established, the 
AACP played an important role in advocating value and monitoring compliance through 
routines such as providing seminars and intellectual support to the schools and 
professional development for practitioners (cf., Dezalay & Garth, 1996; Greenwood et al; 
Lalonde, 2010).    
Research Question 1b 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
 
 b. the delivery of service? 
 There was considerable debate regarding the Pharm.D. as the sole entry-level 
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degree. Many opinions were voiced in publications about the effect of the Pharm.D. on 
delivery of service. To the author’s knowledge, very few theoretical or empirical studies 
have been published on the effects of the Pharm.D. on the delivery of pharmacy services.  
 Seventh pattern: The success of the transition from product-based to patient-
based pharmaceutical care is not consistent throughout the U.S. healthcare system. 
 In the current study, the unevenness of the process of transition was obvious in 
the series of themes that follow, from variation by state to utilization in hospitals, as well 
as geographic and community differences. A constant across all of these is that local 
context, combined with inevitable variance in commitment to and approach from the 
faculty at each pharmacy school, produced trajectories of change that differed by efforts 
at compliance, emphasis, substance, innovation, scope, and pace.  
 In contrast, the author came across no literature that acknowledges there was 
inconsistency in the change in practice philosophy throughout the U.S. Some 
representative literature is noted for comparison. Elenbaas and Worthen (2009) 
concluded that the results of the 1946 Elliott survey found that the pharmacists believed 
there was a professional nature of pharmacy, but that the general perception was much 
less. The results from the 1967 study by the Task Force on Prescription Drugs indicated 
that society’s perception of the pharmacist was primaryly product-based, supplying pills 
and calculating the cost, but did acknowledge those pharmacists who were providing 
patient care, primarily in the hospital setting. Elenbaas and Worthen concluded that, 
through the 1970s and 1980s, the clinical pharmacy concept was becoming rooted in the 
practice model; and the Pharm.D. degree was gaining steam, but they were not 
synonymous.  
 Theme: With the introduction of the Pharm.D., the role for the new clinically 
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trained pharmacist expanded rapidly in hospital settings. The respondents concluded 
that the introduction of the Pharm.D., based on what the early adopters such as UCSF had 
done, demonstrated the value of the pharmacist in the clinical setting. This was nurtured 
in the hospital setting but was not embraced in the community setting. These findings are 
new to the field, as the author did not uncover publications in the literature review that 
discuss the effects of the Pharm.D. on hospital practice versus community practice.  
 Theme: The advancements in the delivery of services and the scope of practice 
are dependent on geographic location. The respondents indicated that the delivery of 
pharmaceutical services is noticeably different in certain regions of the country. 
California requires that a pharmacist who fills a prescription must give advice to the 
patient, while the Northeast has been slow to make the transition to clinical care. Again, 
these are new findings; the author did not locate any literature that addressed differences 
in pharmacy practice based on geographic distinction.  
 Theme: State regulations regarding the scope of practice of pharmacy are 
widely varied throughout the country and have a direct impact on the delivery of 
services. In the United States, licensing of health professionals and regulation of practice 
standards are administered by a division of the state government. The state bureaus work 
together with the education accrediting agencies when developing a profession’s scope of 
practice within the particular state (cf. Hawkins et al., 2009; Head, 2006). In 1998 the 
Pew Commission recommended that congress pass legislation that facilitating uniform 
scope of practice in each profession that would be transferable between states. Regarding 
these findings from the literature, respondents noted that a few states have endorsed 
collaborative steps, primarily in bordering states (Washington and Oregon, Kansas and 
Nebraska); but the efforts have been slow to develop across the U.S. A national approach 
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to the licensing of health professionals would improve consistencies in competence and 
performance standards across state lines (Hawkins et al., 2009; Head, 2006; Wakefield, 
1999). One respondent believed the resistance to a national approach goes back to the 
Civil War and states’ rights. He acknowledges movement toward national guidelines has 
occurred in specific situations, but each state will always have the right to license 
professionals within their borders because of history and the foundation of this country.    
 Theme: There appears to be a relationship between licensure, state 
governments, and the protection of salaries. Many respondents expressed the opinion 
that changing the scope of professional practice within a state is rooted in politics, and the 
political arena is centered on control and money. The respondents discussed that the 
political lobbying occurred within the pharmacy profession with respect to the Pharm.D.,  
primarily from professional associations. One respondent indicated that lobbying groups 
representing a specific profession (i.e., medicine, nursing, physical therapy, chiropractic) 
attempt to limit the scope of practice of other professions at the state level. In contrast, 
the author did not discover literature that speaks of the political environment related to 
the conversations about health professions scope of practice.   
 Theme: One issue that makes pharmacy unique is that it is the only profession 
in which two sets of licenses are required: the practitioner who has the license and the 
space or facility in which the pharmacist works. Respondents spoke to this dual 
licensure, in large part due to the reality of the pharmacy industry being responsible for 
the distribution of prescription drugs, which carries specific and unique rules and 
regulations by state and federal regulators. Once again, these findings are new regarding 
the complexity of how licensure affects the delivery of services, with no other literature 
found on the issue. 
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 Eighth pattern: Finances play a major role in changing pharmaceutical 
practice. While this theme may be obvious, the focus in the field was on changes in 
education and practice. Yet for any business, the bottom line is the cost-benefit model. In 
the area of healthcare this relates to how much individual time it takes to care for a 
patient and the amount of reimbursement for that time. According to one respondent, this 
is a conversation that is avoided by health professions because the orientation of cost-
benefit ratio is product-based, not value of time based. This is one of several issues for 
which the Affordable Care Act (2010) represents the beginning effort to transform the 
healthcare system in the United States.  
 Theme: A primary player is the pharmaceutical industry. The author did not 
discover literature that speaks directly to how the impact of the drug companies’ profit 
margin impacts the delivery of pharmaceutical services. Several respondents explained 
that drug manufacturers exist as business entities, concerned with the cost benefit of 
producing a particular drug. It is a unique situation, because they make a profit based on 
how much product (drug) is sold at the hospital and community pharmacy level. When 
the price of a drug is set, the profit for the pharmacy or hospital is included, as is the 
profit margin for the drug manufacturer. One respondent clarified that, in hospital or 
community pharmacy, the largest financial item is the cost of drug products; but the 
dispensing fees and insurance reimbursements continue to be restricted, resulting in 
declining profit margins for both the pharmacy and the manufacturer. Drug companies 
find avenues to maintain their profit margin, creating internal problems for providers who 
deliver the medicine.  
 Theme: The business model of the chain drugstores limits the roles and 
responsibilities of pharmacists in practice. The respondents articulated that a large 
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percentage of pharmacists are in community practice, primarily in chain drugstores. The 
business model of the chain drugstores is product-based because the revenue stream is 
dependent on dispensing drugs. The author got the impression that the respondents did 
not put blame on the chain drugstores, because they are seeing changes occurring as a 
result of a transformation in healthcare and healthcare initiatives. On the other hand, one 
respondent believed that the whole healthcare system is already so expensive and resists 
increasing costs by adding pharmacy services. 
 The respondents seemed to direct responsibility on the third party payers. There is 
no incentive for chain drugstores to change their mode of operation because there is no 
significant revenue stream for clinical services in the community setting. The reality is 
that drugstores need to make a profit and the current community practice model is 
extraordinarily efficient and effective for distributing drug products. That point is clearly 
important. But in opposition to the dispensation of medicines, the transition to a 
pharmaceutical care model has been and continues to evolve, albeit slowly. The author is 
unaware of literature that addresses the relationship between the chain drugstore business 
model and its limitation on changes in pharmacy practice. 
  Theme: In the attempt to modernize the pharmacy practice from a product-
oriented to a patient-oriented profession, one concern was how pharmacists were going 
to get paid for the advanced services. Respondents explained that Medicare is the leader 
in establishing third-party reimbursement models. Medicare Part D set pharmacy 
reimbursement to be the price of the drug based on the cost of the ingredients plus a 
dispensing fee; insurance companies followed suit. One respondent described that, now 
that this is being ratcheted down, the concern for pharmacy reimbursement is becoming 
an important and immediate issue. This new information parallels Cohen (2008), who 
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concluded that, for pharmacists to realize their full potential in the U.S. healthcare 
system, serious reform and revised payment systems are needed that distinguish the value 
of time spent in patient care from dispensing. 
 Theme: A limiting factor is that an organized system for compensation for 
services has not been established. The Affordable Healthcare Act (2009) contains 
initiatives related to reimbursement to pharmacists for cognitive services and medication 
therapy management services. Many respondents explained that these new guidelines, 
designed to provide quality care at the most reasonable price, are misplaced. When 
medicine is managed properly, costs decrease and patients are healthier. One respondent 
explicated that the current initiatives emphasize utilization of low cost medicines, such as 
generic brands, rather than instituting methods that produce affordable drugs and 
services. Several respondents noted that the incentives are backwards, and this has 
unified professional organizations that were at odds in the 1980s, to advocate for a 
system that pays attention to the human side of care. 
 The respondents explained that reimbursement methods for hospitals are even 
more complex. In the current reimbursement model, savings on drugs are not included in 
the “patient outcomes” that reflect saving lives, etc. Pharmacy reimbursement is related 
directly to the product, so there is no incentive for the hospital to advocate for cognitive 
services to be reimbursed. The detail provided in these interviews provides new 
understanding of the complexities of the healthcare reimbursement model that 
accentuates what Cohen (2008) concluded, that if pharmacists are to realize their full 
potential in the U.S. system, serious reform and altered payment systems that recognize 
value of time spent in patient care are necessary, rather than just dispensing medicines. 
 Theme: The current third-party reimbursement model does not provide 
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incentives for pharmaceutical care. The current third-party reimbursement model for 
community pharmacy is product-based. One respondent advised that a system of 
reimbursement for professional services (i.e., time) will need to be established before 
pharmaceutical care can be implemented in the community setting. The hospital 
reimbursement policies are independent from the community pharmacy. Many 
respondents acknowledged that this is a difficult situation, and the professional 
associations need to advocate the value of pharmacists in saving lives and saving money. 
One respondent proposed that the professional associations should advocate for 
transformation of the third-party payment model. This new information supports 
Greenwood et al. (1996), who concluded that professional associations play a vital role 
when a profession is going through a change process. The researcher is unaware of 
published literature that addresses the challenges with third-party reimbursement and the 
influence on the delivery of pharmaceutical services.  
  Research Question 1c 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on:  
  
 c. interdisciplinary relationship of practicing physicians?  
 The following patterns and subsequent themes encapsulate the perceptions of the 
subjects related to the interdisciplinary relationship of the Pharm.D. and other disciplines.  
 Ninth pattern: Professionals in the U.S. healthcare system are strongly 
resistant to change and seek evidence-based research that a change is necessary. 
With respect to how the other fields responded to the changes happening in 
pharmacy, evidence is growing that an interprofessional, team-based approach to 
patient care is the best-practice model. The respondents supported the ACCP (2002) 
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position that the transformation of pharmacy practice is an encompassing process 
requiring collaboration from all segments of healthcare workforce and an inclusive 
approach for adoption. Several subjects suggested that the U.S. healthcare delivery 
system has been moving toward inter-professional collaboration in patient care, but 
health professionals expect evidence-based research that proves the need to change. One 
subject pointed to the fact that the Commission to implement change in pharmacy 
education, in background paper 3 [Commission to Implement Change in Pharmaceutical 
Education, 1997c], provides evidence of a societal need for pharmaceutical care to be the 
practice model.  
 The Transtheoretical Model of Health Behavior (Kraft et al., 1999) divides the 
process of change into three stages: pre-contemplation of the change, motivation and 
intention to change, and maintenance that includes absorption of the new behavior. 
Currently, other health professions (i.e., physicians, nurses, etc.) are still moving through 
these phases of change related to their relationship with the Pharm.D., yet how they blend 
into the delivery system is unknown because these changes are still in their infancies. The 
details of these interviews provides empirical data that supports the IOM (2000) report 
that concluding that the expanded role of the pharmacist in patient care will require 
changes in the structure and processes in which health professionals and organizations 
function.    
  Theme: The pharmacy profession did not have a strategic plan to inform the 
other stakeholders; however, there is a slow but continual acceptance of the abilities of 
the pharmacist. This theme represents an important finding from this study. During the 
decision-making process, the AACP reached out to other professional (i.e., nurses, 
physicians, audiologists, etc.) to participate in the discussions but did not develop a prior 
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strategy to educate other health professions on how the advanced knowledge and skills 
would benefit the collaborative healthcare team. The leaders initially focused this major 
change effort on educating pharmacists differently to provide better patient care 
outcomes, but not much past that. Now that the Pharm.D. education has been solidified, 
many respondents indicated that the profession needs to become progressive about its 
place on the collaborative care team by educating other professionals about the value of 
the pharmacist as the expert in medications and their proper use.  
 The respondents were realistic that this will not be an easy task, possibly facing 
more resistance than that which occurred in academia. Patterns three and four that dealt 
with resistance within academia have their parallel in the arena of practice. One 
respondent commented that, “I have little hope of seeing that change radically in my 
lifetime. That is the next decade.” Regarding these pessimistic findings, Wall et al. 
(2005) reported that it can take up to 20 years before scientific findings become part of 
bedside practice. The clinical doctorate programs based on interdisciplinary, evidence-
based education attempt to take transitional knowledge from research institutions to 
practicing professionals, significantly reducing that timeframe. However, without explicit 
strategies that go beyond the research on the pharmaceutical issues, both political and 
practice-based, these changes will not be easily or widely embraced.  
   Theme: There is a trend in the healthcare delivery system toward a 
collaborative care model. Respondents indicated that the changing healthcare delivery 
system toward a collaborative care model will require primary healthcare providers to be 
partners in promoting health and preventing disease. They emphasized that health 
professionals must learn how to work in a collaborative team environment, starting at the 
early stages of the educational process. These explicit comments reinforce Wall et al. 
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(2005) who concluded that opportunities for collaboration with multiple disciplines at the 
university level will improve the integration of health disciplines and reengineer the 
health delivery system. In addition, the American Association of Colleges of Nurses (as 
cited in Wall et al., 2005) support the emphasis of an integrative approach to patient care 
that provides opportunities for evidence-based practices in clinical care delivery, patient 
outcomes, and systems management.  
 Other research has been published to substantiate the collaborative education 
model for health professionals. Rapport (2007) concluded that the ability to collaborate 
includes an underlying assumption that the team members have a respectful knowledge 
base regarding one another’s disciplines, preparation, and expertise so they can 
effectively contribute to the efforts of the team. Along with Reeves (2009), who 
suggested that to be fully integrated, interprofessional intervention needs to be education-
based, practice-based, and organization-based. Reeves inferred that situating 
interprofessional learning, working, and quality improvement can create a continuum 
between interprofessional learning and service improvement.   
 Theme: Many respondents have confidence that physicians will rely more and 
more on the information from the pharmacist. Respondents noted that this is happening, 
slowly but surely. The respondents gave specific examples of situations that are 
organized where the professionals are equal partners such as Kaiser Permanente, Indian 
Health Services, and Group Health of Puget Sound in Washington State. Respondents 
frequently repeated during the interviews that interdisciplinary relationships between 
providers are developing at a faster rate in hospital settings than in the community 
practice.   
 Theme: The changing landscape in healthcare requires a team-based approach 
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and the pharmacist was the best professional to manage the drug therapy. Respondents 
explained that the overarching belief at the time was drug therapy becoming more 
complex and complicated, requiring pharmacy to be more involved in the outcomes of 
drug therapy intervention, which was going to require a transformation in pharmacy 
education. This attests to the IOM (2000) report that the rapid changes occurring in the 
U.S. healthcare delivery system have resulted in a gap in the ability to translate the 
knowledge and skills of practitioners into the best-practice model. One respondent 
stressed that physicians know a lot about a small number of drugs that they routinely 
prescribe, but it is unreasonable to expect the treating physician to comprehend the 
complexities of thousands of drugs that are available. On the other hand, pharmacists 
have the capability to understand all the drugs, be informed on all the complications, and 
have the ability to tailor a drug treatment specifically for an individual.  
 Respondents noted that people, primarily in education, were highly visionary and 
were advocating for collaborative clinical practice as an essential in effective patient care. 
This approach may not have been so visionary because Worthen (2006) revealed that the 
final report of the Millis study, Pharmacists for the Future, suggested that pharmacists be 
trained with other health professionals, exposing the student to team-based patient care. 
Additionally, the 1992 ACPE curriculum standards include that students must be 
prepared for the “emerging roles and responsibilities that ensure the rational use of drugs 
in the individualized care of patients” [ACPE, 1993, standard 8].  
 This new information expands on Clark (1999), who noted that one of the major 
trends in health professions education is the evolution of interdisciplinary teams, 
including community-based experiential learning. Similarly, Luke et al. (2009) reported 
that the Institute for Interprofessional Health Sciences Education (IHSE) was founded to 
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promote interprofessional education across institutions, faculties, practice sites, and 
communities of practice. In addition, Brazeau et al. (2009a) believed that Pharm.D. 
education would enable pharmacists to serve in a multitude of practice settings as well as 
serve as a change agent in the complex healthcare system.    
 Tenth pattern: Most patients need drug therapy and many physicians, 
nurses, and other health professionals are recognizing that there is somebody on the 
team who has expertise about medication therapy and not diagnosis. Understanding 
the complementary competencies and skill sets of each individual on the 
interdisciplinary team needs to occur at the educational level. One respondent 
remarked that whenever a group exists, whether it is a team of health professionals or an 
athletic team, there has to be some structure. Furthermore, responsibilities are assigned to 
each individual, resulting in a collaborative effort for a collective solution to a problem. 
As an extension of the findings in pattern three, the pharmacist is being recognized as the 
expert in pro-therapy and drug management in interdisciplinary healthcare teams.   
 Theme: Pharmacists lack the skills in physical assessment that are necessary 
for patient diagnosis but are experts on the drug management of disease. Several 
respondents addressed the contrast between educational programs that support the 
collaborative practice model of patient care. Pharmacy education focuses on the 
medicinal management of disease and disease processes, while other healthcare providers 
such as medical physicians and nurses are trained in the physical assessment and 
diagnosis of disease and disease processes. This distinction supports the need for 
interdisciplinary collaborative patient care. For the pharmacist to be an autonomous, 
primary healthcare provider, more training would be required in assessment and 
diagnosis, resulting in an extended educational process.  
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 Theme: One way to change the face of a profession is to educate health 
professionals together in a collaborative environment. The respondents described the 
theory that educating health professionals together develops respect between disciplines, 
producing change in practice over time. One respondent was mindful that this theory of 
interdisciplinary education has been a conversation among academic leaders in health 
professions for over 40 years, but the application of interdisciplinary learning on 
campuses has been both exhausting and slow to develop. 
   Most of the discussion regarding interdisciplinary education is centered on the 
didactic portion, disciplines being educated together in the basic sciences. One obstacle is 
the significant difference in the educational process for medical doctors, nurses, and 
pharmacists. Medical and nursing education focus primarily on diagnosis; whereas, 
pharmacy is more focused on the treatment of conditions, not physical assessment needed 
to diagnose disease. The respondents concluded that interdisciplinary training in both 
types of training--the didactic and clinic components--is key to producing young health 
professionals who understand the importance of collaborative patient care. 
 The respondents affiliated with institutions that are implementing interdisciplinary 
learning declare that the disciplines are increasingly being educated in the experiential 
arena, making rounds in hospitals, on clinical rotations, and on clerkships. One 
respondent reported that there is evidence that in the hospital setting that, if a pharmacist 
rounds with physicians, there are fewer drug reactions and medical errors. This 
information parallels the IOM (1999), who concluded that errors are not caused by the 
actions of one individual or a particular group, but by faulty systems, processes, and 
conditions that lead people to make mistakes or fail to prevent them. In the IOM (1999) 
report, To Err is Human, it is inferred that the know-how already exists to prevent many 
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of the mistakes, but there must be patient safety initiatives to improve the quality of team 
communication between the professionals and organizations. This seminal document 
stresses that safety demands effective communication and collaboration (Reeves, 2009). 
 Theme: There are more opportunities for the disciplines to be educated 
together. Several respondents commented that an increasing number of institutions are 
educating students together in the experiential portion, such as clinical rotations and 
clerkships, resulting in improved respect between disciplines. In addition, respondents 
believed that if you asked a physician the dosage forms, they would refer to the 
pharmacist on the case. One respondent noted that in many chain drug pharmacies, nurse 
practitioners are working collaboratively with the pharmacist, thus building more respect 
and trust between the practitioners. The details of the responses correspond to Clark 
(1999) who believed that interdisciplinary education has important implications for the 
competencies of graduates of health professions programs. In light of this modern trend 
Nair and Webster (2010) declared that change is often difficult in fundamentally 
conservative professions such as health care and education. 
 Research Question 1d 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
  
 d. societal and economic landscape of the health care industry (cost-benefit)? 
 
Respondents were candid in their perceptions of how the Pharm.D. has impacted the 
societal and economic landscape of the health care industry. The following patterns and 
succeeding themes deliver new insights into the subject. 
 Eleventh pattern: The Pharm.D. has resulted in a gradual change in the 
practice and professionalization of pharmacy and the concomitant views of society. 
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One respondent explained that, before the Commission to implement change in pharmacy 
education commenced, the AACP provided strong evidence that pharmacy’s value to 
society would be greatly increased if pharmacists were capable of providing 
pharmaceutical care. This respondent recalls that the first step to reach this goal would be 
more preparation for those responsibilities through more clinical training. Eventually this 
led to the establishment of the six-year curriculum guidelines that included an increase in 
the experiential component. 
 Theme: One of the underlying reasons for the transition to the Pharm.D. was 
that pharmacists wanted more responsibility, but there is a difference between 
increased responsibility and autonomy. Respondents acknowledged that the Pharm.D. 
graduate has the knowledge, skills, and abilities for providing patient-oriented 
pharmaceutical care in a variety of practice settings. They are experts in the field of 
medicinal treatments and patient management of drug therapy. As discussed in the 
thirteenth pattern, the Pharm.D. is limited by the lack of training in physical assessment 
and diagnosis. It is important that they work in a collaborative environment, respectful of 
their scope of practice boundary levels. This information provides quality new thinking 
related to the importance of collaborative care that the author did not discover in the 
literature. 
 Theme: Pharmaceutical care services cannot be forced upon the public, but 
take a slow, steady change in perceptions and expectations of individual patients. Most 
respondents believed society is becoming better educated, with many consumers first 
talking to the pharmacist about drug-related concerns and healthcare options. On the 
other hand, patient literacy is a major public health issue, especially in the aging 
population. One respondent pointed out that many people obtain information about their 
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diseases or conditions from the Internet, and some of it can be confusing. The pharmacist 
plays an important role in the community by making personal connections with 
individuals. These informal networks spread throughout the population the notion that 
patients can go to their pharmacist for help with medications and healthcare needs. The 
respondents’ comments support but give more detail compared to Kreling el al. (2010), 
who perceived the current trends, such as an aging population and increased use of 
prescription drugs, as indicators that society needs patient-based pharmacists in the 
community practice setting.  
 Theme: When opportunities are present for pharmacists to practice to their 
fullest potential, society will benefit as a whole. Multiple respondents believed that, 
when the pharmacist is given the opportunity to communicate directly with the public, 
they accept the responsibilities and patients are appreciative of the service. On the other 
hand, the same respondents noted that these opportunities are currently not the norm in 
pharmacy practice and perceive this to be a disservice to society. This point of view 
aligns with the IOM (2001) report that bringing the best-practice model of health care to 
every community will require a fundamental, sweeping redesign of the U.S. healthcare 
system. These personal reflections bring explicit insight to the field related to the 
difficulties of change in a complex system. 
 Theme: Opportunities to practice pharmaceutical care are still in their infancy. 
Many Respondents believed that, if community pharmacists are given the opportunity, 
they excel at providing clinical pharmacy services. One respondent professed that now 
that Pharm.D. graduates have the training to practice pharmaceutical care, the profession 
has the responsibility of educating the public at large the capabilities and the benefits to 
the individual and society as a whole. This is a process, one that has evolved over the past 
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20 years, but has not been immersed into mainstream healthcare. Increased expectations 
of the pharmacist and practice should develop through recognition accrued from greater 
accessibility. Yet the notion that people will ask questions and trust them has evolved 
much more slowly than anyone imagined. This perception endorses Morgan and Hunt 
(1994), who accepted that when commitment and trust are present, outcomes such as 
efficiency, productivity, and effectiveness flourish. In addition, Wilson (1995) suggested 
that when both parties invest in the relationship, there is an increase in value and stronger 
bonds between individuals. Moreover, Gruen et al. (2000) concluded that when in a long-
term, committed relationship, customers become more involved and participate in the 
value of the exchange. The data provide new thoughts and explicit illustration of the 
importance related to communication between the pharmacist and the patient.   
  Theme: The pharmacy profession, as a whole, has not been proactive in public 
relations. The health literacy of an individual seemed to be directly related to personal 
interaction with a pharmacist. We [Respondents speaking as a profession] need to 
practice speaking to the public, in lay person, terms, to help them build trust and 
understanding of the valuable role pharmacy can play in their healthcare decisions.   
Respondents agreed that a large-scale campaign to educate the public on the value of 
pharmacy has not been established. Efforts by the U.S. Public Health Service have 
promoted pharmacists and the intervention with drug therapies, but the profession needs 
to be its own advocate. This parallels Brazeau et al. (2009b) who recommended that 
pharmacy graduates must be engaged in their communities and be leaders as well as 
advocates. This study provides new advancements in the field related to the importance 
of self-advocacy of pharmacists to create situations in which pharmaceutical care can be 
practiced. 
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Research Question 2 
 What is the transferability of an entry-level clinical doctorate related to 
 professional opportunities? 
  
 The respondents spoke to the issues regarding professional opportunities 
associated with the Pharm.D. Many opinions have been voiced in publications about the 
expanded professional opportunities in the pharmaceutical industry and the understanding 
of the degree on a global level. Compared to this literature, the patterns that were 
identified seem to be more narrowly focused in the respondents’ reflections on the 
questions representing this second research question. Most of this information is new to 
the field because, to the author’s knowledge, very few theoretical or empirical studies 
have been published on the transferability of the Pharm.D. related to professional 
opportunities both nationally and internationally.  
 Twelfth pattern: The Doctor of Pharmacy is well prepared for a larger area 
of professional practice and related careers, such as the pharmaceutical industry 
and prescription development. Most respondents believed that new opportunities have 
opened for pharmacists and are confident that greater opportunities still await the 
Pharm.D. because of the uniqueness of pharmacy education. The following themes 
capture these thoughts. 
 Theme: Opportunities are expanding in hospital and community settings. 
Respondents believed that opportunities that allow the pharmacist to communicate and 
interact with patients are expanding, but slowly. The hospital setting is growing more 
rapidly than community pharmacies. This retrospective investigation provided original 
data regarding the opportunity differences between hospital and community settings. The 
author was unable to identify any prior research on this distinction.  
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 Theme: Pharmacy is a huge industry and Pharm.D.s are highly sought today 
throughout the field. Respondents noted that the pharmaceutical skills associated with 
the Pharm.D. are becoming an integral part of biotechnology research and development, 
as well as other related fields. Once again, this retrospective inquiry provides new 
insights in the field, with no related studies found that addressed this benefit to both 
society and the new Pharm.D. graduates, i.e., their knowledge and skills enhanced 
biotechnology research while some individuals found a demand for their services outside 
the practice of pharmacy per se.   
 Thirteenth pattern: There were external forces behind the progression of the 
clinical doctorate in pharmacy, and other professions that are contemplating the 
transition may want to address these factors. The respondents were cognizant that the 
transition for other health disciplines will be a unique and individual experience, but there 
are commonalities in the process where the experiences are transferable. Because 
pharmacy has experienced many mistakes and successes related to the transition to the 
Pharm.D., the awareness of those in the field may assist other professions in their 
transition to the clinical doctorate. The explicit details provided in this reflective study 
yield new insights to the specifics of the errors and triumphs that pharmacy experienced 
in the transition to the Pharm.D., which contribute to the transition to the clinical 
doctorate in other fields.  
 Specifically, the respondents considered the change in accreditation standards, 
curriculum requirements, and the degree change to be positive achievements for the 
profession as a whole. The uncertainty of the worth of the clinical doctorate and the 
queries regarding potential degree creep (requiring ever more degrees for beginning 
professional practice) were quieted with the above-mentioned decisions. On the other 
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hand, the respondents addressed the inattention to the complexities of the change process 
and the lack of a strategic plan to advocate for the changes as errors. 
 Theme: The respondents perceivedd this transition to be successful in pharmacy 
because all stakeholders were involved. Most respondents believed a major facet in the 
success of the Pharm.D. was commitment to include all stakeholders in the decision-
making process. Taking the time to involve people, even those who were not viewed as 
allies, prolonged the process but it was necessary. Pharmacy leaders were dedicated to 
getting as many stakeholders as possible, to buy into the mandate before it was passed. 
The current study supports Boydeen (2006), who opined that the leaders and stakeholders 
were at the core of the pharmacy-degree changeover; but this retrospective inquiry 
provides explicit details of situations in which stakeholder involvement proved to be a 
vital component to the decision-making process.    
 Theme: The respondents agreed that other professions might want to take time 
to learn this process, because this process has worked well for pharmacy. Many 
respondents believed that, if other professions read what is in the published literature 
about how this process worked, the tasks and steps it took to change the pharmacy 
practice can be used as a template for the transition. Collectively, they noted that the 
accomplishments in advancing the pharmacy profession, beginning with the Pharm.D., 
have been impressive. To the author’s knowledge, these findings are the first empirical 
study on the topic. Available resources on the advancement of the pharmacy profession 
are in the form of position papers, opinions, and commentaries; but this study allows for 
empirical evidence that there have been advancements in pharmacy education and greater 
opportunities in clinical practice as a result of the Pharm.D.  
 Theme: If the various stakeholders in the educational institutions successfully 
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implement change in the educational requirements, the graduates of the Pharm.D. 
programs will have a ripple effect through the rest of society due to their upgraded 
capabilities and professional practice. The respondents understood that in order to 
transform the face of a profession successfully, conquering change in educational 
requirements must be the first step. From there it is a slow evolution through the many 
stages from policy change to public acceptance. The respondents warned that any 
profession that assumes this will happen in two to three years will be grievously 
disappointed. This reinforces the IOM (2001) report that indicated changing the 
professional philosophy does not guarantee all stakeholders will embrace the changes. In 
addition, studies by Brazeau et al. (2009), Greenwood et al. (2002), and Siler and 
Randolph (2006) testify that the changing the degree required to enter into a profession is 
accompanied by fundamental barriers or concerns that underlie an organizational change 
process. This retrospective study provides explicit insight demonstrating that pharmacy 
did change the professional philosophy, yet not all stakeholders have accepted these 
changes. In addition, this study provides details of the obstacles and issues that pharmacy 
experienced with the change to the Pharm.D. 
 Theme: It is important for a profession to articulate clearly what the difference 
will be when the professional doctorate program is implemented and how that will 
translate to better outcomes for patients. Respondents urged any profession that is 
considering changes in required credentials to document how the outcomes will benefit 
the patient. Several respondents pointed to nursing as a profession that needs to address 
possible overlap of credentials related to the multiple layers of nursing certifications as 
they move toward the DNP. This supports Griffiths and Padilla (2006), who provided 
linkage to the influences between the decision to move to the clinical doctorate in 
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occupational therapy and other fields such as pharmacy, nursing, and physical therapy. 
Yet, the current study differs, in that specific issues are reported in more detail, especially 
with respect to the conflicts and resistance from various stakeholders, e.g., changes in 
accreditation standards, curriculum redesign, and interdisciplinary opportunities that 
pharmacy confronted during the transition.  
 Theme: The intention of the profession to transition to the practicing doctorate 
should be to establish a role as part of a collaborative team with other healthcare 
professionals, not increase the professional autonomy. The respondents suggested those 
professions considering changes in required credentials need to be transparent, mindful, 
and reflective regarding the intention for the changes. This new information confirms 
Rapport et al. (2007), who noted that external forces behind the progression of the 
clinical doctorate pertain to all disciplines undergoing the same transformation. In 
addition, Threlkeld et al. (1999) argued that discussing trends occurring in other fields 
that have resulted in the transition to the clinical doctorate, valuable knowledge and 
guidance can guide leaders of other health care disciplines involved in this organizational 
change. This study provides new empirical information on the transition to the Pharm.D. 
focused on understanding the micro trends and issues relating to implementation 
associated with the  progression to the clinical doctorate in health professions. 
 Fourteenth pattern: The biggest surprise from the establishment of the 
Pharm.D. as the sole entry-level degree has been the unexpected rise in pharmacy 
schools. Several respondents acknowledged that the expansion of pharmacy schools was 
an unexpected outcome of the Pharm.D. The growth in pharmacy schools over the past 
20 years opposed all predications that were forecast at the time regarding the changes 
being contemplated. Knapp (2012) argued that there was pressure to expand pharmacy 
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school enrollment at the existing schools to alleviate the pharmacist shortage. But some 
institutions focused on increasing the number of Pharm.D. programs and schools to 
address the shortage in the workforce. Together, the increasing enrollment at existing 
schools and the expansion of new programs and schools led to a situation in which the 
number of new graduates was growing at a faster rate than the workforce needs. This 
study expands the understanding that this was not an anticipated outcome and one that 
has caused concern within the profession.    
 Theme: During the transition period, leaders thought that this educational 
change would decrease the number of applicants. This turned out not to be true. Many 
schools of pharmacy thought the expansion to a six-year program would not be attractive 
to potential students and were discussing alternatives. At the time, however, there was a 
shortage of pharmacists in the workforce, which was appealing to prospective students. 
These demands from the marketplace resulted in an increase in applicants and a growth in 
new schools. This reflective investigation has provided new insight to previous 
researchers, such as Brown et al. (2003) and Tennant (2004), who documented the 
increase in doctoral programs in the past decade and acknowledge that new graduates 
expect high levels of knowledge, skills, and abilities when they obtain the qualifications 
to graduate. This study contributes explicit insight related to how the increase in 
Pharm.D. applicants has had an inverse relationship with the workforce demands in 
pharmacy, a point that might be a concern for other disciplines transitioning to the 
clinical doctorate. 
 Theme: In addition to the increased number of schools, the class size has grown 
as well. Greater number of schools and larger class size equates to more Pharm.D.s 
entering the workforce. Some respondents acknowledged that, at one time, there was a 
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shortage of pharmacists but questioned whether the saturation point regarding the number 
of pharmacy schools and the number of graduates who will be entering the marketplace 
has now been reached. In contrast, the Pew Commission (1995), now known to have been 
not only off the mark but to have erred in the wrong direction, warned of a potential 
surplus of pharmacists and recommended a cutback in pharmacy schools. 
 More recently, Knapp (2012) suggested that the pharmacy education community 
rejected the Pew Commission’s report, with seven new schools founded between 1995 
and 2000. Within 15 years of the Pew Commission’s report, 44 additional pharmacy 
schools had been founded. In addition, DiPiro (2003) proposed that the expansion of 
pharmaceutical education underscored issues about quality in pharmacy education. 
Knapp noted that the attention was on increasing the capacity of existing schools, 
resulting in a sizable increase in enrollment. In contrast to all of these reports, what the 
current study contributes is retrospective insight as opposed to studies that are policy-
focused and based on secondary data on numbers of students and schools related to the 
projections on the need for pharmacists in the future. This study is micro, focused on 
personal experiences of individuals, whereas the other work contains little if any insight 
about how this played out at the level of lived experience, one institution at a time.    
 Theme: There was the perception of uncertainty regarding the quality of some 
of the new schools and new programs within existing schools that have been started in 
the past 20 years. The respondents suggested that some of the new schools are focused 
solely on producing new graduates and disregarding research. They have stacked the 
faculty positions with clinicians, not hiring trained researchers. Although the ACPE 
accreditation standards do not specify scholarship requirements, some respondents argued 
that the lack of ongoing research may be a disservice to the profession. This is consistent 
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with Campbell (2008), who reported that successful programs were committed to the 
foundation of professional practice with a balanced emphasis on research and teaching. 
 One respondent suggested that schools established before the Pharm.D. have been 
successful in hiring clinical faculty and developing the experiential component without 
compromising the research and basic science component of education. This contrasts 
with Campbell (2008), who opined that a pharmacy school that lacks a strong basic 
science curriculum becomes segregated philosophically and geographically from the 
pharmaceutical basis of pharmacy and from other health professions. Further, those 
schools that lack the resources to create a robust clinical component cannot assemble a 
quality program in pharmacy education.  
 The respondents were concerned, but cautious, in their critique that many newer 
Pharm.D. programs are established in schools that do not have an understanding of 
graduate education or health professions education. Many respondents believed the 
culture of an institution is important to the success of the degree programs offered. Yet, 
respondents acknowledged that it is difficult to measure the quality of the programs, 
primarily because of the difficulties in measuring the quality of the amorphous outcomes 
that constitute education in its broader meanings. 
 Despite all the problems in assessing quality in educational programs, accrediting 
agencies and professional associations have developed standards by which to assess 
efforts to produce the best professionals. DiPiro (2008) concluded that quality relates to 
the adequacy of resources, professionalization of students, faculty scholarship, and 
achievement of competencies and outcome measures that are valued in that field. 
Collectively, these standards ensure that graduates are capable of meeting the current and 
future needs for patient-oriented healthcare. While DiPiro and Campbell (2008) spoke 
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broadly about quality, standards, and the changes inherent in the accreditation process 
(preparation, including curricular revision and updates; the visit, including feedback and 
further revisions; and final approval, including preparations for the next cycle), the 
current study reflects the role that the culture of an institution plays with respect to 
understanding of graduate education and consideration of quality and success at the micro 
level.  
 Theme: The largest increase of new programs has been in private schools, 
many without the established culture of doctoral or health professions education. Some 
respondents believed that, because a perception of a shortage of pharmacists still exists, 
schools see an opportunity for increased revenue. This raises the question, What is the 
intention of the institution to develop a Pharm.D. program? The author is unaware of 
empirical data that supports this idea, but one respondent shared his opinions based on 
extensive experience assisting schools contemplating a pharmacy program. This 
individual concluded that many of the schools, particularly those that have no existing 
health professions or graduate programs, seek to improve their institutional image by 
developing a doctoral program. They think that if they start with the Pharm.D. program, 
the enhanced prestige will trickle down to new undergraduate programs in health 
sciences. This respondent noted that the accreditation agencies are beginning to address 
this issue, which is a new trend in the field. The speculation of this respondent suggests 
the need for more systematic investigations on the motivations for starting new programs 
in the health care professions and the adequacy with which accreditation agencies have 
monitored these new programs both in the past and looking forward. 
 Fifteenth pattern: The conversation about redefining the pharmacy 
profession is happening on a global scale. Respondents raised a number of issues that 
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focused on the scope of pharmacy internationally. International communication and 
collaboration has been transformed by the invention of the Internet, resulting in drug 
information being shared across borders at the click of the button. Concerns about 
equality of professional credentials are surfacing on a global level. The legal definition of 
pharmacy or professional practice may never be uniform, but efforts to understand the 
definitions as they relate to individual cultures should continue. This new knowledge 
expands on Neumann (2005), who noted that the professional doctorate has structural and 
conceptual differences that vary from country to country. In addition, Jolley (2007) 
acknowledged that, as the professional doctorate is becoming more popular, much of the 
confusion can be attributed to the differences in nomenclature between countries. 
 Theme: Understanding the culture of a country and how that shapes the 
response to a major change effort is vital to professional change. Respondents raised 
issues relating to the training and education of pharmacists from one country to the next, 
emphasizing the dependence on the culture and change processes. Accessibility to drugs 
and information across international borders makes it vital to understand how local 
context affects what happens in other countries in order to have open dialogue and 
communication. This perception expands on Brown and Lauder (2001), who asserted that 
the national prosperity in a competitive global market is dependent on the advancement 
of knowledge and skills of the workforce. Additionally, Brown et al. (2003) proposed that 
a knowledge-driven society has influenced the rise of mass higher education, especially 
for the terminal degree. This micro, focused investigation advances the understanding 
that global exchange of information is expanding at a rapid rate, but how the information 
is utilized within the context of a particular society requires in depth consideration of the 
culture of one country compared to another.      
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 Theme: On a global scale, the Pharm.D. is not equivalent around the world. 
The ACPE has opened several international initiatives and dialogue opportunities. As 
respondents spoke about these international trends, they noted that the ACPE has begun 
to explore how other countries train pharmacists, specifically regarding what 
pharmaceutical care training would resemble within the standards of that particular 
culture. One respondent explained that there is an effort to harmonize the way pharmacy 
and pharmacy education is experienced across the Eurozone. This is under the 
jurisdiction of the World Health Organization (WHO) whose leadership is dominated by 
Swiss medical practioners. While WHO is addressing the changing role of the 
pharmacist, Switzerland pharmacists have only recently achieved recognition so the 
awareness by the WHO leadership is in the early stages. These new insights expand on a 
problem that Hunt (2009) addressed that countries for which the educational accreditation 
is primarily controlled by the government, accountability standards are robust but 
institutional autonomy is limited. This compares to countries such as the United States, 
where the accreditation system allows for greater institutional autonomy but 
accountability to societal stakeholders is weak. Furthermore, Engel (2000) was mindful 
that there are countries with an increasing number of professionals with an earned 
doctorate who are either underemployed or unemployed, during a time when the cost of 
education continues to escalate. The work in the current study differs from the extant 
literature by focusing on advancements of pharmacy on a global level and represents the 
commonality of concerns internationally. This information will help advance the work of 
professional leaders as they work toward unification of pharmacy worldwide. 
Additional Findings 
 The respondents raised a number of issues that augmented the author’s attempt to 
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obtain insight related to the research questions. The following patterns and subsequent 
themes are important perspectives that provide contemporary revelations related to the 
Pharm.D.  
 Sixteenth pattern: The Pharm.D. must rely on the pharmacy technician in 
the dispensing role in order to have time for patient care. Respondents recognized 
explicitly that for pharmaceutical care to become the primary task of the Pharm.D., 
pharmacists will have to relinquish dispensing duties (allocation of medicines) to the 
pharmacy technicians. Respondents raised issues related to employment, salary, role, 
responsibilities, and the business model. Underlying all this was the question: When? 
This was not addressed in the research questions; accordingly, the author’s search of 
previous literature that pertains to the capacity in which pharmacy technicians impacted 
the Pharm.D. is less exhaustive. Noteworthy, the issues raised are rife with resistance to 
change, and further research on this is clearly warranted.  
 Theme: The role of the pharmacy technician has created huge internal conflict 
for many years, and this continues to this day. According to several respondents, the 
debate surrounding the role and responsibilities of pharmacy technicians is as long 
standing as the Pharm.D. discussion. The reflections of these respondents constitute 
information new to the field, as the author is unaware of published literature that 
addresses the conversations and decision-making process of the pharmacy technician’s 
scope of practice.    
 Theme: The profession needs to get technicians licensed, but the idea of 
accomplishing this in this country will require a daunting political battle. The 
respondents indicated that, although opportunities for pharmaceutical care are expanding, 
the majority of Pharm.D.s are in a community practice dominated by the chain drugstore 
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business model. The debate is an extension of previous discussion segments in this 
dissertation. The licensing of pharmacy technicians is a potential threat to the pharmacist 
in this situation. The scope of practice of pharmacy technicians is inconsistent throughout 
the United States, mimicking the issues of the Pharm.D. Despite the complexities, and 
ultimately the importance of this issue, the author is unaware of published literature that 
addresses the debate regarding the regulation and scope of practice of the pharmacy 
technician. 
 Seventeenth pattern: Location, age, and patient compliance affect access to 
and quality of healthcare. The following themes relate to the respondents’ perceptions 
related to with access to quality health care, especially for high-risk populations.   
 Theme: One of the surprises has been the rather quick movement of 
pharmacists out of the inner cities. Respondents spoke generally regarding the 
expectation in the caring professions that the practitioner is there to serve the best 
interests of the patients. Education in most health professions has a service duty 
requirement. The respondents noted a limited presence of pharmacists in underprivileged 
areas, specifically the inner cities. One respondent believed this is a result of two things: 
(a) the pharmacy education curriculum has dismissed the civic duty requirement, and (b) 
new graduates are attracted to practice situations that provide the highest salary. In other 
health professions, there is an agreement with the federal government that provides a 
tuition waiver for graduates who practice in underserved regions within the U.S. This 
option is not available to the Pharm.D. at the time of this writing. To the author’s 
knowledge, this study is the only one that explicitly addresses the changes in the 
demographics of pharmacy practice. The concomitant issue regarding the omission of the 
service duty/tuition waiver in pharmacy education has received far too little attention in 
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the literature. For that reason alone, the current study makes an important contribution to 
the field.  
 Theme: One out of every five Medicare patients ends up in the hospital because 
they do not take their medications correctly. The respondents spoke passionately about 
issues related to health literacy because of a deficiency in access to quality care, 
especially for the at-risk populations. Several respondents believed pharmacists have a 
responsibility to address the accessibility problems but acknowledged that this is a major 
challenge because of no compensation system established for health literacy services for 
pharmacists. These comments provide a present day perception of a discussion described 
by Worthen (2006) that started in 1967 when the Task Force on Prescription Drugs were 
charged with investigating the impact of extending outpatient prescription coverage to 
Medicare patients. Again, the literature on this topic is sparse, and raising this issue 
explicitly is an important contribution to the field.  
Recommendations 
 While it is commonplace for the Recommendations section of a dissertation to be 
divided into two sections--one on policy and one on future research--this study includes a 
third section, Suggestions for Other Health Professions. Throughout the findings from 
this study, the participants provided strategies specific to other health professions that are 
considering the educational requirement change to a clinical doctorate. The general 
responses to the interview questions were covered with a sense of “we have been there, 
and we would like to assist any other health profession considering the clinical doctorate 
so it will be a successful transition.” 
Policy Considerations 
 First, the U.S. licensing regulations rest in the hands of each individual state. 
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There is great diversity in the scope of pharmacy practice across the country. 
Technological advances allow for information transfer to cross borders in the blink of an 
eye. This raises concern at both the product level and the patient level of pharmaceutical 
care. The conversation of a national, uniform scope of practice and licensing process 
would support pharmacy’s clarity of its internal vision. 
 Second, the accreditation process as it exists has evolved from an independent 
self-regulated entity to a complex system with relationships and interdependencies among 
government and institutions. Currently, the accreditation process does not have regulation 
over the number of schools or number of students enrolled in a program.  
Yet, the educational system could take some responsibility for balancing the workforce 
supply/demand with the appropriate number of highly qualified practitioners. 
 Third, Clement (2005) suggested that one measure of quality improvement in 
health professional programs is increasing numbers of doctoral prepared faculty. Clement 
linked the trend for the increase in doctoral prepared faculty to the accreditation 
requirements of the doctoral degree. Yet, this does not necessarily equate to the 
development of critical thinking and reflective skills that Barnett (as cited in Davis & 
Burnard, 1992) noted that were once thought to be cultivated only through experience 
and professional practice. Documentation shows many health professions are deficient in 
clinical faculty who are capable of educating the next generation of health practitioners in 
experiential practice. Is it plausible to think that educators can move an individual 
through the newly established clinical doctorate program and assume that, without 
pharmaceutical practice in field, they are qualified to teach the next generation 
sufficiently in clinical practice? Should the accreditation agencies require a minimum of 
clinical experience before a clinician is qualified to take on the role of clinical faculty in 
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the experiential portion of the educational process? How does the pharmacy profession 
bridge the gap between the necessary number of faculty and the actually qualified faculty 
responsible for experiential education? 
 Fourth, conflict exists at the institutional level related to the responsibilities and 
career advancement for clinical faculty as compared to the responsibility and tenure track 
of Ph.D. faculty. The establishment of parallel guidelines that put these two important 
faculty appointments on the same playing field would bring cohesiveness between the 
departments, strengthening the program outcomes. At the very least, the guidelines for 
tenure and promotion for clinical track faculty need to be revisited to ensure they are 
consistent with responsibilities and skill sets, the changing nature of professional 
practice, and the need for competent instructors in the clinical arena. Given this latter 
point, questions about whether faculty with clinical appointments should be allowed to 
chair doctoral committees deserve serious consideration. 
 Fifth, third party payer systems are apprehensive of paying higher levels of 
reimbursement. To date, few reimbursement sources have altered payments to reflect 
advanced degrees held by health professionals (ASAHP, 2012). It is unlikely that payers 
will reward the pharmacist financially unless the Pharm.D. results in a reimbursement 
skill that the individual (or profession) did not have previously. The current 
reimbursement model is product-oriented and directly related to dispensing. Perhaps a 
pharmacy-wide, national initiative parallel to the set of four agencies that worked 
together to mandate the transition to the Pharm.D. back in 1992 could be convened to 
discuss/implement a strategy for the transition from product-oriented to patient-oriented 
pharmaceutical care.   
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Suggestions for Other Health Professions 
 First, clarity and transparency of the intention to change the educational 
requirements are important. Be specific on how the new requirements will advance the 
knowledge, skills, and abilities of the practitioner. Explain how the advance in 
capabilities benefits the patient, healthcare delivery, and society as a whole. 
 Second, involve all stakeholders in the discussions at every step along the way. 
Take the time to gain confidence that the change in educational requirements is 
necessary. 
 Third, the healthcare system is moving to collaborative practice, not increasing 
the autonomy of individual specialist. The clinical doctorate allows the practitioner a 
position on the patient-care team to work together with other disciplines for the best 
practice for the patient. Aspects of this collaboration include both education (e.g., clinical 
rounds as a multi-disciplinary team) and practice (professionals from different healthcare 
professions consult to share complementary knowledge/skills for improved patient care). 
  Fourth, understand the necessity of advocacy. Changing only the educational 
requirements does not result in immediate changes in practice. Establish a strategic plan 
to educate the stakeholders, other health professionals, regulators, and the public. 
 Fifth, prepare for the inevitability of resistance to change, both internally and 
externally. Thus the need is present to address strategies for overcoming the recalcitrance, 
including the possibility of restructuring incentive systems. 
 Sixth, consider the impact of curricular changes on students and the entire 
educational experience.  
 Seventh, investigate the role finances play in changing the educational 
requirements, such as the increase in educational cost to the student, institutional 
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expenses to obtain the necessary resources, and the state of the reimbursement system for 
the practitioner in the field. 
 Eighth, be prepared for a long, slow process. This type of major change effort is 
an evolution, not a revolution. 
Future Research 
 First, a fundamental question before the profession is, What should the pharmacy 
profession be doing to take care of patients at every single practice setting? One 
respondent said that he tried to get students to write a paper that describes the 
professional role, set of functions, practice activities, and job descriptions of what they 
visualize themselves doing in practice before they graduate. An evidence-based 
articulation of what practice should be and how to get there successfully would constitute 
a powerful research agenda. 
 Second, Clark (1999) suggested that many educational programs use the term 
interdisciplinary when they mean multidisciplinary. Some experiential learning situations 
have multiple contributions from different departments or disciplines, but they fall short 
of the level of integration of perspectives demanded by the interdisciplinary context. A 
respondent criticized the experiential piece of pharmacy education, noting that it is a 
disservice to send students to chain drugstores while in college and call that a community 
pharmacy rotation, which is supposed to constitute a clinical experience and expose the 
student to counseling patients. Reeves (2009) proposed that academic leaders have a poor 
idea of what form of faculty support is necessary to prepare students for facilitating 
interprofessional learning. Thus, research is needed to explore the structure, goals, and 
functioning of the experiential portion of pharmacy education.  
 Third, a theme discovered from the responses was that the primary external 
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opposition was from the chain drugstores and owners of regional chains. The NACDS 
was a strong lobbyist against the move to the Pharm.D. In the past few years, many chain 
drugstores are shifting the business model of the pharmacy departments. One respondent 
suggested that it might be interesting to investigate the factors influencing chain 
drugstores to change the store layout so that pharmacists are actually talking to patients. 
 Fourth, the role and responsibilities of technicians in pharmacy continue to build. 
Knapp (2012) noted decisions over the appropriate training, credentialing, and the scope 
of practice of technicians are still unsolved. These issues are rife for systematic research. 
 Fifth, accreditation is a self-regulated process driven by the adherence to quality 
of the individual institution, not from the perspective of the overall quality of pharmacy 
education (Knapp, 2011). The general position of the accrediting agencies is that all 
Pharm.D. schools meeting the minimum requirements for accreditation are basically the 
same, regardless of inclusion or exclusion of research requirements. Knapp (2012) argued 
that the ACPE has been criticized for allowing these schools to start up too easily. There 
is expressed concern about the increasing number and types of Pharm.D. schools and 
implications for the quality of these programs, vis-à-vis pharmacy education enterprise 
and patient care. A major investigation on the components that relate to quality 
professional education, akin to the Flexner Report of 1910, is warranted (Thelin, 2004). 
 Sixth, institutional issues related to differences in prestige and the hierarchy 
among faculty can have consequences for the educational program and practice. The 
effects of this phenomenon for achieving tenure/promotion for different salaries, and 
even the structure of appointments within the tenure stream (e.g., membership in graduate 
faculty) is suitable for valuable empirical research. 
 Seventh, as other fields transition to the clinical doctorate, systematic research on 
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the development and implementation of the new degree for entry-level practice should 
occur throughout the process. The pharmacy profession failed to do this. The possibility 
of discovery that some policies have generated negative, unintended consequences and 
concomitant corrective action is too important to leave unmonitored. 
 Based on the potential implications for further research, conceptualizing the 
transition to the Pharm.D. based on empirical work may contribute to understanding the  
scope of pharmacy practice in emerging contexts, redefining the position of the 
pharmacist in the healthcare system, and advancing theories relevant to a wider range of 
individual. 
Conclusions 
 A common trend that is occurring in health professions education is the many 
disciplines that are elevating the entry-level degree into practice to the doctoral level. 
Possibly even more prominent is the performance gap related to the competencies 
associated with the new degree and the opportunities to maximize the capabilities in 
practice. While there are significant resources on this trend in the form of position papers, 
literature reviews, opinions, and commentaries regarding the benefits, risks, and 
alternatives to the change in educational requirements, empirical research in the field is 
lacking.  
 The purpose of this retrospective qualitative study was to understand the 
perceptions of professional leaders and policy makers regarding the benefits, risks, and 
alternatives of the clinical doctorate as an entry-level degree for pharmacists. The 
subjects interviewed were all participants in the four key policy groups involved in the 
decision to mandate the Pharm.D. as the entry-level degree for the profession of 
pharmacy.  
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 The 1992 mandate specified the implementation was to be completed for 
graduates after January 1, 2003. This provided institutions 7-10 years to execute the 
requirements of the mandate. In addition, the timeframe allowed leaders and professional 
organizations to advocate the benefits of the Pharm.D. to other health care providers and 
the general public. Therefore, the central research question for this study is: “What are 
the current perceptions (benefits, risks, and alternatives) of key policy makers in the 
pharmacy profession who participated in the decision to require the clinical doctorate 
(Pharm.D.) as the entry-level degree for practitioners?” 
 Study results demonstrate that the implementation of the Pharm.D. required major 
changes to occur at four levels: health professions education, delivery of services, 
interdisciplinary relationships, and society as a whole. Decisions at each level acted as a 
building block for decisions at the next level. Decisions did not occur in a linear fashion, 
but rather they overlapped one another. Each level requires constant reflection and on-
going improvements, but the profession is moving forward and the Pharm.D. mandate 
was the starting block in these sweeping changes.  
 This study reveals that many pharmacy leaders believe that the Pharm.D. is the 
most important decision that has ever been made for the advancement of pharmacy, and 
the most difficult. The profession prepared for pharmaceutical care through the 
guidelines set forth by the Commission to Implement Change in Pharmacy Education. 
One of the greatest benefits uncovered in the data analysis was the development of a 
competency-based framework for the Pharm.D. curriculum: the combination of 
knowledge, dispositions, and clinical skills required for pharmacists as individuals, with 
the recognition that this clinical doctorate also may change the very nature of public 
sector pharmaceutical care.  
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 The data exposing the challenges to the academy when establishing a curriculum 
that ensures this transformational understanding of pharmacy were monumental. Yet, the 
collective sense of the respondents in this study suggests that the academics have 
overcome them and succeeded. While the landscape of pharmacy practice continues to 
evolve, with the inevitability of new issues, the Pharm.D. envisioned in the 1992 mandate 
has clearly changed the face of the profession.  
 A major benefit is that the new Pharm.D. graduate has the capabilities to create 
opportunities in the healthcare delivery system, especially in the hospital setting. Risks 
associated with the entry-level Pharm.D. consist of increasing educational costs, 
increasing consumer costs, underuse of the pharmacist’s preparation, a reduction in 
quality of Pharm.D. programs, inadequate faculty to train Pharm.D. students, and a 
shortage of Ph.D. prepared pharmaceutical researchers. In the current business 
framework (dominated by the large chain drugstores), the relative return to the student is 
problematic: the product-oriented model (dispensation of medicines) does not reflect the 
capabilities of Pharm.D.s to practice pharmaceutical patient care. Without a fundamental 
shift in the business model (from product to patient care), it is likely that salaries will 
become commensurate with the educational preparation.  
 A serious barrier to the advancement of pharmaceutical care identified in this 
study is that the third-party reimbursement model for community pharmacist has always 
been, and still is, primarily product-based. As pharmacists move from product-focused 
services to patient-care services, establishment of reimbursement rates for services 
rendered must be a priority. A base rate for the personal time required for providing 
direct patient care is complicated, but necessary, if the role of a patient-based pharmacist 
is to become the best practice of pharmacists in all practice settings. If pharmacists are 
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not paid for the cognitive services they are capable of providing, many will be 
apprehensive about assuming primary roles in a patient’s care.    
 In order for education to be effective, it must result in the effective translation into 
practice of the knowledge, skills, and abilities learned. While this study is limited with 
respect to the broader (macro) forces of changes in education and scope of practice, this 
work provides some practical implications for other disciplines, particularly for how the 
practice has changed at the institutional (middle range) and professional (micro) levels. 
For those in other health professions contemplating the clinical doctorate, pharmacy 
already has debated, discussed, and struggled with the transition to an entry-level clinical 
doctorate. The Pharm.D. has now been solidified, yet the profession must acknowledge 
that the hoped for impact on the larger U.S. healthcare system and patients depends on 
the clarity of pharmacy’s internal vision. For all the participants, including insurers and 
payers, regulators, and other health professions, the progress thus far has been significant 
but far from universal and fraught with resistance. The envisioned shift to a patient-based 
pharmaceutical care model is still a goal to be realized. Yet, given the explosion of 
pharmaceutical research and utilization, and an aging population, the need for advanced 
preparation and integration of patient care by the healthcare team is inevitable; and the 
quest for a patient care model, in lieu of a product focus on the dispensation of medicines, 
will almost certainly continue.  
 Among the interdisciplinary professions, the pharmacists possess the expertise to 
provide drug management and intervention. Patients, clinics, hospitals, and insurers are 
quietly pleading for competent pharmaceutical care practitioners. Opportunities would 
rise if these and other stakeholders understood the profession. It is essential that the 
recognition of each profession’s unique skills and competencies and mutual respect 
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among related disciplines be instilled at the educational level. This requires situations 
where students in health professions program work together, as equals, in real-life 
patient-care environment.  
 With respect to pharmaceutical care becoming the best-practice model, the 
pharmacist must assume a more proactive role and increased responsibility in patient care 
outcomes. Pharmacy needs to possess the confidence to advocate for its own purpose and 
provide assurance of its own internal clarity and value to society. In addition, the 
pharmacist must develop open, professional relationships with patients and other 
members of the healthcare team. 
 Finally, this study asked a central question related to the current perceptions 
(benefits, risks, and alternatives) of key policy makers in the pharmacy profession who 
participated in the decision to require (by January 1, 2003) the clinical doctorate 
(Pharm.D.) as the entry-level degree for practitioners. The overarching conclusion is that 
these leaders are confident that establishing the Pharm.D. as the sole degree for entry into 
pharmacy practice was the right decision for the profession. In light of the changing 
landscape of the healthcare demands of the public and the advancement of the 
pharmaceutical industry, a societal need exists for advancement in the competencies of 
the pharmacist to practice in the 21st century. Most were proud and honored to have been 
part of this evolution in pharmacy practice. These key policy makers acknowledged that 
the transition to the Pharm.D. was long and charged with debate, emotion, and discourse, 
both hoping for few unexpected/problematic outcomes. This study allowed these 
individuals to reflect on the process. 
  That these key policy makers are unquestionably satisfied that the systematic and 
inclusive approach taken was the right one is incontrovertible. Across all the interviews, 
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this retrospective sense of the correctness of their decision, highly controversial and 
embroiled in resistance as it was at the time, comes across clearly and not without a sense 
of professional pride in having participated in such a momentous policy mandate. Thus, 
the leaders are triumphant that success in changing the professional philosophy from 
product-based to the patient-based pharmaceutical care was accomplished. The 
respondents were content that the academic leaders have created an educational 
curriculum that provides new graduates the capabilities of practicing in a variety of 
practice settings.  
 However, these leaders accept the fact that the changing the Pharm.D. was only 
the starting block and more is needed. Now that the pharmacists are capable of providing 
direct patient care and being an important member of the healthcare team, the focus now 
turns to establishing their solid place in the collaborative health delivery system. This 
requires advocacy from the professional associations, policy makers, and practicing 
pharmacists on the value of pharmacy to other health providers, the public, and, most 
important the reimbursement system. The perception of pharmacists by other healthcare 
providers will be remodeled by advancement in interdisciplinary learning at the 
educational level and collaborative care at the practice level.  
 As important as interdisciplinary education and collaboration by teams of 
professionals with complementary skills are, the current study raises another issue that 
may be even more problematic with respect to pharmacy’s progress toward a patient care 
model. Respondents discussed the current business model of the large chain drugstores, 
by far the most common means by which the public obtains pharmaceutical products in 
the U.S. These retrospective interviews with the key policy decision makers for the 
original mandate of the Pharm.D. back in 1992 clearly demonstrate their concern that, as 
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long as the chains continue their practice of dispensing medicines as a product, progress 
toward the pharmaceutical care model will be both slow and limited.  
 That point demonstrates the power of the current study. The retrospective micro 
focus on the development and implementation of the decision to transform pharmacy 
education to the entry-level clinical doctorate, from the perceptions of key decision 
makers, brings to light numerous factors on one issue after another that the predominant 
literature of policy and position papers, political commentary and opinion, or focus on the 
accrediting process had simply not addressed. The reality is that, while the larger macro 
policies set broad parameters for scope and practice, there is much latitude at the micro 
level--and this often plays out one pharmacy school at a time. This study reveals these 
very real differences and their impact. 
 Those insights not withstanding, the public’s knowledge and acceptance of the 
value of pharmaceutical care will be established only through development of health 
literacy programs and improved access to high quality healthcare, especially in the at-risk 
population. The most important challenge remains: changing the current U.S. healthcare 
reimbursement model for pharmacists, from product-based medicinal distribution to 
pharmaceutical patient care. Until there are systemic changes related to compensation for 
cognitive and direct-patient services, the full benefits of the Pharm.D. will be restricted 
and the true potential of the transition to the clinical Pharm.D. unrealized.
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Appendix A 
Interview Schedule Mapped to Research Questions 
 
These interview questions are intended to provide a retrospective understanding from key 
individuals who were decision makers for the transition to the entry-level Pharm.D. in 
pharmacy education. The transition to the Pharm.D. was a long process and faced 
controversies and tradeoffs that will be addressed in this interview. The respondents have 
the benefit of hindsight and your reflections may profit other health professions that are 
contemplating the transition to the clinical doctorate as the entry-level degree into 
practice.  
Research questions are in bold. Interview schedule queries are numbered IS1, IS2, IS3, 
etc.   
1. What are the benefits, risks, and alternatives of the elevation of requirements to 
an entry-level doctorate degree on: 
  
 a. Health professions education? 
 
 IS1. In general, what benefits do you think the Pharm.D. has had on Pharmacy 
 education? 
 
 IS2. To what extent has the curriculum/knowledge base changed for students? 
 What have been some of the trade-offs for changes in the curriculum/knowledge 
 base for students?  
 
 IS3. The entry-level degree into Pharmacy practice changed from a Master’s to a 
 Pharm.D. Why was the Pharm.D. chosen instead of a Ph.D.? How did this change 
 the structure of the educational programs? Were more clinical hours required or 
 length in program? Have institutions made the necessary changes?  
  
 IS4. Educational institutions had the responsibility of creating new Pharm.D. 
 programs that satisfied the accreditation requirements. One controversy of the 
 changeover has been the charge of “degree creep.” Do you feel that programs 
 have been successful in elevating the educational experience to the level 
 anticipated.  
 
 IS5. Was there a formal, structured plan developed to assist educational 
 institutions through challenges associated with the transition? What resources 
 have been available to institutions and program leaders in regard to establishing 
 curricular changes, faculty credentials, funding sources to implement the change, 
 etc?   
 
 b. Delivery of services? 
 IS6. The profession adopted the mission of “pharmaceutical care” as more 
 comprehensive, going beyond dispensing medications. Do you think the 
 profession has been successful in becoming primary pharmaceutical care 
 providers?  
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 IS7.  How have the state regulatory agencies accommodated the advanced 
 knowledge and skill base of the pharmaceutical professional? Have they expanded 
 the scope of practice and revised the licensure requirements?   
  
 IS8. How has the distribution of services been affected? For example, what effect 
 has the Pharm.D. had on rural or underserviced communities?  
  
 IS9. There were many opinions voiced in publications about how the Pharm.D. 
 would affect the delivery of service. Some reported that with the increased 
 autonomy, the  pharmacist would have direct patient contact and be the primary 
 manager of the patient pharmaceutical needs. Others reported that with the 
 increase in knowledge and skill, the new Pharm.D. would focus on increased 
 financial opportunities and move away from direct patient care. Now, 20 years 
 after the mandate, how do you think the delivery of  pharmaceutical services has 
 changed? 
 
 IS10. In hindsight, what roles and responsibilities of the pharmacy profession 
 have been most affected by the Pharm.D.? Which elements of professional 
 practice have benefited from the degree change and which ones did not change as 
 anticipated? 
 
 c. Interdisciplinary relationship of practicing clinicians? 
 
 IS11. Compare the status of pharmacy as a field within the hierarchy of the health 
 care industry in regards to:  
  i. salary?  
  ii. prestige?  
  iii. supply and demand? 
 
 IS12. How has the interaction between Pharmacists and other autonomous 
 providers changed, e.g., medical doctors, osteopathic physicians, or dentists? Is 
 there more of a partnership? Any conflicts? 
 
 IS13. Once the clinical practice of pharmacy was established as the professional 
 philosophy, what type of strategic plan was developed to inform and educate 
 members of other healthcare disciplines about the expansion of knowledge, 
 skills, and abilities of the pharmacy profession? 
 
 IS14. Do you recall what opportunities and threats from other disciplines were 
 presented during the decision-making process? What strategies were implemented 
 to embrace the opportunities or counteract the threats? 
  
 IS15. Retrospectively, what are the trade-offs that have come from the transition 
 to the Pharm.D? To what extent do you think that was recognized as being an 
 issue at the time that the transition was first implemented? 
 
 d. Societal and economic landscape of the health care industry (cost-benefit)? 
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 IS16. How does the change to the Pharm. D. serve the greater good? 
 
 IS17. Think about the strategic plan that the Pharm.D. represented as a policy 
 change. Retrospectively, to what extent has the “turf” of the health care fields 
 changed due to the implementation of the Pharm.D? How much did the balance of 
 power between healthcare professionals actually change? How much did the 
 perceptions of prestige, professional scope of practice for pharmacists actually 
 change? 
 
 IS18. What is your perception on how the Pharm.D. is viewed by the general 
 public? Do you think that the general population is familiar with the advanced 
 knowledge, skills, and abilities of pharmacists?  
 
 IS19. What is your sense about the public’s perceptions about the prestige of a 
 Pharm.D.? The public’s sense of advanced degrees and the people who earn 
 them? The effects on society as a whole? 
 
 IS20. What is your perception about society and the need for more classifications 
 of credentials or degrees? 
 
2. What is the transferability of an entry-level clinical doctorate related to 
professional opportunities? 
 
 IS21. What is the transferability of an entry-level clinical doctorate related to 
 professional opportunities, in theory? and Empirically? 
 
 IS22. What opportunities have evolved to allow the pharmacy profession to meet 
 more effectively the health care needs of society since the Pharm.D.?  
 
 IS23. What are your perceptions about how the Pharm.D. has enhanced the 
 professionalization of pharmacists? How? Why? 
 
 IS24. The decision to transition from a master’s to a clinical doctorate begins with 
 the internal decision and a strong rationale by the profession that change is 
 warranted. What are some of the external forces that are behind the progression of 
 the clinical doctorate as an entry-level degree that pertain to all other disciplines 
 that are undergoing the same transformation? Based on your retrospective, what 
 are the trade-offs/conflicts that other disciplines may face? 
 
 IS25. Inevitably, policy change leads to latent and unexpected developments. 
 Retrospectively, what do you think was the biggest surprise that resulted from the 
 change to the Pharm.D.? The biggest disappointment? 
 
 IS26. The conversation of the clinical doctorate is occurring on a global level. The 
 UK and Australia are experiencing their own transformations within health 
 professions. Was the impact of the Doctor of Pharmacy on the professional on a 
 global level discussed during the decision-making process? Considerations such 
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 as the equality of the scope of practice from country-to-country, educational 
 requirements, licensing processes, etc.? 
 
 IS27. Can you think of anything else that might be relevant? Anything on power? 
 Backlash? Positive effects? Other? 
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Appendix B 
Document Analysis Protocol 
  
These document analysis items are intended to provide background information and 
verify the knowledge and skills of key individuals who were decision makers for the 
transition to the entry-level degree in pharmacy education. The protocol provides a 
structured approach for obtaining details from each individual’s curriculum vitae. This 
provides consistent data from documents (CVs) that are highly personalized, with no set 
template for presentation. The protocol is applied preliminary to the interviews, giving 
the researcher a better sense of how each subject fits into the wider policy matrix when 
the full interview is conducted.  
 
DA 1. What is the full name of the individual being interviewed? 
 
DA 2. What type of degree and university/certifications does the interviewee hold? What 
year was each degree received? 
DA 3. What is the current occupation of the interviewee? 
 
DA 4. Outline the professional experience of the interviewee? 
 
DA 5. From the four stakeholder domains, list the person’s involvement, position held, 
and years of service. 
DA 6. Note any unique qualities or experiences of the individual. 
 
DA 7. List three things that are important for the interview. 
 
DA 8. List two things that the document tells the researcher about the person at the time it 
was written. 
DA 9. Write a question to the individual that is left unanswered by the document. 
 
DA 10. Note any authored publications that are directly related to this research study. 
 
DA 11. What is the date of the document? Is it the most recent edition? 
 
DA 12. Confirm current contact information for the interviewee. 
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Appendix C 
Interview Schedule  
 
The questions in the Interview Schedule focused on retrospective insights and effects of 
participants involved in the decision to make the Pharm.D. the entry-level degree for 
pharmacy.  
 
IS1. In general, what benefits do you think the Pharm.D. has had on Pharmacy education? 
 
IS2. To what extent has the curriculum/knowledge base changed for students? What have 
been some of the trade-offs for changes in the curriculum/knowledge base for students? 
  
IS3. The entry-level degree into Pharmacy practice changed from a Master’s to a 
Pharm.D. Why was the Pharm.D. chosen instead of a Ph.D.? How did this change the 
structure of the educational programs? Were more clinical hours required or length in 
program? Have institutions made the necessary changes? 
  
IS4. Educational institutions had the responsibility of creating new Pharm.D. programs 
that satisfied the accreditation requirements. One controversy of the changeover has been 
the charge of “degree creep.” Do you feel that programs have been successful in 
elevating the educational experience to the level anticipated?  
 
IS5. Was there a formal, structured plan developed to assist educational institutions 
through challenges associated with the transition? What resources have been available to 
institutions and program leaders in regard to establishing curricular changes, faculty 
credentials, funding sources to implement the change, etc?  
  
IS6. The profession adopted the mission of “pharmaceutical care” as more 
comprehensive, going beyond dispensing medications. Do you think the profession has 
been successful in becoming primary pharmaceutical care providers?  
 
IS7.  How have the state regulatory agencies accommodated the advanced knowledge and 
skill base of the pharmaceutical professional? Have they expanded the scope of practice 
and revised the licensure requirements?  
  
IS8. How has the distribution of services been affected? For example, what effect has the 
Pharm.D. had on rural or underserviced communities? 
  
IS9. There were many opinions voiced in publications about how the Pharm.D. would 
affect the delivery of service. Some reported that with the increased autonomy, the 
pharmacist would have direct patient contact and be the primary manager of the patient 
pharmaceutical needs. Others reported that with the increase in knowledge and skill, the 
new Pharm.D. would focus on increased financial opportunities and move away from 
direct patient care. Now, 20 years after the mandate, how do you think the delivery of 
pharmaceutical services has changed? 
 
IS10. In hindsight, what roles and responsibilities of the pharmacy profession have been 
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most affected by the Pharm.D.? Which elements of professional practice have benefited 
from the degree change and which ones did not change as anticipated? 
 
IS11. Compare the status of pharmacy as a field within the hierarchy of the health care 
industry in regards to:  
 i. salary?  
 ii. prestige?  
 iii. supply and demand? 
 
IS12. How has the interaction between Pharmacists and other autonomous providers 
changed, e.g., such as medical doctors, osteopathic physicians, or dentists? Is there more 
of a partnership? Any conflicts? 
 
IS13. Once the clinical practice of pharmacy was established as the professional 
philosophy, what type of strategic plan was developed to inform and educate members of 
other healthcare disciplines about the expansion of knowledge, skills, and abilities of the 
pharmacy profession? 
 
IS14. Do you recall what opportunities and threats from other disciplines were presented 
during the decision-making process? What strategies were implemented to embrace the 
opportunities or counteract the threats? 
 
IS15. Retrospectively, what are the trade-offs that have come from the transition to the 
Pharm.D? To what extent do you think that was recognized as being an issue at the time 
that the transition was first implemented? 
 
IS16. How does the change to the Pharm. D. serve the greater good? 
 
IS17. Think about the strategic plan that the Pharm.D. represented as a policy change. 
Retrospectively, to what extent has the “turf” of the health care fields changed due to the 
implementation of the Pharm.D? How much did the balance of power between healthcare 
professionals actually change? How much did the perceptions of prestige, professional 
scope of practice for pharmacists actually change? 
 
IS18. What is your perception on how the Pharm.D. is viewed by the general public? Do 
you think that the general population is familiar with the advanced knowledge, skills, and 
abilities of pharmacists? 
  
IS19. What is your sense about the public’s perceptions about the prestige of a Pharm.D.? 
The public’s sense of advanced degrees and the people who earn them? The effects on 
society as a whole? 
 
IS20. What is your perception about society and the need for more classifications of 
credentials or degrees? 
 
IS21. What is the transferability of an entry-level clinical doctorate related to professional 
opportunities, in theory? and Empirically? 
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IS22. What opportunities have evolved to allow the pharmacy profession to meet more 
effectively the health care needs of society since the Pharm.D.? 
  
IS23. What are your perceptions about how the Pharm.D. has enhanced the 
professionalization of pharmacists? How? Why? 
 
IS24. The decision to transition from a master’s to a clinical doctorate begins with the 
internal decision and a strong rationale by the profession that change is warranted. What 
are some of the external forces that are behind the progression of the clinical doctorate as 
an entry-level degree that pertain to all other disciplines that are undergoing the same 
transformation? Based on your retrospective, what are the trade-offs/conflicts that other 
disciplines may face? 
 
IS25. Inevitably, policy change leads to latent and unexpected developments. 
Retrospectively, what do you think was the biggest surprise that resulted from the change 
to the Pharm.D.? The biggest disappointment? 
 
IS26. The conversation of the clinical doctorate is occurring on a global level. The UK 
and Australia are experiencing their own transformations within health professions. Was 
the impact of the Doctor of Pharmacy on the professional on a global level discussed 
during the decision-making process? Considerations such as the equality of the scope of 
practice from country-to-country, educational requirements, licensing processes, etc.? 
 
IS27. Can you think of anything else that might be relevant? Anything on power? 
Backlash? Positive effects? Other? 
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Appendix D 
Letter to Expert Panel Members 
 
Researcher’s Address 
 
 
Expert Panel Member’s address 
Dear Expert Panel Member: 
 I am a student in the Doctoral Program at Western Kentucky University. I am 
completing a research project under the direction of Dr. Stephen Miller, College of 
Education and Behavioral Sciences, Department of Educational Administration, 
Leadership, and Research at Western Kentucky University. 
 The qualitative research project is titled “A Case Study on Pharmacy 
Accreditation Governing Agency on the Benefits, Risks, and Alternatives of the 
Doctorate as the ENTRY-LEVEL Degree.” This study is an study of how the transition to 
the clinical doctorate in one profession, Pharmacy, was perceived during the 
establishment and implementation phases of the Doctor of Pharmacy.  
 The purposeful sample will come from members of the Commission to Implement 
Change in Pharmaceutical Education, the Janus Commission, the AACP Board of 
Directors, and the ACPE Board of Directors that served from 1989 – 2002. 
  The participant will provide a current curriculum vitae followed by a semi-
structured interview. I would like feedback into the questions on the interview. I have 
attached the interview schedule as mapped to the research questions. I would like for you 
to review the set of questions and provide feedback on the forms included.  
 I believe this project is of importance to understanding the process of elevating a 
professional entry-level degree to a practice doctorate, a trend that is occurring in health 
professions. Your feedback will help me improve the clarity and concision of the 
questions, ensuring the most information from the subjects.  
 Thank you for your time. Please contact me by phone (314-616-4694) or email 
(heidi.crocker682@wku.edu) if you are unclear what the task is or if you are unable to 
participate. Your anticipated cooperation is appreciated.  
Sincerely, 
 
Heidi M. Crocker, D.C., M.A.  
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Appendix D 
Expert Review of Interview Schedule 
 
Please respond to the following questions regarding concerns affecting the Pharm.D. as 
the entry-level degree into Pharmacy decision. Comments may be written directly on the 
instrument. If additional space is needed, please attach a separate sheet of paper and 
specify to which item your comments refer. 
 
Please note that the research questions were developed from the literature and theoretical 
perspective included in Chapter II. If you would like to examine this section, please 
contact me and I will provide you with a copy. 
 
Thank you again for your time. 
 
The Interview Schedule Mapped to Research Questions (Appendix A) is attached for 
your convenience. 
 
1. Introduction: 
  
 Is the introductory statement of purpose clear? 
 
2. Format: 
 Is the format clear? 
 Easy to follow? 
 Are the questions clear and understandable? 
3. Topics: 
 Is the wording appropriate for pharmacy leaders? 
 Do the questions make sense in terms of content? 
4. Directions? 
 Are the directions clear and understandable to the interviewee? 
5. Feasibility? 
 Is the instrument practical? 
 Is the instrument too long? 
6. Do you have any general comments or suggestions on the overall format and 
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presentation of the interview schedule? 
7. Do you have any final thoughts about the constructs? Any particular suggestions? 
 
 
Thank you for your time and effort! 
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Appendix E 
Letter to study participants 
 
 
April 9, 2012 
 
Researcher’s Address 
Recipient’s Address Dear Recipient: 
 I am a student in the Educational Leadership Doctoral Program at Western 
Kentucky University. I am completing a research project under the direction of Dr. 
Stephen Miller, College of Education and Behavior Sciences, Department of Educational 
Administration, Leadership, and Research at Western Kentucky University. 
 You are being invited to participate in a qualitative research project entitled “A 
Case Study on Pharmacy Accreditation Governing Agency on the Benefits, Risks, and 
Alternatives of the Doctorate as the ENTRY-LEVEL Degree.” This study is an study of 
how the transition to the clinical doctorate in one profession, Pharmacy, was perceived 
during the establishment and implementation phases of the Doctor of Pharmacy. For this 
research, members of the Commission to Implement Change in Pharmaceutical 
Education, the Janus Commission, the AACP Board of Directors, and the ACPE Board of 
Directors that served from 1989-2002 will be interviewed to determine perceptions about 
the dynamic changes that have been made related to the Doctor of Pharmacy mandate. 
Specifically, this study will explore the perceptions on the benefits, risks, and alternatives 
that were considered in the decision-making process and the impact that the transition to 
the clinical doctorate has had on pharmaceutical education, the Pharmacy profession, and 
society. 
 Two instruments will be used to gather information. Prior to participation, you 
will be required to complete a consent form. Then, before the interview, you will be 
asked to complete a short background questionnaire. A semi-structured format with open-
ended questions will be used for the interview. The approximately one hour recorded 
session will be conducted by your method of choice: face-to-face, videoconference, or 
telephone, at a mutually agreed upon time. 
 Be assured that there are no physical, psychological, financial, or legal risks to 
you or any participant associated with this study. The benefits gained from your 
participation will provide information about the key policy and operational issues, as well 
as the complications of the change process during the transition to the clinical doctorate 
as the entry-level degree. The dialogue occurring in many health professions may be 
enhanced by the query of other professions that have moved toward clinical doctorates to 
discover commonalities in pursuing a higher entry-level degree.  
 Absolute confidentiality cannot be guaranteed; however, data will be held in 
confidence to the extent permitted by law. All information collected may be reviewed by 
Dr. Miller and/or others associated with the research study.  
 Your participation in this study is voluntary. You are free to withdraw your 
consent at any time without penalty. You are free to decline to answer any particular 
question that may make you feel uncomfortable.  
 If you have any questions, please contact myself or Dr. Miller. You may contact 
the Human Studies Committee offices at Western Kentucky University to discuss any 
questions about your rights as a research subject, in confidence, with a member of the 
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respective committee. These are independent committees composed of faculty and staff 
of Western Kentucky University. The committees have reviewed this study. 
Sincerely, 
 
Heidi M. Crocker, D.C., M.A. 
Cell: (314) 616-4694 Email:  heidi.crocker682@topper.wku.edu 
Dr. Miller: (270) 745-6901 
WKU Human Studies Committee office: (270) 745-6733 
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INFORMED CONSENT 
Project Title: A Case Study on Pharmacy Accreditation Governing Agency on the 
Benefits, Risks, and Alternatives of the Doctorate as the ENTRY-LEVEL Degree  
Investigator:   Heidi M. Crocker, WKU Educational Leadership Doctoral Program  
           Telephone: (314) 616-4694 Email: heidi.crocker682@topper.wku.edu 
You are being asked to participate in a project conducted through Western Kentucky 
University. The University requires that you give your signed agreement to participate in 
this project. 
The investigator will explain to you in detail the purpose of the project, the procedures to 
be used, and the potential benefits and possible risks of participation. You may ask 
him/her any questions you have to help you understand the project. A basic explanation 
of the project is written below. Please read this explanation and discuss with the 
researcher any questions you may have. 
If you then decide to participate in the project, please sign on the last page of this form in 
the presence of the person who explained the project to you. You should be given a copy 
of this form to keep. 
1. Nature and Purpose of the Project: The purpose of this qualitative study is to 
understand the perceptions of the benefits, risks, and alternatives of the clinical doctorate 
as an entry- level degree for pharmacists among professional leaders and policy makers.  
2. Explanation of Procedures: A content questionnaire will be sent by email to all 
participants that have completed this informed consent form. This form will be returned 
to the investigator by email. Once the content questionnaire is received, the investigator 
will contact the participant to schedule the interview. The participant will have the choice 
of interview method: face-to-face, videoconference, or telephone. All participants will be 
ensured confidentiality of the interview transcripts. The interview session per participant 
is designed to not exceed one hour. 
3. Discomfort and Risks: There are no physical, psychological, financial, or legal risks 
to your any of the other participants associated with this study. 
4. Benefits: The benefits gained from your participation may provide information about 
the decision-making process of Pharmacy moving to a doctorate as the entry-level into 
practice and expand the knowledge base for other health professions contemplating 
transitioning to the doctorate as an entry-level into practice. 
 
 
 
5. Confidentiality: Absolute confidentiality cannot be guaranteed; however, data will be 
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held in confidence to the extent permitted by law. All information collected may be 
reviewed by Dr. Miller and /or the University Human Studies Committee.  
6. Refusal/Withdrawal: 
  
Refusal to participate in this study will have no effect on any future services you may be 
entitled to from the University. Anyone who agrees to participate in this study is free to 
withdraw from the study at any time with no penalty. 
You understand also that it is not possible to identify all potential risks in an 
experimental procedure, and you believe that reasonable safeguards have been taken to 
minimize both the known and potential but unknown risks. 
 
__________________________________________           _______________  
Signature of Participant            Date 
  
__________________________________________           _______________  
Witness              Date  
 
THE DATED APPROVAL ON THIS CONSENT FORM INDICATES THAT 
THIS PROJECT HAS BEEN REVIEWED AND APPROVED BY 
THE WESTERN KENTUCKY UNIVERSITY INSTITUTIONAL REVIEW BOARD 
Paul Mooney, Human Protections Administrator 
TELEPHONE: (270) 745-6733 
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Appendix G 
 
Summary Outline 
 
 This summary outline will make it easier for the reader to view the entire chapter 
in holistic context. Patterns one through seventeen are presented in bold and the 
associated themes are presented in bold italic. Patterns sixteen and seventeen did not fit 
directly under any of the research questions and are addressed as additional findings.  
 Research Question 1a 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate on: 
  
 a. health professions education? 
 First pattern: Historical accounts leading up to the ACPE mandate. There 
was a slow, incremental understanding that the practice of pharmacy both in 
hospitals and in community settings should be patient-care based. Because of the 
uncertainty and magnitude of the changes, this process was going to require 
comprehensive and explicit dialogue among all stakeholders.  
 Theme: The decision-making and implementation timeframe was a constructive 
process, but it was very controversial with a lot of anxiety about it.  
 Theme: Many respondents believe that pharmacists are the most 
underappreciated health profession. The pharmacist’s contribution to healthcare is 
undervalued because they are invisible to the public. 
 Theme: There is still debate whether pharmacy education should focus on 
patient care or the product. 
 Second pattern: For this transition to be uniform and organized, it had to 
stem from the academic accreditation bodies and the educational profession. 
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Curricular changes in pharmacy education were necessary for successful conversion 
to the doctorate level. 
 Theme: During the transition, many schools revisited their clinical curriculum 
in making changes because those 7-10 years sustained a major overhaul in 
accreditation standards. 
 Theme: In order for the pharmacist to take on the responsibilities associated 
with drug management, the pharmacy education would need to be revamped. 
 Theme: Concern was expressed over which degree was appropriate. 
 Theme: A large group of individuals, these being academics, opposed the 
doctorate as the entry-level degree into pharmacy.  
 Theme: The biggest curricular change was the addition of the one year of 
experiential work. 
 Third pattern: When converting to the Doctor of Pharmacy degree program, 
many institutions experienced internal resistance related to universities and their 
educational programs.  
 Theme: The state universities, in many cases, were much more research 
focused and research intensive, with NIH or FDA funding, and that is viewed 
positively across the country and internationally. 
 Theme: Schools that established the educational model of the 
Pharm.D./medical school had an easier time with the transition. 
 Theme: It was a struggle to create another position called clinical faculty. This 
position was necessary because of the inclusion of the experiential component that was 
added to the curriculum. 
 Theme: Originally, a shortage of clinical faculty in the Pharm.D. programs 
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existed. A major challenge for the programs was obtaining additional clinical faculty. 
  Theme: An issue faced by the schools is how to treat these new academics in 
terms of getting them promoted. 
 Theme: Within the schools and colleges of pharmacy, the biggest opposition 
was the basic science faculty.  
 Fourth pattern: Institutions making the conversion to the Doctor of 
Pharmacy degree were met with external resistance with respect to the practice of 
pharmacy.  
 Theme: There was opposition within the profession as well as that within 
universities.  
 Theme: Many of the people who held a Bachelor of Science degree (B.S.) in 
pharmacy as the main credential for a lifelong practice as a registered pharmacist were 
facing a choice. 
 Theme: The B.S. pharmacists said “wait a minute”; soon people will be asking 
for a Pharm.D. and we are not going to be considered for some positions. 
 Theme: The ability for pharmacy practice to evolve is dependent on the 
opportunities that exist in community and hospital practice settings. The 
responsibilities and duties of pharmacists are expanding in the work-place 
environment, but very slowly. 
 Theme: The educational outcomes of the pharmacy curriculum limit the roles 
and responsibilities of pharmacists in practice. 
 Theme: The respondents unanimously agreed that the primary external 
opposition came from the chain drugstores and owners of regional chains.  
 Fifth pattern: Recognition that the impact on students and the entire 
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educational experience was an important factor in both the decision and 
implementation of the professional doctorate in pharmacy. 
 Theme: A student can’t go through this program without going full time and 
having a structured curriculum. 
 Theme: There is a sense that to differentiate themselves now, new graduates 
have to go through residencies or obtain certifications. 
 Theme: The type of student attracted to pharmacy is part of the problem. 
 Sixth pattern: The changes in pharmacy education curriculum as related to 
academia have been an evolution, not a revolution. 
 Theme: The ACPE developed the add-on Pharm.D. to allow B.S. pharmacists to 
upgrade their credentials. 
 Theme: The complexity of drug interactions was rising and it is necessary to 
educate pharmacists to reflect this with skills in-patient counseling.  
 Theme: The changes wrought by the new Pharm.D. required extensive debate 
about and changes in pharmacy curriculum and instruction. 
 Theme: The Commission to Implement Change did not approach this 
conversation from the standpoint of whose material was going to be deleted. It was far 
more concerned with how the program could obtain what was needed or a curriculum 
to reflect the nature of the practice of the profession, and to do this in a reasonable 
period of time.  
 Theme: The combination of new requirements in content and knowledge for the 
Pharm.D. as well as necessity of background understanding of science has led some 
schools to institute a pre-pharmacy program requirement of up to three years.  
 Theme: One result of institutions being required to bring in additional qualified 
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people to implement the revised programs has been a rise in tuition.  
 Theme: Not one grand scheme, template, or module exists to follow. A formal, 
strategic plan was not developed to assist institutions through this paramount change 
process. 
 Research Question 1b 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on: 
  
 b. the delivery of service? 
  Seventh pattern: The success of the transition from product-based to 
patient-based pharmaceutical care is inconsistent throughout the U.S. healthcare 
system.   
 Theme: With the introduction of the Pharm.D., the role for the new clinically 
trained pharmacist expanded rapidly in hospital settings. 
 Theme: The advancements in the delivery of services and the scope of practice 
are dependent on geographic location. 
 Theme: State regulations regarding the scope of practice of pharmacy are 
widely varied throughout the country and have a direct impact on the delivery of 
services. 
 Theme: There appears to be a relationship between licensure, state 
governments, and the protection of salaries. 
 Theme: One issue that makes pharmacy unique is that it is the only profession 
in which two sets of licenses are required: the practitioner who has the license and the 
space or facility in which the pharmacist works.  
 Eighth pattern: Finances play a major role in changing pharmaceutical 
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practice.  
 Theme: A primary player is the pharmaceutical industry. 
 Theme: The business model of the chain drugstores limits the roles and 
responsibilities of pharmacists in practice.  
 Theme: In the attempt to modernize the pharmacy practice from a product-
oriented to a patient-oriented profession, one concern was how pharmacists were going 
to get paid for the advanced services. 
 Theme: A limiting factor is that an organized system for compensation for 
services has not been established. 
 Theme: The current third-party reimbursement model does not provide 
incentives for pharmaceutical care. 
 Research Question 1c 
 What are the benefits, risks, and alternatives of the elevation of requirements 
 to an entry-level doctorate degree on:  
  
 c. the interdisciplinary relationship of practicing physicians? 
  
 Ninth pattern: Professionals in the U.S. healthcare system are strongly 
resistant to change and seek evidence-based research that a change is necessary. 
With respect to how the other fields responded to the changes happening in 
pharmacy, evidence is growing that an interprofessional, team-based approach to 
patient care is the best-practice model.  
  Theme: The pharmacy profession did not have a strategic plan to inform the 
other stakeholders; however, there is a slow but continual acceptance of the abilities of 
the pharmacist. 
  Theme: There is a trend in the healthcare delivery system toward a 
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collaborative care model. 
 Theme: Many respondents have confidence that physicians will rely more and 
more on the information from the pharmacist. 
 Theme: The changing landscape in healthcare required a team-based approach 
and the pharmacist was the best professional to manage the drug therapy. 
 Tenth pattern: Most patients need drug therapy and many physicians, 
nurses, and other health professionals are recognizing that there is somebody on the 
team who has expertise about medication therapy and not diagnosis. Understanding 
the complementary competencies and skill sets of each individual on the 
interdisciplinary team needs to occur at the educational level. 
 Theme: Pharmacists lack the skills in physical assessment that are necessary 
for patient diagnosis but are experts on the drug management of disease.  
 Theme: One way to change the face of a profession is to educate health 
professionals together, in a collaborative environment. 
 Theme: There are more opportunities for the disciplines to be educated 
together.  
 Research Question 1d 
 What are the benefits, risks, and alternatives of the elevation of 
 requirements to an entry-level doctorate degree on: 
   
 d. societal and economic landscape of the health care industry (cost-benefit)? 
 
 Eleventh pattern: The Pharm.D. has resulted in a gradual change in the 
practice and professionalization of pharmacy and the concomitant views of society. 
 Theme: One of the underlying reasons for the transition to the Pharm.D. was 
that pharmacists wanted more responsibility, but there is a difference between 
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increased responsibility and autonomy. 
 Theme: Pharmaceutical care services cannot be forced upon the public, but 
take a slow, steady change in perceptions and expectations of individual patients. 
 Theme: When opportunities are present for pharmacists to practice to their 
fullest potential, society will benefit as a whole.  
  Theme: Opportunities to practice pharmaceutical care are still in their infancy. 
 Theme: The pharmacy profession, as a whole, has not been proactive in public 
relations. The health literacy of an individual seemed to be directly related to personal 
interaction with a pharmacist.  
 Research Question 2 
 What is the transferability of an entry-level clinical doctorate related to 
 professional opportunities? 
 
 Twelfth pattern: The Doctor of Pharmacy is well prepared for a larger area 
of professional practice and related careers, such as the pharmaceutical industry 
and prescription development.  
 Theme: Opportunities are expanding in hospital and community settings. 
 Theme: Pharmacy is a huge industry and Pharm.D.s are highly sought today 
throughout the field. 
 Thirteenth pattern: There were external forces behind the progression of the 
clinical doctorate in pharmacy and other professions that are contemplating the 
transition may want to address these factors.  
  Theme: The respondents perceive this transition to be successful in pharmacy 
because all stakeholders were involved.  
 Theme: The respondents agreed that other professions might want to take time 
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to learn this process, because this process has worked well for pharmacy.   
 Theme: If the various stakeholders in the educational institutions successfully 
implement change in the educational requirements, the graduates of the Pharm.D. 
programs will have a ripple effect through the rest of society due to their upgraded 
capabilities and professional practice. 
 Theme: It is important for a profession to articulate clearly what the difference 
will be when the professional doctorate program is implemented and how that will 
translate to better outcomes for patients. 
 Theme: The intention of the profession to transition to the practicing doctorate 
should be to establish a role as part of a collaborative team with other healthcare 
professionals, not increase the professional autonomy.   
 Fourteenth pattern: The biggest surprise from the establishment of the 
Pharm.D. as the sole entry-level degree has been the unexpected rise in pharmacy 
schools.  
 Theme: During the transition period, leaders thought that this educational 
change would decrease the number of applicants. This turned out not to be true. 
 Theme: In addition to the increased number of schools, the class size has grown 
as well. 
 Theme: There was the perception of uncertainty regarding the quality of some 
of the new schools and new programs within existing schools that have been started in 
the past 20 years.   
 Theme: The largest increase of new programs has been in private schools, 
many without the established culture of doctoral or health professions education. 
 Fifteenth pattern: The conversation about redefining the pharmacy 
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profession is happening on a global scale. 
 Theme: Understanding the culture of a country and how that shapes the 
response to a major change effort is vital to professional change. 
 Theme: On a global scale, the Pharm.D. is not equivalent around the world. 
The ACPE has opened several international initiatives and dialogue opportunities. 
Additional Findings 
 Sixteenth pattern: The Pharm.D. must rely on the pharmacy technician in 
the dispensing role in order to have time for patient care.  
 TTheme: The role of the pharmacy technician has created huge internal 
conflict for many years, and this continues to this day. 
 Theme: The profession needs to get technicians licensed, but the idea of 
accomplishing this in this country will require a daunting political battle. 
 Seventeenth pattern: Location, age, and patient compliance affect access to 
and quality of healthcare.  
 Theme: One of the surprises has been the rather quick movement of 
pharmacists out of the inner cities. 
 Theme: One out of every five Medicare patients ends up in the hospital because 
they do not take their medications correctly. 
 
 
 
 
 
 
 
   
 
